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Instead	of	a	dedication	
Toute	la	joie	silencieuse	de	Sisyphe	est	là.	Son	destin	lui	appartient.	Son	rocher	est	sa	chose.	
De	même,	 l'homme	absurde,	quand	il	contemple	son	tourment,	fait	taire	toutes	 les	 idoles.	
Dans	 l'univers	 soudain	 rendu	 à	 son	 silence,	 les	mille	 petites	 voix	 émerveillées	 de	 la	 terre	
s'élèvent.	 Appels	 inconscients	 et	 secrets,	 invitations	 de	 tous	 les	 visages,	 ils	 sont	 l'envers	
nécessaire	et	le	prix	de	la	victoire.	Il	n'y	a	pas	de	soleil	sans	ombre,	et	il	faut	connaître	la	nuit.	
L'homme	absurde	dit	oui	et	son	effort	n'aura	plus	de	cesse.	S'il	y	a	un	destin	personnel,	il	n'y	
a	point	de	destinée	supérieure	ou	du	moins	il	n'en	est	qu'une	dont	il	juge	qu'elle	est	fatale	et	
méprisable.	Pour	le	reste,	il	se	sait	le	maître	de	ses	jours.	À	cet	instant	subtil	où	l'homme	se	
retour-	ne	sur	sa	vie,	Sisyphe,	revenant	vers	son	rocher,	contemple	cette	suite	d'actions	sans	
lien	qui	devient	son	destin,	créé	par	lui,	uni	sous	le	regard	de	sa	mémoire,	et	bientôt	scellé	par	
sa	mort.	Ainsi,	persuadé	de	 l'origine	 tout	humaine	de	 tout	 ce	qui	est	humain,	aveugle	qui	
désire	voir	et	qui	sait	que	 la	nuit	n'a	pas	de	 fin,	 il	est	 toujours	en	marche.	Le	rocher	roule	
encore.	
Je	 laisse	Sisyphe	au	bas	de,	 la	montagne!	On	 retrouve	 toujours	 son	 fardeau.	Mais	Sisyphe	
enseigne	la	fidélité́	supérieure	qui	nie	les	dieux	et	soulevé	les	rochers.	Lui	aussi	juge	que	tout	
est	bien.	Cet	univers	désormais	sans	maître	ne	lui	paraît	ni	stérile	ni	futile.	Chacun	des	grains	
de	cette	pierre,	chaque	éclat	minéral	de	cette	montagne	pleine	de	nuit,	à	lui	seul,	forme	un	
monde.	 La	 lutte	 elle-même	 vers	 les	 sommets	 suffit	 à	 remplir	 un	 cœur	 d'homme.		
Il	faut	imaginer	Sisyphe	heureux.	
(Camus,	1942)	
	
	
	
	
All	 Sisyphus’	 silent	 joy	 is	 contained	 therein.	 His	 fate	 belongs	 to	 him.	His	 rock	 is	 his	 thing.	
Likewise,	 the	absurd	man,	when	he	contemplates	his	 torment,	silences	all	 the	 idols.	 In	the	
universe	suddenly	restored	to	its	silence,	the	myriad	wondering	little	voices	of	the	earth	rise	
up.	Unconscious,	secret	calls,	invitations	from	all	the	faces,	they	are	the	necessary	reverse	and	
price	of	victory.	There	is	no	sun	without	shadow,	and	it	 is	essential	to	know	the	night.	The	
absurd	man	says	yes	and	his	effort	will	henceforth	be	unceasing.	If	there	is	a	personal	fate,	
there	is	no	higher	destiny,	or	at	least	there	is	but	one	which	he	concludes	is	inevitable	and	
despicable.	For	the	rest,	he	knows	himself	to	be	the	master	of	his	days.	At	that	subtle	moment	
when	man	glances	backward	over	his	 life,	Sisyphus	returning	toward	his	rock,	 in	that	slight	
pivoting	he	contemplates	that	series	of	unrelated	actions	which	becomes	his	fate,	created	by	
him,	combined	under	his	memory’s	eye	and	soon	sealed	by	his	death.	Thus,	convinced	of	the	
wholly	human	origin	of	all	that	is	human,	a	blind	man	eager	to	see	who	knows	that	the	night	
has	no	end,	he	is	still	on	the	go.	The	rock	is	still	rolling.	
I	 leave	 Sisyphus	 at	 the	 foot	 of	 the	 mountain!	 One	 always	 finds	 one’s	 burden	 again.	 But	
Sisyphus	teaches	the	higher	fidelity	that	negates	the	gods	and	raises	rocks.	He	too	concludes	
that	all	 is	well.	This	universe	henceforth	without	a	master	seems	to	him	neither	sterile	nor	
futile.	Each	atom	of	that	stone,	each	mineral	flake	of	that	night-filled	mountain,	in	itself	forms	
a	world.	The	struggle	itself	toward	the	heights	is	enough	to	fill	a	man’s	heart.	
One	must	imagine	Sisyphus	happy.	
	 III	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
“Jojo,	wenn	du	die	Chaosarmee	jetzt	nicht	umbringst,	dann	ist	die	am	Ende	ja	
gar	nicht	tot?!“	-	T.	Ahlich	(2015)	
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Thesis	abstract	
Novel	ways	to	produce	bilayered	chromatography	adsorbent	media	featuring	a	functionalised	
core	surrounded	by	an	inert	size	exclusion	layer	for	nanoplex	purification	were	explored.	
Surface	 functionalisation	 of	 anion	 exchange	 chromatography	 media	 via	 cold	 atmospheric	
pressure	plasma	etching	and	oxidation	was	investigated.	Both,	a	dielectric	barrier	discharge	
plasma	generation	system	and	a	 fluidised	bed	underwater	reactor	produced	bead	samples	
with	significantly	reduced	surface	binding,	while	maintaining	their	core	binding	capacities.		
A	 3D	 visualisation	 method,	 allowing	 the	 study	 of	 the	 binding	 topography	 of	 the	 spatial	
distribution	of	pDNA	and	BSA	adhered	to	Q	ligands	within	particles	was	developed.	This	CLSM	
method	 revealed	 imperfections	on	 the	 surface	of	 adsorbents,	providing	additional	binding	
sites	for	pDNA	due	to	micro	crevices.	
Implementing	 beads	 with	 a	 more	 homogenous	 surface,	 restricted	 access	 media	 were	
produced	via	an	AGE	activation-partial	bromination	method.	The	thickness	and	homogeneity	
of	the	size	exclusion	layer	was	controlled	via	viscosity	enhanced	reaction	diffusion	balancing,	
yielding	a	distinct	layer	devoid	of	ligands.	The	particles	did	not	show	residual	pDNA	binding	
and	selectivity	of	core	vs	surface	binding	increased	by	100-fold	cf.	previous	studies.	
The	commercial	adsorbent	Capto	Core	700	was	successfully	implemented	as	a	first	capture	
step	for	pDNA	purification	from	crude	E.coli	lysates.	
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Chapter	1 Introduction	
1.1.	Gene	therapy	and	DNA	vaccination	
It	is	within	the	authors	awareness	that	the	following	section	concerning	gene	therapy	is	not	
directly	 interconnected	 with	 subsequent	 parts	 of	 this	 thesis,	 focussing	 on	 the	 practical	
implementation	of	a	DSP	unit	operation	for	nanoplex	purification.	However,	as	nanoplex	of	
choice	throughout	the	study	pDNA	was	chosen.	
It	 is	 hence	 desired	 to	 give	 the	 reader	 an	 introductory	 overview	 over	 a	 promising	 field	 of	
application.	
1.1.1.	Overview	
In	 medical	 terms,	 human	 gene	 therapy	 has	 been	 defined	 as	 the	 precise	 and	 intentional	
delivery	of	therapeutic	genetic	material	into	a	patient’s	cells	as	a	drug	to	treat	disease.	
Its	impact	on	human	healthcare	in	the	future	is	promising	and	expected	to	offer	a	plethora	of	
therapeutic	options	for	treating	and	improving	control	over	cancer	and	several	devastating	
medical	conditions	(Kay,	2011).	
Gene	therapy	as	a	way	to	cure	genetic	defects	by	replacing	defective	DNA	with	‘exogenous	
good	DNA’	was	first	conceptualised	in	the	1960s	and	early	1970s	(Friedmann	et	al.,	1972).	The	
first	 approved	 successful	 gene	 therapy	 in	 human	 was	 conducted	 in	 1990,	 when	 Ashanti	
DeSilva	was	 treated	 for	 severe	 combined	 immunodeficiency	disorder.	 The	4-year-old	 girls’	
immune	system	could	be	partially	restored	using	ex	vivo	gene	transfer	of	a	healthy	adenosine	
deaminase	gene	copy	into	T-cells	followed	by	reinjection	of	the	altered	cells	into	her	blood	
stream	(Anderson,	1990;	Rosenberg	et	al.,	1990).		
This	 and	 other	 early	 breakthroughs	 sparked	 scientific	 enthusiasm	 for	 gene	 therapy	 and	
conceptually	similar	pDNA	vaccination	using	viral	vectors	as	delivery	vehicles.	In	1999,	Jesse	
Gelsinger	died	of	an	 immune	rejection	 response	caused	by	viral	vector	associated	 toxicity,	
while	participating	in	a	clinical	trial	of	a	viral	gene	therapy	agent	designed	to	treat	ornithine	
transcarbamylase	deficiency.	This	incident	tempered	the	rapid	development	of	gene	therapies	
and	raised	interest	in	non-viral	vectors	as	potentially	safer	options,	for	gene	delivery	(Glover	
et	al.,	2005;	Wilson,	2009). 
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Despite	 the	 sorrowful	 1999	 setback,	 from	 1989	 to	 2018,	 more	 than	 2800	 clinical	 trials	
associated	with	gene	 therapy	were	conducted	 (Edelstein,	2018)	and	 in	2003	 the	 first	gene	
therapy	 product	 “Gendicine“	was	 approved	 for	 clinical	 use	 in	 humans.	 It	 is	 a	 cancer	 gene	
therapy	delivering	 the	 tumor	 suppressor	 gene	p53	 via	 a	 recombinant	 adenovirus	 and	was	
approved	by	the	Chinese	Food	and	Drug	Administration	for	the	treatment	of	squamous	cell	
carcinoma	(Pearson	et	al.,	2004;	Wilson,	2005).	The	first	gene	therapy	treatment	receiving	
approval	 in	 the	 Western	 World	 by	 the	 European	 Medicines	 Agency	 (EMA)	 was	 Glybera,	
designed	for	reversion	of	 lipoprotein	 lipase	deficiency	(uniQure,	2012).	Recently,	 in	August	
2017,	 the	US	Food	and	Drug	Administration	 (FDA)	approved	 the	 first	 form	of	human	gene	
therapy	in	the	US-	Tisagenlecleucel	(marketed	as	Kymriah)	is	an	adaptive	ex-vivo	T-cell	therapy	
(viral	delivery)	for	B-cell	acute	lymphoblastic	leukaemia	(FDA,	2017b).	
		
Generally,	 gene	 therapy	 aims	 to	 cure	 genetic	 disorders,	 caused	 by	mutations	 in	 the	 gene	
sequence	 that	 if	 left	 uncorrected	 cause	 expression	 of	 ill	 phenotypes.	 These	 can	 either	 be	
hereditary	in	nature	or	caused	by	new	mutations	in	the	hosts	gDNA.		
These	genetic	defects	can	be	repaired	by	making	 functional	genes	available	to	the	cells	by	
either:	(i)	replacing	the	mutated	gene	with	a	working	copy	(replacement	therapy);	(ii)	addition	
of	 a	 working	 copy	 (supplement	 therapy);	 or	 (iii)	 inactivation	 of	 the	 malfunctioning	 gene	
(‘knock-out’)	(Yang	et	al.,	1996).		
In	general,	gene	therapy	could	be	applied	to	all	human	cell	types	(Parker	et	al.,	2003).	Yet,	
somatic	(non-reproductive)	cells	are	generally	safer	than	germ-line	cells,	due	to	their	inability	
	
Figure	1-1	Gene	therapy	clinical	trials	worldwide	in	various	development	stages	from	1989	to	2018	
(Edelstein,	2018)	
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to	pass	genomic	alterations	on	to	future	generations,	therefore	limiting	potential	off-target	
effects	to	the	treated	individual	rather	than	its	offspring.	
	
For	the	delivery	of	therapeutic	genetic	material,	scientists	have	explored	two	different	types	
of	strategies:	‘ex	vivo’	and	‘in	vivo’	(Figure	1-2).	In	the	ex	vivo	route	of	administration	cells	are	
extracted	either	from	the	patient	(autologous)	or	from	a	different	host	(allogenic),	transduced	
with	 the	 therapeutic	 genetic	 material,	 optionally	 multiplied	 in	 a	 laboratory	 and	 (re-)	
administered	to	the	patient.	Modifying	cells	outside	the	human	body	is	generally	preferred	as	
it	 allows	 for	harsh	 transfection	 conditions	 (e.g.	 electroporation	etc.)	 to	be	used	and	 limits	
genetic	alteration	to	the	target	cell	population.	However,	these	techniques	are	limited	to	cells	
amenable	to	surgical	removal	and	re-administration	(i.e.	blood	cells,	skin	cells)	and	often	fail	
for	 cell	 types	 requiring	 embedding	 in	 intricate	 functional	 networks	 for	 their	 function	 (i.e.	
neurons).	 In	 contrast,	 in	 vivo	 techniques	work	 by	 directly	 injecting	 carriers	 of	 therapeutic	
genetic	material	into	the	body.	
	 	
	
Figure	1-2	Ways	genetic	material	can	be	administered	to	the	human	body	for	gene	therapy;	(image	
retrieved	from	(Kaushansky	et	al.,	2016))	
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1.1.2.	Gene	delivery	systems	
Common	for	most	different	ways	to	introduce	therapeutic	genes	into	patients,	the	success	of	
gene	 therapy	 as	 a	 therapeutic	 treatment	of	 diseases	 remains	 a	 delivery	 challenge	 to	date	
(Gonçalves	et	al.,	2017).	Ideally,	delivery	of	exogenous	DNA	is	cell	type	specific	and	provides	
a	precise	amount	of	genetic	material	being	delivered	to	each	cell,	allowing	for	gene	expression	
but	 avoiding	 toxicity	 (Mali,	 2013).	 Further,	 the	 ideal	 gene	 delivery	 vehicle	 accommodates	
foreign	DNA	of	sufficient	size	for	the	target	application,	achieves	ample	levels	of	long-lasting	
transgene	expression	and	is	non-immunogenic	(Gardlik	et	al.,	2005;	Shillitoe,	2009).	
The	plethora	of	gene	delivery	approaches	can	be	divided	into	three	main	categories,	non-viral	
delivery	strategies	such	as	(i)	physical	methods	and	(ii)	chemical	carriers	as	well	as	(iii)	viral	
vector	 based	 strategies	 (i.e.	 gene	 transfer	 via	 viral	 vectors	 is	 called	 transduction	 cf.	
transfection	for	non-viral	vectors	(Biceroglu	et	al.,	2005;	Ramamoorth	et	al.,	2015).	
1.1.3.	Non-viral	delivery	strategies	
Poor	 toxicological	 profiles	 associated	with	 viral	 vectors	 have	 sparked	 interest	 in	 non-viral	
vectors	in	clinical	gene	therapy	(Akhtar,	2005).	Other	incentives	for	non-viral	vector	delivery	
techniques	are	mainly	associated	with	the	lack	of	immune	responses,	as	well	as	comparatively	
easy	manufacturing	and	assembly	(Merdan	et	al.,	2002).		
In	depth	discussion	about	non-viral	delivery	vectors	for	gene	therapy,	highlighting	advantages	
and	disadvantages	of	each	technique	are	plentiful	in	the	literature,	the	following	paragraphs	
hence	aim	to	provide	a	brief	overview	over	the	most	commonly	applied	methods	(Parker	et	
al.,	2003;	Patil	et	al.,	2005;	Mali,	2013;	Ramamoorth	et	al.,	2015;	Altwaijry	et	al.,	2018).	
Physical	methods	employ	physical	force	to	introduce	genetic	material	into	cells,	by	countering	
the	membrane	barrier.		
Initially	the	use	of	naked	plasmid	DNA	for	systemic	gene	delivery	was	discarded	as	unrealistic	
due	to	rapid	DNA	degradation	by	endogenous	nucleases.	However,	direct	injection	of	pDNA	
into	a	patient’s	blood	stream	constitutes	the	simplest	way	to	introduce	genetic	material	to	
host	cells	(Parker	et	al.,	2003).	Needle	injections	of	naked	pDNA	have	been	employed	for	gene	
therapy	applications	in	tissues	such	as	muscle,	skin,	liver	and	solid	tumours,	however,	rapid	
degradation	by	endonucleases	yield	very	low	efficiencies.		
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Particle	bombardment	(i.e.	gene	gun)	aims	to	deliver	DNA	coated	heavy	metal	particles	with	
the	aid	of	high	 velocity.	 The	necessary	 speed	 is	 hereby	evoked	 via	high	 voltage	electronic	
discharges,	gas	pressure	discharge	or	spark	discharges	(Al-Dosari	et	al.,	2009;	Aravindaram	et	
al.,	2009).	
Electroporation	utilises	an	electrostatic	field	causing	an	electric	potential	difference	greater	
than	 the	 trans-membrane	 pressure	 of	 the	 cell,	 leading	 to	 transient	 breakdown	 of	 the	
membrane.	The	formation	of	pores	allows	genetic	material	to	be	incorporated	into	the	cell	
before	it	regenerates	(reversible).	Irreversible	electroporation	uses	high	power	electric	fields	
to	permanently	disrupt	cell	membranes.	The	technique	has	been	successfully	used	in	cancer	
treatment	for	destroying	cancer	cells	via	electroporation	or	utilising	the	created	pores	as	an	
entry	point	for	gene	delivery	(Au	et	al.,	2013;	Deipolyi	et	al.,	2014).	The	method	has	emerged	
as	a	reliable	tool	for	pDNA	delivery	intradermally,	intratumoural,	intramuscularly,	as	well	as	
‘ex	vivo’	(Regnier	et	al.,	2000;	Zhang	et	al.,	2002;	Shirley	et	al.,	2014).	
In	 sonoporation,	 genetic	material	 is	 incorporated	 into	micro-bubbles	 and	 administered	 to	
patients.	Subsequent	application	of	ultrasound	waves	cause	localised,	temporary	permeability	
of	 the	cell	membrane	via	cavitation,	allowing	uptake	of	genetic	material	 in	close	proximity	
(Newman	et	al.,	2007).	
Delivery	 via	 the	use	of	 photoporation	 is	 in	 concept	 similar	 to	 electroporation.	 Single	 laser	
pulses	 shoot	 holes	 into	 cell	 membranes	 leading	 to	 uptake	 of	 genetic	 material	 through	
transient	 pores.	 The	 technique	 is	 still	 in	 an	 early	 experimental	 stage,	 lacking	 documented	
clinical	application	(Li	et	al.,	2007;	Ramamoorth	et	al.,	2015).	
Magnetofection	couples	therapeutic	genes	to	magnetic	nanoparticles	which	can	be	kept	at	
the	 target	 site	 via	 strong	 external	 magnets.	 Following	 enzymatic	 cleavage	 of	 crosslinking	
molecules	in	the	complex,	DNA	molecules	are	released.	The	technique	mostly	finds	application	
‘in	 vitro’	 (Dobson,	 2006).	 Other	 physical	 methods	 include	 hydroporation	 and	 mechanical	
massage	(Herweijer	et	al.,	2007;	Su	et	al.,	2012)	
In	contrast	 to	physical	 transfection	methods,	 chemical	 transfection	 introduces	 the	gene	of	
interest	via	the	use	of	inorganic	particles	or	lipid-,	polymer-	or	peptide-based	vectors	(Su	et	
al.,	2012).	Among	other	inorganic	particles,	the	use	of	calcium	phosphate,	calcium	chloride,	
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silica,	gold,	magnetic	compounds	and	fullerenes	are	the	most	applied	methods	(Al-Dosari	et	
al.,	2009;	Mali,	2013).	
Most	chemical	vectors	condense	DNA	via	electrostatic	interactions,	protecting	the	molecule	
from	nucleases	of	the	host,	while	DNA	complexation	reduces	the	charge	repulsion	of	the	cell	
membrane	and	DNA,	aiding	delivery	into	the	cells	(McCrudden	et	al.,	2013).	Non-viral	vectors	
can	complex	large	DNA	molecules	in	addition	to	targeting	of	specific	tissues	due	to	the	use	of	
targeting	ligands	(Altwaijry	et	al.,	2018).		
Liposomes	as	a	chemical	formulation	comprise	of	a	phospholipid	bilayer,	forming	a	spherical	
vesicle	 around	 the	 genetic	 material	 (Allen,	 1997).	 Cationic	 lipids	 bind	 strongly	 to	 DNA	
molecules	encapsulated	inside,	providing	protection	against	nuclease	degradation	(lipoplex).	
The	positive	net	charge	of	the	 liposome	aids	transport	of	the	pDNA	product	to	target	cells	
through	the	blood	stream	(Gregoriadis	et	al.,	2000).	
	
The	internalization	mechanism	of	lipoplexes	is	thought	to	be	mediated	by	endocytosis	(Figure	
1-3).	Although	the	majority	of	endosomes	fuse	with	lysosomes	degrading	the	DNA,	some	will	
be	released	into	the	cytoplasm	where	they	can	travel	to	and	fuse	with	the	nucleus,	culminating	
in	 gene	 expression	 (Parker	 et	 al.,	 2003).	 Linking	 neutral	 colipids	 such	 as	
dioleoylphosphatidylethanolamine	 (DOPE)	 or	 cholesterol	 to	 the	 liposomes	 improves	
	
Figure	1-3	Lipoplex-mediated	transfection	and	endocytosis	(Parker	et	al.,	2003)	
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transfection	through	the	cell	membrane	by	promoting	endosomal	escape	and	release	of	pDNA	
into	the	cytoplasm	(Fasbender	et	al.,	1997).		
Polymersomes	are	synthetic	versions	of	liposomes,	made	of	amphiphilic	copolymers	(Figure	
1-4).	Polycationic	polymers	readily	complex	pDNA	molecules,	condensing	them	in	the	process	
due	to	their	high	avidity	(Brenner	et	al.,	2014).	Several	different	copolymers	have	been	used	
to	form	nanoparticle-DNA	complexes,	with	polylysine	and	polyethylenimine	being	the	most	
significant	candidates	(Cherng	et	al.,	1999).	Similar	to	the	protection	granted	by	liposomes,	
polymerosomes	 protect	 the	 enclosed	 NA	 against	 degradation	 until	 its	 release	 into	 the	
cytoplasm.	However,	delivery	via	synthetic	polymers	offers	several	advantages	over	liposome	
formulations	 such	 as	 enhanced	 mechanical	 strength,	 plasmid	 storage	 capacity	 and	 blood	
circulation	time	(Krishnamoorthy	et	al.,	2014;	Yin	et	al.,	2014).	However,	both	lipids	as	well	as	
cationic	polymers	show	inherent	toxicity	to	the	host,	limiting	applicable	dosage	sizes	(Lv	et	al.,	
2006).	
	
	
Figure	1-4	Intracellular	gene	delivery	mediated	by	a	polymeric	gene	carrier;	therapeutic	nucleic	acid	is	
mixed	with	a	cationic	polymers	to	form	polyplex	particles	which	can	enter	target	cells	by	endocytosis;	major	
processes	include	electrostatic	interactions	(A),	cellular	internalization	(B),	endosomal	escape	(C),	nuclear	
translocation	(D)	and	polyplex	dissociation	(E)	(image	adapted	from	(Lai	et	al.,	2018)) 
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1.1.4.	Viral	delivery	vectors	
Recombinant,	replication-defective	viral	vectors	were	the	first	molecular	tools	used	to	enable	
efficient,	nontoxic	gene	transfer	into	human	somatic	cells	(Kotterman	et	al.,	2015)	
Despite	recent	advances	made	in	the	development	of	non-viral	based	strategies,	viral	vectors	
are	still	by	far	the	most	commonly	used	delivery	methods	in	clinical	trials	(Figure	1-5)	(Ginn	et	
al.,	2018).	Selection	of	viral	system	of	choice	is	typically	based	on	safety	considerations,	target	
cell	specificity	and	availability	of	permissive	cells	(Wu	et	al.,	2000).		
	
Gene	delivery	via	viral	vectors	has	several	advantages	over	chemical	and	physical	methods,	
such	 as	 high	 transduction	 efficiency	 and	 targeting	 precision	 in	 vivo	 (Selvam	 et	 al.,	 2006).	
Furthermore,	physical	and	chemical	methods	demand	repeated	dosage	applications,	whereas	
fewer	(single)	administrations	may	be	sufficient	for	viral	delivery	methods	(Xi	et	al.,	2003).		
The	 main	 disadvantages	 for	 the	 application	 of	 viral	 vectors	 as	 gene	 delivery	 vehicles	 are	
associated	 with	 safety	 concerns	 (immunogenicity	 and	 insertional	 mutagenesis),	 size	
limitations	 for	 therapeutic	 DNA	 constructs,	 as	 well	 as	 manufacture	 and	 quality	 control	
(Phillips,	2001).	
Among	other	criteria	for	categorisation,	viral	delivery	can	be	divided	into	(i)	integrating	and	
(ii)	non-	integrating	viral	vectors.		
	
Figure	1-5	Gene	therapy	vectors	currently	used	in	clinical	trials	(data	retrieved	from	the	Journal	of	Gene	
Medicine;	http://www.abedia.com/wiley/vectors.php;	last	modified	August	2018;	accessed	December	
2018)	
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In	 order	 to	 replicate,	 viruses	 introduce	 their	 genetic	 material	 into	 (human)	 host	 cells	 by	
tricking	its	cellular	machinery	to	use	the	viral	genome	as	a	blueprint	for	replication.	Integrating	
viruses	hereby	insert	their	genome	at	a	specific	spot	in	the	genome.	Scientists	have	utilised	
this	 property	 by	 altering	 viruses	 to	 transduce	 therapeutic	 genes	 instead	 of	 their	 own.	
Elimination	of	 obligate	 viral	 genes	 has	 led	 to	 replication	deficient	 viruses	 causing	 reduced	
biosafety	concerns	as	they	require	complementation	of	helper	genes	for	successful	replication	
only	possible	in	laboratory	environment.	(Mali,	2013).	Among	other	integrating	viral	vectors,	
retroviruses	 (such	 as	 lentiviruses),	 and	 adeno-associated-virus	 have	 shown	 the	 most	
promising	transduction	results	in	clinical	trials	(Verma,	2013;	Yin	et	al.,	2017).	
Retroviruses	 can	 either	 be	 replication-competent	 or	 replication-defective.	 The	 biggest	
limitations	for	the	use	of	retroviruses	as	gene	delivery	vehicles	are	the	limited	size	of	the	gene	
insert	they	can	accommodate	(between	8-10	kbp	for	replication	defective	retroviruses),	and	
the	 requirement	 for	 cells	 to	be	 actively	 dividing	 for	 transduction	 (Coffin	 et	 al.,	 1997).	 The	
theoretical	fear	of	insertional	mutagenesis	causing	leukaemia	or	cancer	became	reality	when	
20%	 of	 patients	 involved	 in	 a	 gene	 therapy	 clinical	 trial	 aiming	 to	 treat	 X-linked	 severe	
combined	 immunodeficiency,	 using	 a	 retroviral	 formulation	 in	 2002,	 developed	 leukaemia	
(Hacein-Bey-Abina	et	al.,	2002).	
Adeno-associated	 virus	 is	 a	 small	 virus	 causing	 only	 a	 mild	 immune	 response	 in	 human	
patients	and	is	generally	seen	as	non-pathogenic.	It	can	infect	both,	dividing	and	non-dividing	
cells,	leading	to	long	and	stable	gene	expression	(Nussbaum	et	al.,	2015).	These	features	make	
adeno-associated	viruses	attractive	candidates	for	gene	delivery,	however,	size	limitations	of	
the	gene	insert	(up	to	5	kbp)	severely	hamper	their	application	potential.	
Among	 the	 group	 of	 non-integrating	 viral	 vectors,	 adenovirus	 is	 the	most	widely	 studied.	
Following	infection,	the	adenoviral	genome	remains	in	the	nucleus	without	integrating	into	
chromosomal	DNA.	In	most	tissue	types	the	duration	of	transgene	expression	is	limited	as	the	
effects	are	prone	to	disappear	after	cell	division	(transient	gene	expression).	
Table	1-1	compares	the	most	important	viral	delivery	vectors	and	non-viral	delivery	strategies,	
highlighting	their	advantages	and	restrictions	(Mountain,	2000;	Dunbar	et	al.,	2018).	
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Table	1-1	Advantages	and	disadvantages	of	different	gene	delivery	vectors	(adapted	from	(Mountain,	2000))	
Vector	 Advantages	 Disadvantages	
Adenovirus		 Very	high	transfection	efficiency	ex	vivo	
and	in	vivo		
Transfects	proliferating	and	non-
proliferating	cells		
Substantial	clinical	experience	acquired 	
Efficient	retargeted	transfection	
demonstrated	
Repeat	dosing	ineffective	owing	to	strong	
immune	responses		
Insert-size	limit	of	7.5	kb 	
Manufacture,	storage,	quality	control	(QC)	are	
moderately	difficult		
Short	duration	of	expression		
Retrovirus	 Fairly	prolonged	expression	
High	transfection	efficiency	ex	vivo	
Substantial	clinical	experience	ex	vivo	
Low	immunogenicity		
Low	transfection	efficiency	in	vivo 	
Insert-size	limit	of	8	kb 	
Transfects	only	proliferating	cells 	
Safety	concern	of	insertional	mutagenesis	
Manufacture,	storage,	QC	are	extremely	
difficult		
Lentivirus	 Transfects	proliferating	and	non-
proliferating	cells		
Transfects	haematopoietic	stem	cells		
Safety	concerns	from	immunodeficiency	virus	
origins		
Manufacturing,	storage,	QC	are	extremely	
difficult		
Insert-size	limit	of	8	kb 	
No	clinical	experience		
AAV	 Efficiently	transfects	a	wide	variety	of	
cells	in	vivo	
Very	prolonged	expression	in	vivo 	
Low	immunogenicity		
Insert-size	limit	of	4.5	kb 	
Manufacture,	QC	are	very	difficult 	
Little	clinical	experience 	
Safety	concern	of	insertional	mutagenesis	
Repeat	dosing	affected	by	neutralizing	antibody		
responses		
Naked	pDNA	 Manufacturing,	storage,	QC	are	simple	
and	cheap		
Very	low	immunogenicity 	
Clinical	efficacy	demonstrated	in	critical	
limb	ischaemia 	
Very	good	safety	profile		
Very	short	duration	of	expression	in	most	
tissues		
Very	inefficient	transfection	ex	vivo	and	in	vivo	
Retargeting	transfection	very	difficult		
Cationic	lipids	 Relatively	simple	manufacturing,	
storage,	QC		
Efficient	transfection	ex	vivo 	
Low	immunogenicity 	
Good	safety	profile		
Inefficient	transfection	in	vivo		
Very	short	duration	of	expression		
Little	clinical	experience		
Retargeting	transfection	difficult		
Condensed	
DNA	particles	
Relatively	simple	manufacturing,	
storage,	QC		
Efficient	transfection	ex	vivo 	
Low	immunogenicity 	
Good	safety	profile		
Retargeted	transfection	demonstrated		
Inefficient	transfection	in	vivo		
Very	short	duration	of	expression		
No	clinical	experience		
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1.1.5.	DNA	vaccination	
In	 addition	 to	 treating	 diseases,	 plasmids	 can	 be	 used	 as	 DNA	 vaccines	 for	 genetic	
immunization	against	several	ailments.	Vaccines	have	changed	the	quality	and	span	of	human	
life	 since	 their	 discovery	 and	 many	 diseases	 such	 as	 polio	 and	 tuberculosis	 have	 been	
eradicated	 in	the	western	world,	due	to	the	availability	of	respective	vaccines.	Many	more	
previously	 epidemic	 maladies	 can	 nowadays	 be	 contained	 and	 controlled	 due	 to	 the	
introduction	of	their	vaccine.		
These	 traditional	 vaccines	 work	 by	 presenting	 the	 patient’s	 immune	 system	 with	 an	
immunogenic	 antigen	 via	 oral	 gavage	 or	 direct	 injection	 and	 causing	 an	 immune	 reaction	
leading	 to	 immunological	 memory.	 These	 antigens	 are	 typically	 attenuated	 or	 dead	
pathogens.	There	is	also	another	way	to	present	the	body	with	a	well-defined	antigen:	have	
the	body	transiently	express	said	antigen	in	its	own	cells	–	this	is	called	DNA	vaccination.	
Plasmids	are	well	suited	for	use	in	vaccinations	as,	opposed	to	applications	in	gene	therapy	
techniques,	 patient	 immunity	 does	 not	 require	 long-term,	 sustained	 expression	 of	 the	
transduced	antigen	and	instead	can	be	accomplished	in	short-term	gene	expression.	To	invoke	
an	 immune	 response,	 pDNA	 is	 injected	 into	 (predominantly)	 muscle	 tissue,	 where	 it	 is	
translated	 into	 an	 antigen	 protein.	 Plasmids	 as	 therapeutic	 agents	 in	 vaccination	 work	
differently	 than	 traditional	 vaccines,	 as	 they	 can	 stimulate	 the	 human	 immune	 system	 to	
produce	 both	 humoral	 and	 cellular	 responses,	 including	 the	 production	 of	 cytotoxic	 T	
lymphocytes	(Phillips,	2001).		
In	comparison	to	traditional	types	of	vaccination	such	as	live	attenuated	viruses,	weakened	
bacterial	 strains,	modified	endotoxins,	 viruses	etc.,	 pDNA	vaccines	 are	 considered	 safe	 for	
administration	and	tolerated	by	human	hosts.	Further	advantages	over	conventional	vaccines	
based	 on	 viral	 formulations	 include	 moderate	 storage	 conditions	 and	 ease	 of	 large-scale	
production	development	(Ferreira	et	al.,	2000b).	The	main	disadvantage	of	DNA	vaccines	cf.	
their	viral	counterparts,	are	low	efficiency	that,	as	a	result,	make	the	use	of	large	dosages	(up	
to	several	milligrams	per	full	treatment)	a	necessary	requirement	(Ferreira	et	al.,	2000b).	
Several	pDNA	vaccines	have	been	approved	for	their	use	in	veterinary	medicine	(Jorge	et	al.,	
2017),	however,	to	date	no	vaccine	has	been	approved	for	the	use	in	humans.	Several	diseases	
with	complex	etiologies	such	as	cancer,	neurodegenerative	diseases	such	as	Alzheimer’s	and	
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Parkinson’s	disease	are	being	target	by	researchers	and	clinicians	(Patil	et	al.,	2005;	Yang	et	
al.,	2014).	In	addition,	pDNA	vaccination	techniques	targeting	ZIKA	virus	(Kudchodkar	et	al.,	
2018),	Dengue	Virus	(Danko	et	al.,	2018),	human	papillomavirus	(Cheng	et	al.,	2018),	AIDS	and	
tuberculosis	 (Bruffaerts	 et	 al.,	 2014)	 as	 well	 as	 many	 other	 diseases	 are	 currently	 being	
developed.	Furthermore,	DNA	vaccines	have	also	been	 investigated	as	a	means	to	prevent	
allergic	 responses	 through	 desensitisation	 (Horner	 et	 al.,	 2001).	 Currently	 the	 two	 most	
common	approaches	for	delivery	of	pDNA	vaccines	are	injection	of	DNA	in	saline	buffers	by	
hypodermic	needle	and	delivery	via	the	use	of	gene	guns	(Aravindaram	et	al.,	2009).	
Experts	estimate	that	annual	production	and	purification	of	many	kilograms	or	even	tons	of	
pDNA	 could	 become	 a	 necessity	 to	 satisfy	 future	 needs	 for	 large	 scale	 pDNA	 vaccination	
applications	(Aldridge,	2006).	
	
This	 demand	 puts	 the	 pressure	 on	 engineers	 to	 develop	 scalable,	 cost-effective	methods	
capable	of	 large	 scale	pDNA	production	and	purification	 that	meet	pharmacological	purity	
standards.	
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1.2.	Production	and	purification	of	plasmid	DNA	formulations	
Many	different	nanoplex	systems	have	been	explored	as	gene	therapy	vectors	for	the	delivery	
of	pDNA	 to	 target	 cells.	However,	 all	of	 those	processes	 require	highly	purified	pDNA	and	
plasmids	have	become	an	indispensable	tool	for	the	biotechnological	industry,	crucial	for	the	
production	 of	 pharmaceutical	 proteins,	 antibodies,	 vaccines,	 enzymes	 and	 molecular	
diagnostic	 tools	 (Prazeres	 et	 al.,	 2014).	 This	 work	 centres	 around	 the	 production	 and	
formulation	of	naked	pDNA	for	therapeutic	applications.		
The	introduction	of	respective	DSP	techniques	and	unit	operations,	presented	in	the	following	
paragraphs,	hence	focusses	on	their	implementation	for	pDNA	purification.	
1.2.1.	Structure	and	physicochemical	properties	of	pDNA	
For	 the	 development	 of	 a	 successful	 production	 and	 purification	 method	 of	 pDNA,	 an	
understanding	of	 its	 structure	and	properties	 is	 imperative,	 to	be	able	 to	exploit	 them	 for	
various	purification	strategies.		
Plasmid	DNA	is	a	small,	circular	DNA	molecule	spatially	separated	from	host	cell	chromosomal	
DNA,	that	can	replicate	autonomously	within	a	suitable	host.	For	that	reason,	it	bears	at	least	
one	sequence	that	serves	as	origin	of	replication	initiating	the	replication	(Brown,	2010).		
Most	 commonly,	 plasmids	 can	 be	 found	 as	 double	 stranded	 (ds)	 DNA	 ring	 structures	 in	
bacteria,	 where	 they	 carry	 at	 least	 one	 specialised	 gene	 responsible	 for	 conditional	
characteristics	 in	 the	cell	 (e.g.	antibody	resistances;	adaptive	metabolic	 functions,	allowing	
the	 host	 to	 survive	 on	 different	 nutrient	 sources;	 ability	 to	 metabolise	 otherwise	 toxic	
compounds)	(Casali,	2003).	This	characteristic	 is	often	used	 in	 laboratory	applications,	as	 it	
allows	for	bacterial	selection	within	a	culture,	via	antibiotic	resistance	genes	carried	by	pDNA	
(Nethe-Jaenchen,	2001).	
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Its	primary	structure	consists	of	a	linear	sequence	of	nucleotides,	covalently	linked	together	
by	 phosphodiester	 bonds	 (Figure	 1-6).	 Each	 nucleotide	 comprises	 of	 three	 components;	 a	
nitrogenous	base	(either	adenine,	guanine,	cytosine	or	thymine),	a	2-desoxyribose	and	at	least	
one	phosphate	group	(Lodish,	2000).	DNA	is	a	polymer	comprising	of	repeating	nucleotides,	
forming	 two	 helical	 chains,	 linked	 together	 via	 hydrogen	 bonding	 (secondary	 structure)	
(Watson	et	al.,	1953).	These	chains	are	coiled	around	the	same	axis	with	a	diameter	of	~2	nm	
and	 stabilised	 via	 base-stacking	 forces	 of	 aromatic	 nucleobases	 (AT	 and	 GC)	 in	 the	
hydrophobic	centre	of	the	molecule	(Yakovchuk	et	al.,	2006).		
The	exterior	of	DNA	is	hydrophilic	due	to	phosphate	groups	forming	the	backbone	structure	
of	 the	molecule.	The	phosphate	groups	are	negatively	charged	at	pH	>	4,	making	the	DNA	
molecule	 as	 a	 whole	 bear	 a	 partial	 negative	 charge	 (Sinden,	 1994).	 pDNA	 has	 different	
conformations	in	which	it	occurs;	these	are	mainly	open	circular	(oc),	linear	and	supercoiled/	
covalently	closed-circuit	(sc/ccc)	and	its	isoform	has	a	large	impact	on	the	molecules	spatial	
uptake	(radius	of	gyration;	).	
	
Figure	1-6	Structure	of	DNA	(adapted	and	extended	from	(Lumen,	2018))	
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In	order	to	reduce	the	free	Gibbs	energy	of	the	molecule,	DNA	contorts	around	itself	in	space,	
forming	supercoils	(Figure	1-7).	Supercoiling	(in	nature)	is	important	for	a	number	of	reasons,	
such	as	compaction	of	the	molecule	to	limit	its	spatial	uptake	and	regulation	of	access	to	the	
genetic	code.	Supercoiling	furthermore	increases	the	stability	of	the	molecule	via	enhanced	
base	exposure,	leading	to	an	increased	net-charge	compared	to	other	conformations	(Almeida	
et	al.,	2015).	Disruption	of	hydrogen	bonding	may	cause	unfolding	and	ultimately	loss	of	the	
supercoiled	(sc)	isoform,	however	anchor	base	pairs	prevent	the	separation	of	double	strands	
and	aids	 renaturation	of	 sc	 conformation,	 given	 the	pH	does	not	 raise	 above	12.5	 (Diogo,	
1999).	
	
Other	isoforms	of	pDNA	occurring	in	cell	lysates	include	open	circular	(single	strand	nick)	and	
linear	pDNA	(result	of	a	double	strand	nick,	cleaving	both	phosphodiester	bonds	on	opposite	
sides	of	the	double	strand,	causing	the	molecule	to	unwind)	(Thomas,	2008;	Li	et	al.,	2011).	
Due	 to	 its	 length	 and	 circular	 nature	 of	 the	 molecule,	 knots	 or	 multimers	 (catenanes,	
Table	1-2	Radius	of	gyration	and	M	values	from	SLS	analysis	of	sc,	oc,	and	linear	isoforms	of	5.76,	9.80,	and	
16.8	kbp	plasmids	in	10	mM	Na2	EDTA-200	mM	NaCl	(Latulippe	et	al.,	2010)	
	
	
	
Figure	1-7	SEM	images	of	pDNA;	molecule	on	the	far	left	is	in	oc	conformation,	with	the	level	of	supercoiling	
increasing	from	left	to	right	(Kornberg	et	al.,	1992)	
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concatamers)	can	occur	 (Summers,	2009;	Higgins	et	al.,	2015).	Sizes	of	pDNA	 intended	 for	
vaccination	 range	 typically	 from	3-15	kilo	base	pairs	 (kbp),	with	estimations	 that	 sizes	will	
increase	in	the	future	(Levy	et	al.,	2000).	Although	stable	in	solution,	pDNA	is	shear	sensitive	
and	 known	 to	 suffer	 structural	 damage	when	 exposed	 to	mechanical	 stress	 (Zhang	 et	 al.,	
2007).		
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1.2.2.	Industrial	scale	production	of	pharmaceutical	grade	pDNA	
Since	their	application	in	gene	therapy	and	use	in	vaccination,	the	demands	for	therapeutic	
pDNA	formulations	have	increased	tremendously	over	the	past	decades	(Xenopoulos	et	al.,	
2014).	
From	an	industrial	point	of	view,	sc	pDNA	is	the	most	desirable	isoform	of	pDNA	due	to	its	
stability,	bioavailability	(therapeutically	most	active	form),	eminent	antigenicity	and	the	fact	
that	it	is	the	isoform	thought	to	be	most	effective	at	transferring	gene	expression	(Prazeres	et	
al.,	2001;	Stadler	et	al.,	2004;	Sousa	et	al.,	2012).	The	quality	of	pDNA	formulations	 is	as	a	
result	judged	by	their	sc	content,	with	the	FDA	specifying	a	minimum	of	80%	supercoiling	for	
pDNA	vaccines	(FDA,	2007),	with	a	quality	of	over	90%	being	recommended.	
When	developing	a	manufacturing	process	for	pDNA	formulations,	it	is	important	to	comply	
with	all	quality	specifications	posed	by	the	different	regulatory	agencies	(such	as	European	
Medicines	 Evaluation	 Agency	 (EMEA),	 World	 Health	 Organization	 (WHO),	 Food	 and	 Drug	
Administration	(FDA)	and	others,	depending	on	the	targeted	market	(Epstein,	1996).	Beside	
regulatory	 constraints	 controlling	 the	 level	 of	 contaminants	 in	 final	 formulations,	
manufacturers	are	also	being	held	responsible	to	comply	with	Current	Good	Manufacturing	
Practice	(CGMP)	to	ensure	high	industrial	manufacturing	standards	(WHO,	2007;	FDA,	2017a;	
MHRA,	2017).	
Table	1-2	Example	of	purity	requirements	for	a	pDNA	vaccine,	the	required	testing	method	is	added	in	brackets	
(Prather	et	al.,	2003)	adapted	from	(Sagar,	2003)	
Contaminant	 Purity	requirement	
Endotoxin	 level	 (assessed	 by	 Limulus	 amebocyte	
lysate	(LAL)	test)	
<0.5	endotoxin	units	(EU)/mg	pDNA	
Host	 cell	 protein	 (HCP)	 (Bicinchoninic	 acid	 (BCA)	
Assay)	
<1%	
gDNA	(qPCR)	 <1%	
sc	conformation	of	the	product	 >90%	
RNA	(HPLC	ribose	assay)	 <0.1%	
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Outside	of	regulatory	constraints,	a	production	process	for	pDNA	manufacturing	needs	to	be	
economically	viable.	The	choice	of	which	unit	operations	to	incorporate	hence	needs	to	be	
made	with	care,	aiming	to	reduce	the	overall	number	of	process	steps	to	a	minimum	while	
maximizing	 plasmid	 yield	 in	 each	 (Figure	 1-8).	 In	 a	 very	 broad	 sense,	 the	 production	 of	
therapeutic	 pDNA	 can	 be	 considered	 a	 three-step	 process,	 comprising	 of	 upstream	
manufacturing	(vector	design,	transformation,	fermentation	and	cell	harvest),	cell	 lysis	and	
purification/	formulation	(Figure	1-9)	(Urthaler	et	al.,	2005a;	Huber,	2008).	
	
	
On	a	commercial	scale,	pDNA	is	produced	via	biosynthesis	in	E.	coli	K12	strains	(such	as	DH5α),	
a	bacterial	host	that	has	been	used	extensively	for	bio-manufacturing	of	therapeutic	proteins	
and	pDNA	(Carnes	et	al.,	2006).	 
Historically	 yields	have	been	very	 low	 (<200	mg/L)	however,	 recent	 advances	 in	upstream	
protocols,	 have	 gradually	 led	 to	 increasing	 product	 titres,	 enabling	 cost	 effective	 plasmid	
	
Figure	1-8	Even	high	single	step	yields	can	add	up	to	significant	product	losses,	threatening	economic	
viability	of	a	production	strategy	if	too	many	unit	operations	are	implemented		
	
	
Figure	1-9	General	structure	of	the	production	and	formulation	steps	incorporated	for	pDNA	manufacturing	
(Abdulrahman	et	al.,	2018)	
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manufacture	 (Listner	 et	 al.,	 2006;	 Singer	 et	 al.,	 2009).	 Currently	 titres	 up	 to	 2	 g/L	 are	
achievable	in	optimised	production	facilities	(Williams	et	al.,	2009).	
The	 industrial	scale	production	has	been	reviewed	in	depth	 in	other	studies	(Swartz,	2001;	
Prather	et	al.,	2003;	Williams	et	al.,	2009),	in	this	work	the	main	focus	was	put	on	purification	
of	pDNA	from	E.	Coli	lysates.	
1.2.3.	Cell	disruption	and	clarification/	pre-purification		
In	an	initial	solid-liquid	separation	step,	the	high-density	fermentation	broth	is	collected	via	
centrifugation	(Tinnes	et	al.,	1992)	or	microfiltration	(Riesmeier	et	al.,	1989).	In	addition	to	
concentrating	the	slurry,	this	harvest	step	aims	at	removing	most	of	the	used	up	fermentation	
broth,	which	otherwise	can	interfere	with	some	purification	techniques	(Prather	et	al.,	2003).	
The	pDNA	product	is	still	locked	inside	the	host	bacteria	(intracellular),	thus	purpose	of	cell	
lysis	 is	 to	 release	 the	 pDNA	 molecules	 from	 the	 biomass	 into	 the	 surrounding	 buffer	
(Abdulrahman	et	al.,	2018).	This	enables	the	pDNA	to	be	isolated	from	lysate	components.	
Several	different	techniques	have	been	employed	to	liberate	pDNA	from	cells.		
Mechanical	cell	disruption	of	E.	coli	can	cause	significant	damage	to	sc	pDNA	(Levy	et	al.,	1999;	
Lengsfeld	et	al.,	2002)).	This	shear	sensitivity	renders	cell	lysis	unit	operations	used	for	DSP	of	
other	biopharmaceutical	products	impracticable	and	calls	for	other	process	design	solutions	
(Carlson	et	al.,	1995;	Levy	et	al.,	1999).	However,	a	recent	study	highlights	bead	milling	as	an	
efficient	disruption	method	of	E.	coli	for	the	release	of	pDNA	on	a	small	scale	(92%	recovery	
of	sc	pDNA)	(Padilla-Zamudio	et	al.,	2017).	
For	industrial	applications,	alkaline	lysis,	based	on	chemical	disruption	of	the	cell	membrane,	
is	still	the	most	prevalently	used	method	for	cell	disruption	(Birnboim	et	al.,	1979;	Prather	et	
al.,	2003;	Abdulrahman	et	al.,	2018).	
Thermal	 lysis,	 relies	on	 lysozyme	digestion,	breaking	down	 the	peptidoglycan	 in	 cell	walls,	
followed	by	membrane	dissociation	via	boiling	of	the	lysate	(Holmes	et	al.,	1981).	
Following	cell	lysis,	solid-liquid	separation	for	the	removal	of	cell	debris	and	conditioning	of	
lysate	in	preparation	for	subsequent	chromatographic	purification	is	implemented.	Due	to	its	
ease	 of	 use,	 centrifugation	 has	 been	 a	 mainstay	 for	 clarification	 of	 crude	 lysates	 in	 the	
laboratory	and	preparative	scales	(Lahijani	et	al.,	1996;	Prazeres	et	al.,	1998;	Ferreira	et	al.,	
1999).	
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However,	centrifugation	cannot	be	scaled	to	meet	industrial	demands	while	maintaining	low	
shear	energy	 input	and	 is	not	suitable	for	 large	scale	production	feeds	of	pDNA	containing	
lysates	(Ferreira	et	al.,	2000b).	For	large	scale	operations,	filtration,	using	5	µm	pore	diameter	
filters,	has	proven	to	be	the	most	suitable	option	(Marquet	et	al.,	1995;	Theodossiou	et	al.,	
1997;	Borujeni	et	al.,	2014).	Transmembrane	pressure	build-up	can	be	reduced	by	the	use	of	
filter	 aids,	 such	 as	 diatomaceous	 earth,	 which	 also	 help	 to	 reduce	 shearing	 of	 the	 gDNA	
precipitates	and	reduces	RNA	contamination	due	to	specific	binding	(Horn	et	al.,	1996).	
To	further	clarify	the	lysate	and	for	volume	reduction,	several	techniques	are	used.	Protein	
levels	can	be	reduced	via	addition	of	chaotropic	‘salting-out’	agents	such	as	lithium	chloride	
(Chakrabarti	et	al.,	1992),	or	ammonium	acetate	(Horn	et	al.,	1995),	which	have	the	additional	
advantage	to	precipitate	high	molecular	weight	RNA	(Ferreira	et	al.,	1999).		
Plasmid	DNA	can	be	precipitated	using	polyethylene	glycol	(PEG),	further	reducing	the	process	
volume	while	offering	the	opportunity	for	a	buffer	exchange	step,	conditioning	the	lysate	for	
subsequent	chromatographic	purification	(Silva-Santos	et	al.,	2017).	
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1.2.4.	The	use	of	chromatography	in	pDNA	purification	
Among	 other	 DSP	 operations,	 chromatography	 in	 its	many	 forms	 is	 still	 the	most	 applied	
method	 throughout	 the	 industry	 (Xenopoulos	 et	 al.,	 2014).	 Its	 importance	 throughout	
different	 pDNA	 purification	 strategies	 as	 well	 as	 associated	 financial	 burdens,	 has	 made	
chromatography	the	assessment	standard	for	the	whole	manufacturing	process	(Sousa	et	al.,	
2012).		
Chromatography,	as	a	family	of	purification	methods	is	based	on	the	differential	partitioning	
of	the	target	product	from	its	contaminants	by	exploiting	differences	in	molecular	properties.	
Consequently,	the	complex	composition	of	the	lysate	and	similarity	of	physical,	chemical	and	
structural	 properties	 that	 the	 target	 molecule	 shares	 with	 its	 contaminants	 in	 crude	 cell	
lysates	needs	to	be	taken	into	consideration	for	the	development	of	an	economically	viable	
pDNA	purification	process	(see	Table	1-3)	
Table	1-3	Physical,	chemical,	and	structural	similarities	between	pDNA	and	contaminants	in	E.	coli	lysate	(Sousa	
et	al.,	2012)	
Parameter	 oc	pDNA	 sc	pDNA		 gDNA	 RNA	 Endotoxins	
Size	 X	 X	 X	 	 X	
Negative	charge	 X	 X	 x	 X	 X	
Hydrophobicity	 X	 X	 	 	 	
Bases	exposition	 	 X	 	 X	 	
NA	conformation	 Relaxed	circular;	
double-stranded	
Compact	sc;	
Double-stranded	
Denatured	
single/	 double-	
stranded	
Single-	
stranded	
	
	
Chemical	properties,	such	as	charge	and	hydrophobicity,	physical	properties	 like	molecular	
weight,	radius	of	gyration,	the	accessibility	of	nucleotide	bases	to	binding	ligands	as	well	as	
topological	 constraints	 based	 on	 the	 molecules	 conformation	 can	 all	 be	 exploited	 to	
selectively	separate	sc	pDNA	from	contaminating	impurities	and	other	pDNA	conformations	
(Ferreira	et	al.,	2000b).	
One	 way	 to	 categorise	 chromatographic	 purification	 strategies	 is,	 (i)	 by	 the	 mode	 of	
interaction	 (hydrophobicity,	 size,	 net	 charge,	 etc.),	 or	 (ii)	 by	 mode	 of	 operation	 (frontal	
loading-,	negative	mode	chromatography,	expanded	bed	adsorption	(EBA),	etc.).	
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In	adsorptive	chromatography	(ion	exchange	chromatography	(IEC),	hydrophobic	interaction	
chromatography	 (HIC),	 affinity,	 etc.)	 the	 target	 product	 binds	 to	 ligands	 provided	 on	 the	
surface	of	a	stationary	phase.	A	reversion	of	attractive	forces,	by	changing	the	environmental	
conditions,	subsequently	elutes	bound	moieties	from	the	ligands	on	the	basis	of	their	strength	
of	 interaction.	 To	 this	 date,	 the	majority	 of	 pDNA	 purification	 strategies	 still	 use	 beaded	
chromatography	in	frontal	loading	mode.	
For	the	design	and	manufacturing	of	chromatographic	media,	several	different	materials	have	
been	explored.	The	three	main	families	of	materials	are	inorganic	resins	(such	as	porous	silica,	
hydroxyapatite	 or	 sintered	 glass),	 synthetic	 organic	 polymers	 (polystyrene,	 methacrylate,	
polyacrylamide)	or	natural	organic	polymers	(cellulose,	dextran,	amylose,	agarose)	(Leonard,	
1997).	Due	to	 its	mechanical	and	chemical	stability,	neutral	charge,	hydrophilic	nature	and	
biocompatibility,	 agarose	 based	 adsorbents	 have	 been	 extensively	 employed	 in	
chromatographic	purifications	of	biomolecules	(Ioannidis	et	al.,	2012).	
The	manufacturing	of	agarose	based	supports	can	be	achieved	by	several	methods	including	
spray	gelation,	extrusion	through	membranes,	or	via	agitation/	cooling-induced	gelation	of	
agarose	solutions	dropped	in	mineral	oil	(Egorov	et	al.,	1970;	Jahanshahi	et	al.,	2003;	Zhou	et	
al.,	2007;	Yan	et	al.,	2009).	Pore	size	of	 the	adsorbents	can	be	controlled	by	adjusting	 the	
agarose	content	as	well	as	ionic	strength	of	the	agarose	solution	(Ioannidis	et	al.,	2012).	
To	enhance	mechanical	rigidity	of	agarose	supports,	chemical	cross-linking	is	employed	(e.g.	
epichlorohydrin	 or	 divinylsulfone).	 Although	 cross-linking	 does	 not	 alter	 the	macroporous	
nature	of	the	media,	undesired	interactions	with	solutes	in	biological	feeds	(namely	proteins)	
have	been	reported	(Noel	et	al.,	1996).		
Controlling	the	different	parameters	influencing	the	size	and	pore	size	distribution,	make	the	
formation	 of	 agarose	 based	 adsorbents	 a	 challenging	 process,	 with	 a	 high	 propensity	 for	
batch-to-batch	 variations	 (Gilbert,	 2018).	 Advantages	 of	 agarose	 based	 beaded	
chromatography	 media	 as	 well	 as	 other	 natural	 occurring	 polymers	 are	 their	 very	 low	
unspecific	 adsorptivity	 as	well	 as	 excellent	 flow	properties	 due	 to	 the	 use	 of	 cross-linking	
chemistry	enhancing	their	rigidity	(Jungbauer,	2005).		
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The	 agarose	 based	 stationary	 phases	 are	 in	 subsequent	 steps	 functionalised	 by	 coupling	
ligands	on	the	surface	of	the	internal	pores	of	the	media,	determining	the	mode	of	interaction	
with	the	mobile	phase.		
To	provide	an	overview	over	different	modes	of	interaction	applied	for	pDNA	purification,	the	
following	paragraphs	discuss	each	mode	in	detail.		
1.2.4.1.	Ion	exchange	chromatography	
Due	to	the	similarity	 in	net	charge	of	pDNA	and	most	of	 its	contaminants,	anion	exchange	
chromatography	(AEC)	has	proven	itself	to	be	the	ion-exchange	chromatographic	operation	
of	choice.	Cation	exchange	chromatography	(CEC)	could	be	used	pH	dependently	to	rid	the	
feed	of	proteins	but	falls	short	of	selectively	removing	RNA	and	endotoxins,	both	carrying	a	
negative	net	charge	(Schromm	et	al.,	1998).	
Together	 with	 size	 exclusion	 chromatography	 (SEC),	 AEC	 is	 the	 most	 widely	 applied	
chromatographic	mode	 for	 pDNA	purification	 (Abdulrahman	 et	 al.,	 2018).	 It	 is	 based	on	 a	
binding	interaction	of	positively	charged	ligands	on	the	stationary	phase,	such	as	quaternary	
amines	(Chandra	et	al.,	1992),	diethylaminoethyl	(DEAE;	(Müller,	1986))	and	the	negatively	
charged	phosphate	group	on	the	backbone	of	pDNA	(Figure	1-10).		
	
Bound	molecules	 are	 subsequently	 eluted	 from	 the	 column	via	 reversion	of	 the	attractive	
forces	by	applying	a	salt/	pH	gradient.	The	binding	strength	of	NA	is	gradually	reversed,	eluting	
different	NA	on	the	basis	of	their	charge	density,	chain	length,	nitrogenous	base	composition	
and	nucleotide	sequence	(Yamakawa	et	al.,	1996).	Due	to	its	compact	nature	and	high	charge	
density,	sc	pDNA	binds	more	tightly	to	AEC	columns	and	consequently	elutes	after	other	pDNA	
isoforms	 (Prazeres	 et	 al.,	 1998),	 making	 it	 suitable	 for	 the	 separation	 of	 different	 pDNA	
Figure	1-10	Chemical	structures	of	two	of	the	most	widely	applied	AEC	ligands;	left:	DEAE;	right:	Q	
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conformations	from	solution	(Li	et	al.,	2011).	To	further	enhance	selectivity	of	the	sc	isoform	
over	 other	 conformations,	 addition	 of	 highly	 charged	 cationic	 additives	 such	 as	 urea,	
spermidine	and	sperime	have	been	shown	to	selectively	compact	 sc	pDNA	(Murphy	 et	al.,	
1999).	
Most	commercially	available	AEC	media	have	been	developed	for	the	purification	of	protein	
bioproducts.	However,	the	size	difference	between	protein	based	and	large	plasmid	products	
results	 in	 very	 poor	 binding	 capacities	 of	 pDNA	 to	 AEC	 resins	 (0.2-2	 g/LSBV	 vs		
10-100	g/LSBV	 in	protein	purification)	 (Prather	 et	al.,	 2003).	With	 typical	pore	diameters	of	
around	25	nm	(for	beaded	resins	of	6%	agarose	content	(Hagel	et	al.,	1996b))	pDNA	molecules	
are	unable	to	diffuse	 into	the	 internal	pores	of	 the	media	and	hence	binding	 is	exclusively	
limited	to	the	support	surface	(Ljunglof	et	al.,	1999).		
Attempts	have	been	made	to	enhance	pDNA	binding	capacity	via	the	addition	of	compacting	
agents	aiming	to	reduce	the	radius	of	gyration	of	pDNA.	However,	increasing	the	capacity	by	
40%	 still	 barely	 utilises	 a	 fraction	 of	 binding	 area	 in	 comparison	 to	 a	 protein	 purification	
column	(Colpan	et	al.,	1984;	Murphy	et	al.,	1999;	Murphy,	2003;	Sagar,	2003).	
The	 introduction	 of	 superporous/	 perfusion	 beads	 increases	 the	 available	 binding	 area	 of	
conventional	 AEC	 media	 by	 crafting	 supports	 containing	 flow	 through	 pores	 (2-30	 µm	
diameter).	These	pores	allow	pDNA	to	enter	the	beads	via	convective	flow,	with	additional	
binding	sites	being	provided	by	the	pore	walls,	while	at	the	same	time	allowing	for	increased	
flow	velocities	(Tiainen	et	al.,	2007c).		
The	limited	availability	of	stationary	phase	for	pDNA	binding	has	led	to	the	development	of	
monolith	stationary	phases	(Sousa	et	al.,	2011).	These	consist	of	a	single	piece	of	highly	porous	
solid	material	 (Tennikova	et	al.,	1993;	Svec	et	al.,	1995),	 forcing	the	mobile	phase	through	
large	 ligand	 lined	pores	 and	 in	 the	process	eliminating	diffusion	barriers	 found	 in	 classical	
column	chromatographic	operations	(Urthaler	et	al.,	2005a).	
While	high	levels	of	protein	and	NA	clearance	can	be	achieved,	the	selectivity	of	AEC	for	pDNA	
separation	from	other	lysate	components	is	hampered	by	its	electrostatic	mode	of	interaction	
(Lyddiatt	et	al.,	1998;	Diogo	et	al.,	2005).	Competitive	binding	makes	co-elution	of	similarly	
charged	 contaminants	 such	 as	 high	 molecular	 weight	 RNA	 and	 endotoxins	 hard	 to	 avoid	
(Ferreira	et	al.,	2000b).	Superior	elution	can	be	achieved	using	shallow	salt	gradients	during	
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elution,	 however	 this	 compromises	 on	 process	 time	 (Lahijani	 et	 al.,	 1996;	 Prazeres	 et	 al.,	
1998).	
Despite	all	efforts	to	enhance	the	separation	efficiency	of	AEC,	high	purity	standards	in	final	
pDNA	formulations	call	 for	other	purification	steps,	exploiting	complimentary	properties	of	
the	target	molecule	and	its	contaminants	(Bellot	et	al.,	1993;	Abdulrahman	et	al.,	2018).	
1.2.4.2.	Size	exclusion	chromatography		
SEC	(also	referred	to	as	‘gel	filtration’)	fractionates	different	molecules	in	a	feed	on	the	basis	
of	size.	It	is	a	non-adsorptive	technique,	where	the	lysate	is	loaded	on	a	porous	matrix	with	a	
broad	pore	size	distribution	(Figure	1-11).	While	large	molecules	cannot	access	small	pores,	
their	effective	distance	of	travel	through	the	column	is	comparatively	short,	causing	them	to	
elute	 first,	 while	 smaller	molecules	 have	 a	 longer	 diffusional	 pathway,	 resulting	 in	 longer	
retention	times	(Ferreira	et	al.,	1997).	Different	pDNA	isoforms	are	eluted	as	a	 function	of	
their	 effective	 size	 (Potschka,	 1991),	 with	 gDNA	 eluting	 first	 followed	 by	 linear	 and	 open	
circular	(oc)	pDNA	(Moreau	et	al.,	1987).	The	compact	structure	of	sc	pDNA	leads	to	a	reduced	
size	in	comparison	to	other	conformations	and	causes	the	molecule	to	elute	last	(Urthaler	et	
al.,	 2005b).	Due	 to	 the	 significant	difference	 in	 size,	 endotoxins,	proteins	 and	RNA	can	be	
separated	easily	from	pDNA	(Horn	et	al.,	1995).	
The	biggest	disadvantages	of	the	method	are	its	very	limited	capacity	and	non-specificity	for	
pDNA.	For	industrial	purification	of	pDNA	products,	SEC	is	still	used	as	a	final	polishing	step,	
combining	 a	 rigorous	 removal	 of	 residual	 impurities	 with	 a	 buffer	 exchange	 step	 in	
preparation	 for	 formulation	 (Ghanem	et	al.,	2013).	However,	 the	 implementation	of	a	SEC	
step	prior	to	further	purification	steps	was	reported	to	reduce	endotoxin	levels	by	as	much	as	
8000	fold	(Horn	et	al.,	1995).	
	
	
	 -	26	-	
	
Whilst	not	a	SEC	mode	in	the	strict	sense,	slalom	chromatography	has	been	applied	for	size-
fractionation	 of	 large	 (>5	 kbp)	 pDNA	 molecules	 (Hirabayashi	 et	 al.,	 2000).	 Although	 the	
retention	mechanism	is	not	yet	fully	understood,	it	has	been	suggested	that	the	application	
of	high	flow	rates	results	in	a	steep	flow	rate	gradient	in	the	crevices	between	microbeads.	
These	forces	cause	pDNA	molecules	to	extend	and	the	resulting	longer	reorientation	times	
increase	their	retention.	Unlike	in	SEC,	retention	of	NA	is	based	on	length	rather	than	size,	
with	hydrodynamic	effects	playing	a	pivotal	role	in	the	mechanism	of	separation	(Diogo	et	al.,	
2005).	
	
Figure	1-11	SEC	for	the	separation	of	different	pDNA	isoforms;	A:	different	pDNA	isoforms;	B:	Topologic	
fractionation	of	a	pDNA	sample	containing	various	isoforms	with	the	use	of	capillary	gel	electrophoresis;	
adapted	from	(Schleef	et	al.,	2004)	
	 -	27	-	
1.2.4.3.	Hydrophobic	interaction	chromatography	(HIC)	
HIC	is	a	purification	tool	based	around	a	difference	in	hydrophobicity	of	the	components	in	
the	 feed	 (Leonard,	1997),	 that	has	been	applied	 for	pDNA	purification	 (Diogo	 et	al.,	 2000;	
Freitas	et	al.,	2009b;	Pereira	et	al.,	2010).	
The	retention	time	of	NA	molecules	in	HIC	columns	is	predominantly	determined	by	their	size,	
base	composition	and	secondary	 structures	 (Colote	 et	al.,	1986)	 In	aqueous	 solution,	DNA	
forms	 a	 double	 helix	 structure,	 exposing	 its	 hydrophilic	 phosphate	 backbone	 to	 the	
surrounding	buffer,	while	keeping	its	aromatic	bases	tucked	away	inside	the	tertiary	structure	
(Li	 et	al.,	 2005).	While	 the	double-stranded	nature	of	NA	 is	 intact,	 its	 interaction	with	HIC	
ligands	 is	 very	minimal.	 Binding	 of	 pDNA	 to	 HIC	 columns	 can	 be	 achieved	 via	 addition	 of	
‘salting-out’	agents	(e.g.	ammonium	sulphate).	Following	sample	application,	weakly	bound	
molecules	are	washed	off	the	column	using	a	buffer	of	moderate	salt	concentration.	Elution	
and	separation	of	different	pDNA	isoforms	is	being	carried	out	by	gradually	reducing	the	salt	
concentration.	 In	 a	 final	 step,	 strongly	 bound	 molecules	 (linear	 pDNA,	 denatured	 gDNA	
fragments,	 RNA)	 are	 stripped	 from	 the	 column	 and	 the	 column	 regenerated	 for	 future	
applications	(McCue,	2014).		
In	 an	attempt	 to	minimise	 the	 reliance	on	 the	hazardous	 ammonium	sulphate,	 the	use	of	
potassium	phosphate	has	been	investigated,	yielding	99%	pDNA	purity	(Bonturi	et	al.,	2013).	
Despite	a	low	recovery,	the	purity	of	the	formulation	is	enough	to	meet	international	vaccine	
purity	 recommendations	 and	 the	 cleanliness,	 cost	 effectiveness	 and	 speed	 of	 the	method	
make	 it	 a	 promising	 candidate	 for	 a	 single-step	 purification	 (Abdulrahman	 et	 al.,	 2018).	
Unfortunately,	the	method	was	unable	to	distinguish	between	different	pDNA	isoforms.		
Further	single-step	purification	strategies	for	the	formulation	of	sc	pDNA	have	yielded	98%	
purity	at	75%	recovery	(Bo	et	al.,	2013).	However,	a	process	involving	the	use	of	ammonium	
sulfate	 comes	 with	 regulatory	 constraints	 and	 is	 generally	 considered	 disadvantageous	
(Iuliano	et	al.,	2002).		
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1.2.4.4.	Affinity	chromatography	(AC)	
The	principle	of	interaction	in	AC	is	based	on	biological	macromolecules	in	a	feed,	interacting	
reversibly	with	 immobilised	 ligands	with	high	 specificity	 through	 several	different	 types	of	
bonds	and	interactions	(Ninfa	et	al.,	2010).	It	has	the	unique	ability	to	purify	biomolecules	via	
exploiting	 their	 biological	 function	 or	 individual	 chemical	 structures	 due	 to	 the	
implementation	of	specific	binding	agents	(Lowe	et	al.,	2001).	
Separation	of	pDNA	isoforms	can	be	achieved	by	abusing	the	difference	in	the	conformational	
structure	of	the	molecules.	Supercoiling	of	the	NA	chain	adds	torsional	strain,	which	elevates	
both,	the	local	charge	density	as	well	as	base	exposure	in	comparison	to	the	oc	conformation	
(Almeida	 et	 al.,	 2015).	 Scientists	have	explored	many	different	 types	of	AC	 interaction	 for	
capturing	sc	pDNA;	brief	descriptions	of	some	commonly	applied	methods	are	given	below.	
	(i)	Triple-helix	affinity	chromatography	(THAC)		
THAC	is	based	on	a	triple-helix	formation	between	a	specific	homopurine	duplex	sequence	in	
the	target	pDNA	and	a	pyrimidine	oligonucleotide	ligand	covalently	attached	to	the	stationary	
phase	(Schluep	et	al.,	1998;	Sousa	et	al.,	2008b).	Although	it	was	reported	that	it	is	possible	
to	purify	sc	pDNA	by	 reducing	gDNA,	endotoxins	and	RNA	 in	a	single	step	operation,	poor	
yield,	enrichment	of	denatured	pDNA	and	the	requirement	 for	 long	 incubation	times	have	
limited	the	success	of	the	technique	(Wils	et	al.,	1997;	Schluep	et	al.,	1998).	
(ii)	Immobilised	metal	affinity	chromatography	(IMAC)		
IMAC	relies	of	the	interaction	of	charged	CU(II)	or	Ni(II),	immobilised	onto	a	stationary	phase,	
with	exposed	purine	bases	(adenine	and	guanine)	on	molecules	in	the	lysate.	As	pDNA	does	
not	have	any	exposed	purine	bases	 in	 the	sc	 isoform,	 the	 technique	has	been	successfully	
applied	 for	 capturing	 endotoxins,	 RNA,	 and	 denatured	 DNA,	 while	 the	 target	molecule	 is	
eluted	in	the	flow	through	(Murphy	et	al.,	2003;	Cano	et	al.,	2005;	Tan	et	al.,	2007).	
(iii)	Protein/	amino	acid–DNA	affinity	chromatography	
Selecting	amino	acids	and	protein	based	ligands	was	initially	based	on	the	natural	occurrence	
of	 different	 proteins	 and	 amino	 acids	 in	 biological	 organisms.	 These	 interactions	 mainly	
involve	 basic	 amino	 acids	 such	 as	 histidine	 or	 arginine	 (Sousa	 et	 al.,	 2010a)	 and	 involves	
proteins	 presenting	 domains	 that	 recognise	 specific	 DNA	 sequences	 (Blanco	 et	 al.,	 2005;	
Privalov	et	al.,	2007).	
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The	use	of	arginine	as	a	ligand	promotes	multiple	different	interactions	with	pDNA,	including	
electrostatic	and	hydrophobic	as	well	as	biorecognition	of	nucleic	acids.	The	strong	specific	
biorecognition	interaction	of	arginine	with	the	sc	pDNA	isoform	is	based	on	higher	availability	
and	exposition	of	base	pairs	as	a	result	of	the	increased	degree	of	supercoiling	cf.	other	pDNA	
isoforms	(Sousa	et	al.,	2008a).	
Similarly	to	arginine,	the	ability	of	histamine	and	agmantine	has	been	exploited	for	specific	
recognition	and	purification	of	pDNA	isoforms	(Sousa	et	al.,	2014).	
1.2.4.5.	Multimodal/	mixed	mode	chromatography	
Unlike	traditional	chromatographic	techniques	(IEC,	HIC,	etc.),	in	multimodal	chromatography	
(MMC)	 the	stationary	phase	 interacts	 in	more	 than	one	way	with	molecules	 in	 the	mobile	
phase.	While	in	single	mode	chromatography,	weak	secondary	interactions	may	occur	(e.g.	
weak	electrostatic	 interactions	observed	in	SEC	(McLaughlin,	1989)),	MMC	actively	exploits	
both	interactions	for	the	retention	of	molecules	from	the	lysate	(Yang	et	al.,	2011).		Compared	
with	other	modes,	higher	selectivities	can	often	be	achieved	in	MMC	due	to	the	more	specific	
nature	of	the	resulting	binding	interactions	(Matos	et	al.,	2014).	
AC	multimodal	ligands	such	as	histamine	and	agmantine	have	been	explored	recently	for	the	
purification	of	pDNA	(Černigoj	et	al.,	2013;	Sousa	et	al.,	2014;	Bicho	et	al.,	2016).	The	imidazole	
ring	in	histamine	exhibits	hydrophobic	properties	while	amino	groups	interact	on	the	basis	of	
electrostatic	 forces.	 Purification	of	 a	 5.17	 kbp	plasmid	 from	other	 lysate	 components	 in	 a	
double	elution	 from	the	same	column	yielded	97%	sc	pDNA	at	98%	purity	 (Černigoj	 et	al.,	
2013).	
Although	unable	to	distinguish	between	isoforms,	the	application	of	a	monolith	functionalised	
with	octylamine	was	found	to	be	an	easier	and	simpler	route	of	purification	compared	to	HIC	
followed	by	AEC,	reducing	99%	of	impurities	at	80%	recovery	(Smrekar	et	al.,	2013).	
Capto	 Adhere	 resin	 (containing	 a	 N-benzyl-n-methyl	 ethanolamine	 ligand	 showcasing	
properties	of	a	strong	AE	ligand	in	conjuncture	with	hydrophobic	interaction	(Ma	et	al.,	2013))	
was	first	used	for	the	purification	of	pDNA	from	crude	lysate	by	Matos	et	al.	with	little	success	
(Matos	et	al.,	2014).	However,	Silva-Santos	et	al.	used	the	resin	for	the	selective	formulation	
of	pDNA	isoforms	from	a	pre-purified	mixture	of	topoisomers,	yielding	purities	of	91.8%	and	
92.3%	oc	and	sc	pDNA	respectively	(Silva-Santos	et	al.,	2016).	Applying	crude	lysates	to	the	
	 -	30	-	
resin	has	in	a	subsequent	study	provided	a	successful	baseline	separation	between	isoforms	
in	the	lysate,	however	at	the	expense	of	yield	(47%)	(Silva-Santos	et	al.,	2017).	
1.2.5.	Facing	the	challenges	of	chromatographic	pDNA	purification/	Multifunctional	
and	bilayered	chromatography	supports		
The	 use	 of	 conventional	 chromatography	 for	 the	 purification	 of	 pDNA	 formulations	 is	
attributed	to	several	challenges,	 inherent	to	the	structural	nature	of	beaded	supports.	The	
availability	of	binding	sites	 for	pDNA	being	 limited	to	particle	surfaces	and,	as	a	result	 low	
binding	 capacities	 of	 beaded	 supports	 have	 inspired	 researchers	 to	 find	ways	 to	 improve	
chromatographic	 operations	 for	 pDNA	 purification.	 Reducing	 the	 size	 of	 target	 pDNA	
molecules	using	condensation	agents	leads	to	lower	spatial	uptake	on	the	column;	however,	
the	problem	of	surface	restricted	binding	resides	(Murphy	et	al.,	1999;	Murphy,	2003).	
Changing	the	shape	of	the	stationary	phase	from	beaded	media	to	a	homogenous,	single	piece	
of	porous	solid	into	a	monolith	allows	for	excellent	mass	transfer	and	high	binding	capacities	
(Zöchling	et	al.,	2004;	Saunders	et	al.,	2009).	Low	backpressure	is	the	result	of	the	rigid	nature	
of	the	media,	allowing	for	high	operational	 flow	rates	(Jungbauer	et	al.,	2004).	Forcing	the	
lysate	 through	specific	pathways	 in	 the	stationary	phase	via	macropores,	enhances	 ligand-
lysate	contact	by	convective	flows,	making	the	separation	process	in	monolith	columns	non-
diffusion	limited	(Josić	et	al.,	1999;	Mihelič	et	al.,	2000;	Josic	et	al.,	2001).		
Functionalisation	of	monolithic	base	matrices	with	different	ligands	of	interaction	for	pDNA	
purification,	 such	 as	 HIC,	 AEC	 and	 affinity	 ligands	 has	 been	 demonstrated	 in	 various	
publications,	making	it	a	promising	alternative	to	beaded	chromatographic	media	(Strancar	et	
al.,	2002;	Branovic	et	al.,	2004;	Sousa	et	al.,	2011;	Ongkudon	et	al.,	2013;	Sousa	et	al.,	2014).	
Membranes	can	be	described	as	a	monolith	purification	strategy	with	a	very	extreme	aspect	
ratio	 comprising	 of	 very	 thin	 beds,	 providing	 very	 low	 pressure	 drops	 along	 the	
chromatographic	unit	and	allowing	for	increased	flow	rates	and	consequently	high	throughput	
(Heath	et	al.,	1992;	Zeng	et	al.,	1999;	Endres	et	al.,	2003).	Problems	of	the	technique	include	
large	void	volumes	and	difficult	scalability	(Urthaler	et	al.,	2005c).	
EBA	utilises	the	binding	modes	of	traditional	chromatography,	while	abandoning	the	classical	
set-up	of	beaded	media	tightly	packed	into	columns.	Instead	the	technique	follows	the	design	
of	a	fluidised	bed	(Hjorth,	1997).	
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Due	 to	 the	 loose	 organization	 of	 the	 beads	 in	 the	 column,	 shear	 stress	 to	 the	 product	 is	
minimal	and	gentle	sample	handling	guaranteed	by	design	(Theodossiou	et	al.,	2000).	
EBA	has	been	used	for	pDNA	recovery	from	crude	E.	coli	feedstocks,	however,	limited	pDNA	
binding	capacities	were	reported	 (Thatcher	et	al.,	1997;	Varley	et	al.,	1999;	Ferreira	et	al.,	
2000a).	Binding	capacity	for	EBA	adsorbents	in	comparison	to	traditional	AEC	media	can	be	
improved	 by	 enhancing	 charge	 density	 on	 small	 beads	 in	 conjuncture	 with	 grafting	
polyethylene	 imine	 chains	 onto	 the	 surface,	 giving	 the	 adsorbents	 a	 higher	 surface	 area	
(Theodossiou	et	al.,	2000).	Over	recent	years,	interest	in	EBA	techniques	have	declined,	due	
to	(still)	limited	binding	capacities	and	problems	associated	with	collapsing	beds	as	a	result	of	
inter-particulate	linking	of	adsorbents	by	long	NA	chains	(Ferreira	et	al.,	2000a;	Abdulrahman	
et	al.,	2018).	
Tentacle	chromatography	employs	long	tentacle-like	polyelectrolyte	chains	with	large	linkers	
extending	 from	 the	 surface	 of	 supports	 to	 reduce	 interparticulate	 mass	 transfer	 during	
elution,	whilst	minimizing	contact	between	the	target	product	and	the	adsorbents	stationary	
phase	(Weitzhandler	et	al.,	1998;	Ghanem	et	al.,	2013).	The	 long	chains	allow	for	a	higher	
binding	capacity	of	the	supports;	however,	scientific	interest	in	the	field	has	been	low	(Prather	
et	al.,	2003).	
The	problem	of	surface	restricted	binding	of	pDNA	can	be	partly	overcome	by	the	application	
of	perfusion	media	(Ghanem	et	al.,	2013).	This	allows	for	higher	processing	flow	rates	as	well	
as	 slightly	 enhanced	pDNA	 capacity	 (Meyer,	 2013).	 The	 internal	 structure	of	macroporous	
beads	comprises	of	two	differently	sized	pore	types,	namely	flow	through	pores	(6000-8000	Å)	
and	diffusive	pores	(800-1500	Å),	allowing	for	deeper	penetration	and	binding	of	pDNA	to	the	
particles	 as	 well	 as	 quicker	 elution	 times	 (Deshmukh	 et	 al.,	 2005;	 Tiainen	 et	 al.,	 2007a;	
Arpanaei,	2008).	
Reducing	 the	 bead	 size	 of	 adsorbents	 increases	 the	 relative	 binding	 surface	 available	 for	
pDNA.	Such	small	beads	however,	suffer	from	high	pressure	backdrops	due	to	the	reduced	
interparticulate	void	volume.	To	maintain	high	flow	rates,	researchers	have	crafted	rigid,	non-
porous	adsorbent	materials,	however	the	enhanced	flow	velocities	cause	higher	shear	stress	
to	the	product	(Sumita	et	al.,	1994;	Tiainen	et	al.,	2007b).		
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Negative	chromatography	aims	to	bind	contaminants	from	the	load,	while	the	target	product	
elutes	from	the	column	in	the	flow	through	(Figure	1-12)	(Lee	et	al.,	2014).	One	advantage	of	
the	 method	 is	 that	 it	 circumvents	 the	 limited	 binding	 capacity	 of	 pDNA	 to	 traditional	
chromatographic	media.	Due	to	size	limitations,	pDNA	can	only	adsorb	to	the	outer	surface	of	
chromatography	supports	as	the	pore	size	of	the	porous	media	is	too	narrow	for	molecules	to	
diffuse	into	and	bind	throughout	the	matrix	(Grunwald	et	al.,	2001;	Eon-Duval	et	al.,	2004;	
Gustavsson	et	al.,	2004).		
The	 fragile	 nature	 of	 nanoplex	 bioproducts	 and	 the	 avoidance	 of	 binding	 in	 negative	
chromatography,	 have	 made	 this	 technique	 appealing	 to	 researchers,	 however	 the	
electrostatic	similarities	between	pDNA	and	its	contaminates	in	the	feed	make	adaptation	of	
the	 technique	 for	 pDNA	 purification	 challenging	 outside	 of	 affinity	 based	 purification	
strategies	(Caramelo-Nunes	et	al.,	2014).	
	
Implementation	 of	 negative	 adsorption	 chromatography	 for	 the	 separation	 of	 large	
biomolecules	 from	smaller	contaminants,	possessing	similar	surface	chemistries,	calls	 for	a	
different	type	of	adsorbent	architecture.	
	
Figure	1-12	Working	principle	of	negative	mode	chromatography,	the	stationary	phase	interacts	only	with	
the	contaminants	in	the	feed,	allowing	the	target	molecule	to	pass	through	the	column	in	flow	through	
mode;	adapted	from	(Lee	et	al.,	2014)	
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In	 order	 to	 be	 able	 to	 capture	 nanoplex	 molecules	 in	 the	 flow	 through	 while	 retaining	
contaminants	 in	 the	 column,	 a	 new	 type	 of	 adsorbents	 has	 been	 proposed.	 These	 beads	
possess	a	non-interactive	exterior,	preventing	binding	of	large	entities	(such	as	pDNA),	while	
providing	binding	ligands	for	interaction	with	smaller	molecules	inside	the	bead.	To	provide	
such	an	environment,	bilayered	chromatography	supports	surround	a	functionalised	core	with	
a	porous	shell	allowing	diffusional	access	of	small	molecules	to	pores	inside	the	beads.	
Such	AEC-SEC	media	combines	the	strength	of	both	the	adsorptive	capacity	of	AEC	for	small	
molecules,	 while	 the	 inert	 outer	 shell	 layer	 prevents	 adsorption	 of	 pDNA.	 This	 type	 of	
architecture	allows	 for	a	 ‘one-column-one	bead’	 separation;	 small	 contaminants	have	 free	
access	to	the	core,	where	they	are	retained	due	to	electrostatic	interaction	with	the	ligands,	
while	target	pDNA	molecules	are	prevented	from	interaction	due	to	their	size	(Figure	1-13).	
	
Although	 separation	media	based	on	multilayer	 structures	have	 found	wide	 application	 in	
analytical	 techniques	 (high	 performance	 liquid	 chromatography	 (HPLC)),	 the	 use	 and	
development	 for	media	 targeted	 for	 large	 scale	 production	 of	 nanoplex	 biomolecules	 is	 a	
comparatively	new	approach	(Haginaka,	1991;	Pinkerton,	1991;	Hayes	et	al.,	2014;	de	Faria	et	
al.,	2017).	Several	different	manufacturing	approaches	have	been	explored	to	provide	XEC/	
SEC	bilayered	media	(X-	several	modes	of	 ligand	 interaction	are	conceivable,	such	as	 ionic,	
hydrophobic,	 multimodal,	 etc.)	 for	 the	 purification	 of	 large	 target	 products	 from	 smaller,	
chemically	similar	contaminants.	
Coating	an	AEC	Amberlite	matrix	by	adsorbing	negatively-charged,	hydrophilic	polyacrylic	acid	
resulted	 in	 a	 bilayered	 structure	 that	 allowed	 capture	 of	 shikimic	 acid	 directly	 from	 the	
	
Figure	1-13	Working	principle	of	AEC-SEC	bilayered	supports	for	the	purification	of	nanoplex	bioproducts	
(here	VLPs)	from	small,	chemically	similar	contaminants,	exploiting	size	differences	in	conjuncture	with	
electrostatic	interactions	in	a	single	step	operation	(image	courtesy	by	Dr	E.	Theodosiou)	
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fermentation	media,	while	larger	entities	(such	as	cell	debris)	were	excluded	from	interacting	
with	the	AEC	core	of	the	media,	due	to	the	cross-linked	polymer	coating	(Dainiak	et	al.,	2002a).	
Another	 coating	 technique	applied	 to	an	AEC	Amberlite	 resin	allowed	 for	 lactic	 acid	 to	be	
adsorbed	to	the	media	while	preventing	various	types	of	cells	and	cell	debris	from	binding.	
The	adsorbents	were	coated	with	a	thin	agarose	layer	followed	by	cross-linking	to	enhance	
stability	of	the	bilayered	structure	(Viloria-Cols	et	al.,	2004).	
Several	prototype	media	for	EBA	purification	of	target	proteins	from	complex	feedstocks	were	
manufactured	by	a	 three-phase-emulsion	process.	AEC,	CEC	and	affinity	 core	phases	were	
coated	 by	 an	 agarose	 gel,	 reducing	 non-specific	 binding	 of	 cells	 and	 cell	 debris,	 while	
maintaining	the	core’s	ability	for	selective	capturing	of	target	proteins.	The	non-stick	exterior	
was	reported	to	reduce	bead	fouling	and	inter-particle	cross-linking,	leading	to	improved	bed	
stability	 (Jahanshahi	 et	 al.,	 2008).	 However,	 concerns	 about	 coating	 beaded	 media	 with	
agarose	layers	were	reported.	Casting	of	uniform,	thin	and	mechanically	robust	agarose	layers	
is	challenging	and	as	a	result,	particle	volume	increased	by	three-fold,	compromising	on	bed	
expansion	properties,	binding	capacity	and	intra-particle	mass	transfer	(Arpanaei	et	al.,	2010).	
	
The	 first	 SEC-AEC	 bilayered	 media	 for	 pDNA	 purification	 in	 a	 packed	 column	 was	 first	
introduced	by	Gustavsson	 in	2004	(Gustavsson	et	al.,	2004).	 Instead	of	 laminating/	coating	
pre-functionalised	 AEC	 supports,	 the	 researchers	 applied	 an	 allyl	 glycidyl	 ether	 (AGE)	
activation,	 partial	 bromination	 technique,	 based	 on	 several	 previously	 published	 patents	
(Bergstrom,	1997;	Berg,	2003).	Starting	with	the	SEC	base	matrix	Sephacryl	S-500	HR	(pore	
size	200	nm;	predicted	size	cut-off	1	kbp),	functionality	was	built	into	the	particles	in	a	three	
step	‘bottom	up’	approach;	(i)	Allylation	of	support	particles	by	reacting	AGE	with	hydroxyl	
	
Figure	1-14	‘Top	down’	(starting	from	fully	derivatised	AEC	materials;	Left)	vs	'Bottom	up'	(build-up	of	
functionality	specifically	inside	the	core	of	SEC	materials;	Right)	approaches	for	the	preparation	of	SEC-AEC	
bilayered	media	for	packed	bed	chromatography	
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groups	throughout	the	surface	of	the	agarose	based	stationary	phase,	(ii)	partial	bromination	
of	an	outer	 layer,	 followed	by	hydrolysis	of	allylated	beads,	 (iii)	coupling	of	the	strong	AEC	
ligand	Q	(quaternary	amine)	throughout	the	core	of	the	supports.	
Light	micrographs	of	Congo	red	(CR)	stained	beads	showcase	a	distinct	separation	of	a	charged	
core	 surrounded	by	a	 thin	 inert	outer	 layer.	The	 ‘lid	beads’	were	applied	 in	a	 two-column	
strategy	for	pDNA	purification	of	a	5.9	kbp	plasmid	from	crude	E.	coli	lysate	with	89%	yield,	
removing	99.5%	of	endotoxins	and	96%	HCP	(Gustavsson	et	al.,	2004).	The	media	was	further	
used	 as	 part	 of	 an	 integrated	 pDNA	 purification	 strategy	 of	 a	 6.1	 kbp	 plasmid	 with	 69%	
recovery	(88%	single	process	step	yield)	(Kepka	et	al.,	2004).	Due	to	the	spherical	nature	of	
chromatography	supports,	binding	capacity	of	AEC-SEC	media	is	strongly	dependent	on	the	
amount	of	available	binding	sites	distributed	across	the	core	(Table	1-5).	
Table	1-4	Loss	of	volumetric	binding	capacity	with	increased	thickness	of	SE	layer	for	spherical	beads	of	100	µm	
diameter	
Thickness	 of	 SE	
layer	[µm]	
Loss	 of	 core	
binding	
capacity	[%]	
2	 10.4	
4	 20.1	
6	 29.1	
8	 37.3	
10	 44.9	
12	 51.9	
14	 58.2	
16	 64.0	
18	 69.2	
20	 73.9	
	
In	order	to	compromise	binding	space	as	little	as	possible,	it	is	imperative	for	the	production	
of	 bilayered	 supports	 via	 the	 AGE	 activation-	 partial	 bromination	 route,	 to	 keep	 the	 shell	
thickness	as	thin	as	possible.	To	achieve	such	thin	non-adhesive	layers,	the	diffusion	pathway	
of	bromine	into	the	bead	has	to	be	as	short	as	possible	while	maintaining	a	homogenous	layer	
shape.	 The	 very	 fast	 convective	 transport	 of	 bromine	 in	 aqueous	 solution	 to	 the	 particles	
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surface,	 its	high	diffusion	 rate	 into	 the	agarose	media	and	 its	high	 reactivity	with	 the	AGE	
activated	stationary	support	phase	make	control	of	the	reaction	challenging.	
Two	different	options	to	balance	the	reaction	and	the	diffusion	rates	of	bromine	with	AGE	
activated	supports	have	been	investigated	by	Karnchanasri	(Karnchanasri,	2012).	
Enhancing	the	viscosity	of	support	slurries	via	addition	of	sucrose	slows	down	the	convective	
transport	of	bromine,	allowing	it	to	surround	the	supports	prior	to	diffusion/	reaction	into	the	
pores	 of	 AGE	 activated	 supports.	 By	 optimizing	 the	 reaction	 temperature,	 viscosity	 and	
addition	of	additives,	SEC-AEC	media	on	the	basis	of	Sepharose	CL-6B	were	produced.	These	
supports	yielded	selectivity	indices	of	up	to	3.52	in	static	pDNA/	bovine	serum	albumin	(BSA)	
binding	studies	 (loss	of	 surface	vs	core	binding,	 see	Chapter	3	 for	definition	of	SI)	 for	10%	
bromine	addition	at	room	temperature	with	64%	(w/v)	sucrose.	
Loading	the	supports	into	a	column,	the	media	was	used	to	effectively	purify	a	27.4	kbp	and	a	
4.1	kbp	plasmid	directly	from	cleared	E.	coli	feedstocks.	Controlling	the	RDB	by	heating	the	
reaction	vessel	via	microwave	irradiation	during	the	partial	bromination	step	led	to	an	almost	
complete	 elimination	 of	 surface	 charge	 (SI=	 57.4)	 (Karnchanasri,	 2012).	 Plasma	 irradiation	
treatment	 of	 material	 surfaces	 is	 a	 well-established	 technology	 that	 is	 used	 for	 the	
modification	of	surface	properties	at	the	‘nano-scale’	(Fisher,	2002).	
Plasma	 treatment	 of	 material	 surfaces	 has	 several	 advantages;	 (i)	 low	 operational	
temperatures	 (room	temperature);	 (ii)	 shallow	 ‘nano-scale’	modifications	can	be	achieved,	
without	changing	the	bulk	properties;	(iii)	modification	of	various	types	and	compositions	of	
surfaces;	and	(iv)	no	generation	of	large	amounts	of	toxic	by-products	(Schram	et	al.,	1987).	
Plasma	 modifications	 have	 been	 used	 to	 induce	 surface	 modifications	 in	 biopurification	
materials	including	analytical	chromatography	beaded	supports	(Haginaka,	1991;	Sudo	et	al.,	
1998;	Souverain	et	al.,	2004)	and	membrane	materials	(Ulbricht	et	al.,	1995;	Chen	et	al.,	1999;	
Pieracci	et	al.,	1999;	Pieracci	et	al.,	2000;	Liu	et	al.,	2004).		
The	 application	 of	 low	 temperature	 glow	 discharge	 plasma	 irradiation	 treatments	 for	
modification	 of	 AEC	 media	 surfaces	 has	 been	 demonstrated	 to	 prepare	 bilayered	
chromatography	 supports	 with	 a	 non-adsorptive	 surface	 (Arpanaei	 et	 al.,	 2010).	 Plasma	
technology	was	hereby	used	in	two	different	ways;	(i)	plasma	etching	was	used	to	remove	the	
strong	AEC	ligand	quaternary	amine	from	the	surface	of	Q	Hyper	Z,	replacing	it	with	polar,	
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oxidizing,	 oxygen	 containing	 groups	 (‘plasma	 etching	 and	 oxidation’);	 (ii)	 coating	 surface	
exposed	Q	 ligands	 under	 a	 thin	 polymer	 layer,	 by	 providing	 appropriate	monomers	 (vinyl	
acetate,	pyrrolidone,	safrole),	using	argon	as	the	carrier	gas	(‘plasma	polymerization	coating’).	
Both	media	were	found	to	have	substantial	changes	to	the	structural	nature	of	the	particles	
surfaces	and	reduced	pDNA	and	sonicated	ct	DNA	binding	capacities	cf.	untreated	Q	Hyper	Z.	
Under	static	binding	conditions,	these	plasma	etched	beads	showed	loss	of	~53%	of	‘surface’	
DNA	binding,	while	losing	just	9.3%	of	‘core’	protein	binding	capacity.	Dynamic	EBA	studies	
showed	that	the	10%	breakthrough	capacity	of	the	media	with	respect	to	DNA	binding	had	
fallen	significantly	 (up	 to	80%)	after	plasma	etching,	while	protein	binding	capacities	were	
unchanged	cf.	untreated	Q	Hyper	Z.	Furthermore,	prior	issues	with	bed	contractions	due	to	
inter-particle-cross-linking	of	adsorbents	by	DNA	were	completely	eradicated.	
Many	 common	 chromatography	 adsorbents	 such	 as	 Sepharose	 and	 Sephacryl	 have	 a	 soft	
hydrogel	 structure.	Under	 aqueous	 condition	 at	 atmospheric	 pressure,	water	 accounts	 for	
>90%	of	the	support	volume	and	plays	a	pivotal	structural	role.	Under	low	pressure	conditions,	
water	is	easily	evaporated	from	the	pores	of	these	hydrogels,	resulting	in	a	loss	of	support	
structure,	 rendering	 low	 pressure	 plasma	 treatments	 unsuitable	 for	 etching	 of	 hydrogel	
materials.	Q	Hyper	Z	is	a	rigid	material	composed	of	stable	porous	zirconium	oxide	beads	filled	
with	a	high	charge-density,	cross-linked	hydrogel	(Pall	Life	Sciences,	2006),	targeted	for	EBA	
chromatography,	that	can	withstand	the	dry	state	necessary	for	the	plasma	system	employed	
by	Arpanaei.	 The	extension	of	 these	 low	 temperature,	 low	pressure	plasma	 treatments	 to	
beaded	hydrogel	chromatographic	support	materials	is	hence	hindered,	by	the	low	pressure	
(~10	Pa)	at	which	 the	plasma	 treatment	was	carried	out.	 Low	 temperature	plasma	can	be	
generated	 at	 atmospheric	 pressure	 using	 atmospheric	 pressure	 glow	 discharge	 (APGD)	
approaches	(Kanazawa	et	al.,	1988;	Xiaogui	et	al.,	2012).	Modification	of	polymeric	surfaces	
using	APGD	treatment	has	been	demonstrated	 in	a	number	of	studies	(Temmerman	et	al.,	
2005;	Choi	et	al.,	2006;	Pappas	et	al.,	2006;	Walsh	et	al.,	2007),	indicating	that	APGD	may	be	
a	suitable	candidate	for	plasma	etching	of	soft	chromatography	adsorbent	surfaces.	
Olszewski	et.al.	utilised	APGD	plasma	etching	treatments	for	the	selective	modification	of	soft	
hydrogel	supports	surfaces	(Olszewski	et	al.,	2013).	Instead	of	etching	the	support	media	in	a	
desiccated	or	 semi-dry	 state,	 the	use	of	 a	 custom	built	 fluidised	bed	 reactor	 (FBR)	 system	
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allowed	for	treatment	in	situ,	generating	reactive	oxygen	species	(ROS)	inside	plasma	filled	
bubbles	travelling	upwards	through	an	aqueous	support	suspension.		
Plasma	etching	was	able	to	significantly	reduce	the	static	surface	binding	capacity	of	treated	
Q	Sepharose	FF	(up	to	70%	loss	of	pDNA	binding	capacity)	at	the	expanse	of	a	small	loss	of	
core	binding	capacity	(loss	of	~10%	BSA	capacity),	when	using	He-O2	as	a	carrier	gas	(Knake	et	
al.,	2008;	Park	et	al.,	2010).	Treatment	of	Q	Sepharose	Fast	Flow	(FF)	media	by	using	pure	O2	
plasmas	yielded	very	poor	selectivities	of	surface	vs	core	binding	reduction.	This	was	seen	as	
a	 result	 of	 thermal	 damage	 to	 the	media,	 resulting	 from	 contact	 of	 single	 supports	 with	
intensely	hot	plasma	filaments	during	the	treatment.		
However,	 the	 ease	of	 application	 to	modify	 soft	 hydrogel	 support	media	 in	 their	 aqueous	
(native)	 state	 has	 considerable	 application	 potential	 for	 the	 field	 of	 packed	 bed	
chromatography	(Olszewski	et	al.,	2013).	
Although	initial	uptake	of	restricted	access	media	(RAM)	application	for	nanoplex	purification	
was	 slow,	 several	 companies	 have	 been	working	 on	 the	manufacturing	 of	multifunctional	
chromatography	adsorbent	materials	over	the	last	years.	In	2012	GE	Healthcare	launched	the	
first	commercial	MMC/	SEC	media	Capto	Core	700	(CC	700),	for	the	intermediate	purification	
and	polishing	of	viruses	and	other	large	biomolecules	(GE	Healthcare	Life	Sciences,	2012).		
The	media	comprises	of	a	cross-linked	agarose	stationary	phase,	whose	core	is	functionalised	
with	 the	 MMC	 ligand	 octylamine,	 employing	 hydrophobic	 and	 electrostatic	 modes	 of	
interaction	for	the	selective	and	efficient	capture	of	impurities.	The	core	is	surrounded	by	an	
agarose	 shell	 of	 approximately	 5	 µm	 thickness	 with	 a	 molecular	 size	 cut-off	 of	 700	 kDa,	
preventing	large	biomolecules	from	passing	through	the	shell	and	interacting	with	the	core.	
Further	multifunctional	adsorbents	with	options	 to	modulate	different	properties	and	vary	
multiple	parameters	 in	designing	a	separation	protocol,	 including	porosity,	bead	size,	 layer	
thickness,	pore	size	distribution,	type	of	ligand,	and	ligand	concentration	have	been	heralded	
(Glaser,	2013).	
However,	 to	 date,	 only	 one	 more	 material	 utilizing	 the	 ‘core	 bead	 technology’	 of	 GE	
Healthcare	 has	 been	 released	 to	 the	market	 in	 Capto	 Core	 400.	 The	media	 has	 a	 similar	
targeted	application	cf.	Capto	Core	700	(CC700),	however	a	slightly	higher	agarose	content	
reduces	the	size	cut-off	of	the	media	to	400	kDa	(GE	Healthcare,	2018c).	
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Cunha	introduced	a	prototype	of	an	EBA	core-shell	media	based	on	agarose	using	the	MMC	
octylamine	ligand.	The	media	was	integrated	in	DSP	of	hMSC,	where	it	improved	the	washing	
efficiency	 more	 than	 10-fold,	 recovering	 ~70%	 of	 cells	 after	 global	 processing,	 without	
compromising	characteristics	of	the	target	cells,	with	cell	viability	above	95%	(Cunha	et	al.,	
2016). 
In	 2018,	 BioToolomics	 introduced	 a	 ‘Negative	 chromatography	 Antibody	 Purification’	
technology	based	on	bilayered	adsorbents.	The	company	offers	a	library	of	MMC	ligands	for	
the	 specific	 capture	 of	 different	 impurities	 and	 provides	 a	 platform	 technology	 for	 the	
development	of	more	efficient	and	cost-effective	purification	processes	(BioToolomics,	2018).	
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1.3.	Aims	of	this	thesis	
This	study	explores	the	preparation	of	multifunctional,	bilayered	chromatography	supports	
for	 nanoplex	 purification,	 in	 a	 single	 negative	 chromatography	 mode	 purification	 step,	
creating	a	SE	shell	surrounding	a	charged	core.	
Early	successes	applying	plasma	etching	and	oxidation	techniques	to	selectively	modify	the	
chemical	 exterior	 of	 beaded	 chromatography	 supports	 have	 yielded	 encouraging	 results	
treating	EBA	media	with	low	pressure	Helium	plasmas	to	reduce	the	pDNA	binding	capacity	
while	maintaining	BSA	adsorption.	Expanding	on	the	idea	of	using	ROS	to	etch	away	functional	
ligands,	this	study	aims	to	in	situ	modify	the	surfaces	of	agarose	hydrogel	adsorbents	in	their	
native	wet	state.	To	selectively	eliminate	surface	binding	ligands,	cold	atmospheric	pressure	
plasma	is	generated	in	a	novel	custom	build	fluidized	bed	reactor.	The	main	aim	of	chapter	
three	is	to	identify	suitable	plasma	parameters	to	ideally	eliminate	all	ligands	on	the	surfaces	
of	AEC	beaded	supports,	exploring	different	parameters	such	as	overall	treatment	time,	power	
input,	sample	size	etc.	
Bilayered	 supports,	 manufactured	 via	 partial	 bromination	 followed	 by	 ligand	 coupling,	
applying	reaction	diffusion	balancing	to	control	the	shape	of	the	non-binding	zone	have	shown	
significant	reductions	of	pDNA	binding	capacity	cf.	fully	brominated	controls.	However,	with	
all	preparations	 levelling	out	at	a	max	of	80%	pDNA	binding	reductions,	the	residual	pDNA	
binding	on	the	surface	could	not	be	explained.	Exploring	different	visualisation	tools,	such	as	
confocal	 laser	 scanning	 microscopy	 (CLSM),	 Environmental	 Scanning	 Electron	 Microscope	
(ESEM)	and	light	microscopy	this	study	aims	to	identify	the	origin	of	the	residual	binding	sites	
and	 if	 possible	 adjust	 the	 manufacturing	 protocol	 to	 enhance	 selectivity	 by	 eliminating	
remaining	surface	charges.	
With	 CC700	 being	 the	 first	 marketed	 restricted	 access	 media	 for	 nanoplex	 purification,	
chapter	five	focusses	on	the	characterization	of	the	media.	Furthermore,	the	medias	suitability	
as	 a	 first	 capture	 step	 for	 pDNA	 purification	 from	 crude	 E.	 coli	 lysates	 in	 negative	
chromatography	mode	will	be	explored.	
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Chapter	2 General	Materials	and	Methods	
This	 section	 introduces	 the	 materials	 and	 methodology	 used	 to	 conduct	 experiments	
throughout	this	project.	
All	the	methods	that	were	applied	in	more	than	one	chapter	of	this	work	are	listed	below,	
where	methods	are	‘exclusive’	to	one	chapter,	the	methodology	will	be	given	in	the	respective	
section	of	the	chapter.	However,	some	of	the	methods	presented	here	only	give	a	general	
overview	over	the	practical	implementation	due	to	the	number	of	variables	associated	with	
some	experiments	(e.g.	plasma	operation).	
When	the	actual	methods	differ	from	or	require	more	specificity,	complimentary	remarks	on	
the	 methodology	 were	 made	 in	 the	 respective	 experimental	 sections	 of	 the	 associated	
chapters.	The	inclusion	of	this	section	as	a	separate	chapter	was	nonetheless	chosen	to	aid	
readability	and	avoid	repetition	of	similar	but	not	identical	practical	executions.	
2.1.	Materials	
The	chromatography	resins	Q	Sepharose	FF,	Capto	Q,	DEAE	Sepharose	FF,	Capto	Core	700,	
Sepharose	 Cl-6B	 were	 purchased	 from	 GE	 Healthcare	 Bio-Sciences	 (Uppsala,	 Sweden).	
Q	Hyper	 Z	was	gifted	by	Pall	 Corporation	 (Portsmouth,	UK).	 EMD	Fractogel	 (M)	DEAE	was	
purchased	from	Merck	(Darmstadt,	Germany).		
Helium	(CP	grade),	oxygen	(CP	grade)	and	He-O2	(99.5%-0.5%	v/v)	were	obtained	from	BOC	
Speciality	Gases	(UK).	
E.	 coli	DH5α	 and	 plasmid	 IT14:	 pPR322-p170	was	 kindly	 provided	 by	Dr	 Eirini	 Theodosiou	
(Applied	Chemistry	and	Chemical	Engineering,	Aston	University,	Birmingham,	UK).	
For	transformation	and	fermentation	of	pDNA,	Luria	Bertani	(LB)	broth,	bacteriological	agar,	
D-glucose,	ampicillin,	kanamycin,	polypropylene	glycol	(PPG)	Sodium	hydroxide	and	antifoam	
were	purchased	from	Sigma-Aldrich	Company	Ltd.	(St.	Louis,	MO,	USA).		
For	pDNA	purification,	QIAfilter	Plasmid	Giga	Kits,	QIAfilter	Plasmid	Mega	Kits	and	QIAprep	
Spin	MiniPrep	Kits	were	purchased	from	Qiagen	GmbH	(Hilden,	Germany).	Propan-2-ol	was	
purchased	from	Sigma-Aldrich	Company	Ltd.	(St.	Louis,	MO,	USA).	
For	 phenol-chloroform	 extraction	 of	 nucleic	 acids	 and	 subsequent	 agarose	 gel	
electrophoresis,	Phenol:	Chloroform:	Isoamyl	alcohol	(25:24:1)	solution,	3	M	sodium	acetate	
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(pH	7.0),	100x	Tris-EDTA	(TE)	(10	mM	Tris-Cl;	1	mM	EDTA;	pH	7.5)	buffer,	agarose,	(high	gelling	
temperature),	6x	Blue	Orange	gel	 loading	dye,	ethanol	(absolute)	and	10x	TBE	buffer	were	
purchased	from	Sigma-Aldrich	Company	Ltd.	(St.	Louis,	MO,	USA).	Lambda-	HinD	III	marker	
was	 purchased	 from	 Thermo	 Scientific	 (Waltham,	 MA,	 USA).	 SYBR	 safe	 DNA	 gel	 stain	
(Invitrogen,	CA,	USA)	was	purchased	from	Life	Technologies	Ltd	(Paisley,	UK).		
For	Diphenylamine	(DPA)	assay,	Diphenylamine,	perchloric	acid,	acetaldehyde,	glacial	acetic	
acid	and	calf	thymus	DNA	were	purchased	from	Sigma-Aldrich	Company	Ltd.	(St.	Louis,	MO,	
USA).		
Pierce	BCA	Protein	Assay	Kit	and	Thermo	Scientific	EA	Sterilin	 clear	microtiter	plates	were	
purchased	from	Thermo	Scientific	(Rockford,	IL,	USA).		
For	 the	 Orcinol	 assay,	 Orcinol,	 iron(III)	 chloride,	 hydrochloric	 acid,	 ribonucleic	 acid	 from	
baker’s	 yeast	 (S.	 cerevisiae)	 were	 purchased	 from	 Sigma-Aldrich	 Company	 (St.	 Louis,	MO,	
USA).		
For	 static	 binding	 studies,	 BSA,	 100x	 TE	 (10	mM	Tris-Cl;	 1	mM	EDTA;	 pH	7.5)	 buffer	were	
purchased	 from	Sigma-Aldrich	Company	Ltd.	 (St.	 Louis,	MO,	USA).	Hoechst	dye	33258	was	
purchased	 from	 Molecular	 Probes,	 Invitrogen	 (Eugene,	 Oregon,	 USA).	 Sodium	 azide	 was	
purchased	from	Sigma-Aldrich	Company	Ltd.	(St.	Louis,	MO,	USA).	
For	 fluorescent	 labelling	 and	 subsequent	 CLSM	 experiments,	 immersion	 oil	 and	 dimethyl	
sulfoxide	(DMSO)	were	purchased	from	Sigma-Aldrich	Company	Ltd.	(St.	Louis,	MO,	USA).	PD-
10	desalting	columns	packed	with	Sephadex	G-25	media	were	purchased	from	GE-Healthcare	
(Uppsala,	Sweden).	
Invitrogen	Molecular	 Probes	 Cy5	 dye	was	 purchased	 from	Thermo	 Scientific	 (Rockford,	 IL,	
USA).	 Syto	 9	 green	 fluorescent	 nucleic	 acid	 stain	 was	 purchased	 from	 Lifetechnologies	
(Eugene,	Oregon,	USA).	VWR	VistaVision	Microscope	 Slides	 and	VWR	Micro	Cover	Glasses	
were	purchased	from	VWR	International	Ltd	(Lutterworth,	Leicestershire,	UK).		
For	 DPD	 plasma	 treatment,	 the	 sample	 support	 cakes	 were	 prepared	 on	 XK	 26	 net	 rings	
(product	11530834;	GE	Healthcare;	Buckinghamshire)	
Milli	Q	water	(MQW)	was	used	in	all	experiment	unless	stated	otherwise.		
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2.2.	Instrumentation	
Experiments	were	performed	using	the	instrumentation	below.		
ÄKTA	Explorer	100	system	controlled	by	UNICORN	4.11	software;	Tricorn	5/50	columns	(GE	
Healthcare,	Uppsala,	Sweden)	
Pearson	Current	Monitor	2877	(Pearson,	California)		
PSP-603	power	supply	(GW	Instek;	Farnell,	Leeds,	UK)	
72-8710	Oscilloscope	(Tenma;	Farnell,	Leeds,	UK)	
TTI	TG	1000	function	generator	(AIM-TTI	Instruments;	Farnell,	Leeds,	UK)	
Tektronix	 P5100	 High	 Voltage	 Probe;	 Tektronix	 DPO4104	 Digital	 Phosphor	 Oscilloscope	
(Tektronix,	Oregon)		
Tektronix	DPO4104	Digital	Phosphor	Oscilloscope	(Tektronix,	Oregon)	
Microtiter	plate	reader	GloMax-Multi	Detection	System	(Promega	UK;	Southampton;	UK)	
10	mm	path	length	Suprasil	quartz	cuvette	(Hellma	Analytics,	UK)	
UVIKON	922	spectrophotometer	(KONTRON	Instruments,	Bletchley,	UK)	
Evolution	300	spectrophotometer	(Thermo	Fisher,	Madison,	USA)	
VM	20	vortex	mixer	(Chil	Tern	Scientific	Instrumentation,	London,	UK)	
The	material	of	 the	purpose-built	plug	comprising	of	machinable	Macor	glass	 ceramic	was	
purchased	from	UK	Farnell	(Leeds,	England)	
J2-21	centrifuge	(Beckman,	High	Wycombe,	UK)	
Mastersizer	2000	(Malvern	Instruments,	Malvern,	UK) 
Philips	XL-30	FEG	Environmental	SEM	(FEI	Company,	OR,	USA)	
HetoVac	Speed	vacuum	system	(Thermo	Fisher,	Madison,	USA)	
blood	rotor	shaker	SB1	(Stuart	Scientific,	Staffordshire,	UK)	
Olympus	BX50	Light	microscope	equipped	with	a	Moticam	800x600	PIX	(Olympus	UK&	Ireland,	
Southend-on-Sea,	UK)	
Microcentrifuge,	MiniStar	silverline	(VWR	International,	Lutterworth,	Leicestershire,	UK)	
Fermac	360	fermenter	(Electrolab	Biotech	Ltd,	Tewkesbury,	Gloucestershire,	UK)	
SHKE4000-8CE	shake	flask	incubator	(Thermo	Scientific,	Rockford,	IL,	USA)	
Series	300	autoclave	(LTE	Scientific,	Greenfield,	UK)	
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2.3.	Methods	
2.3.1.	Transformation	of	plasmid	IT14:	pPR322-p170	
The	high	copy	number	plasmid	IT14:	pPR322-p170	(26.88	kbp)	was	introduced	into	competent	
E.	coli	DH5a	cells	via	heat	shock	transformation,	following	a	modified	protocol	from	Nishimura	
(Nishimura	et	al.,	1990).		
50	 μL	 of	 competent	 E.	 coli	 cells	 (DH5a)	 were	 thawed	 on	 ice	 and	 transferred	 into	 a	
microcentrifuge	tube	containing	100	pg	of	IT14:	pPR322-p170	and	incubated	on	ice	for	30	min.	
The	cells	were	treated	with	a	heat	pulse	(42°C;	60	s)	to	induce	uptake	of	the	plasmid	by	the	
cells	followed	by	immediate	cooling	on	ice.	The	cells	were	diluted	10-	fold	in	pre-warmed	LB	
media	 (containing	 100	 µg/mL	 ampicillin)	 and	 incubated	 for	 1	 h	 (37°C)	 to	 assist	 the	
development	of	antibiotic	resistance.		
For	 the	 preparation	 of	 a	 cell	 bank,	 the	 cells	 were	 plated	 out	 on	 a	 selective	 agar	 plate	
(0.25%	(w/v)	LB	broth;	0.15%	(w/v)	bacteriological	agar;	100	μg/mL	ampicillin)	and	incubated	
overnight	(37°C).	A	single	colony	was	transferred	into	8	mL	LB	media	(containing	100	µg/mL	
ampicillin)	and	incubated	overnight	on	an	incubator	shaker	(37°C;	200	rpm).	Sterile	glycerol	
(2	mL)	was	added	and	mixed	thoroughly.	The	sample	was	aliquoted	into	0.5	mL	aliquots	and	
stored	in	cryotube	vials	at	-80°C.	
2.3.2.	Fermentation	of	IT14:	pPR322-p170	containing	cells	
An	individual	colony	of	E.	coli	Dh5α	containing	the	26.88	kbp	plasmid	IT14:	pPR322-p170	was	
obtained	via	culturing	on	selective	agar	plates	overnight	at	37°C	(0.15%	(w/v)	bacteriological	
agar;	100	μg/mL	ampicillin;	MQW).	A	single	colony	was	cultured	in	a	shake	flask	(10	mL	LB	
media;	100	μg/mL	ampicillin	in	a	100	mL	conical	flask)	overnight	(37°C;	220	rpm)	until	OD600	=	
1-	1.5	was	reached.	This	pre-inoculum	(0.5	mL)	was	transferred	into	an	inoculum	flask	(80	mL	
LB	media;	100	μg/mL	ampicillin	in	a	500	mL	conical	shake	flask)	and	grown	overnight	until	an	
OD600	of	around	3	was	reached	(37°C,	220	rpm).	
For	the	production	of	the	bulk	of	pDNA	containing	cells,	the	content	of	the	inoculum	flask	was	
transferred	to	a	5	L	fermenter	(FerMac	360,	Electrolab,	Tewkesbury,	UK)	which	was	used	in	
batch	 mode,	 using	 the	 following	 (starting)	 conditions;	 4	 L	 of	 LB	 media,	 30	 g/L	 glucose,	
100	 μg/mL	 ampicillin,	 PPG	 antifoam,	 37°C,	 pH	 =	 7,	 agitator	 speed	 400	 rpm,	 air	 flow	 rate	
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4	standard	litres	per	minute	(SLM).	The	pH	was	maintained	constant	using	automated	loop	
pumps	providing	either	2	M	NaOH	or	1	M	H2SO4	respectively.	The	dissolved	oxygen	tension	
(DOT)	was	monitored	and	maintained	above	50%	via	manual	regulation	of	the	air	flow	rate	as	
well	as	automated	regulation	of	the	agitation	speed.	Temperature	was	kept	constant	using	a	
built-in	heating	mantle	and	water	cooling.		
Cell	 growth	was	monitored	 hourly	 by	measuring	 the	 OD600	 and	 after	 the	 cell	 growth	 had	
reached	late	exponential	stage	the	fermentation	was	terminated.	
An	exemplified	growth	curve	of	the	cells	can	be	found	in	Appendix	A-1.	
The	cells	were	then	harvested	via	centrifugation	(J2-21	centrifuge;	15,000	g;	15	min;	4°C),	the	
supernatant	was	discarded	and	the	cell	pellets	aliquoted	and	stored	at	-20°C.	
2.3.3.	Alkaline	cell	lysis	and	obtaining	purified	pDNA	solution	for	static	binding	studies	
For	 the	 production	 of	 high	 purity	 pDNA	 solutions,	 Qiagen	 Giga	 and	Mega	 kits	 were	 used	
following	the	manufacturers	protocol.	
Cells	were	gently	thawed	on	ice	overnight	and	resuspended	in	125	mL	of	resuspension	buffer	
P1	(containing	100	µg/mL	RNase	A).	Lysis	buffer	P2	was	added	(125	mL)	and	following	mixing	
by	 6	 times	 inversion,	 the	 sample	was	 incubated	 at	 room	 temperature	 (5	min).	 Prechilled	
neutralisation	buffer	P3	was	added	(125	mL),	thoroughly	mixed	and	incubated	on	ice	(30	min).	
The	broth	was	centrifuged	 in	aliquots	of	500	mL	 (10,000	g;	20	min;	4°C).	The	QiagenÒ	 tip	
column	was	equilibrated	(75	mL	QBT	buffer)	before	the	supernatant	of	the	sample	was	applied	
and	washed	with	600	mL	QC	buffer	before	the	pDNA	was	eluded	with	100	mL	of	elution	buffer	
QF.	
The	pDNA	was	precipitated	by	adding	70	mL	of	propan-2-ol	and	centrifuged	down	(10,000	g;	
30	min;	4°C).	The	supernatant	was	discarded	and	the	pellet	washed	with	70%	ethanol	and		
re-	centrifuged	(10,000	g;	5	min;	4°C).	The	supernatant	was	carefully	removed,	the	pellet	air	
dried	(up	to	2	h)	and	resuspended	in	TE	buffer	(10	mM	Tris-HCl;	1	mM	disodium	EDTA;	pH	8.0).	
The	purified	pDNA	solution	was	visualised	by	agarose	gel	electrophoresis	and	measured	for	
pDNA	concentration	using	DPA	assay	as	well	as	OD260. 
The	solution	was	aliquoted	and	stored	at	-20°C	(1	mL;	50	µg/mL)	until	 it	was	used	in	static	
binding	studies.	
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For	 the	 production	 of	 cleared	 E.	 coli	 lysate	 for	 frontal	 loading	 column	 chromatography	
experiments,	 an	 alkaline	 cell	 lysis	 was	 performed	 as	 described	 by	 Gustavsson	 et	 al.	
(Gustavsson	et	al.,	2004);	an	adapted	method	first	described	by	Birnboim	(Birnboim	et	al.,	
1979).	
5	g	of	frozen	cell	paste	was	gently	thawed	in	a	refrigerator	before	 it	was	resuspended	and	
vortex	mixed	on	a	VM20	Vortex	mixer	(Chil	Tern	Scientific	Instrumentation,	London,	UK)	with	
36	 mL	 resuspension	 buffer	 (10	 mM	 Tris-HCl;	 61	 mM	 glucose;	 50	 mM	 ETDA;	 pH	 8).	 The	
suspension	 was	 transferred	 to	 a	 fresh	 vessel	 before	 78	 mL	 of	 lysis	 buffer	 (0.2	 M	 NaOH;	
1%	(w/v)	SDS)	was	added	and	gently	inverted	for	10	min	before	neutralizing	the	suspension	
by	addition	of	59	mL	neutralization	buffer	 (5°C;	3	M	potassium	acetate;	glacial	acetic	acid;	
pH	5.5).	The	white	precipitate	containing	genomic	DNA,	cell	debris	and	potassium	dodecyl	
sulfate	 was	 removed	 by	 centrifugation	 (10,000	 g;	 4°C;	 30	 min)	 and	 the	 supernatant	 was	
analysed	for	pDNA	and	RNA	contents	using	DPA	and	Orcinol	assay	respectively.	The	solution	
was	stored	in	a	clean	vessel	at	-20°C	until	usage.	
2.3.4.	Characterisation	of	pDNA		
2.3.4.1.	Agarose	Gel	electrophoresis	(with	preliminary	phenol	chloroform	extraction	of	
nucleic	acids)	
Agarose	Gel	Electrophoresis	was	performed	on	a	0.8%	(w/v)	agarose	gel	(0.64	g	high	gelling	
temperature	agarose;	80	mL	TBE	buffer;	12	µL	SYBR	stain).	Samples	were	prepared	on	mixing	
tape	(3	µL	pDNA	sample/Lambda-	HinDIII	marker;	3.5	µL	0.5X	TBE	buffer;	1.5	µL	Blue	orange	
loading	dye	6x).	The	gel	was	run	in	horizontal	mode	(constant	voltage,	75	V)	using	0.5x	TBE	
buffer	as	running	buffer	for	2.5	h.	
The	 gels	 were	 imaged	 using	 a	 Uvitec	 Imaging	 System	 (Uvitec	 Alliance,	 Version	 15.16	 for	
Windows).	
Due	to	the	low	concentrations	of	nucleic	acid	species	in	column	chromatography	fractions,	a	
nucleic	acid	extraction	was	performed	prior	to	loading	the	fractions	on	gel	for	electrophoresis:	
200	µL	 of	 sample	 were	 added	 to	 200	µL	 of	 phenol:	 chloroform:	 isoamyl	 alcohol	 solution	
(25:	 24:	 1)	 and	 inverted	 seven	 times	 to	 form	 an	 emulsion.	 The	 samples	were	 centrifuged	
(10,000	g;	10	min)	and	the	 top	phase	collected.	The	sample	was	mixed	with	40	µL	of	3	M	
sodium	acetate	(0.2	µm	filtered;	pH	7)	and	0.5	mL	of	ethanol	 (-20°C)	and	stored	overnight		
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(-20°C).	 The	 samples	 were	 centrifuged	 (10,000	 g;	 10	 min)	 and	 the	 supernatant	 carefully	
pipetted	out	and	discarded.	The	nucleic	acid	pellet	was	washed	with	0.5	mL	of	ice	cold	70%	
(v/v)	ethanol	and	centrifuged	(10,000	g;	10	min).	The	supernatant	was	carefully	decanted	and	
the	pellet	left	to	air	dry	before	dissolving	it	again	in	20	µL	TE	buffer	(10	mM	Tris-HCl;	1	mM	
disodium	EDTA;	pH	8.0).	
2.3.4.2.	pDNA	sequencing	of	pBR322-P170	
A	sample	tube	containing	1	mL	pDNA	solution	(20	µg/mL	in	10	mM	Tris-HCl,	1	mM	disodium	
EDTA,	pH	8.0)	was	shipped	to	and	the	sequencing	experiments	were	performed	with	the	help	
of	MSc	Manuel	Mohr	(Department	of	Biosystems	Science	and	Engineering;	ETHZ).	
Sequencing	 of	 the	 plasmid	 has	 been	 performed	 via	 Sanger	 capillary	 sequencing	 using	 the	
primers	 displayed	 in	 Table	 2-1	 The	 resulting	 sequencing	 stretches	 and	 their	 respective	
overlaps	are	presented	in	Figure	2-1.	
It	is	a	pPR322-based	high	copy	number	plasmid	(45.79	kbp),	containing	a	22.800	kbp	insert	
from	Saccharomyces	cerevisiae	chromosome	III	at	the	BamHI	site.	
	
	
	 	
	
Figure	2-1	Linear	plasmid	map	of	the	circular	plasmid	pBR322-P170:	Top:	common	restriction	endonuclease	
recognition	sites	are	annotated	(cleavage	position	in	parenthesis)	above	the	overlapping	sequencing	reads	from	
the	individual	Sanger	sequencing	runs	(dark	red	arrows).	Bottom:	Known	features	are	annotated	as	different	
coloured	blocks/	arrows	depending	on	their	orientation.	Sequence	map	was	created	using	Snapgene	3.1.4	
software	(GLS	Biotech	LLC) 
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Table	2-1	pDNA	primer	sequences	of	pBR322-P170	
Name	 Sequence	(5’-3’)	
AmpStart	(Microsynth	standard)	 AAAACAGGAAGGCAAAATGC		
AmpStop	(Microsynth	standard)		 TCAGGCAACTATGGATGAAC		
Seq-Jo-001fwd		 GGATCTTCACCTAGATCC		
Seq-Jo-001rev	 TTTGTGATGCTCGTCAGG		
Seq-Jo-002fwd	 TACGCCGGACGCATCGTG	
Seq-Jo-002rev		 CGTATCGGTGATTCATTCTGC		
Seq-Jo-003fwd	 ATCTCCAGCAGCCGCACG		
Seq-Jo-003rev	 CCATACCCACGCCGAAAC		
Seq-Jo-004fwd	 AGCGGTATCAGCTCACTC		
Seq-Jo-004rev	 GATAGAGGCGCTAGTATG		
Seq-Jo-005fwd	 GTTCTTGACCTACCAGAAG	
Seq-Jo-005rev	 CACGTTTATTGCACACTC		
Seq-Jo-006fwd	 GAGAAATGCATCAGGCTG		
Seq-Jo-006rev	 GATGCATAGGATAGGTCG	
Seq-Jo-007fwd	 GGTTCTAACAATTCCTCC	
Seq-Jo-007rev	 GTGGCGCTGGTAATGATG	
Seq-Jo-008fwd	 GCTGAAAGGGATGGCTACG	
Seq-Jo-008rev	 GACCTAGATTCTCATAGAC	
Seq-Jo-009fwd	 CCTCTTCGTAGAATGCGG	
Seq-Jo-009rev	 CAAGAATACGCCAACAGC	
Seq-Jo-010fwd	 CGACACAGTTCATAACCG	
Seq-Jo-010rev	 GAAAAAGATCCTGGGGTG	
Seq-Jo-011fwd	 CCATCCTCATCCACTATAG	
Seq-Jo-011rev	 CCAGCGAGATTCTTATTTCG		
Seq-Jo-012fwd	 CACAGCGTTTCTGTGACC	
Seq-Jo-012rev	 GATCCTCACACTTACTCTGC		
Seq-Jo-013fwd	 CAATAGGACGAGGGAATC	
Seq-Jo-013rev	 GAGTTATTGCCCAGGTAGG	
Seq-Jo-014fwd	 TGATTGGAGAAAACACCG	
Seq-Jo-014rev	 CGTTTGTATCGCTATATGTACG	
Seq-Jo-015fwd	 GATCTCTTCGTGTAGTTGG	
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2.3.5.	Cold	atmospheric	pressure	plasma	treatment	for	in-situ	modification	of	anion	
exchange	chromatography	media	to	create	SEC-IEC	adsorbents	
2.3.5.1.	Plasma	etching	of	chromatography	supports	at	ambient	temperatures		
IEC	adsorbents	were	treated	in	a	custom-built	fluidised	bed	reactor	attached	to	an	underwater	
plasma	generation	system	(Figure	2-2).	
	
In	preparation	for	plasma	treatment,	adsorbents	were	washed	and	equilibrated	in	MQW	and	
a	5x	suspension	(water:	supports)	was	created.	The	suspension	was	vortex	mixed	on	a	VM	20	
vortex	mixer	(Chil	Tern	Scientific	Instrumentation,	London,	UK)	and	5	mL	(2.5	mL)	was	pipetted	
into	a	15	mL	Eppendorf	tube	and	filled	up	with	MQW	to	a	total	of	8	mL	to	create	a	12.5%	v/v	
(6.25%	v/v)	suspension	and	allowed	to	settle	overnight	(Figure	2-4	A).	
For	treatment,	sample	tubes	were	attached	as	shown	in	Figure	2-4	B;	the	purpose-built	plug	
comprising	 of	 ceramic	 (machinable	 Macor	 glass	 ceramic	 (Figure	 2-3;	 UK	 Farnell,	 Leeds,	
England))	and	PTFE	sealing	rings	plus	a	hollow	electrode	attached	to	a	gas	supply	set	to	0	SLM,	
was	inserted	into	the	open	end	of	the	sample	tube	(Figure	2-4	B).	
	
Figure	2-2	Set-up	of	the	fluidised	bed	plasma	reactor	with	associated	periphery	
A:	gas	flow	meter;	B:	reaction	vessel;	C:	oscilloscope;	D:	function	generator;	E:	DC	Power	supply;	F:	gas	
cylinder	(not	shown)	
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To	avoid	the	sample	slurry	flowing	back	into	the	gas	
line,	the	gas	supply	was	opened.	The	tube	was	then	
inverted	(Figure	2-4	C)	and	the	tube	tip	was	sliced	
off	using	a	razorblade	(Figure	2-4	D)	to	allow	gas	to	
exit	during	plasma	operation.	The	second	electrode	
was	inserted	from	the	top	into	the	slurry,	with	the	
tip	of	the	electrode	1	cm	below	the	surface	of	the	
slurry	(Figure	2-4	E).	The	upward	flow	of	gas	via	the	
hollow	 syringe	 electrode	 at	 the	 base	 of	 the	 tube	
was	set	to	the	desired	value,	providing	mixing	of	the	sample	slurry	while	equilibrating	it	with	
the	respective	carrier	gas.	
Frequency	and	flow	rate	were	set	to	desired	values	and	the	slurry	was	treated	for	a	set	amount	
of	time.	During	the	plasma	treatment,	power	input	was	kept	constant	by	manually	adjusting	
the	voltage.		
Current	 and	 voltage	 were	 measured	 with	 a	 Pearson	 Current	 Monitor	 2877	 (Pearson,	
California)	 and	 a	 Tektronix	 P5100	 High	 Voltage	 Probe	 (Tektronix,	 Oregon).	 Signals	 were	
recorded	on	a	Tektronix	DPO4104	Digital	Phosphor	Oscilloscope	(Tektronix,	Oregon).	Power	
was	regulated	and	supplied	using	a	PSP-603	power	supply	(GW	Instek;	UK	Farnell,	Leeds,	UK).	
After	the	time	of	treatment	had	finished,	the	Power	supply	was	cut	and	the	slurry	washed	out	
of	the	reactor	into	a	vacuum	filter	vessel.	The	supports	were	washed	with	3X	150	mL	of	MQW	
and	vacuum	dried	before	gently	scraping	the	sample	cake	off	the	filter	and	resuspending	it	in	
TE	 buffer	 (10	 mM	 Tris-HCl;	 1	 mM	 disodium	 EDTA;	 pH	 8.0;	 10	 mL	 total	 slurry	 volume,	
10%	slurrry).		
Post	treatment,	each	support	sample	was	analysed	in	duplicate	(results	averaged)	for	its	BSA	
and	pDNA	static	binding	capacities,	to	assess	the	reduction	of	core	and	shell	binding	levels	
respectively	as	described	in	2.3.6.		
Unless	stated	otherwise,	all	sample	media	were	treated	in	MQW	as	surrounding	buffer.	
	
	
Figure	2-3	Custom	built	Macor	ceramic	plug	
of	FBR	
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Figure	2-4	Sketch	drawing	of	‘top	down’	fabrication	process	of	cold	atmospheric	pressure	plasma	treatment	
for	in-situ	plasma	etching	and	oxidation	of	chromatography	supports	to	create	SEC-IEC	adsorbents	
A:	15	mL	Eppendorf	tube	with	settled	chromatography	supports	in	MQW	(left);	purpose-built	ceramic	plug,	
supplied	with	PTFE	O-rings	with	a	hollow	syringe	attached	to	a	gas	supply	and	a	copper	electrode	collar	
(right)	
B:	Vortex	mixed	Eppendorf	tube	with	chromatography	media	slurry	connected	to	the	plasma	apparatus	(no	
gas	flow)	
C:	Inversion	of	the	set-up	(start	gas	flow	to	prevent	backflow	of	slurry	into	the	gas	supply	line)	
D:	Slicing	off	the	top	of	the	Eppendorf	tube	with	a	razor	blade	allowing	gas	flow	to	mix	slurry	and	
equilibrate	buffer	with	working	gas	
E:	Insertion	of	electrode	into	the	slurry;	connection	of	electrical	equipment,	ready	for	plasma	treatment	
operation	
	
Figure	2-5	Fluidised	bed	plasma	reactor	under	operational	conditions	
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2.3.5.2.	Plasma	etching	of	chromatography	supports	after	addition	of	a	stirred	ice	bath	
To	 investigate	 the	 influence	 of	 slurry	 temperature	 during	 plasma	 etching	 treatment,	 the	
reactor	was	modified	by	adding	a	stirred	ice	bath	(Figure	2-6).	The	cooling	tank	was	directly	
attached	 to	 an	 inverted	 15	 mL	 Eppendorf	 tube	 imposing	 several	 modifications	 to	 the	
operational	work	flow.	
Instead	of	attaching	the	sample	tube,	inverting	it	and	cutting	off	the	tip	of	the	tube,	the	gas	
flow	through	the	reaction	chamber	was	set	and	the	slurry	directly	pipetted	into	the	reactor	
vessel.	To	avoid	interference	with	dissolved	gas	impurities	in	the	sample	buffer,	the	gas	was	
allowed	to	flow	through	the	slurry	for	one	minute	prior	to	application	of	voltage	to	the	reactor.	
The	plasma	operation	was	then	conducted	as	described	above.	
	
2.3.6.		Analysis	of	the	binding	properties	of	multifunctional	chromatography	supports	
‘Perfect’	bilayered	SEC-IEC	chromatography	supports	(functionalised	core	surrounded	by	an	
inert	size	excluding	outer	shell)	ideally	have	a	very	thin	size	excluding	outer	shell	that	prevents	
large	 nanoplexes	 to	 access	 and	 bind	 to	 the	 charged	 core	 of	 the	 supports	 as	 large	 non-
adsorptive	layers	surrounding	the	charged	core	increase	the	dead	volume	of	the	media	in	a	
column	chromatography	operation.	
In	a	‘top-down’	approach	for	the	manufacturing	of	such	supports	the	aim	has	to	be	to	create	
a	thin	outer	shell	while	maintain	full	core	functionality	in	order	to	avoid	the	loss	of	binding	
capacity.	The	lower	limit	for	the	thickness	of	the	non-adsorptive	layer	is	hereby	the	length	of	
	
Figure	2-6	Modified	reactor	with	the	addition	of	a	stirred	ice	bath	to	allow	lower	operational	temperatures	
during	the	plasma	treatment	operation	
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the	 intermolecular	 forces	 that	 cause	 the	nanoplex	of	 interest	 to	 bind	 to	 the	 ligand	of	 the	
support.	
2.3.6.1.		Static	pDNA	binding	studies	
Chromatography	supports	were	washed	in	MQW	and	equilibrated	in	TE	buffer	(10	mM	Tris-
HCl;	 1	mM	disodium	 EDTA;	 pH	 8.0)	 in	 a	 10x	 suspension	 for	 ease	 and	 precision	 of	 sample	
handling.	The	supports	were	aliquoted	into	750	µL	(75	µL	settled	bed	volume	(SBV))	aliquots,	
allowed	to	settle	and	the	supernatant	was	carefully	pipetted	out.	The	beads	were	incubated	
with	 1.5	 mL	 pDNA	 solution	 (concentration	 dependent	 on	 maximum	 binding	 capacity	 of	
respective	media)	on	a	blood	rotor	shaker	SB1	(Stuart	Scientific;	Staffordshire;	UK).	Then	the	
samples	were	centrifuged	(2,000	g;	10	sec)	and	the	supernatant	was	carefully	pipetted	out	for	
quantification.		
2.3.6.2.	Static	BSA	binding	studies	
Chromatography	supports	were	washed	in	MQW	and	equilibrated	in	TE	buffer	(10	mM	Tris-
HCl;	 1	mM	disodium	 EDTA;	 pH	 8.0)	 in	 a	 10x	 suspension	 for	 ease	 and	 precision	 of	 sample	
handling.		
The	 supports	 were	 aliquoted	 into	 750	µL	 (75	µL	 SBV)	 aliquots,	 allowed	 to	 settle	 and	 the	
supernatant	was	carefully	pipetted	out.	The	beads	were	incubated	with	1.5	mL	BSA	solution	
(concentration	 dependent	 on	maximum	binding	 capacity	 of	 respective	media)	 on	 a	 blood	
rotor	 shaker	 SB1	 (Stuart	 Scientific;	 Staffordshire;	 UK)	 for	 1	 h.	 Then	 the	 samples	 were	
centrifuged	 (2,000	 g,	 10	 sec)	 and	 the	 supernatant	 was	 carefully	 pipetted	 out	 for	 protein	
quantification.	
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2.3.7.		Protein	concentration	measurements	
2.3.7.1.	Bicinchoninic	acid	(BCA)	assay	for	total	protein	concentration	measurement	
Total	protein	concentration	in	liquid	samples	was	measured	using	the	Pierce	BCA	Protein	Kit	
following	the	manufacturers	protocol:	
The	working	 reagent	was	prepared	by	mixing	50	parts	of	Reagent	A	 (sodium	bicarbonate;	
bicinchoninic	acid;	sodium	tartrate	in	0.1	M	NaOH)	to	1	part	of	Reagent	B	(4%	cupric	sulfate).	
Aliquots	of	25	µL	of	sample	were	incubated	with	200	µL	of	the	working	reagent	on	a	plate	
rotor	(37°C;	30	min;	200	RPM).	Absorbance	was	measured	after	the	plate	was	allowed	to	cool	
to	room	temperature	on	a	GloMax-Multi	Detection	System	(Promega	UK;	Southampton;	UK)	
plate	reader	at	562	nm	and	compared	to	BSA	standard	curve	for	concentration	determination.		
2.3.7.2.	Spectrophotometric	measurement	of	protein	concentration	
For	 small	 numbers	 of	 samples	 (highly	 pure	 BSA	 samples	 in	 TE	 buffer),	 a	 simple	
spectrophotometric	 assay	was	 used.	 Protein	 solution	 (900	µL)	was	 pipetted	 into	 a	 quartz	
cuvette	 (path	 length	 10	mm;	 Suprasil,	 Hellma	Analytics,	UK)	 and	 the	OD280	was	measured	
(Evolution	 300,	 Thermo	 Fisher,	Madison,	 USA).	 The	 protein	 concentration	 in	 solution	was	
calculated	according	to	Beer’s	Law	(Beer,	1852):	A = 	e	 ∗ b ∗ c	
With	A	=	Absorbance;	c	=	concentration;	e	=	molar	extinction	coefficient	(eBSA=	6.6	(Fasman	et	
al.,	1989));	b	=	path	length	
TE	buffer	(10	mM	Tris-HCl;	1	mM	disodium	EDTA;	pH	8.0)	was	used	as	a	blank.	
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2.3.8.	Nucleic	Acid	Quantification	
Several	 different	 methods	 have	 been	 employed	 for	 pDNA	 quantification	 in	 solutions.	
Depending	on	sample	purity	requirements,	simple	optical	density	and	fluorometric	analyses	
methods	were	used,	while	DNA	contents	in	E.	Coli	 lysate	fractions	were	analysed	with	DPA	
assay.	
2.3.8.1.	Spectrophotometric	analysis	of	pDNA	concentration	in	solution	
For	small	numbers	of	samples	(highly	pure	pDNA	in	TE	buffer,	purified	using	Qiagen	lysis	as	
described	 in	 2.3.3.	 ),	 a	 simple	 spectrophotometric	 assay	 was	 used.	 Plasmid	 DNA	 solution	
(800	µL)	was	pipetted	into	a	quartz	cuvette	and	absorbance	was	measured	at	OD260.	TE	buffer	
(10	mM	Tris-HCl;	1	mM	EDTA;	pH	8.0)	was	used	as	a	blank,	using	a	10	mm	path	length	quartz	
cuvette,	 the	 concentration	 of	 ds	 pDNA	 in	 solution	 and	 the	 optical	 density	 are	 linearly	
correlated	for	OD260	=	0.1	-	1	and	were	calculated	using	the	following	equation	(Barbas	et	al.,	
2007):	 𝑐 = 𝑂𝐷260 ∗ 50	 	µ𝑔	[𝑝𝐷𝑁𝐴]𝑚𝐿	[𝑇𝐸	𝑏𝑢𝑓𝑓𝑒𝑟]	
with	c	=	concentration	[µgpDNA/mLTE]	
2.3.8.2.	Fluorometric	quantification	of	pDNA	content	in	aqueous	solution	using	Hoechst	dye	
33258	ds	DNA	label	
Hoechst	dye	33258	is	a	known	fluorescent	label	that	is	used	for	the	quantification	of	DNA	due	
to	its	fluorescent	enhancement	upon	binding	to	A-T	rich	regions	of	ds	DNA	(Latt	et	al.,	1976;	
Loontiens	et	al.,	1990).	The	following	microwell	plate	method	is	an	adapted	protocol	by	Rago	
et	al.	(Rago	et	al.,	1990).	
Due	to	the	light	sensitivity	of	the	dye,	all	experiments	were	conducted	in	a	dark	environment	
with	all	equipment	wrapped	in	aluminium	foil.		
Hoechst	 dye	 33258	was	 dissolved	 till	 oversaturation	 in	 a	DMSO/MQW	 (1/4-	 v/v)	 solution,	
centrifuged	 (2,000	 g;	 20	 s)	 and	 the	 saturated	 supernatant	 was	 pipetted	 out,	 centrifuged	
(2,000	g;	20	s)	and	the	supernatant	was	pipetted	out	into	a	clean	vessel	to	avoid	undissolved	
dye	in	the	solution.	
Aliquots	of	25	µL	of	Hoechst	dye	33258	solution	were	mixed	with	10	mL	of	TNE	buffer	(10	mM	
Tris;	2	M	NaCl;	1	mM	EDTA;	2	mM	sodium	azide;	pH	7.4)	to	create	the	working	reagent.		
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100	µL	of	working	reagent	were	mixed	with	100	µL	of	pDNA	solution	in	a	microwell	plate	and	
after	10	min	incubation	time	the	fluorescence	intensity	was	measured	(excitation/	emission	
(ex/em):	360/460	nm).	The	blank	fluorescence	of	MQW	was	subtracted	from	each	value.	
Calf	thymus	DNA	(in	TE	buffer;	10	mM	Tris-HCl,	1	mM	disodium	EDTA,	pH	8.0)	was	used	to	
create	a	standard	curve.		
The	fluorescence	intensity	counts	are	linearly	correlated	up	to	pDNA	concentrations	of	at	least	
20	µg/mL	(calf	thymus	(ct)	DNA	standard	curve	is	depicted	in	Appendix	A-2).	As	the	binding	
specificity	is	strongly	affected	by	the	ionic	strength	of	the	surrounding	buffer	(Labarca	et	al.,	
1980),	all	samples	were	kept	in	the	same	(TE)	buffer	environment	without	addition	of	further	
solutes.	
2.3.8.3.	Diphenylamine	(DPA)	assay	to	quantify	pDNA	concentrations		
DPA	assay	is	a	colorimetric	procedure	to	determine	the	concentrations	of	DNA	in	solution	first	
described	by	(Burton,	1956).	Total	pDNA	concentrations	of	column	chromatography	fractions	
were	determined	following	a	modified	protocol	(Gendimenico	et	al.,	1988),	by	mixing	175	µL	
of	pDNA	solution	with	25	µL	of	2	mg/mL	BSA	solution	(in	MQW)	in	a	screw	cap	microcentrifuge	
tube	before	adding	200	µL	of	0.4	M	perchloric	acid	and	mixing	on	a	VM20	vortex	mixer	(Chil	
Tern	Scientific	Instrumentation,	London,	UK).	The	samples	were	incubated	(0.5	h;	at	4°C)	and	
then	 centrifuged	 (10,000	 g;	 20	 min).	 The	 supernatant	 was	 carefully	 pipetted	 out	 and	
discarded.	The	pellet	was	resuspended	in	250	µL	of	1	M	perchloric	acid	by	vortex	mixing	and	
incubated	on	a	spinning	heating	block	(70°C;	200	rpm;	30	min).	Samples	were	allowed	to	cool	
to	 room	temperature	and	mixed	 thoroughly	with	500	µL	of	 freshly	prepared	chromogenic	
reagent	 (prepared	 by	mixing	 200	 parts	 of	 diphenylamine	 solution	 (1.5	 g	 DPA	 dissolved	 in	
100	mL	glacial	acetic	acid	and	1.5	mL	of	concentrated	sulfuric	acid)	with	1	part	of	2%	(v/v)	
acetaldehyde).	The	samples	were	then	incubated	overnight	on	a	heating	block	mixer	(37°C;	
18	h)	and	following	incubation	taken	for	OD600	measurement	(MQW	was	used	as	a	blank).	Calf	
thymus	 DNA	 solutions	 (in	 TE	 buffer;	 10	 mM	 Tris-HCl,	 1	 mM	 disodium	 EDTA,	 pH	 8;	
concentrations	determined	by	OD260	measurements)	were	used	to	construct	a	standard	curve	
for	DNA	concentration.	Due	to	the	hazardous	nature	of	some	of	the	compounds,	the	whole	
assay	was	performed	in	a	fume	cupboard.	
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2.3.8.4.	Orcinol	assay	for	RNA	quantification	(Almog	et	al.,	1978)		
Orcinol	assay	for	RNA	concentration	measurement	used	in	this	study	is	based	on	a	protocol	
first	described	by	(Almog	et	al.,	1978).		
Solution	A	was	prepared	by	dissolving	100	mg	of	 iron(III)	 chloride	 in	100	mL	concentrated	
hydrochloric	acid.	Solution	B	was	prepared	by	dissolving	300	mg	of	orcinol	 in	5	mL	MQW.		
A	working	reagent	was	prepared	by	mixing	70	mL	of	solution	A	with	2.45	mL	of	solution	B.		
200	μL	of	the	chromatography	fraction	sample	containing	RNA	(diluted	1:2	with	MQW)	was	
mixed	and	incubated	with	300	μL	of	freshly	prepared	working	reagent	in	a	water	bath	(95°C;	
20	min).	After	cooling	to	room	temperature,	the	samples	were	centrifuged	(600	rpm;	15	min)	
and	the	supernatants	were	pipetted	out	 for	spectrophotometrical	analysis	at	OD665	 (MQW	
used	as	blank).	
RNA	standards	from	baker's	yeast	(S.	cerevisiae)	were	handled	alongside	the	RNA	samples	at	
a	concentration	range	of	0-100	μg/mL	to	construct	a	standard	curve.		
2.3.9.	Ionic	capacity	measurements	
Measurement	of	ionic	capacity	of	beaded	chromatography	materials	was	conducted	following	
a	protocol	by	(Theodossiou	et	al.,	2002).	
Chromatography	supports	(0.25	mL	SBV	in	MQW)	were	incubated	with	25	mL	of	2	M	NaCl	for	
1.5	 h.	 To	 remove	 excess	 Cl-	 ions	 (from	 both	 the	 supernatant	 and	 unspecifically	 bound	 to	
supports),	the	supports	were	washed	and	drained	five	times	with	50	mL	MQW	on	a	vacuum	
filter.	 The	 drained	 supports	 were	 subsequently	 transferred	 to	 50	 mL	 centrifuge	 tubes	
containing	25	mL	of	0.1	M	NaOH	and	incubated	overnight	on	a	blood	tube	rotator	SB1.	During	
the	incubation	with	NaOH,	excess	OH-	ions	displace	the	Cl-	ions	on	the	beads,	releasing	them	
into	 the	 surrounding	 buffer.	 Supports	 were	 left	 to	 settle	 and	 1	mL	 was	 taken	 for	 Cl-	 ion	
determination.	 
Cl-	 ion	 quantification	 was	 performed	 by	 either	 mixing	 1	 mL	 sample	 or	 calibration	 ladder	
solution	with	both	100	μL	of	0.25	M	ammonium	iron	(III)	sulphate	in	9	M	HNO3	and	100	μL	of	
mercury	(II)	thiocyanate	saturated	in	96%	ethanol.	The	sample	was	then	mixed	vigorously	on	
a	VM20	 vortex	mixer	 (Chil	 Tern	 Scientific	 Instrumentation,	 London,	UK).	 The	 reaction	was	
stopped	after	5	min	and	the	OD460	was	measured	(UVIKON	922	spectrophotometer;	KONTRON	
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Instruments,	Bletchley,	UK).	NaCl	solutions	(range	0.1-	2	mM)	were	used	to	obtain	a	standard	
curve	for	the	Cl-	ion	concentration. 
2.3.10.	Sample	preparation	of	plasma	treated	chromatography	supports	for	Time	of	
Flight	Secondary	Ion	Mass	Spectrometry	(ToF	SIMS)	analysis		
Prior	to	their	usage	in	ToF	SIMS,	support	samples	were	dried	following	an	adapted	protocol	
by	(Johansson	et	al.,	2004).		
For	each	sample,	50	µL	of	SBV	beads	were	equilibrated	three	times	in	a	2	mL	Eppendorf	tube	
in	2	mL	of	MQW,	centrifuged	(2,000	g;	10	sec)	and	the	supernatant	was	carefully	pipetted	out.	
The	samples	were	suspended	in	2	mL	of	0.5	M	NaCl	(in	MQW),	centrifuged	(2,000	g;	10	sec)	
and	the	supernatant	was	carefully	pipetted	out	before	suspending	the	pellet	in	2	mL	of	MQW	
followed	by	centrifugation	(2,000	g;	10	sec)	and	the	supernatant	was	discarded.	The	supports	
were	transferred	to	a	HetoVac	Speed	vacuum	system	and	gently	dried	overnight	at	1	mbar.	
The	 samples	 were	 sealed,	 shipped	 to	 and	 ToF-SIMS	 spectra	 for	 analysis	 of	 the	 chemical	
composition	of	adsorbent	surfaces	were	recorded	with	the	help	of	Dr	Martina	Modic	(Jožef	
Stefan	Institute,	Ljubljana).	
2.3.11.	Imaging	of	chromatography	media	
For	selection	of	chromatography	media	for	nanoplex	purification,	several	parameters	such	as	
stability	(how	often	can	the	column	be	used	before	the	media	needs	to	be	replaced?),	rigidity	
(what	cleaning	in	place	(CIP)	regiment	can	be	applied	without	damaging	the	media?),	pore	size	
distribution	(what	is	the	exclusion	limit	of	the	media?),	breakthrough	capacity	(how	much	can	
be	loaded	onto	the	column	in	a	single	chromatographic	(batch)	operation?)	and	level	of	cross-
linking	(what	pressures/	flow	velocities	can	be	applied	to	a	packed	column?)	are	important	
factors	to	be	considered.		
Often	secondary	for	the	choice	of	media	is	its	visual	appearance;	however,	when	aiming	to	
modify	the	exterior	of	particles’	surfaces,	their	structural	integrity	becomes	relevant.		
It	was	previously	reported	that	plasma	treatments	of	chromatography	media	to	modify	the	
chemical	 composition	 of	 the	 surface	 of	 hydrogel	 chromatography	 particles	 lead	 to	 severe	
visual	alteration	(Olszewski	et	al.,	2014).	Several	techniques,	used	in	this	study	to	monitor	the	
visual	 integrity	 post	 plasma	 treatment	 (ESEM,	 light	 microscopy),	 to	 assess	 the	 spatial	
	 -	59	-	
distribution	 of	 protein	 and	 pDNA	 binding	 (CLSM)	 of	 the	 particles	 as	 well	 as	 their	 size	
distributions,	were	therefore	employed.		
2.3.11.1.	Environmental	Scanning	Electron	Microscopy	
Chromatography	 support	 samples	 were	 prepared	 by	 dehydration	 in	 ethanol	 followed	 by	
critical	point	drying.	Imaging	of	samples	was	carried	out	on	a	Philips	XL-30	FEG	Environmental	
SEM	(FEI	Company,	OR,	USA).	 
ESEM	visualization	of	chromatography	supports	was	kindly	assisted	by	Mr	Paul	Stanley,	School	
of	Metallurgy	and	Materials,	University	of	Birmingham.	
2.3.11.2.	Light	microscopic	analysis	of	chromatography	media	
80	µL	 of	 chromatography	 supports	 slurry	 in	MQW	were	pipetted	onto	 a	microscope	 slide	
(VWR	VistaVision	Microscope	Slides,	VWR	International,	UK)	and	covered	with	a	cover	glass	
(VWR	Micro	 Cover	Glasses),	 carefully	 avoiding	 the	 formation	 of	 air	 bubble	 inclusions.	 The	
sample	was	 then	analysed	 in	an	Olympus	BX50	 light	microscope	using	4x,	10x,	20x	or	40x	
magnification	 respectively.	 For	 images	 taken	 with	 a	 100x	 magnification,	 a	 droplet	 of	
immersion	oil	(Sigma	Aldrich)	was	used	to	bridge	the	gap	between	the	lens	and	the	cover	slide.	
Images	were	 taken	with	 a	Moticam	800x600	PIX,	 controlled	by	Motic	 Images	 plus	 2.0	ML	
software.	Further	image	analysis	was	conducted	with	(Fiji	is	just)	ImageJ	(Version	1.0	for	Mac).	
	
2.3.12.	Exploring	the	binding	topography	of	SEC-AEC	media	using	confocal	laser	
scanning	microscopy	(CLSM)	
2.3.12.1.	Tagging	of	BSA	with	fluorescent	dye	Cy5	
To	 get	 an	 insight	 into	 the	 spatial	 distribution	 of	 bound	 probes	 (BSA	 and	 pDNA)	 to	
chromatography	media,	CLSM	was	employed.	The	fluorescent	probe	Cy5	was	attached	to	BSA	
according	 to	 the	 following	 protocol	 (due	 to	 light	 sensitivity	 of	 Cy5,	 all	 sample	 tubes	were	
wrapped	in	aluminium	foil	and	kept	away	from	light):	
5	mL	of	BSA	solution	(70	mg/mL)	was	prepared	in	TE	buffer	(10	mM	Tris-HCl,	1	mM	disodium	
EDTA,	 pH	 8.0).	 The	 solution	 was	 incubated	 with	 32.4	µL	 of	 Cy5	 NHS	 Ester	 stock	 solution	
(1	mg/mL	in	DMSO)	for	1	h	on	a	Stuart	Scientific	SB1	rotor.	
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To	acquire	a	molar	ratio	of	1:	100	Cy5:	BSA	(Hubbuch	et	al.,	2008)	the	required	amounts	were	
calculated	using	the	following	equations:	𝑛 𝐵𝑆𝐴 = A BCD	EFGHIJFK 	∗	L BCD	EFGHIJFKM BCD 		
			= N.NP	 QRS	∗	T	UVWWXYN	 QRZ[ = 5.267 ∗ 10^W	𝑚𝑜𝑙	𝑛 𝐶𝑌5 	 = 	𝑛 𝐵𝑆𝐴100 = 5.267 ∗ 10^c	𝑚𝑜𝑙	𝑚 𝐶𝑌5 = 𝑛 𝐶𝑌5 ∗ 𝑀 𝐶𝑌5 																		= 5.267 ∗ 10^c	𝑚𝑜𝑙 ∗ 616.19 𝑔𝑚𝑜𝑙 = 0.0324	𝑚𝑔	𝑉 𝐶𝑌5	𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛; 	1𝑚𝑔𝑚𝐿 = 	𝑚 𝐶𝑌5𝑐 𝐶𝑌5 = 	0.0324	𝑚𝑔1𝑚𝑔𝑚𝐿 = 0.0324	𝑚𝐿 = 32.4	𝜇𝐿	
The	used	dye:	protein	ratio	was	found	to	reduce	re-adsorption	of	emitted	light	and	allowed	
for	efficient	purification	of	labelled	protein.	Free,	un-conjugated	dye	was	separated	from	the	
bio-conjugated	proteins	using	single-use	PD-10	desalting	columns	packed	with	SE	Sephadex	
G-25	media.	 The	 column	was	 equilibrated	 in	 25	mL	 of	 TE	 buffer	 (10	mM	 Tris-HCl,	 1	mM	
disodium	EDTA,	pH	8.0)	before	2.5	mL	of	 the	Cy5	 tagged	BSA	 solution	was	applied	 to	 the	
column	in	gravitational	flow	and	subsequently	eluted	using	3.5	mL	of	TE	buffer	(10	mM	Tris-
HCl,	1	mM	disodium	EDTA,	pH	8.0),	yielding	3.5	mL	of	Cy5	tagged	BSA	solution	(c=	50	mg/mL).	
The	solution	was	stored	away	from	light	in	the	fridge	until	further	usage.	
2.3.12.2.	Labelling	of	pDNA	with	green	fluorescent	stain	Syto	9	
To	provide	a	quantitative	correlation	between	signal	intensity	and	pDNA	binding	capacity,	the	
pDNA	 solution	 was	 pre-	 stained	 using	 the	 minor	 grove	 binding	 fluorescent	 dye	 Syto	 9	
according	to	the	following	protocol:	𝑉𝑑𝑦𝑒 = 𝑚𝑝𝐷𝑁𝐴 ∗	#𝑏𝑝	𝑝𝑒𝑟	𝑝𝐷𝑁𝐴	𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑡𝑎𝑔𝑔𝑖𝑛𝑔	𝑓𝑎𝑐𝑡𝑜𝑟 ∗ 	 1𝑀𝑝𝐷𝑁𝐴 ∗ 𝑐𝑑𝑦𝑒	
Purified	pDNA	stock	solution	(26.688	kbp;	M	=	16.49	*	10^6	g/mol	(Bioinformatics,	2017)	in	
TE	buffer	(10	mM	Tris-HCl;	1	mM	disodium	EDTA;	pH	8.0);	see	2.3.3.	)	was	thawed	overnight	
in	the	fridge	and	diluted	with	TE	buffer	(10	mM	Tris-HCl;	1	mM	disodium	EDTA;	pH	8.0)	to	a	
concentration	of	15	µgpDNA/mL.	A	sample	of	4	µL	Green	fluorescent	stain	Syto	9	stock	solution	
(c	=	5mM	in	DMSO)	was	mixed	with	96	µL	of	MQW	to	create	a	Syto9	working	solution	(c	=	0.2	
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mM;	due	to	the	light	sensitivity	of	the	Syto9	dye	all	tubes	were	wrapped	in	aluminium	foil	and	
kept	away	from	light).		
pDNA	solution	was	incubated	with	Syto9	working	solution	(ratio	of	100	bases	of	nucleic	acid	
to	1	dye molecule)	on	a	Stuart	Scientific	SB1	rotor	mixer	for	1	h:	Vsyto	9	working	solution1	mL	pDNA	solution = 1.215	µL		
During	the	assay	development,	 it	was	found	that	a	separation	step,	ridding	the	solution	of	
unconjugated	dye	was	unnecessary	for	subsequent	use	in	the	CLSM	analysis.	This	is	the	result	
of	 both	 the	 high	 binding	 affinity	 of	 the	 dye	 to	 ds	 DNA	 as	 well	 as	 its	 enhancement	 of	
fluorescence	intensity	upon	binding	(Stocks,	2004).		
2.3.12.3.	CLSM	Analysis	of	chromatography	supports		
50	µL	SBV	of	chromatography	supports	were	equilibrated	three	times	in	TE	buffer	(10	mM	
Tris-HCl;	1	mM	disodium	EDTA;	pH	8.0),	centrifuged	(2,000	g;	10	sec)	and	the	supernatant	
carefully	pipetted	out.	 The	beads	were	 incubated	with	1	mL	Syto	9	 tagged	pDNA	 solution	
(c	=	15	µg/mL)	on	a	Stuart	Scientific	SB1	rotor	mixer	for	1	h.	Then	the	samples	were	centrifuged	
(2,000	g;	10	s)	and	the	supernatant	was	carefully	pipetted	out.	The	beads	were	washed	three	
times	with	1	mL	of	TE	buffer	(10	mM	Tris-HCl;	1	mM	disodium	EDTA;	pH	8.0)	to	avoid	unspecific	
binding.		
The	samples	were	then	incubated	with	1	mL	of	Cy5	labelled	BSA	solution	(c=	5	mg/mL)	on	a	
Stuart	 Scientific	 SB1	 rotor	mixer	 for	 2	 h,	 centrifuged	 (2,000	 g;	 10	 s)	 and	 the	 supernatant	
carefully	pipetted	out.	The	beads	were	washed	three	times	with	1	mL	of	TE	buffer	(10	mM	
Tris-HCl;	1	mM	disodium	EDTA;	pH	8.0)	to	avoid	unspecific	binding	and	resuspended	in	950	µL	
of	TE	buffer	(1	mL	total	volume).	
100	µL	of	the	suspension	was	pipetted	onto	a	microscope	slide	and	covered	with	a	cover	glass.	
A	droplet	of	immersion	oil	was	used	for	the	microscopic	analysis.		
All	 samples	were	analysed	on	a	 Leica	TCS	SPE	102A	CLSM	system	equipped	with	krypton/	
argon	(λ	=	488	nm	and	λ	=	568	nm)	and	helium/	neon	(λ	=	633	nm)	lasers,	using	a	40x/	1.15	Oil	
ACS	Objective.	A	light	microscopic	image	was	taken	of	the	analysed	beads	(LCMOS	3M,	Brunel	
Microscopes),	focussing	on	the	central	meridian	of	each	bead.		
The	beads	were	manually	focussed	and	a	z-stack	image	series	was	recorded	for	both	excitation	
wavelengths;	 Cy5	 tagged	 BSA	 ex/em:	 635	 nm/654-	 715	 nm;	 Syto9	 tagged	 pDNA	 ex/em:	
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488	nm/492-	533	nm.	Images	were	captured	using	the	Leica	Application	Suite	(LAS	X)	software	
(Version	1.9;	Leica	Microsystems,	GmbH).	Settings	including	laser	intensity,	signal	gain,	offset	
and	emission	detection	range	were	optimised	to	suppress	auto-fluorescence.	Control	 tests	
ensured	that	the	detected	emitted	light	intensity	was	within	detection	range	and	blank	tests	
confirmed	the	absence	of	auto-fluorescence	of	untagged	protein,	pDNA	and	chromatography	
resin	(Close	et	al.,	2013).	Emission	detection	ranges	for	the	photomultiplier	tube,	gain,	offset	
and	thresholds	were	adjusted	to	enhance	fluorescence	detection.		
ImageJ	was	used	for	data	analysis	and	processing.	GIMP	2.8.22	was	used	to	remove	artefacts	
from	images.	
2.3.13.	Measurement	of	the	particle	size	distribution	of	beaded	chromatography	
media	
Particle	 size	 distributions	 of	 various	 chromatography	 media	 were	 analysed	 using,	 a	
Mastersizer	Hydro	2000	SM	(Malvern	Instruments;	Malvern;	UK).	
The	optic	cell	was	drained	and	flushed	three	times	with	MQW.	To	remove	air	bubbles	from	
the	sample	lines,	the	stirrer	speed	was	set	to	1,000	RPM	for	10	s	prior	to	sample	addition.	
Chromatography	supports	were	washed	three	times	in	water	(1	mL	of	supports	(SBV)	in	15	mL	
MQW)	and	gently	centrifuged	to	assist	sedimentation	and	clearance	of	fines	(500	RPM;	2	min).		
A	background	measurement	was	taken	to	ensure	absence	of	artefacts	and	to	calibrate	the	
baseline	of	laser	obscuration.	Chromatography	support	samples	in	MQW	were	then	pipetted	
into	the	chamber	(laser	obscuration	between	10	and	20%-	aim	13%).	
For	 the	 SOP	 controlling	 the	measurement,	 the	 refractive	 index	 of	 agarose	was	 used	 (1.42	
(Deane,	2013)).	After	the	measurement	was	done,	the	support	sample	was	drained	from	the	
chamber	and	flushed	three	times	with	MQW	before	the	next	measurement.	
For	post	experimental	data	analysis;	number,	surface	and	volume	weighted	size	distributions	
were	calculated	and	the	respective	histograms	plotted	using	MATLAB_R2017a.	
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Chapter	3 Cold	atmospheric	pressure	plasma	etching	and	oxidation	of	AEC	
media	for	preparation	of	multifunctional	bilayered	supports	
Abstract	
Means	for	the	production	of	bilayered	size	exclusion/	ion	exchange	chromatography	materials	
by	modification	of	support	exteriors	via	plasma	etching	and	oxidation	using	cold	atmospheric	
pressure	 plasmas	 was	 investigated.	 Four	 different	 anion	 exchange	 chromatography	
adsorbents	(Q	Sepharose	Fast	Flow,	DEAE	Sepharose	Fast	Flow,	Q	Hyper	Z	and	EMD	Fractogel	
DEAE)	were	treated	using	plasmas	generated	from	He-O2	admixed	gasses	in	a	Dielectric	Barrier	
Discharge	 and	 a	 novel	 underwater	 fluidised	 bed	 reactor	 configuration.	 The	 degree	 of	
bilayering	was	assessed	via	static	binding	studies	using	BSA	and	pDNA	as	probes	for	retention	
of	core	and	surface	binding	respectively.		
In	the	DBD	configuration,	SI	values	were	seen	to	have	an	 inverse	correlation	with	distance	
between	 the	 sample	 and	 upper	 electrode	 plate	 during	 treatment,	 with	 treatments	 at	 a	
distance	of	4.5	mm	producing	SI	values	up	to	~5	(85%	loss	of	pDNA	binding	with	<25%	loss	of	
BSA	binding).	In	the	fluidised	bed	configuration,	treatment	of	supports	with	a	He-O2	plasma	
produced	supports	with	SI	 values	up	 to	~3,	 corresponding	 to	70%	 loss	of	pDNA	binding	 in	
exchange	for	8%	loss	of	BSA	binding.	
A	 CLSM	 method	 was	 developed	 to	 visualise	 the	 binding	 topography	 of	 BSA	 and	 pDNA,	
adsorbed	 to	 chromatography	 supports,	 revealing	 limitations	 of	 the	 plasma	 etching	 and	
oxidation	technique	due	to	the	presence	of	irregularities	on	the	surface	of	single	adsorbents.		
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3.1.	Introduction	
Preparative	 chromatography	 is	 considered	a	pivotal	 tool	 in	DSP	 for	 the	biopharmaceutical	
industry	(Ghanem	et	al.,	2013;	Abdulrahman	et	al.,	2018).	
However,	 in	 comparison	 to	 advances	made	 in	 upstream	 production	 of	 biopharmaceutical	
manufacturing,	 DSP	 has	 seen	 little	 innovation,	 especially	 in	 development	 of	 novel	 column	
chromatography	approaches.	Advances	in	the	development	of	high-level	expression	systems	
for	upstream	processing	have	led	to	dramatic	cost	reductions	as	well	as	titre	increases,	and	
DSP	is	increasingly	viewed	as	a	bottleneck	for	the	overall	manufacturing	costs	associated	with	
the	 production	 of	 biopharmaceuticals	 (Pinto	 et	 al.,	 2015).	 New	 challenges,	 that	 column	
chromatography	 is	 facing	 include	 increased	 size	 and	 complexity	of	 emerging	bio-products,	
rising	product	 titres,	 increasing	costs	of	goods	and	waste	disposal	 requirements	as	well	as	
tougher	 competition	 from	 other	 DSP	 purification	 techniques.	 Confronted	 with	 such	
multifaceted	challenges,	it	becomes	increasingly	unlikely	that	optimisation	of	existing	mono-
functional	chromatography	techniques	will	be	able	to	hold	up	to	fulfil	all	expectations	posed	
on	beaded	chromatography	as	a	purification	technique.	As	opposed	to	the	‘one	column-	one	
functionality’	 approach	 that	 has	 dominated	 the	 chromatographic	 research	 for	 decades,	
solutions	 for	 the	 outlined	 challenges	 can	 be	 achieved	 by	 reimagining	 chromatographic	
separation	based	on	multifunctional	adsorbents.		
Among	more	complex	geometries,	the	simplest	multifunctional	support	design	is	a	bilayered	
adsorbent	 featuring	 a	 ligand	 functionalised	 core	 surrounded	 by	 an	 inert,	 outer	 layer	 that	
restricts	 access	 of	 large	 molecular	 entities	 such	 as	 plasmid	 DNA,	 viruses,	 VLPs,	
immunoglobulin	M	(IgM)	to	the	binding	core	via	size	cut	off	(Figure	3-1,	B).	Bilayered	beads	
based	on	combining	adsorptive	chromatography	with	a	SE	shell	have	been	successfully	utilised	
in	the	purification	of	pDNA	molecules	(Gustavsson	et	al.,	2004;	Kepka	et	al.,	2004),	separation	
of	organic	acids	(Dainiak	et	al.,	2002b;	Viloria-Cols	et	al.,	2004)	and	in	protein	purification	in	
the	form	of	EBA	media	(Dainiak	et	al.,	2002b;	Jahanshahi	et	al.,	2008).	Since	2012,	media	with	
the	outlined	properties	have	been	introduced	to	the	market	(GE	Healthcare	Bio-Science,	2012)	
and	are	commercially	available	for	purification	of	viruses	and	other	large	biomolecules	(Blom	
et	al.,	2014;	Weigel	et	al.,	2014;	Lagoutte	et	al.,	2016;	Somasundaram	et	al.,	2016).	
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Most	chromatographic	purification	techniques	available	for	the	separation	of	bio-therapeutic	
entities	were	originally	developed	and	optimised	for	the	separation	of	protein	based	products.	
More	complex	bioproducts	such	as	pDNA,	viral	vectors	or	vaccines	of	high	molecular	weight	
do	however	differ	dramatically	in	size	and	properties	to	protein	based	products	and	as	a	result	
require	different	purification	strategies	(Lyddiatt	et	al.,	1998;	Prazeres	et	al.,	1999;	Ferreira	et	
al.,	 2000b;	 Theodossiou	 et	 al.,	 2001).	 Current	 industrial	 purification	 techniques	 for	 pDNA	
products	still	rely	heavily	on	packed	bed	chromatography	with	IEC	being	the	most	prevalent	
first	capture	step,	followed	by	SEC	to	polish	the	elution	fractions	(Prazeres	et	al.,	1999;	Ferreira	
et	al.,	2000b;	Freitas	et	al.,	2009a).		
Bilayered	SEC-IEC	support	media	based	on	a	charged	core	surrounded	by	a	non-binding,	size	
restricting	 shell	 have	 shown	 to	 improve	 performance	 of	 pDNA	 purification	 from	 smaller,	
chemically	similar	contaminants	such	as	RNA,	HCP	and	endotoxins	(Gustavsson	et	al.,	2004;	
Kepka	et	al.,	2004).	
	
Figure	3-1	Working	principle	of	plasma	etching	and	oxidation	to	create	SEC-	AEC	supports	(A):	the	ROS	react	
with	the	N(CH3)3+	ligand	groups	etching	them	off	the	surface,	leaving	only	the	agarose	base	matrix	behind.		
Small	charged	contaminants	are	able	to	penetrate	through	the	outer	SEC	layer	and	bind	to	the	
functionalised	interior	of	the	bead	whereas	large	pDNA	molecules	are	too	big	to	access	the	pores	-the	inert	
exterior	prevents	them	from	binding	altogether,	passing	the	column	in	the	flow	through	(B) 
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The	bilayered	SEC-IEC	design	also	shows	benefits	for	EBA	(Arpanaei	et	al.,	2010).	Problems	
associated	with	collapsing	beds,	due	to	cross-linking	of	the	surfaces	of	IEC	particles	by	‘sticky’	
molecules	 in	 the	 feedstock,	 have	 resulted	 in	 a	 slow	 uptake	 of	 the	 technique	 in	 industry	
(Ameskamp	et	al.,	1999;	Theodossiou	et	al.,	2001;	Abdulrahman	et	al.,	2018).	Attempts	 to	
resolve	inter-particle	linking	of	the	adsorbents	via	chemical	and	mechanical	conditioning	of	
the	feedstock	have	yielded	limited	success	(Lin	et	al.,	2004;	Hubbuch	et	al.,	2006;	Sonnenfeld	
et	 al.,	 2006).	 Ideally,	 the	 surfaces	 of	 EBA	 supports	 would	 hence	 be	 non-interactive,	 with	
bilayered	media	offering	exactly	that-	small	entities	of	the	feedstock	such	as	RNA	and	proteins	
are	bound	within	the	core,	while	larger	molecules	cannot	link	the	adsorbents	due	to	the	non-
interactive	nature	of	the	surrounding	shell	and	pass	through	the	system	in	the	flow	through.	
To	compromise	the	least	on	mass	transport	and	binding	capacity,	the	particle	exteriors	need	
to	be	as	thin	as	possible,	while	still	preventing	surface	binding	(Theodossiou	et	al.,	2002).	
In	order	to	provide	such	multifunctional	media,	new	approaches	must	be	developed,	that	are	
capable	of	modifying	surfaces	at	the	nano	scale	by	either	applying	ultra-thin	coatings	to	bury	
exposed	ligands	or	removing	them	from	the	surface.	
Plasma	irradiation	has	been	shown	to	be	a	useful	technology	for	modifying	material	surfaces	
at	 the	 ‘nano-scale’.	 Plasma	 hereby	 is	 defined	 as	 a	 wholly	 or	 partially	 ionised	 medium	
comprising	of	ions,	electrons,	as	well	as	neutral	species	and	photons	(Fisher,	2002;	Arpanaei	
et	 al.,	 2010).	 Advantages	 of	 such	 plasma	 treatments	 include:	 (i)	 operation	 at	 low	 (room)	
temperatures;	(ii)	shallow	modifications	can	be	achieved,	without	altering	the	bulk	properties	
of	 underlying	media;	 (iii)	 suitable	 for	modifying	many	different	 types	 and	 compositions	of	
surfaces;	and	(iv)	no	generation	of	large	amounts	of	toxic	by-products	(Schram	et	al.,	1987).	
Surface	modification	by	plasma	 is	performed	 in	a	reactor	supplied	with	a	suitable	gas	(e.g.	
helium	 admixed	 with	 oxygen	 (Knake	 et	 al.,	 2008;	 Park	 et	 al.,	 2010)).	 An	 electrical	 or	
electromagnetic	supply	of	energy	is	provided	to	ignite	a	plasma	within	the	reactor.	Collisions	
between	 the	 energetic	 plasma	 species	 and	 gas	 particles	 lead	 to	 the	 generation	 of	 highly	
reactive	oxygen	species	suitable	for	carrying	out	surface	modifying	reactions,	such	as	etching	
away	 functionalised	 groups	 off	 substrate	 surfaces	 and	 replacing	 them	 with	 polar	 oxygen	
containing	 functions	 (Figure	 3-1,	 A)	 (Bruggeman	 et	 al.,	 2016).	 Surface	 modifications	 of	
materials	for	bioseparations,	induced	by	the	application	of	plasma	have	been	demonstrated	
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for	numerous	studies	involving	adsorbents	for	analytical	chromatography	(Sudo	et	al.,	1998)	
and	membrane	materials	(Ulbricht	et	al.,	1995;	Chen	et	al.,	1999;	Pieracci	et	al.,	1999;	Liu	et	
al.,	2004).		
Recent	 approaches	 have	 demonstrated	 the	 use	 of	 low	 temperature,	 low	 pressure	 plasma	
methods	to	remove	anion	exchange	ligands	from	the	surface	of	Pall’s	Q	Hyper	Z	AEC	media,	
leading	to	bilayered	chromatography	adsorbents	with	non-adsorptive	exteriors	(Arpanaei	et	
al.,	2010).	Under	static	binding	conditions,	these	plasma	etched	beads	showed	a	loss	of	~53%	
of	their	DNA	binding	capacity	at	the	expense	of	merely	9.3%	loss	of	protein	binding.	Dynamic	
EBA	 studies	 showed	 that	 10%	 breakthrough	 capacities	 of	 the	 beads	with	 respect	 to	 DNA	
binding	 dropped	 significantly	 after	 plasma	 etching,	 while	 retaining	 their	 protein	 binding	
capacity	of	the	untreated	Q	Hyper	Z.		
Given	 the	 rigid	nature	of	 its	base	matrix,	 transferring	 these	 low	temperature	 low	pressure	
plasma	treatments	to	other	beaded	chromatographic	support	media	is,	however,	hindered	by	
the	 low	pressure	 (~10	Pa)	at	which	 the	plasma	treatment	was	carried	out.	Many	common	
chromatography	adsorbents,	based	on	stationary	phases	 such	as	Sepharose	and	Sephacryl	
have	 soft	 hydrogel	 structures.	 Under	 aqueous	 conditions	 at	 atmospheric	 pressure,	 their	
stationary	phases	comprise	of	swollen	agarose	(or	allyl	dextran-N,Nʹ-methylenebisacrylamide	
copolymer	 for	 Sephacryl)	 beaded	 structures,	 with	 water	 accounting	 for	 over	 90%	 of	 the	
support	volume,	playing	an	important	role	to	the	structural	integrity	of	the	supports.	Under	
low	pressure	conditions,	water	is	easily	evaporated	from	the	pores	of	these	hydrogels,	due	to	
the	reduced	vapor	pressure	of	water,	leading	to	loss	of	support	structure	and	rendering	low	
pressure	plasma	treatment	unsuitable	for	etching	of	hydrogel	materials.		
Alternatively,	 low	 temperature	 plasma	 can	 be	 generated	 at	 atmospheric	 pressure	 using	
atmospheric	pressure	glow	discharge	approaches	(Kanazawa	et	al.,	1988;	Xiaogui	et	al.,	2012).		
Modification	of	polymeric	surfaces	using	APGD	treatment	has	been	demonstrated	in	a	number	
of	studies	(Temmerman	et	al.,	2005;	Choi	et	al.,	2006;	Pappas	et	al.,	2006;	Walsh	et	al.,	2007),	
indicating	 that	 APGD	 may	 be	 a	 suitable	 alternative	 for	 plasma	 etching	 of	 soft	 hydrogel	
chromatography	adsorbent	surfaces.	
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In	this	chapter,	the	feasibility	of	creating	bilayered	chromatography	support	media	based	on	
hydrogel	stationary	phases	by	modifying	the	exteriors	of	AEC	supports	through	plasma	etching	
at	atmospheric	pressure	was	investigated.	
Initial	plasma	etching	treatments	were	conducted	using	a	dielectric	barrier	discharge	(DBD)	
parallel	 plate	 reactor	 set-up	 using	 helium	 as	 a	 carrier	 gas.	 The	 produced	 supports	 were	
analysed	using	static	pDNA	and	BSA	binding	studies	(combined	in	the	SI,	providing	a	parameter	
to	judge	the	selectivity	of	surface	vs	core	binding	reduction),	featuring	a	continuation	of	the	
early	work	conducted	by	Willet	(unpublished)	and	(Arpanaei	et	al.,	2010)	(Figure	3-2,	A).	
Results	obtained	in	these	parallel	plate	experiments	have	led	to	the	design	of	a	fluidised	bed	
reactor	system.	The	system	allows	for	in	situ	treatment	of	fully	hydrolysed	chromatographic	
media;	the	ROS	are	transported	to	the	supports	by	bubbling	plasma	gas	through	the	reaction	
vessel,	 providing	 turbulent	 mixing	 of	 the	 suspension	 during	 treatment	 (Figure	 3-2,	 B).	
Parameters	 controlling	 the	 performance	 of	 resulting	 multifunctional	 chromatography	
supports	were	screened	by	assessing	the	bulk	binding	properties	of	manufactured	supports	
via	static	protein	and	pDNA	binding	studies.	The	samples	were	further	analysed	via	ESEM	and	
light	microscopic	techniques.	Spatial	distribution	of	protein	and	residual	pDNA	binding	sites	
	
Figure	3-2	Parallel	plate	set-up	(A);	Fluidised	bed	reactor	design	for	in	situ	treatment	of	chromatography	
media	in	aqueous	suspension	(B);	arrows	indicating	inlet	of	carrier	gas		
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post	 treatment	 to	 the	exterior	of	 the	beads	was	made	visible	by	 implementing	CLSM.	The	
chemical	composition	of	the	surface	of	supports	was	assessed	via	ToF-SIMS	analysis.	
3.2.	Materials	and	Methods	
To	avoid	repetition	of	almost	identical	method	descriptions	across	different	chapters	of	this	
work,	the	methods	as	well	as	a	conclusive	list	of	materials	(instrumentation)	used	for	their	
practical	implementation	are	presented	in	a	separate	‘general’	Materials	and	Methods	(M&M)	
section	of	this	thesis	(Chapter	2).	
Some	 of	 the	 conducted	 experiments	 do	 however	 require	 more	 explanation	 in	 regard	 to	
specific	parameters,	complementing	the	content	of	Chapter	2.	When	further	information	is	
essential,	 it	 is	 given	 in	 the	 respective	 sections	 to	 aid	 readability	 and	understanding	of	 the	
processes.	
3.2.1.	Calculation	of	SI	
The	effectiveness	of	plasma	etching	of	chromatography	supports	was	assessed	by	static	pDNA	
(surface	 restricted)	 and	 protein	 (diffusional	 access	 throughout	 adsorbent	 pores)	 binding	
studies	of	treated	media	in	comparison	to	an	untreated	control	sample.	
The	%	reductions	of	static	pDNA	binding	capacities	 in	comparison	to	the	untreated	control	
samples	were	calculated	using:	
	
Reduction	of	pDNA	binding	capacity	=	(𝑝𝐷𝑁𝐴	𝑐𝑎𝑝𝑎𝑐𝑖𝑡𝑦	𝑜𝑓	𝑐𝑜𝑛𝑡𝑟𝑜𝑙	𝑠𝑎𝑚𝑝𝑙𝑒 − 𝑝𝐷𝑁𝐴	𝑐𝑎𝑝𝑎𝑐𝑖𝑡𝑦	𝑜𝑓	𝑝𝑙𝑎𝑠𝑚𝑎	𝑡𝑟𝑒𝑎𝑡𝑒𝑑	𝑠𝑎𝑚𝑝𝑙𝑒)	𝑝𝐷𝑁𝐴	𝑐𝑎𝑝𝑎𝑐𝑖𝑡𝑦	𝑜𝑓	𝑐𝑜𝑛𝑡𝑟𝑜𝑙	𝑠𝑎𝑚𝑝𝑙𝑒 	𝑋	100%	
	
The	%	reductions	of	static	BSA	binding	capacities	in	comparison	to	untreated	control	samples	
were	calculated	using:	
	
Reduction	of	BSA	binding	capacity	=	(𝐵𝑆𝐴	𝑐𝑎𝑝𝑎𝑐𝑖𝑡𝑦	𝑜𝑓	𝑐𝑜𝑛𝑡𝑟𝑜𝑙	𝑠𝑎𝑚𝑝𝑙𝑒 − 𝐵𝑆𝐴	𝑐𝑎𝑝𝑎𝑐𝑖𝑡𝑦	𝑜𝑓	𝑝𝑙𝑎𝑠𝑚𝑎	𝑡𝑟𝑒𝑎𝑡𝑒𝑑	𝑠𝑎m𝑝𝑙𝑒)	𝐵𝑆𝐴	𝑐𝑎𝑝𝑎𝑐𝑖𝑡𝑦	𝑜f	𝑐𝑜𝑛𝑡𝑟𝑜𝑙	𝑠𝑎𝑚𝑝𝑙𝑒 	𝑋	100%	
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When	modifying	IEC	supports	to	create	a	bilayered	SEC-IEC	media	it	is	desirable	to	reduce	the	
outer	 shell	 binding	 capacity	 as	 much	 as	 possible,	 while	 maintaining	 a	 high	 core	 binding	
capacity.	To	assess	the	selectivity	of	shell	vs	core	binding	capacity,	the	Selectivity	Index	value,	
first	described	by	Professor	Thomas	(Arpanaei	et	al.,	2010)	was	used:	
		 𝑆𝑒𝑙𝑒𝑐𝑡𝑖𝑣𝑖𝑡𝑦	𝐼𝑛𝑑𝑒𝑥 = 	 100% − 𝑟𝑒𝑑𝑢𝑐𝑡𝑖𝑜𝑛	𝑜𝑓	𝐵𝑆𝐴	𝑏𝑖𝑛𝑑𝑖𝑛𝑔	𝑐𝑎𝑝𝑎𝑐𝑖𝑡𝑦100% − 𝑟𝑒𝑑𝑢𝑐𝑡𝑖𝑜𝑛	o𝑓	𝑝𝐷𝑁𝐴	𝑏𝑖𝑛𝑑𝑖𝑛g	𝑐𝑎𝑝𝑎𝑐𝑖𝑡𝑦	
	
It	describes	the	ratio	between	the	residual	BSA	binding	capacity	and	the	residual	pDNA	binding	
capacity	and	consequently	the	core	charge	vs	the	elimination	of	functional	binding	ligands	off	
the	 surface	of	 the	chromatography	 supports.	 It	 aids	 to	assess	 the	quality	of	 the	bilayering	
process	by	factoring	in	not	only	the	absolute	reduction	levels	but	providing	a	tool	to	determine	
the	thinness	of	the	inert	layer	created	via	the	bilayering	method	of	choice.	
3.2.2.	Plasma	etching	of	various	chromatography	media	under	atmospheric	pressure	
gas	in	a	dielectric-barrier	discharge	(DBD)	configuration		
Plasma	 etched	 chromatography	 resins,	 manufactured	 by	 using	 the	 DBD	 plasma	 reactor	
configuration	used	in	this	section	were	functionalised	and	kindly	provided	for	further	analysis	
by	Dr	Thomas	C.	Willett. 
A	range	of	anion	exchange	adsorbents	(Q	Sepharose	FF,	DEAE	Sepharose	FF,	EMD	Fractogel	
DEAE	 and	 Q	 Hyper	 Z)	 were	 treated	 under	 cold-atmospheric	 plasma	 etching	 conditions	 to	
produce	bilayered	SEC-AEC	supports	using	a	DBD	set-up	(Figure	3-3).		
Voltage	was	applied	between	two	circular	powered	electrodes	measuring	30	x	0.8	mm	each	
attached	to	an	aluminium	tile	of	40x40	mm	with	a	gap	of	5	mm	between	the	surfaces	of	the	
two	tiles	(Figure	3-3).	The	electrode	unit	was	closed	off	to	surrounding	air,	with	a	gas	inlet	
supplying	helium	gas	to	the	chamber.		
Supports	were	equilibrated	in	MQW	and	allowed	to	settle.	Support	samples	were	pipetted	
from	the	settled	bed	onto	a	30	mm	diameter	nylon	net	(10	µm)	rings	cut	from	XK	26	net	rings	
(GE	 Healthcare,	 Buckinghamshire),	 forming	 a	 cake	 of	 20	 mm	 diameter,	 which	 was	 then	
allowed	to	dry	in	air	(600	s).	A	pipette	tip	was	used	to	form	each	cake	into	circular	shape	of	
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consistent	height,	air	dried	for	300	s	before	placing	it	on	the	base	electrode	in	the	chamber	
under	helium	and	consecutively	directly	exposed	to	the	plasma	treatment.		
	
Supports	were	treated	under	helium	(4	SLM)	in	a	parallel	plate	set-up	under	continuous	and	
pulsed	AC	operation	modes.	A	range	of	support	cake	volumes	(0.16-	1.3	mL),	sample	distances	
between	plate	and	sample	(0.5-	4	mm),	contact	times	(100-	600	s)	and	input	powers	(5-	7	W)	
were	investigated.	
Current	 and	 voltage	 waveforms	 were	 measured	 with	 a	 Pearson	 Current	 Monitor	 2877	
(Pearson,	California)	and	a	Tektronix	P5100	High	Voltage	Probe	(Tektronix,	Oregon).	Signals	
were	recorded	on	a	Tektronix	DPO4104	Digital	Phosphor	Oscilloscope	(Tektronix,	Oregon).	
	 	
Figure	3-3	‘Top	down’	fabrication	of	bilayered	chromatography	supports	using	atmospheric	pressure	gas	
plasma	treatment	in	a	DBD	configuration	
Left:	Sketch	of	apparatus	
Right:	In	situ	treatment	of	chromatography	supports	under	He	plasma	
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3.2.3.	Decomposition	of	azo	dye	solutions	using	cold	atmospheric	pressure	plasma	
treatment	to	explore	the	parameters	influencing	the	efficacy	of	the	FBR		
Plasma	generated	ROS	are	routinely	used	in	wastewater	facilities	to	reduce	the	amount	of	dye	
molecules	 in	 aqueous	 solutions	 (Tichonovas	 et	 al.,	 2013).	 Plasma	oxidation	methods	 have	
proven	to	be	a	viable	option	for	effective	decomposition	of	complex	structures	such	as	Acid	
Orange	7	(Du	et	al.,	2008)	or	Methylene	Orange	(MO)	(Jin	et	al.,	2014).	
For	scouting	of	parameters	for	the	fluidised	bed	(FB)	plasma	reactor,	a	series	of	experiments	
was	conducted	decolouring	aqueous	dye	solutions	in	the	reactor.	Although	the	mechanisms	
of	 ligand	 surface	 etching	 and	 decolourization	 are	 not	 directly	 transferable,	 they	 do	 yield	
insights	into	the	efficacy	of	the	ROS	generated	in	the	reactor	in	quantitatively	easily	assessable	
manner.	
The	dye	molecules	are	subject	to	photobleaching	when	exposed	to	light	(Guo	et	al.,	2011).	To	
avoid	interference	via	fading	of	dye	molecules,	all	sample	tubes	were	wrapped	in	aluminium	
foil	and	kept	away	from	light	whenever	possible.	The	azo	dyes	MO	and	CR	were	dissolved	in	
MQW	 and	 subsequently	 serially	 diluted	 to	 a	 final	 concentration	 of	 20	 µg/mL	 for	 MO	
(absorption	maxima	 270	 nm	 and	 465	 nm	 (Al-Qaradawi	 et	 al.,	 2002))	 and	 1.073e-5	mol/L	
(absorption	maximum	at	 497	nm	 (Iwunze,	 2010))	 for	 CR	 respectively.	 A	 total	 of	 8	mL	dye	
solution	was	pipetted	into	the	FBR	supplied	with	1	SLM	upward	gas	flow	to	avoid	backflow	of	
the	solution	into	the	gas	supply	line.	After	equilibrating	the	solution	with	the	feed	gas	for	1	
minute,	 the	 solution	 was	 plasma	 treated	 as	 described	 in	 2.3.5.After	 treatment	 time	 had	
finished,	the	solution	was	poured	into	a	clean	15	mL	Eppendorf	tube	and	analysed	for	OD460	
using	a	Suprasil	High	Precision	Quartz	Cuvette	(10	mm	path	length)	at	various	time	points	post	
treatment.	MQW	was	used	as	a	blank.	
	
	 -	73	-	
		
	 	
	
	
Figure	3-4	Top:	UV-	visible	spectrum	of	MO	in	MQW,	adapted	from	(Al-Qaradawi	et	al.,	2002)	
Bottom:	UV-visible	spectrum	of	CR	in	MQW	
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3.3.	Results	and	Discussion	
3.3.1.	Plasma	etching	and	oxidation	of	chromatography	supports	in	parallel	plate	
Dielectric	Barrier	Discharge	plasma	reactor		
A	total	of	four	AEC	adsorbents	(Q	&	DEAE	Sepharose	FF,	Q	Hyper	Z,	EMD	Fractogel	(M)	DEAE)	
were	 plasma	 treated	 in	 a	 parallel	 plate	 DBD	 set-up,	 using	 helium	 as	 a	 carrier	 gas.	 The	
adsorbent	samples	were	exposed	to	plasmas	with	input	power	levels	reaching	from	1	W	up	to	
16.6	W	for	treatment	times	up	to	600	s	(2	mm	sample	cake;	650	µLSBV;	3	mm	sample-electrode	
distance).	 Reductions	 of	 pDNA	 (shell)	 and	 BSA	 (core)	 binding	 capacities	 cf.	 an	 untreated	
control	 were	 analysed	 using	 static	 binding	 studies	 as	 described	 in	 2.3.6.2	 and	 2.3.6.3	
respectively,	and	results	are	presented	in	Figure	3-5.	
	
	
	
Figure	3-5	Bar	charts	illustrating	loss	of	surface	pDNA	(white	bars),	core	BSA	(black	bars)	binding	capacities	
of	anion	exchange	adsorbents	following	exposure	to	helium	plasmas	in	the	parallel	plate	DBD	set-up.	
Adsorbents	(sample	volume	=	650	μL,	sample	depth	=	2	mm,	‘plate	to	sample’	gap	=	3	mm)	were	exposed	to	
plasma	of	various	electrical	power	plasmas	for	up	to	600	s	(all	measurements	performed	in	triplicates	with	
errors	<5%)	
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Plasma	etching	 and	oxidation	of	AEC	 in	 the	DBD	 configuration	 led	 to	 reduction	of	 surface	
pDNA	binding	capacities	up	to	around	80%	for	all	adsorbent	types.		
For	Q	Sepharose	FF,	necessary	conditions	for	pDNA	clearance	above	70%	involve	either	(i)	high	
energetic	plasma	operations	 for	short	 treatment	 times	 (11	W;	120	s).	Reductions	of	pDNA	
binding	capacity	levelled	out	for	(ii)	longer	treatments	irrespective	of	power	input	at	around	
80%	(i.e.	1.9	W	for	600	s).	
Whilst	treatment	at	moderate	conditions	(120	s;	1-1.8	W)	eliminated	20%	of	BSA	binding	in	all	
support	 types,	 either	 longer	 treatment	 times	or	 increase	of	 power	 input	 resulted	 in	more	
severe	losses	of	BSA	binding	(up	to	>50%).	
	
	
Figure	3-6	Retained	surface	pDNA	binding	capacity	(£),	core	BSA	binding	capacity	(¢),	and	SI	(¢)	of	AEC	
adsorbents	as	functions	of	plasma	energy	for	helium	plasma	treatment	in	the	DBD	configuration	(sample	
volume	=	650	μL;	sample	depth	=	2	mm,	‘plate	to	sample’	gap	=	3	mm).	The	lines	through	the	pDNA	(―)	and	
BSA	(---)	binding	data	points	are	fitted	second	order	exponential	decay	curves,	whereas	those	through	the	
SI	(―)	data	were	obtained	by	dividing	the	BSA	binding	decay	curves	by	the	corresponding	pDNA	binding	
decay	curves	(all	measurements	performed	in	triplicates	with	errors	<5%)	
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To	correlate	the	losses	of	pDNA	binding	and	BSA	binding,	SI	values	for	each	adsorbent	type	
were	calculated	and	plotted	alongside	the	binding	retention	levels	of	pDNA	and	BSA	against	
the	overall	energy	input	(Figure	3-6).	
As	expected,	increasing	the	total	 input	plasma	energy	to	which	the	supports	were	exposed	
resulted	in	greater	loss	of	pDNA	binding	capacity	for	all	support	types	(Figure	3-6).	However,	
exposure	to	 increased	plasma	energy	also	 led	to	greater	 loss	of	BSA	binding.	The	resulting	
relationship	between	total	plasma	energy	used	during	treatment	and	SI	shows	that	the	softer	
Sepharose	FF	supports	reached	their	optimum	SI	values	at	lower	treatment	energies	(<2	kJ)	in	
comparison	to	the	harder	EMD	Fractogel	(M)	DEAE	and	Q	Hyper	Z	supports.		
Results	indicated	that	optimum	selectivity	indices	for	EMD	Fractogel	(M)	DEAE	were	achieved	
with	longer	treatment	times,	and	that	plasma	treatments	exceeding	600	s	might	be	beneficial	
for	achieving	higher	SI	values,	as	neither	BSA	binding	reduction,	nor	pDNA	binding	levelled	out	
for	total	input	energies	up	to	7	kJ.	In	contrast,	optimum	selectivity	indices	were	obtained	with	
treatment	 times	of	~200	s	 for	Q	Sepharose	FF,	at	a	 sample-electrode	distance	of	3	mm	at	
energy	 inputs	of	1.5	kJ,	with	an	SI	of	2.75	(80%	loss	of	pDNA	binding	with	45%	loss	of	BSA	
binding)	and	DEAE	Sepharose	FF	at	energies	>2	kJ,	with	 the	SI	 levelling	out	at	around	2.4.	
Surface	binding	of	Q	Hyper	Z	was	mostly	reduced	at	energy	inputs	of	<2	kJ,	with	additional	
energy	contributing	only	to	enhanced	loss	of	core	binding.	
Reducing	 the	 distance	 between	 the	 top	 of	 the	 sample	 cake	 and	 the	 top	 electrode	 of	 the	
plasma	 rig	 (increased	 thickness	 of	 the	 sample	 cake)	 from	 4.5	mm	 to	 1	mm	 resulted	 in	 a	
decrease	of	selectivity	for	all	adsorbent	types	(Figure	3-6).	The	SI	decreased	from	4.8	to	1.1	
for	Q	Sepharose	FF,	4.7	to	1.2	for	DEAE	Sepharose	FF,	4.1	to	1.0	for	EMD	Fractogel	(M)	DEAE	
and	4.9	to	1.2	for	Q	Hyper	Z.	These	SI	values	correspond	to	additional	losses	of	BSA	binding	
seen	when	decreasing	the	sample-electrode	distance	from	4.5	mm	(BSA	binding	reductions	of	
~20%	for	both	Sepharose	media)	to	1	mm	which	yielded	a	BSA	binding	reduction	of	up	to	56%	
for	DEAE	Sepharose	FF	and	49%	for	Q	Sepharose	FF.	
With	the	sample	cake	being	slightly	conductive	and	the	electrode	gap	remaining	fixed	at	5	mm,	
increased	sample	heights	serve	to	reduce	the	gas	gap.	For	treatments	at	a	given	power	setting,	
a	smaller	gap	is	likely	to	result	in	a	more	concentrated,	hotter	plasma	treatment,	so	thermal	
damage	to	the	supports	may	play	a	pivotal	role	in	the	loss	of	BSA	binding	capacity.	
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Reducing	the	sample/	electrode	gap	and	consequently	increasing	the	process	temperature	of	
the	supports	also	 led	to	enhanced	evaporation	of	 (remaining)	water	during	the	treatment.	
After	the	“hotter”	treatments	had	finished,	the	sample	cake	appeared	to	have	dried	a	lot	more	
in	the	process	than	was	observed	with	larger	gaps	between	sample	and	electrode.	
	
	
Figure	3-7	Impact	of	sample	depth/	’plate	to	sample’	gap	on	the	loss	of	surface	pDNA	(white	bars)	and	core	
BSA	(black	bars)	binding	capacities,	and	SI	(grey	symbols)	of	AEC	adsorbents	following	exposure	to	helium	
plasmas	in	parallel	plate	DBD	set-up.	Adsorbent	bed	volumes	of	160	μL	to	1.3	mL,	corresponding	to	sample	
depths	of	0.5	to	4	mm	and	upper	plate	to	sample	gaps	of	4.5	to	1	mm,	were	exposed	to	7	W	plasmas	for	
300	s	(all	measurements	performed	in	triplicates	with	errors	<5%)	
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A	continuous	problem,	that	the	plasma	treatment	in	the	DBD	configuration	is	facing,	 is	the	
formation	 of	 streamers	 (Figure	 3-8).	 Although	 operation	 at	 the	 scale	 used	 in	 this	 work	
produced	 some	 good	 selectivity	 indices,	 operation	 at	 larger	 scale	 would	 require	 a	 larger	
treatment	area	likely	leading	to	localised	hotspots,	with	lower	uniformity	of	treatment	and	an	
overall	hotter	sample	temperature.		
All	treatments	with	sample-electrode	distances	of	3	mm	or	more	gave	SI>1.5,	indicating	that	
the	DBD	configuration	used	for	plasma	etching	under	atmospheric	pressure	gas	was	suitable	
for	creating	a	degree	of	bilayered	SEC/	IEC	structure	on	the	AEC	beads	tested.		
Previous	studies	into	the	effectiveness	of	treating	Q	Hyper	Z	materials	using	low	temperature	
low	pressure	plasma	etching	(Arpanaei	et	al.,	2010)	gave	selectivity	 indices	up	to	2.0	 (53%	
reduction	 in	pDNA	binding	 and	9%	 loss	of	 protein	binding)	 from	 static	 binding	 studies.	By	
comparison,	 treatment	of	Q	Hyper	Z	 in	 the	DBD	configuration	gave	a	maximum	selectivity	
index	 of	 5	 (corresponding	 to	 84%	 reduction	 of	 pDNA	 binding	 alongside	 20%	 loss	 of	 BSA	
binding)	 for	treatment	of	a	sample	at	4.5	mm	sample-electrode	distance	for	300	s	at	7	W,	
indicating	that	the	cold	atmospheric	pressure	plasma	used	 in	this	work	may	be	even	more	
suitable	for	etching	of	hard	chromatography	support	surfaces	than	the	method	described	by	
Arpanaei	et	al.	However,	it	should	also	be	noted	that	all	treatments	which	achieved	SI	of	2.0	
or	above	in	the	DBD	configuration	also	incurred	at	least	20%	loss	of	BSA	binding,	this	being	
true	 for	 all	 the	 support	 types	 tested.	 This	 indicates	 that	 the	DBD	 configuration	 treatment	
described	here	is	no	more	successful	than	that	of	Arpanaei	et	al.	 in	making	the	outer	layer	
‘ultrathin’.	
Figure	3-8	Treatment	of	chromatography	supports	in	a	DBD	plasma	operation;	while	the	continuous	blue/	
purple	glow	plasma	is	filling	up	the	chamber,	the	occurrence	of	‘streamers’	penetrating	the	sample	cake	are	
clearly	visible	
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Furthermore,	although	all	of	the	selectivity	indices	described	in	this	work	relate	to	capacities	
measured	by	static	binding	studies,	dynamic	binding	studies	with	the	same	materials	might	be	
expected	to	produce	even	better	selectivity	index	values.	This	expectation	arises	from	results	
obtained	with	 low	 temperature	 low	 pressure	 plasma	 (Arpanaei	 et	 al.,	 2010)	 in	which	 the	
method	used	to	produced	Q	Hyper	Z	beads	with	selectivity	index	of	2.0	in	static	binding	studies	
gave	 a	 selectivity	 index	 of	 2.7	when	 used	 in	 dynamic	 binding	 studies	with	 BSA	 and	 pDNA	
feedstocks	in	a	FastLineTM	10	EBA	column	(note:	separate	plasma	treatments	carried	out	on	a	
5	g	batch	for	static	binding	studies	and	a	10.5	g	batch	for	dynamic	binding	studies	while	using	
identical	plasma	parameters).		
From	this,	it	seems	likely	that	adsorbents	etched	with	cold	atmospheric	pressure	plasma	will	
display	higher	SI	values	in	dynamic	binding	modes	than	those	seen	in	static	binding,	due	to	
the	 similarities	 with	 the	 low	 temperature	 low	 pressure	 etching	 method.	 The	 differences	
between	the	effective	contact	time	of	large	pDNA	molecules	cf.	smaller	proteins	in	dynamic	
frontal	 loading	 chromatography	 environments,	 hereby	 result	 in	 slightly	 more	 favourable	
selectivities	cf.	static	binding	data.	While	BSA	as	a	small	molecule	can	easily	diffuse	and	bind	
throughout	the	pores	of	the	AEC	supports,	large	pDNA	molecules	take	longer	contact	times	to	
fully	saturate	all	available	binding	sites	provided	by	the	ligands	lining	the	pores.		
	
Due	 to	 foreseeable	 problems	 with	 scaling	 up,	 it	 was	 decided	 to	 focus	 subsequent	
investigations	on	treatment	by	plasma	filled	gas	bubbles	in	a	fluidised	bed	set-up	which,	in	
contrast	to	the	DBD	configuration,	is	expected	to	produce	a	relatively	well	distributed	plasma	
and	to	achieve	a	more	even	treatment	of	supports.	
Due	to	the	colder	nature	of	the	process	(water	cooled),	streamers	and/	or	hot	spots	are	less	
likely	 to	occur	by	design	of	 the	 reactor	and	hence	 the	 thermal	damage	 to	 the	supports	as	
observed	in	the	DBD	configuration	is	expected	to	have	a	lesser	(if	any)	impact	on	the	structural	
integrity	of	the	adsorbents.	
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3.3.2.	In	situ	plasma	etching	of	hydrogel	chromatography	supports	in	the	Fluidised	
Bed	Reactor	set-up	
Although	EBA	supports	(Q	Hyper	Z)	showed	promising	levels	of	pDNA	binding	reduction	in	the	
parallel	plate	DBD	plasma	configuration,	treating	heavy	support	particle	slurries	 in	the	FBR	
set-up	 was	 hampered	 by	 the	 density	 of	 the	 adsorbents.	Mixing	 via	 gas	 bubbles	 traveling	
through	 the	 reactor	 proved	 insufficient	 for	 a	 functional	 plasma	 operation,	 with	 supports	
settling	at	the	bottom	of	the	reactor.	Plasma	treatment	of	soft	hydrogel	supports	was	hence	
focussed	on	Q	Sepharose	FF,	DEAE	Sepharose	FF	and	EMD	Fractogel	(M)	DEAE.	
Initial	parameter	scouting	was	focussed	on	carrier	gas	composition	(He-O2	(99.5-0.5%);	pure	
oxygen),	 amount	 of	 sample	 treated	 in	 reactor	 as	 part	 of	 the	 overall	 8	mL	 sample	 volume	
(12.5%,	18.8%	and	25%	slurry	concentration),	input	power	(1.5	and	3.7	W)	as	well	as	treatment	
times	(150,	300	and	600	s).	
Reductions	of	pDNA	and	BSA	binding	were	assessed	in	static	binding	studies	as	described	in	
2.3.6	and	the	loss	of	binding	capacities	was	plotted	in	Figure	3-9.	
Unlike	the	DBD	plasma	operation,	treatment	of	hydrogel	supports	in	aqueous	solution	with	
He-O2	plasmas	was	found	to	be	more	moderate,	with	BSA	binding	reductions	below	20%	for	
all	support	types	irrespective	of	plasma	conditions,	while	short	treatment	times	at	low	power	
only	compromised	core	binding	capacity	by	around	5%.	
Surface	etching	and	oxidation	has	eliminated	over	50%	of	initial	pDNA	binding	in	all	support	
types,	with	Q	Sepharose	FF	showing	the	highest	reduction	levels	(up	to	70%).	
While	He-O2	gas	plasmas	indicate	promising	reduction	levels	for	both	BSA	and	pDNA,	supports	
treated	 with	 plasma	 generated	 from	 pure	 oxygen	 tell	 a	 different	 story.	 Plasmid	 DNA	
reductions	 are	 falling	 short	 of	 40%	 while	 core	 binding	 ligands	 were	 attacked	
overproportionately.	 This	 indicated	 that	 ROS	 generated	 from	pure	 oxygen	 gas	 penetrated	
further	into	the	supports	before	reacting	with	core	ligands,	bypassing	ligands	situated	on	the	
very	surface	of	the	AEC	adsorbent.	
Alteration	of	slurry	concentration	yielded	no	significant	difference	between	the	samples.		
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Figure	3-9	Bar	charts	illustrating	loss	of	surface	pDNA	(white	bars)	and	core	BSA	(black	bars)	binding	
capacities	of	packed	bed	anion	exchange	adsorbents	following	treatment	with	He-O2	(99.5-0.5%)	and	pure	
oxygen	(Ox)	plasmas	in	the	underwater	FBR	plasma	generation	system.	Adsorbent	slurries	(12.5	–	25%	v/v)	
were	treated	with	different	plasma	powers	(1.5	–	6.8	W)	for	various	times	(150	–	600	s)	
all	measurements	performed	in	triplicates	with	errors	<5%	
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To	correlate	losses	of	pDNA	and	BSA	binding,	SI	values	were	calculated	and	plotted	alongside	
the	retention	binding	levels	of	pDNA	and	BSA	against	the	overall	energy	input	(Figure	3-10).	
Throughout	He-O2	plasma	treatments,	reduction	of	pDNA	binding	was	found	to	level	out	at	
70%,	75%	and	75%	for	Q	Sepharose,	DEAE	Sepharose	FF	and	EMD	Fractogel	DEAE	respectively,	
after	an	energy	input	of	around	0.5	kJ	for	all	adsorbent	types.	Applying	further	energy	into	the	
system	did,	however,	lead	to	continued	decrease	of	BSA	binding.	
The	highest	surface	binding	reduction	was	recorded	for	Q	Sepharose	FF	with	70%	clearance	
at	a	loss	of	around	8%	core	binding,	leading	to	an	SI	value	of	3.0.	
In	 accordance	 with	 observations	 outlined	 above,	 SI	 of	 samples	 treated	 with	 pure	 oxygen	
plasma	 fell	 short	 cf.	 their	 respective	 He-O2	 counterparts,	 yielding	 SI	 values	 <1.5	 for	 all	
adsorbent	types.		
Neither	the	BSA,	nor	the	pDNA	binding	retention	curve	level	out	after	0.5	kJ	as	observed	in	
the	He-O2	samples,	instead	it	appears	that	oxygen	plasmas	at	higher	energy	inputs	may	reduce	
the	surface	binding	capacity	 further.	However,	 the	selectivities	do	not	 indicate	 that	higher	
energy	inputs	lead	to	a	selective	reduction	of	surface	over	core	binding.	
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Figure	3-10	Retention	of	surface	pDNA	(white	symbols)	and	core	BSA	(black	symbols)	binding	capacities,	
and	variation	in	SI	(grey	symbols)	as	functions	of	plasma	energy	for	He-O2	and	pure	oxygen	(Ox)	plasma	
treatments	of	packed	bed	AEC	adsorbents	in	the	underwater	cold	atmospheric	plasma	apparatus.	Squares,	
circles	and	up	triangle	symbols	indicate	12.5%,	18.75%	and	25%	(v/v)	support	slurry	samples	respectively.	
The	lines	through	the	BSA	and	pDNA	data	points	are	fitted	first	order	exponential	decay	curves,	whereas	
those	through	the	SI	(―)	data	were	obtained	by	dividing	the	BSA	binding	decay	curves	by	the	corresponding	
pDNA	binding	decay	curves	(all	measurements	performed	in	triplicates	with	errors	<5%)	
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3.3.2.1.	Influence	of	leached	substances	created	during	plasma	treatments	of	
chromatography	media	on	spectrophotometric	measurements	to	quantify	pDNA	contents	
post	static	binding	studies	
The	 spectrophotometric	 measurement	 of	 pDNA	 concentration	 in	 liquid	 samples	 by	 UV	
absorbance	(OD260)	relies	on	the	absence	of	contaminants	that	absorb	light	of	the	respective	
wavelength	(Reule,	1976).		
During	 initial	scouting	experiments	 (decolouring	dye	solutions	 in	the	FBR),	 it	was	observed	
that	plasma	 reactions,	 triggered	 in	 situ	proceeded	after	 treatment	had	 finished	 (Appendix		
A-5).	
While	 the	 buffer	 surrounding	 the	 chromatography	media	 during	 the	 plasma	 treatment	 is	
exchanged	 post	 treatment,	 concern	 arose	 whether	 species	 leached	 off	 chromatography	
supports	post	buffer	exchange	(in	storage	tubes)	could	influence	subsequent	analysis	(pDNA	
quantification).	To	ensure	assay	robustness	and	the	absence	of	such	contaminants	(or	their	
respective	 impact	 on	 the	 spectrophotometrical	 measurements	 of	 pDNA	 concentration),	
Q	Sepharose	FF	media	(1	mL	SBV)	was	plasma	treated	as	described	in	2.3.5	(14.5	kHz;	7	W;	
10	min;	He-O2	(99.5-0.5%	v/v)	admixed	gas;	gas	flowrate	750	mL/min).	The	UV	absorbance	
(OD260)	of	the	TE	storage	buffer	of	the	supports	was	analysed	over	time	(immediately	after	the	
treatment,	1,	24	and	48	h	post	buffer	exchange)	and	compared	to	TE	buffer	(Figure	3-11;	MQW	
used	as	blank).	
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Figure	3-11	OD260	of	the	supernatant	(TE	buffer)	after	different	contact	times	with	plasma	treated	Q	
Sepharose	FF	chromatography	supports	(14.5	kHz;	7	W;	10	min;	He-O2	(99.5-0.5%	v/v)	admixed	gas;	gas	
flowrate	750	mL/min)	in	comparison	to	control	TE	buffer	
Control 5 min post contact 1 hour 24 hours 48 hours 
0
0.01
0.02
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OD
26
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The	maximum	variance	of	the	OD260	measurements	(after	1	h	vs	control)	is	0.01	[-],	correlating	
to	0.2	µgpDNA/mLSBV	in	static	pDNA	binding	studies.	With	typical	Q	Sepharose	FF	pDNA	binding	
capacities	of	~300	µgpDNA/mLSBV,	the	difference	accounts	for	a	statistically	irrelevant	error	of	
0.067%.	
The	 results	 obtained	 confirm	 that	 either,	 the	 reaction	 does	 not	 continue	 leaching	 off	
substances	 of	 the	 beads	 post	 plasma	 treatment,	 or	 that	 the	 molecules	 leached	 off	 the	
supports	do	not	compromise	the	assay	by	absorbing	light	in	the	UV-range.		
The	treatment	of	Q	Sepharose	FF	supports	with	cold	atmospheric	pressure	plasma	does	not	
impede	subsequent	static	binding	studies	or	following	measurements	of	pDNA	content	in	the	
supernatant	via	UV-spectrophotometric	analysis.		
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3.3.2.2.	Plasma	parameter	screening	for	FBR		
Due	 to	 the	high	number	of	 parameters	 associated	with	 the	 treatment	of	 chromatography	
supports	in	the	FBR	set-up,	the	amount	of	different	support	media	was	limited	and	the	strong	
AEC	media	Q	Sepharose	FF	was	chosen	throughout	the	experiments.	
	
In	 experiments	 without	 chromatography	 media	 in	 the	 FBR,	 measuring	 the	 conversion	 of	
energy	being	put	into	the	system	to	the	energy	dissipated,	suggests	that	operation	of	the	FBR	
at	 low	 flow	 rates	 was	 beneficial	 (Figure	 3-12,	 left).	 However,	 plasma	 stability	 becomes	 a	
concern	when	the	flow	rate	is	too	low,	with	plasma	sparks	backlashing	into	the	gas	line	(Figure	
3-12,	right).	Furthermore,	the	system	is	reliant	on	a	constant	supply	of	carrier	gas	 into	the	
system,	while	avoiding	spilling	of	supports.	Balancing	both	effects,	a	flow	rate	of	750	mL/min	
was	 found	 appropriate	 to	 ensure	 mixing	 of	 the	 sample,	 avoiding	 plasma	 backlashes	 and	
spilling	of	reactor	contents.	
	 	
	
Figure	3-12	Contour	plot	of	dissipated/	input	power	in	FBR	during	plasma	operation	with	MQW	as	a	buffer	
system	(left);	backflow	of	plasma	gas	into	the	gas	supply	line	at	flow	rates	below	700	mL/min	(right);	flow	
rate	prior	to	conversion	into	mL/min	
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3.3.2.3.	Variation	of	plasma	input	powers		
In	previous	studies	using	plasma	etching	and	oxidation	to	reduce	the	surface	binding	capacity	
of	chromatography	supports,	the	depth	of	the	alteration	induced	by	the	plasma	treatment	in	
AEC	supports,	was	strongly	influenced	by	the	power	input	(Arpanaei	et	al.,	2010);	it	stands	to	
reason	 that	 investigating	 the	 effects	 different	 input	 powers	 have	 on	 the	 chromatographic	
performance	of	plasma	treated	AEC	supports	is	of	utmost	importance.		
1	mL	SBV	Q	Sepharose	FF	media	was	treated	with	He-O2	(99.5%-0.5%	v/v)	plasma	with	varying	
input	powers	(2-12	W),	as	described	in	2.3.5.1	(14.5	kHz;	20	min	treatment	time).	
Post	treatment,	each	support	sample	was	analysed	in	duplicate	(results	averaged)	for	BSA	and	
pDNA	 static	 binding	 capacities,	 to	 assess	 the	 reduction	 of	 core	 and	 shell	 binding	 levels	
respectively	as	described	in	2.3.6.	
To	check	whether	binding	to	plasma	treated	chromatography	supports	has	an	impact	on	pDNA	
stability,	unbound	pDNA	supernatant	was	collected	post	static	binding,	concentrated	using	
phenol	 chloroform	extraction	of	NA	and	visualised	by	agarose	gel	electrophoresis	 (2.3.4.1;	
Figure	3-13).		
	
	 	
	
Figure	3-13	Agarose	gel	of	unbound	IT14:	pPR322-p170	plasmid	in	the	supernatant	after	binding	to		
1:	Q	Sepharose	FF;	2:	He-	O2	plasma	treated	Q	Sepharose	FF	(7	W;	14.5	kHz;	20	min;	He-O2	(99.5%-0.5%)	
admixed	gas	plasma)		
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The	gel	image	confirms	the	stability	of	the	pDNA	in	the	supernatant	and	the	plasma	treatment	
has	 no	 impact	 on	 the	 conformation	 of	 the	 unbound	 pDNA.	 The	 difference	 in	 brightness	
between	the	two	gel	 lanes	 is	due	to	the	reduced	surface	binding	capacity	of	He-O2	plasma	
etched	 support	 samples	which	 consequently	 yields	 a	higher	 concentration	of	pDNA	 in	 the	
supernatant.	
	
The	 reductions	 of	 pDNA	 binding	 levels	 all	 range	 above	 10%,	 with	 higher	 reduction	 levels	
occurring	 at	 higher	 input	powers.	While	 the	plasma	 treatments	do	not	 etch	 away	enough	
ligands	off	the	particles’	surfaces	to	reduce	the	BSA	binding	capacity	significantly	(less	than	
7%	for	all	samples),	higher	input	powers	(9	W	and	above)	do	have	a	larger	impact	on	the	core	
binding	capacity	of	the	beads.		
The	4	W	 sample	 falls	 slightly	out	of	 trend,	both	 for	BSA	as	well	 as	pDNA	binding	 capacity	
reductions.	This	is	assumed	to	be	a	result	of	a	variation	in	the	amount	of	media	(SBV)	either	
treated	(slightly	less	beads	in	reaction	vessel)	or	analysed	(scraping	particles	off	the	filter	frit	
prior	to	their	resuspension	does	inevitably	leave	a	small	portion	of	beads	behind).		
An	increase	in	power	input	leads	to	higher	reduction	levels	of	pDNA	binding	capacity	up	to	
10	W,	after	which	the	samples	show	a	slight	decline	of	surface	binding	reduction.	This	could	
be	due	to	a	number	of	different	reasons;	the	surface	of	the	beads	gets	disrupted	by	the	voltage	
	
	
Figure	3-14	Static	binding	capacity	reductions	(pDNA	and	BSA)	of	Q	Sepharose	FF	media	after	in	situ	
plasma	treatments	with	various	input	powers	(14.5	kHz;	helium-oxygen	(99.5%-	0.5%	v/v)	admixed	
gas;	20	min)	in	comparison	to	an	untreated	control	sample	
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or	the	ROS,	generating	binding	sites	for	pDNA.	These	‘new’	binding	sites	grant	pDNA	access	to	
ligands	previously	inaccessible	to	pDNA	due	to	the	SEC	structure	of	the	base	matrix.	By	etching	
away	the	outer	matrix	(or	piercing	holes	into	the	agarose	backbone)	the	pDNA	can	diffuse	into	
the	holes	and	bind	to	ligands	that	prior	to	the	plasma	treatment	were	part	of	the	‘core	ligands’.		
One	 of	 the	 factors	 that	 could	 lead	 to	 a	 permanent	 alteration	 of	 the	 support’s	 backbone	
structure	 is	 temperature	 spikes	 in	 close	 proximity	 to	 plasma	 filled	 gas	 bubbles	 (similar	 to	
plasma	 streamers	 observed	 in	 DBD	 configuration).	 These	 (localised)	 high	 temperatures	
occurring	at	elevated	input	power	levels,	melt	the	agarose	for	a	short	period	of	time	prior	to	
immediate	 resolidification	 of	 the	media	 as	 the	 beads	 travel	 to	 a	 colder	 region	within	 the	
reactor	(turbulent	mixing	in	the	reactor	as	a	result	of	the	gas	flow	jetting	through	the	reaction	
vessel).	Localised	melting	of	the	agarose	base	matrix	and	subsequent	resolidification	will	alter	
the	pore	structure	of	the	media,	leading	to	a	reduction	of	pore	size	or	blockage	to	the	core	of	
the	 beads	 (the	 matrix	 has	 an	 agarose	 content	 of	 6%,	 even	 a	 short	 overheating	 causes	
significant	alteration	to	the	pore	walls	by	either	‘sealing	them	off’	or	‘burying’	ligand	sites	with	
agarose).	 This	 effect,	 as	well	 as	 reduction	 of	 overall	 accessible	 (core)	 binding	 sites	 due	 to	
‘shrinking’	 of	 the	 media’s	 accessible	 binding	 volume	 lead	 to	 a	 reduction	 of	 BSA	 binding	
capacity.		
Overall,	the	treatment	at	7	W	input	power	achieved	the	highest	reduction	of	surface	binding	
(16.2%)	while	maintaining	a	very	high	BSA	binding	capacity	(98.2%)	yielding	the	best	balance	
between	the	two	effects	outlined	above.	
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3.3.2.4.	Treatment	time	and	temperature	profile	dependency		
The	 plasma	 treatment	 to	 etch	 away	 functional	 ligands	 off	 the	 surface	 of	 chromatography	
beads	 is	 a	 gentle	 treatment	without	 the	generation	of	 large	amounts	of	 toxic	by-products	
(Schram,	1987).	During	the	plasma	operation,	the	support	slurry	in	the	reactor	heats	up	over	
time	due	to	the	dissipation	of	energy	in	the	system	(Figure	3-15).	Elevated	temperatures	can	
not	 only	 have	 a	 crucial	 effect	 on	occurring	 plasma	 reactions	 but	 also	 on	 the	 formation	of	
different	ROS	species	(Fridman,	2008).		
	
To	 investigate	 the	 impact,	 elevated	 temperatures	 have	 on	 plasma	 treatment	 of	
Q	 Sepharose	 FF	 media,	 two	 sets	 of	 samples	 were	 treated	 under	 identical	 electronic	
parameters	 using	 different	 temperature	 profiles	 in	 the	 reaction	 vessel.	 To	 avoid	 the	
occurrence	of	high	average	temperatures	in	the	reactor	(temperature	spikes	around	the	gas	
inlet	are	unavoidable	given	the	geometry	of	the	system),	an	ice-cooled	water	bath	to	maintain	
a	lower	working	temperature	of	the	reactor	was	used	to	modify	the	reactor	as	described	in	
2.5.3.2.	
Both	sets	of	Q	Sepharose	FF	media	(1	mL	SBV;	cooled	and	uncooled)	were	plasma	treated	as	
described	in	2.3.5.	The	samples	were	treated	for	5,	10,	20,	40	and	60	min	respectively	with	
7	W	input	power,	14.5	kHz,	750	mL/min	gas	flow	of	He-O2	(99.5%-0.5%	(v/v)	admixed	gas).		
	
Figure	3-15	Temperature	profiles	of	plasma	treated	MQW	over	time,	both	in	the	uncooled	reactor	(-)	as	
well	as	during	plasma	operation	in	ice	bath	(--);	7	W,	14.5	kHz,	helium-oxygen	admixed	gas	(99.5-	0.5%	v/v)	
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The	reductions	of	pDNA	and	BSA	binding	capacities	compared	to	an	untreated	control	sample	
are	depicted	 in	Figure	3-16.	All	 samples	 showed	very	minor	 reductions	of	 their	 core	 (BSA)	
binding	capacities	post	plasma	treatment	in	comparison	to	the	untreated	control	sample	(the	
uncooled	60	min	treatment	showing	the	highest	reduction	of	BSA	binding	capacity	(10.3%)	
with	 all	 other	 samples	 below	 10%).	While	 no	 severe	 BSA	 binding	 capacity	 reduction	 was	
observed	 in	any	of	 the	samples,	 the	reductions	seen	 in	 the	samples	 treated	 in	 the	reactor	
submerged	 in	 the	 stirred	 ice	 bath	 consistently	 produced	 lower	 values,	 indicating	 that	 an	
increased	process	temperature	of	the	chromatography	slurry	during	the	treatment	aids	the	
ROS	to	penetrate	through	the	outer	several	micrometres	of	the	beads	and	access	(further)	
into	the	core	of	the	particles.	
	
Figure	3-16	Reduction	of	static	binding	capacities	to	an	untreated	control	sample	of	Q	Sepharose	FF	media	
after	plasma	treatment	for	different	times	in	both	uncooled	and	cooled	reaction	vessel;	electrical	plasma	
parameters:	14.5kHz;	7	W;	helium-oxygen	admixed	gas	(99.5-	0.5%	v/v)	
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A	BSA	binding	reduction	of	10%	of	the	original	value	corresponds	to	a	thickness	of	1.72	µm	of	
the	created	uncharged	SE	layer	surrounding	the	core	(Figure	3-17).	The	assumption,	that	all	
particles	are	of	identical	size	hereby	implies,	that	a	SE	layer	thickness	of	1.72	µm	corresponds	
to	different	reduction	levels	for	individual	beads-	particles	of	50	µm	diameter	lose	19.3%	of	
their	BSA	binding	capacity	while	particles	of	150	µm	lose	only	6.8%.	While	the	size	distribution	
of	 chromatography	 media	 has	 a	 large	 impact	 on	 mass	 transfer	 kinetics	 when	 used	 in	
‘traditional’	column	chromatography	(Kaczmarski	et	al.,	2003),	it	is	evident	that	different	sizes	
of	 individual	particles	add	an	additional	burden	when	the	supports	are	functionalised	on	a	
single	bead	basis.		
The	samples	treated	in	the	cooled	reactor	show	reduction	levels	of	max	5%	of	BSA	binding	
capacity	(corresponding	to	0.85	µm	thickness	of	the	SE	outer	shell	for	100	µm	diameter	bead	
size).	Similar	to	the	results	in	the	DBD	configuration,	elevated	temperatures	aid	the	ROS	to	
	
Figure	3-17	Volume	size	distribution	of	Q	Sepharose	FF	media,	measured	as	described	in	2.3.13	(Top	right);	
Calculation	of	the	size	of	the	SE	outer	shell	of	plasma	treated	Q	Sepharose	FF	chromatography	supports	
(bottom	left)	under	the	assumptions	that	the	Q	ligand	is	evenly	distributed	across	the	spherical	volume	of	
the	supports	and	a	mean	volume	particle	size	of	100	µm	
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penetrate	 further	 into	 the	 core	 of	 the	 particles	 etching	 off	 Q	 ligands	 from	 the	 backbone	
structure	of	the	media	further	away	from	the	surface.		
For	the	uncooled	set-up,	the	reductions	of	pDNA	binding	capacities	showcase	that	treatment	
times	of	5	min	are	not	enough	to	achieve	higher	reduction	values	of	shell	binding	than	17%.	
With	 longer	 overall	 treatment	 times	 the	 values	 rise	 up	 to	 and	 level	 out	 at	 around	 40%	
reduction	after	40	min,	with	longer	treatment	times	(60	min)	providing	no	additional	loss.	The	
temperature	in	the	reactor	reaches	steady-state	after	20+	min,	indicating	that	with	a	further	
increase	of	temperature,	pDNA	binding	reductions	may	still	be	going	up.	
The	pDNA	binding	reduction	values	of	the	samples	treated	in	the	ice-bathed	reactor	level	out	
after	10	min	(22%)	with	minor	differences	for	additional	treatment	time	(18,	17,	24%	for	the	
20,	 40	 and	 60	 min	 treatments,	 respectively)	 coinciding	 with	 reaching	 the	 steady	 state	
temperature	of	the	reactor	around	20°C.		
As	not	all	of	the	surface	charges	have	been	eliminated,	the	ROS	must	have	diffused	into	the	
core	 of	 the	 particles	 further	 than	 the	 1.7	µm	 (0.85	µm	 for	 the	 ice-bathed	 reactor	 set-up,	
respectively)	to	cause	the	10%	(5%)	reduction	of	the	BSA	binding	capacity,	as	ligands	on	the	
surface	of	the	particles	that	have	not	been	etched	away	by	the	plasma	treatment	will	still	bind	
BSA	in	static	binding	studies.	This	suggests	that	the	zone	affected	by	the	ROS	is	not	necessarily	
a	sharp	cut	off	zone,	with	some	ROS	travelling	past	the	initial	ligands	presented	on	the	very	
surface	and	reacting	deeper	in	the	bead	with	a	respective	partner.	
Table	3-1	SI	values	dependent	on	treatment	time	for	both	the	ice	bathed	and	ambient	temperature	reactor	
Treatment	time	[min]	 SI	value	(uncooled)	 SI	(ice	bathed	reactor)	
5		 1.13	 1.15	
10		 1.23	 1.27	
20		 1.21	 1.27	
40		 1.14	 1.50	
60		 1.29	 1.45	
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An	 overall	 lower	 temperature	 of	 the	 sample	 slurry	 leads	 to	 lower	 losses	 of	 core	 binding	
capacity	however,	this	is	at	the	expense	of	surface	binding	capacity	reduction	(Table	3-1).	
From	 all	 SI	 values	 being	 higher	 for	 samples	 treated	 at	 elevated	 temperatures,	 it	 can	 be	
concluded	that	the	‘savings’	of	core	binding	capacities	seen	with	the	ice-bathed	reactor	do	not	
justify	the	loss	of	surface	reduction	compared	to	the	uncooled	reactor.		
Overall	 it	 can	 be	 concluded	 that	 cooling	 the	 system	 reduces	 the	 overall	 efficacy	 of	 the	
treatment	while	enhancing	selectivity	of	surface	vs	core	binding	reduction.		
3.3.2.5.	‘Interval	cascade’	treatment		
Plasma	etching	in	batch	reactors	inevitably	leaves	the	etched	species	in	the	surrounding	buffer	
solution.	Whether	 or	 not	 the	 presence	 of	 these	 species	 has	 an	 impact	 (and	 if	 so	 to	what	
extend)	on	the	plasma	etching	and	oxidation	has	not	yet	been	investigated.		
The	maximum	solubility	of	leached	off	species	in	solution	could	be	a	key	parameter	for	the	
success	of	the	plasma	etching	reaction-	if	the	solubility	is	very	low,	the	initial	etched	off	species	
will	prevent	accumulation	of	 further	species	 in	solution	and	the	reaction	chokes	 itself.	The	
presence	 of	 these	 species	 could	 furthermore	 interact	 with	 the	 plasma	 reaction	 itself	 by	
‘poisoning’	the	reaction	due	to	their	high	reactivity.	Interaction	between	the	plasma	species	
and	 leached	molecules	 could	 restrict	 their	ability	 to	 target	other	 ligands	on	 the	 surface	of	
chromatography	supports.	
By	repeatedly	changing	the	surrounding	buffer	during	the	reaction,	both	of	these	effects	can	
be	minimised.	
During	plasma	treatments	of	chromatography	supports	in	the	FB	reactor,	the	slurry	containing	
the	chromatography	media	heats	up	over	time	(Figure	3-18).		
	
	
Figure	3-18	Temperature	profile	of	chromatography	media	suspended	in	plasma	reactor	over	time	(He-O2	
admixed	gas	plasma	(99.5%-0.5%);	7	W;	14.5	kHz)		
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To	reduce	the	amount	of	time	the	media	is	exposed	to	elevated	temperatures	(yielding	higher	
losses	of	core	binding	capacities),	and	to	investigate	whether	changing	the	surrounding	buffer	
of	the	chromatography	media	during	the	plasma	treatment	has	a	significant	 impact	on	the	
media’s	performance	post	 treatment,	 the	overall	 treatment	 time	was	 split	 up	 into	 several	
shorter	intervals	with	buffer	exchange	steps	in	between.	
Rather	than	one	long	treatment	a	‘cascade’	of	intervals	with	overall	constant	treatment	times	
was	 investigated:	 Four	 different	 treatment	 times	 (5	 min,	 10	 min,	 20	 min,	 40	 min)	 were	
analysed	with	e.g.	40	min	overall	treatment	time	correlating	to	4x	10	min,	2x	20	min	and	1x	
40	min.	
Samples	were	 treated	using	99.5%	helium	and	0.5%	oxygen	gas	plasma	 (premixed	by	BOC	
specialty	gasses)	with	a	pulse	frequency	of	14.5	kHz	at	an	input	power	level	of	7	W	(manual	
voltage	modulation	to	maintain	constant	power	supply)	and	gas	flow	rate	was	kept	constant	
at	750	mL/min	(correlation	chart	of	flow	meter	for	pure	helium-	neglecting	the	0.5%	admixed	
Oxygen).		
With	one	 intention	of	 the	 experiment	 being	 the	 investigation	of	 the	 effect,	 constant	 heat	
exposure	has	on	the	Q	Sepharose	FF	media,	the	reactor	was	not	cooled	during	the	reaction	
(ambient	21°C	at	the	beginning	of	each	treatment).	
After	every	treatment,	the	sample	slurry	was	poured	onto	a	vacuum	filter	frit,	suction	dried	
and	washed	three	times	with	150	mL	MQW.	The	dried	media	was	then	gently	scraped	off	the	
filter	frit	and	resuspended	in	MQW	(8	mL	total	sample	volume)	before	the	next	treatment.	
After	 the	 last	 treatment,	 samples	were	 resuspended	 in	 TE	 buffer	 (10	mL	 total	 volume)	 in	
preparation	 for	 subsequent	 analysis	 (2.3.6).	 The	 results	 of	 the	 quantification	 of	 the	 static	
binding	capacities	are	depicted	in	Figure	3-19.		
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The	(shortest)	5	min	single	treatment	of	the	slurry	led	to	a	pDNA	binding	reduction	of	9%	with	
a	loss	of	only	1%	of	the	overall	protein	binding	capacity.		
With	longer	single	treatment	times	pDNA	binding	capacity	was	reduced	to	90%,	84%	and	77%	
compared	 to	 the	 untreated	 control	 samples	 for	 10	 min,	 20	 min	 and	 40	 min	 treatments,	
respectively.	Accompanying	BSA	binding	reductions	(3%;	3%;	4%)	also	show	a	trend	towards	
higher	loss	of	core	binding,	however,	less	so	than	compared	to	the	reductions	seen	for	pDNA	
binding	capacities.	All	protein	binding	reductions	are	below	5%	of	their	initial	binding	capacity,	
indicating	that	in	a	single	plasma	treatment,	the	majority	of	plasma	species	do	not	(or	only	at	
the	start	of	the	treatment)	interact	with	the	core	of	the	chromatography	particles.	
However,	 when	 the	 treatment	 time	 is	 split	 up	 into	 several	 shorter	 intervals,	 the	 protein	
binding	capacity	is	reduced	further	in	comparison	to	the	capacities	observed	in	single	treated	
samples.	By	splitting	10	min	overall	treatment	time	into	2	treatments	of	5	min	each,	the	BSA	
binding	capacity	was	reduced	twice	as	much	(from	3%	to	6%)	while	no	change	in	the	pDNA	
binding	capacity	was	observed.	A	similar	trend	can	be	observed	for	the	20	min	and	40	min	
overall	treatment	time	samples;	while	the	reduction	of	the	pDNA	binding	capacities	is	almost	
identical	across	the	samples	with	the	same	overall	treatment	times,	the	reductions	of	protein	
binding	capacities	are	going	up	with	an	increased	number	of	(shorter)	plasma	treatments;	for	
the	40	min	overall	treatment	time	sample,	reductions	of	BSA	binding	capacities	were	5%,	7%	
and	14%	for	1,	2,	and	4	cycles	respectively.		
	
Figure	3-19	Reduction	of	surface	(pDNA)	and	core	(BSA)	binding	capacities	of	plasma	treated	Q	
Sepharose	FF	media	in	comparison	to	an	untreated	control	sample	assessed	by	static	binding	studies	post	
cascade	plasma	treatments	for	various	times	and	intervals	(7	W;	14.5	kHz;	He-O2	(99.5%-	0.5%)	gas	plasma)	
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From	this	data,	it	can	be	concluded,	that	the	plasma	species	are	etching	regions	further	inside	
the	core	of	chromatography	supports	towards	the	beginning	of	each	plasma	cycle.	Each	of	
those	plasma	cycles	contributes	to	further	core	damage	without	proportionally	reducing	the	
shell	binding	capacity	of	Q	Sepharose	FF	media.	Overall	the	data	suggests	that	by	increasing	
the	number	of	cycles,	mostly	the	core	of	the	supports	gets	‘attacked’.	Additional	treatments	
do	not	contribute	to	the	selectivity	of	shell	over	core	binding	capacity	reduction	and	longer	
single	treatments	are	beneficial	over	shorter	repetitions.	
Linking	 the	 results	 to	 the	 elevated	 temperatures	 occurring	 during	 longer	 treatment	 times	
suggests	that	the	plasma	species	are	actively	reacting	with	the	core	of	the	particles	at	lower	
temperatures.	Longer	treatments	in	which	the	reaction	vessel	as	well	as	the	contained	particle	
slurry	heat	up,	do	not	contribute	to	additional	core	damage	after	an	initial	‘cold’	phase	of	the	
reactor.	
Overall,	no	poisoning	of	the	reaction	due	to	presence	of	ROS	in	the	reactor	over	an	extended	
period	of	time	could	be	observed.	Even	if	such	an	effect	exists,	it	has	no	(negative)	impact	on	
media	performance	in	static	binding	studies	post	plasma	treatment.	
3.3.2.6.	Offline	treatment		
During	cold	atmospheric	pressure	plasma	treatment	of	beaded	chromatography	media,	the	
volatile	plasma	species	adsorb	onto	the	media	and	react	with	compounds	on	the	outside	of	
the	media	(Cardinaud,	2000).	The	created	plasma	species	are	of	various	solubilities	in	water	
especially	 with	 the	 formation	 of	 peroxides	 (ROOH)	 and	 peroxide	 radicals	 (RO2)	 (Fridman,	
2008).	These	and	other	highly	reactive	radicals,	have	various	longevities	in	aqueous	solutions.	
The	FBR	used	 in	 this	 study	 is	effective	 to	etch	 small	batches	of	 chromatography	 supports.	
However,	 scale	 up	 of	 a	 FBR	 that	 requires	 operational	 conditions	 (continuous	 gas	 flow)	 to	
maintain	mixing	 of	 the	 supports	 is	 difficult.	 Other	 designs	 are	 imperative	 for	 larger	 scale	
manufacturing	conditions.		
One	option	to	enhance	the	throughput	of	the	reactor	 is	 to	separate	the	plasma	treatment	
from	the	actual	etching	of	chromatography	media.	 If	 reactive	species	are	stable	enough	 in	
solution,	in	conjuncture	with	a	high	solubility	in	aqueous	solution,	plasma	treatments	of	MQW	
containing	no	chromatography	media	would	offer	several	elegant	solutions:	Plasma	treatment	
of	MQW	 is	much	 easier	 to	 scale	 up	 and	 could	 be	 engineered	 into	 a	 continuous	 reaction,	
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providing	the	plasma	radicals	offline	for	the	subsequent	etching	reaction	of	chromatography	
media.	
In	 order	 to	 explore	whether	 ROS	 retain	 their	 efficacy	 to	modify	 the	 binding	 behaviour	 of	
chromatography	 supports,	 MQW	 was	 treated	 ‘offline’	 with	 no	 chromatography	 supports	
suspended	 in	the	slurry.	Post	 treatment	the	solution	was	then	mixed	with	Q	Sepharose	FF	
chromatography	supports	and	their	subsequent	static	binding	performance	was	analysed.		
1	mL	SBV	aliquots	of	Q	Sepharose	FF	in	MQW	were	scaled	in	15	mL	tubes	and	supernatants	
pipetted	 out.	 The	 MQW	 (7	 mL;	 retaining	 SBV:	 MQW	 ratio	 of	 previous	 experiments)	 was	
treated	in	the	FBR	as	described	in	2.3.5	(14.5kHz;	7	W;	10	min;	gas	flow:	750	mL/min	(flow	
chart	 of	 pure	 helium);	 He-	 O2	 (99.5-	 0.5%)	 premixed	 by	 BOC	 specialty	 gasses)	 with	 the	
exception	of	lacking	supports	in	slurry.	
Due	 to	 the	 volatile	 nature	 of	 the	 experiment,	 two	 sets	 of	 1	 mL	 SBV	 Q	 Sepharose	 FF	
chromatography	 supports	 were	mixed	 separately	 with	 plasma	 treated	MQW	 immediately	
after	the	reactor	was	turned	off	by	pouring	the	contents	of	the	reactor	straight	 into	tubes	
containing	 1	mL	 of	 Q	 Sepharose	 FF	media.	 The	 tubes	were	mixed	 on	 a	 vortex	mixer	 and	
incubated	for	10	min	on	a	blood	tube	rotator	SB1.	The	beads	were	then	rebuffered	in	TE	buffer	
(10	mM	Tris-HCl;	1	mM	disodium	EDTA;	pH	8.0)	afterwards.	
Static	binding	studies	for	pDNA	and	protein	binding	were	performed	in	duplicate	(averaged),	
immediately	after	mixing,	1	h,	24	h	and	6	days	post	incubation	as	described	in	2.3.6.	
	
	
Figure	3-20	Static	pDNA	and	BSA	binding	capacities	of	Q	Sepharose	FF	media	post	mixing	with	cold	
atmospheric	pressure	plasma	treated	MQW	for	10	min	measured	immediately	after	initial	mixing,	1	h,	24	h	
and	6	days	respectively	
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The	pDNA	binding	capacities	of	both	offline	treated	Q	Sepharose	FF	samples	are	not	different	
from	 adsorption	 capacities	 displayed	 by	 the	 control	 sample,	 for	 both	 pDNA	 and	 BSA	
adsorption.	 The	 reaction	 requires	 the	 plasma	 species	 to	 adsorb	 onto	 the	 chromatography	
supports	in	order	to	etch	away	and	oxidise	ligands	on	their	surfaces.	Even	after	allowing	the	
reaction	 time	 to	 develop,	 no	 alteration	 of	 pDNA	 binding	 capacity	 can	 be	 observed.	 This	
indicates	that,	although	some	of	the	plasma	species	may	have	a	longer	lifespan,	allowing	them	
to	not	react	off	prior	to	contact	with	chromatography	media,	it	is	not	sufficient	to	achieve	a	
reduction	of	pDNA	binding	capacity.	As	one	would	expect,	given	that	the	outer	shell	logically	
would	 be	 affected	 before	 the	 core,	 the	 BSA	 binding	 capacities	 are	 matching	 the	 binding	
properties	of	the	control	sample.	Over	time,	allowing	the	species	to	diffuse	further	into	the	
core,	binding	properties	still	remain	at	their	initial	values	(around	80	mgBSA/mLSBV).	
It	becomes	evident	that	ROS	with	shorter	lifespan	are	responsible	for	the	plasma	etching	of	
the	 supports.	 The	 longer-lived	 ROS,	 present	 in	 the	MQW	plasma	 species	 solution,	 do	 not	
contribute	to	binding	capacity	reductions	observed	in	previous	experiments.	
Although	plasma	is	clearly	altering	the	binding	properties	of	AEC	media	in-situ,	merely	plasma	
treating	aqueous	solutions	with	the	aim	to	create	a	‘ROS	solution’	to	mix	it	with	media	offline	
does	neither	alter	the	binding	behaviour	of	pDNA	nor	BSA.	
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3.3.2.7.	Variation	of	the	surrounding	buffer		
Throughout	the	plasma	treatment	experiments,	MQW	was	used	as	a	non-interactive	buffer	
with	 low	electric	conductivity.	However,	etching	away	ligands	off	the	surface	of	AEC	beads	
leads	to	the	generation	of	other	charged	groups	(where	ligands	have	been	etched	away	and	
replaced	by	ROS).		
Figure	3-21	follows	the	visual	development	of	the	plasma	reaction	containing	1	mL	Sepharose	
CL-6B	media	in	20	mM	NaCl	over	the	first	12	seconds	after	voltage	was	applied.		
The	colour	of	a	plasma	is	determined	by	emitted	photons,	when	electrons	recombine	with	
ions	and	is	dominantly	determined	by	the	carrier	gas	used	(Xu,	2017).	The	photon	energy	and,	
hence,	it's	wavelength	(colour)	is	dependent	on	the	energy	difference	between	the	two	energy	
levels.	
	
The	characteristic	blue-purple	plasma	(helium	associated)	dominates	during	the	first	seconds	
of	plasma	development,	however	quickly	shifting	its	colour	towards	a	bright	yellow	glow.	This	
phenomenon	has	been	attributed	to	the	presence	of	sodium	in	solution	(Bruggeman	et	al.,	
2016).		
However,	with	no	chromatography	supports	suspended	 in	the	reactor,	 the	glow	retains	 its	
initial	blue-pinkish	colour	(Figure	3-22),	indicating	that	the	sodium	is	not	available	with	NaCl	
	
Figure	3-21	Photographic	depiction	of	the	first	12	seconds	(left	to	right)	of	plasma	treatment	of	Sepharose	
Cl-6B	chromatography	supports	in	20	mM	NaCl	(1	mL	SBV;	3.6	W;	14.5	kHz;	He-O2	(99.5%-0.5%	v/v)	gas;	
750	mL/	min)	
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alone	 in	the	chamber.	Either	the	etched	off	species	or	 the	newly	generated	groups	on	the	
surface	of	the	beads	are	reacting	with	the	chloride	ions	allowing	the	sodium	to	influence	the	
plasma	colour.	
	
This	poses	the	question,	whether	quenching	these	groups	in	their	higher	energetic	states	with	
ions	provided	in	the	surrounding	buffer	is	beneficial	for	the	reduction	of	surface	binding	of	the	
chromatography	supports.	Therefore,	Q	Sepharose	FF	media	(1	mL	SBV	each)	was	equilibrated	
in	different	buffers	(8	mL	total	sample	volume;	NaCl,	Na2CO3,	CH3	CO2K2	-	all	100	mM)	before	
plasma	treating	the	suspensions	(as	described	in	2.3.5;	7	W;	14.5	kHz;	10	min;	He-O2	(99.5%-
0.5%	v/v)	gas;	750	mL/min).	
	
	
Figure	3-22	Steady	state	visual	appearance	of	plasma	treatment	of	20	mM	NaCl	(no	chromatography	
supports;	3.6	W;	14.5	kHz;	He-O2	(99.5%-0.5%	v/v)	gas;	750	mL/min)	
	
Figure	3-24	Reduction	of	Q	Sepharose	FF	static	binding	capacities	post	plasma	treatment	(7	W;	10	min;	
14.5	kHz;	He-O2	(99.5%-0.5%	v/v);	750	mL/min)	after	equilibration	in	different	salt	buffers	(100	mM)	
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As	seen	previously,	reduction	of	BSA	binding	capacity	of	Q	Sepharose	FF	media	in	MQW	due	
to	plasma	etching	is	minimal	(3.5%;	Figure	3-24)	and	no	significant	damage	was	done	to	the	
core	of	 the	particles.	 Changing	 the	 surrounding	buffer	of	 the	media	neither	 enhances	nor	
reduces	the	damage	caused	to	the	core	of	the	particles.	With	all	reductions	of	BSA	binding	
capacities	being	below	5%,	in	comparison	to	an	untreated	control	sample,	the	effect	of	the	
plasma	treatment	on	the	core	of	the	particles	 is	therefore	independent	of	the	surrounding	
buffer.	
The	plasma	treatment	reduced	pDNA	binding	of	the	MWQ	buffered	sample	by	24%	(SI=	1.27).	
While	pDNA	binding	capacity	of	the	sample	buffered	in	100	mM	potassium	acetate	is	reduced	
by	20%	(SI=	1.18),	yielding	a	comparable	result.	However,	none	of	the	additional	salt	buffers	
get	close	to	the	reduction	levels	achieved	when	using	pure	MQW	as	surrounding	buffer.	
The	addition	of	different	100	mM	salts	 in	the	surrounding	buffer	(sodium	chloride,	sodium	
acetate,	 potassium	 acetate,	 potassium	 chloride)	 during	 cold	 atmospheric	 pressure	 plasma	
treatments	of	hydrogel	AEC	media,	does	not	contribute	to	a	higher	 loss	of	surface	binding	
capacity	 in	 static	 binding	 studies.	 This	 may	 be	 due	 to	 reduced	 electric	 resistance	 and	
subsequently	 increased	higher	 electric	 current,	 hindering	 the	plasma	development	 and	 its	
efficacy.	
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3.3.2.8.	Visual	Batch	to	Batch	variations	in	Q	Sepharose	FF	media	
Upon	acquisition	of	chromatography	media	and	prior	to	their	usage	for	pDNA	purification,	it	
is	 important	 to	 confirm	 their	 performance	 in	 chromatographical	 scouting	 experiments	
resembling	their	later	field	of	application.	Throughout	the	plasma	etching	experiments	in	the	
FBR,	especially	with	Q	Sepharose	FF,	irregularities	in	results	led	to	light	microscopic	inspection	
of	different	batches	of	starting	media.	
All	media	performed	similarly	(and	in	accordance	with	manufacturer’s	protocols)	with	regards	
to	protein	binding	capacities	and	pDNA	isotherms;	but	despite	these	similarities,	the	media	
behaved	 differently	 before	 and	 after	 plasma	 treatments	 in	 static	 binding	 studies	 across	
batches.	
To	 assess	 which	 batch	 of	 Q	 Sepharose	 FF	 is	 best	 suited	 for	 plasma	 surface	 etching,	 four	
different	batches	of	media	were	equilibrated	in	MQW	and	light	microscopic	images	of	10x	and	
40x	magnification	were	taken	as	described	in	(2.3.11.2).	
Table	3-2	Lot	numbers	of	different	analysed	Q	Sepharose	FF	media	batches	
Media	description	(including	supplier)	 Batch	 Lot	#	of	the	different	batches	
Q	Sepharose	FF	(directly	from	GE	Healthcare)	 1	 10227073	
Q	Sepharose	FF	(directly	from	GE	Healthcare)	 2	 10237687	
Q	Sepharose	FF	(from	Sigma	Aldrich)	 3	 MKCB8745	
Q	Sepharose	FF	(directly	from	GE	Healthcare)	 4	 10037837	
	
At	10x	magnification	(Figure	3-24,	top),	different	batches	of	Q	Sepharose	FF	show	similar	size	
distributions	and	indicate	the	presence	of	small	imperfections	on	the	surfaces	of	the	particles	
as	will	be	discussed	in	detail	later	in	the	respective	sections	(SEM	images	(3.3.2.14.	)	as	well	as	
quantitative	 analysis	 of	 said	 imperfections	 (0)).	 However,	 upon	 higher	 magnifications	 it	
becomes	evident	that	supports	of	batch	2	and	3	show	entirely	different	surface	topologies	
than	the	other	two.	Both	are	punctuated	by	small	holes	in	ways	previously	unobserved.	
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These	small	holes	on	the	surfaces	of	the	beads	grant	pDNA	molecules	access	to	the	core	of	
the	beads,	adsorbing	to	the	ligands	lining	the	pores,	even	if	the	remaining	surface	was	totally	
inert	to	pDNA	binding.	
None	of	the	media	are	ideal	for	plasma	etching	and	oxidising	ligands	off	the	surfaces	of	the	
beads,	 however	 batch	 2	 and	 3	 would	 even	 after	 a	 sorting	 process	 (eliminating	 the	 non-
spherical/	 imperfect	 beads)	 remain	 unsuitable	 due	 to	 the	 amount	 of	 small	 entry	 holes	 to	
regions	inaccessible	to	etching	ROS.		
When	selecting	AEC	media	for	cold	atmospheric	pressure	plasma	experiments	with	the	aim	of	
eliminating	surface	charges,	it	is	crucial	to	inspect	the	beads	on	a	batch	to	batch	basis	not	only	
for	their	chromatographic	performances	in	the	‘native’	state	without	surface	modifications,	
but	also	visually	as	batch-to-batch	variances	of	the	same	media	have	a	severe	impact	on	the	
efficacy	 of	 subsequent	 plasma	 etching	 operations.	 Even	 for	 the	 same	 brand	 of	 beads	 (Q	
Sepharose	FF)	differences	across	batches	make	some	of	the	media	unsuitable,	based	on	their	
optical	properties	alone.	
Figure	3-24	Light	microscopic	images	of	different	Q	Sepharose	FF	batches	(see	Table	3-2	for	description);	10x	
magnification	(top);	40x	magnification	(bottom);	left	to	right	Lot	#:	10227073,	10237687,	MKCB8745,	
10037837	
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3.3.2.9.	How	far	does	pDNA	penetrate	into	the	core	of	AEC	beads	(Q	Sepharose	FF)?	
It	was	previously	reported	that	the	vast	majority	of	the	interior	of	agarose	based	AEC	matrices	
is	inaccessible	to	pDNA	binding	due	to	size	limitations	(Prazeres	et	al.,	1998;	Ljunglof	et	al.,	
1999).	
The	base	matrix	of	Q	Sepharose	FF	is	a	highly	cross-linked	6%	agarose	media	(GE	Healthcare	
Bio-Science,	 2014)	 with	 a	 pore	 size	 limit	 of	 around	 29	 nm	 (Hagel	 et	 al.,	 1996b).	 pDNA	
molecules	are	hence	expected	to	be	unable	to	access	the	inner	core	of	the	particle	and	binding	
is	limited	to	the	surface	of	the	media.	
In	order	to	quantify	the	penetration	depth	of	pDNA	binding	into	the	interior	of	Q	Sepharose	
FF	adsorbents,	CLSM	images	of	single	chromatography	particles	were	recorded	as	described	
in	2.3.12.	
Stack	images	with	a	magnification	of	63x	were	recorded	for	various	support	diameters.	
The	thickness	of	each	adsorptive	layer	was	measured	as	the	radial	length	in	µm	of	peak	areas	
with	intensity	values	>20	counts.	The	numerical	average	of	6	peaks	around	the	perimeter	of	
each	bead	was	calculated	(omitting	values	originating	from	peaks	with	a	large	discrepancy	to	
the	average	peak	height	to	avoid	the	impact	of	discordant	values).	The	intensity	traces’	LUTs	
were	adjusted	to	visualise	the	fluorescent	binding	‘halo’	of	the	adsorptive	layer.		
	 -	106	-	
	
An	example	of	an	intensity	profile	of	one	analysed	bead	diameter	is	depicted	in	Figure	3-25.	
The	consolidation	of	the	obtained	data	(Figure	3-25,	bottom	right)	shows	that	the	thickness	
of	 the	 adsorptive	 layer	 is	 largely	 independent	 of	 the	 particle	 diameter	 (neglecting	 the	
miniscule	slope	of	the	linear	fit	through	the	data	points).	The	extend	of	pDNA	binding	into	the	
core	was	 calculated	 at	 an	 average	 of	 1.9	µm	with	 all	 data	 points	 spreading	 between	 1.5-	
2.5	µm.		
However,	small	particle	diameters	still	result	in	higher	pDNA	binding	capacities	per	volume	of	
media	due	to	the	larger	surface	binding	area	to	volume	ratio	per	bead.	If	a	process	designed	
to	eliminate	all	ligands	on	the	surface	of	chromatography	particles,	to	create	bilayered	SEC-
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Figure	3-25	Top:	Example	fluorescence	intensity	profile	of	Syto	9	tagged	pDNA	along	the	radial	position	along	
the	ROI	of	the	bottom	left	CLSM	image	
Bottom	left:	CLSM	image	of	Q	Sepharose	FF	with	one	(of	3	per	image)	ROI	(73x	5	µm)	for	the	determination	of	
penetration	depth	of	pDNA	into	the	shell	of	the	media	
Bottom	right:	Average	of	penetration	depths	for	different	bead	diameters	of	6	different	pDNA	peaks	
(intensity	counts	>20)	each	around	the	bead	per	image;	linear	fit	of	data	over	all	measured	diameters	
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AEC	supports,	cannot	entirely	etch	away/	cover	the	ligands	on	the	surface,	AEC	media	with	
larger	diameters	as	starting	materials	would	be	beneficial.		
Whether	or	not	the	depth	of	the	binding	layer	of	pDNA	depends	upon	the	binding	region	of	a	
bead	is	of	great	interest	when	considering	that	some	beads	within	a	batch	of	chromatography	
media	 show	 non-spherical	 shapes.	 These	
non-uniform	beads	are	of	particular	interest	
with	 regard	 to	 binding	 of	 pDNA	 to	 surface	
regions	that	are	less	accessible	to	convection	
from	 the	 surrounding	media.	To	assess	 the	
extent	 of	 pDNA	 binding	 depth	 to	 these	
‘unconventional’	 surfaces,	 CLSM	 images	 of	
supports	bearing	‘beads	inside	bead’	shapes	
were	 recorded,	 and	 binding	 penetration	
measured	in	the	same	way	as	for	the	outer	
shell	of	the	particles	(Figure	3-26).	
The	 size	 of	 the	 pDNA	 binding	 layer	 in	 the	
small	 bead	 inside	 the	 ‘main’	 particle	 was	
1.8	µm	showing	no	differences	to	the	‘main’	
bead.	Several	other	CLSM	images	of	similar	particles	confirm	this	trend	and	it	can	be	concluded	
that	the	extend	of	pDNA	binding	to	Q	Sepharose	FF	supports	is	independent	of	bead	diameter	
as	well	as	location	of	the	binding	sites	on	its	surface,	given	enough	incubation	time.	
	 	
Figure	3-26	CLSM	image	of	a	Q	Sepharose	FF	
chromatography	particle	incubated	with	Syto	9	tagged	
pDNA;	the	chosen	stack	of	analysis	focusses	on	the	
centre	of	the	small	bead,	not	the	main	bead,	nor	the	
‘cut	out’	
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3.3.2.10.	CLSM	analysis	of	the	binding	topography	of	plasma	etched	hydrogel	AEC	support	
media	
CLSM	is	a	powerful	visualisation	tool	used	in	biochemical	applications	to	investigate	spatial	
distributions	of	fluorescent	molecules	embedded	in	three-dimensional	scaffolds	(Carlsson	et	
al.,	1987;	Ljunglof	et	al.,	1999;	Pawley,	2006).	It	allows	tracing	positions	of	different	moieties	
within	a	matrix	such	as	beaded	chromatography	supports	(Kim	et	al.,	1996;	Close	et	al.,	2013).		
Fluorophores	with	enhanced	fluorescence	upon	binding	to	target	molecules	(tagging)	are	used	
to	 create	 clear	 images	 and	 help	 to	 avoid	 interference	 caused	 by	 autofluorescence	 of	 the	
scaffold	by	allowing	a	reduction	of	excitation.	Due	to	the	use	of	 fluorescent	 labels	without	
overlapping	 excitation/	 emission	 spectra,	 several	 different	 compounds	 can	 be	 visualised	
simultaneously	within	the	same	environment.	
To	visualise	the	binding	properties	of	different	chromatography	media	and	to	localise	regions	
where	 binding	 of	 different	 species	 occur,	 beaded	 supports	 were	 incubated	 with	 both,	
fluorescently	tagged	BSA	(CY-5)	and	the	26.88	kbp	plasmid	IT14:	pPR322-p170	(tagged	with	
Syto-9).	
Prior	to	applying	the	technique	to	plasma	functionalised	supports,	(untreated)	Q	Sepharose	FF	
was	analysed	as	described	in	2.3.12,	focussing	on	single	supports	of	the	strong	AEC	media.	
Image	size	for	all	images	is	given	at	512x512	pixels	with	a	pixel	size	of	0.42	µm.	To	allow	visual	
inspection	of	the	particles,	light	microscopic	images	of	supports	were	recorded,	respectively.		
The	distribution	of	bound	fluorescent	molecules	(Cy5	tagged	BSA	and	SYTO9	tagged	pDNA)	
through	 the	 adsorbent	 particles	 was	 obtained	 by	 translation	 of	 the	 confocal	 images	 into	
fluorescence	 intensity	 profiles	 after	 manually	 selecting	 equator	 stacks	 (largest	 diameter	
among	z-stacks)	of	each	bead.	 (FIJI	 is	 just)	 ImageJ	 (Version	1.0	 for	Mac)	was	used	 for	data	
processing;	a	region	of	interest	(ROI)	(150	µm	x	5	µm)	was	drawn	through	the	centre	of	each	
bead	and	the	 intensity	profile	depicts	fluorescence	in	arbitrary	units	as	a	function	of	radial	
position	along	ROI.	
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Ljunglof	et	al.	reported	a	6.3	kbp	plasmid	to	be	too	large	to	enter	the	pores	of	Q	Sepharose	FF	
(Ljunglof	et	al.,	1999),	so	binding	of	26.88	kbp	plasmid	IT14:	pPR322-p170	is	 limited	to	the	
ligands	on	the	surface	of	the	adsorbent	particle	(Figure	3-27,	B).		
The	much	smaller	BSA	molecules	(66.43	kDa	(Hirayama	et	al.,	1990);	stokes	radius:	3.48	nm	
(Axelsson,	1978))	have	steric	access	to	diffuse	through	the	porous	stationary	phase	and	adsorb	
to	ligands	lining	the	internal	pores	throughout	the	support	(A).	
To	 ensure	 the	 observed	 fluorescence	 is	 solely	 attributed	 to	 fluorescence	 enhancement	 of	
SYTO-9	and	CY5	binding	to	pDNA	and	BSA	respectively,	a	control	experiment	in	absence	of	
either	fluorophore	was	conducted.	Figure	3-28	confirms	the	absence	of	autofluorescence	of	
pDNA,	BSA	and	the	stationary	phase	at	488	and	635	nm.	
Figure	3-27	CLSM	analysis	of	a	Q	Sepharose	FF	(untreated	control)	chromatography	support	
A:	Cy5	tagged	BSA	fluorescence	emission	(ex/em:	635	nm/654-	715	nm)	
B:	Syto	9	tagged	pDNA	fluorescence	emission	(ex/em:	488	nm/492-	533	nm	
C:	Overlay	of	both	fluorescence	channels,	ROI	for	intensity	distribution	analysis	(150	µm	x	5	µm)	
D:	Light	microscopic	image	of	the	scanned	bead	
E:	Fluorescence	intensity	profile	after	image	analysis:	x-axis	shows	distance	along	the	meridian	of	the	particle	
(as	depicted	in	C),	y-axis	average	fluorescence	intensity	over	5	µm	above	the	x-coordinate	(in	arbitrary	units)	
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3.3.2.11.	CSLM	analysis	of	He-O2	plasma	treated	Q	Sepharose	FF	chromatography	supports	
Cold	 atmospheric	 pressure	helium	plasma	 (admixed	with	0.5	%	 (v/v)	 oxygen)	was	used	 to	
functionalise	chromatography	supports	by	modifying	the	exteriors	of	Q	Sepharose	FF,	DEAE	
Sepharose	FF	and	EMD	Fractogel	(M)	DEAE	via	plasma	etching	and	oxidation	as	described	in	
2.3.5,	 with	 exception	 that	 voltage	was	 held	 constant	 rather	 than	 power	 input.	 Results	 of	
medias	performance	post	plasma	treatment	was	analysed	and	discussed	in	((Olszewski	et	al.,	
2013);	a	summary	of	the	results	is	depicted	in	Table	3-3.		
For	each	media,	two	different	treatment	times	(150	s;	300	s)	at	different	voltages	(10	V;	20	V)	
were	 investigated.	 Static	 protein	 and	 pDNA	 binding	 studies	 were	 preformed	 to	 assess	
reduction	of	core	and	surface	binding	capacities	respectively	as	described	in	2.3.6;		
CSLM	image	analysis	of	plasma	etched	Q	Sepharose	FF	supports	shows	a	qualitative	reduction	
of	pDNA	binding	capacity	cf.	the	untreated	control	for	all	analysed	samples	(Figure	3-29).	The	
pDNA	‘halo’,	surrounding	the	bead,	fluoresces	more	brightly	in	the	untreated	control	sample	
as	opposed	to	the	plasma	treated	samples.		
Quantitatively,	pDNA	peak	intensities	get	reduced	further	with	increased	treatment	time	of	
the	samples	in	the	reactor	(12.5%	reduction	after	150	s	as	opposed	to	39.1%	reduction	after	
300	 s);	 a	 similar	 effect	 can	 be	 observed	with	 an	 increase	 in	 voltage/	 power	 input	 (12.5%	
reduction	at	10	V;	26.2%	reduction	at	20	V).	
	
Figure	3-28	CLSM	analysis	of	Q	Sepharose	FF	chromatography	support	in	the	absence	of	fluorophores	
confirming	the	absence	of	autofluorescence	of	BSA,	pDNA	and	the	support	matrix	at	both	488	nm	and	
635	nm	
A:	Overlay	of	fluorescence	channels	at	emission	ranges	of	492-533	nm	and	654-715	nm		
B:	Respective	light	micrograph	
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Table	3-3	Reduction	of	BSA	and	pDNA	binding	capacities	of	He-O2	plasma	treated	chromatography	supports	in	
comparison	to	their	untreated	control	samples	assessed	with	static	binding	studies	(adapted	from	(Olszewski	et	
al.,	2013))	
Base	Matrix	 Applied	
voltage	[V]	
Treatment	
time	[s]	
Reduction	of	surface	
binding	(pDNA)	capacity	[%]	
Reduction	of	core	binding	
(BSA)	capacity	[%]	
Q	Sepharose	FF	 10	 150	 61.5	 4.8	
Q	Sepharose	FF	 20	 150	 66.3	 (-1.3)	
Q	Sepharose	FF	 10	 300	 67.3	 17.3	
DEAE	Sepharose	FF	 10	 150	 47.5	 6.4	
DEAE	Sepharose	FF	 20	 150	 62.4	 18.8	
DEAE	Sepharose	FF	 10	 300	 61.3	 26.1	
EMD	Fractogel	
DEAE	
10	 150	 55.8	 2.9	
EMD	Fractogel	
DEAE	
20	 150	 74.1	 17.9	
EMD	Fractogel	
DEAE	
10	 300	 69	 16.4	
	
Correlating	pDNA	binding	capacity	to	peak	fluorescence	intensities	can	be	slightly	misleading	
due	to	the	binding	nature	of	pDNA	to	AEC	supports;	however,	when	comparing	the	integral	
values	of	areas	under	the	pDNA	fluorescence	signals	(sum	of	all	intensity	values,	corrected	by	
the	baseline	fluorescence	assuming	no	core	binding	of	pDNA	to	Q	Sepharose	FF),	the	trends	
of	power	input	and	treatment	time	remain	the	same	as	for	the	reductions	of	the	peak	intensity	
values.	
Plasma	etching	of	Q	Sepharose	FF	yielded	significant	 reduction	of	 shell	binding	capacity	 in	
static	pDNA	binding	studies	of	up	to	67%	for	the	300	s,	10	V	sample	(Table	3-3).	
When	 comparing	 the	 data	 to	 reduction	 of	 pDNA	 fluorescence	 intensity	 within	 the	 same	
sample	(both	peak	intensity	and	average	peak	area),	pDNA	binding	capacity	is	reduced	less	
(39.1%	and	32.5%,	respectively).	So,	although	the	trends	of	the	plasma	parameters	for	the	
reduction	of	 shell	 binding	 capacity	with	 increased	 voltage	 and	 treatment	 time	 remain	 the	
same,	quantitatively	the	results	are	not	directly	comparable.	
Comparing	the	fluorescence	intensity	profiles	of	plasma	treated	beads	to	untreated	controls,	
no	significant	alteration	of	average	BSA	fluorescence	intensities	can	be	observed.	Unlike	the	
BSA	static	binding	studies,	there	is	no	indication	that	the	plasma	treatment	has	an	effect	on	
the	core	binding	capacity	of	the	supports.	
Reasons	 for	 this	 discrepancy	 may	 be	 aging	 of	 the	 media,	 differences	 in	 the	 assay	
implementation	or	data	analysis.	
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Figure	3-29	CLSM	analysis	of	plasma	treated	Q	Sepharose	FF;		
left:	overlay	of	Cy5	and	Syto9	fluorescence	channels	with	ROI;		
centre:	intensity	profiles	of	Cy5	and	Syto	9	along	ROI;	
right:	calculated	parameters	of	binding	reduction	to	control	and	others;	loss	in	peak	area	was	calculated	using	
the	integral	intensities	adjusted	by	the	baseline	intensity	
	
Untreated	Q	Sepharose	FF	
control	treated	Q	Sepharose	FF	
Average	pDNA	intensity:	7.4	
Peak	pDNA	intensity:	71.6	
Peak	intensity/average:	9.7		
Average	BSA	intensity:	118.8	
(for	intensities	>10)	
	
10	V;	150	s;	helium	oxygen	
plasma	treated	Q	Sepharose	FF	
Average	pDNA	intensity:	6.5	
Peak	pDNA	intensity:	62.6	
Peak	intensity/average:	9.6	
Average	BSA	intensity:	122.5	
(for	intensities	>10)	
Loss	in	peak	intensity:	12.7	%	
(against	control)	
Loss	in	peak	area:	18.9	%	
(against	control)	
	
20	V;	150	s;	helium	oxygen	
plasma	treated	Q	Sepharose	FF	
Average	pDNA	intensity:	6.0	
Peak	pDNA	intensity:	52.9	
Peak	intensity/average:	9.6	
Average	BSA	intensity:	130.3	
(for	intensities	>10)	
Loss	in	peak	intensity:	26.2	%	
(against	control)	
Loss	in	peak	area:	28.5	%	
(against	control)	
10	V;	300	s;	helium	oxygen	
plasma	treated	Q	Sepharose	FF	
Average	pDNA	intensity:	5.8	
Peak	pDNA	intensity:	43.6	
Peak	intensity/average:	7.5	
Average	BSA	intensity:	139.5	
(for	intensities	>10)	
Loss	in	peak	intensity:	39.1	%	
(against	control)	
Loss	in	peak	area:	32.5	%	
(against	control)	
	
A	
D	
B	
C	
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3.3.2.12.	CSLM	analysis	of	He-O2	plasma	treated	DEAE	Sepharose	FF	chromatography	
supports	
CSLM	image	analysis	of	plasma	etched	DEAE	Sepharose	FF	beads	shows	a	qualitative	reduction	
of	pDNA	binding	capacity	 in	comparison	to	untreated	control	for	all	analysed	samples.	The	
fluorescent	pDNA	bound	to	the	outer	shell	of	the	supports	is	a	lot	brighter	in	the	untreated	
control	sample	cf.	all	plasma	treated	samples	irrespective	of	plasma	parameters	(Figure	3-30).	
Quantitative	comparison	of	fluorescence	signals	of	the	tagged	pDNA	yielded	peak	intensity	
losses	of	up	to	46%	(10	V,	150	s)	with	a	reduction	of	BSA	binding	of	12%	(SI=	1.6).	
Unlike	 the	 plasma	 treatment	 results	 seen	with	Q	 Sepharose	 FF,	 the	 plasma	 treated	DEAE	
Sepharose	FF	samples	do	not	show	the	same	tendencies	with	an	increase	power	input	(similar	
reductions	seen	for	the	10	V	and	20	V	samples)	and	treatment	time	(doubling	the	treatment	
time	did	not	lead	to	a	further	reduction	of	pDNA	peak	height,	nor	peak	area).		
Longer	treatment	times	did	however,	reduce	the	average	BSA	fluorescence	of	the	samples.	
The	sample	treated	for	150	s	(10	V)	lost	7.8%	of	its	BSA	fluorescence	(SI=	1.7),	while	the	sample	
treated	for	300	s	(10	V)	in	the	reactor	shows	a	reduction	of	19%	(SI=	1.47).	
A	loss	in	BSA	fluorescence	cannot	be	observed	in	the	150	s	(20	V)	sample,	yielding	an	SI	of	1.8	
(assuming	no	loss	in	BSA	binding	capacity).		
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Untreated	DEAE	Sepharose	FF	
control	
Average	pDNA	intensity:	7.4	
Peak	pDNA	intensity:79.4	
Peak	intensity/average:10.7	
Average	BSA	intensity:	153.2	
(for	intensities	>10)	
	
10	V;	150	s;	helium	oxygen	
plasma	treated	DEAE	Sepharose	
FF	
Average	pDNA	intensity:	5.3	
Peak	pDNA	intensity:	42.7	
Peak	intensity/average:	8.1	
Average	BSA	intensity:	141.0	
(for	intensities	>10)	
Loss	in	peak	intensity:	46.2	%	
(against	control)	
Loss	in	peak	area:	41.1	%	
(against	control)	
	
20	V;	150	s;	helium	oxygen	
plasma	treated	DEAE	Sepharose	
FF	
Average	pDNA	intensity:	5.3	
Peak	pDNA	intensity:	44.1	
Peak	intensity/average:	8.3	
Average	BSA	intensity:	123.7	
(for	intensities	>10)	
Loss	in	peak	intensity:	44.5	%	
(against	control)	
Loss	in	peak	area:	41.4	%	
(against	control)	
	
10	V;	300	s;	helium	oxygen	
plasma	treated	DEAE	Sepharose	
FF	
Average	pDNA	intensity:	5.3	
Peak	pDNA	intensity:	46.7	
Peak	intensity/average:	8.8	
Average	BSA	intensity:	160.4	
(for	intensities	>10)	
Loss	in	peak	intensity:	44.5	%	
(against	control)	
Loss	in	peak	area:	41.8	%	
(against	control)	
	
Figure	3-30	CLSM	analysis	of	plasma	treated	DEAE	Sepharose	FF;	
left:	overlay	of	Cy5	and	Syto9	fluorescence	channels	with	ROI;		
centre:	intensity	profiles	of	Cy5	and	Syto	9	along	ROI;	
right:	calculated	parameters	of	binding	reduction	to	control	and	others;	loss	in	peak	area	was	calculated	using	
the	integral	intensities	adjusted	by	the	baseline	intensity	
	
A
D	
B	
C	
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3.3.2.13.	CSLM	analysis	of	He-O2	plasma	treated	EMD	Fractogel	DEAE	chromatography	
supports	
The	pDNA	fluorescence	signal	of	the	control	EMD	Fractogel	DEAE	shows	a	distribution	of	pDNA	
binding	throughout	the	support.	The	binding	of	pDNA	on	the	surface	is	higher	than	in	the	core	
of	 the	beads,	however,	 the	 results	 clearly	 show	 that	pDNA	binding	occurs	 throughout	 the	
centre	of	the	support	as	well	as	on	the	surface-	pDNA	diffuses	through	the	stationary	phase	
and	binds	to	the	ligands	lining	its	pores.	With	a	pore	size	of	800	Å	(Millipore,	2016),	the	size	
cut-off	of	the	Fractogel	is	significantly	higher	than	for	the	Sepharose	media	with	a	pore	size	of	
around	29	nm	(Hagel	et	al.,	1996a;	Yao	et	al.,	2004).	It	has	been	reported	that	pDNA	molecules	
can	pass	 through	much	smaller	pores	 than	expected	based	on	 their	molecular	weight	and	
calculated	hydrodynamic	radius	(Arkhangelsky	et	al.,	2011).		
	
	
The	 shape	 of	 the	 pDNA	 distribution	 curve	 showcases	 a	 behaviour	 similar	 to	 the	 protein	
adsorbance;	 diffusing	 through	 the	 pores,	 saturating	 binding	 sites	 from	 the	 outside	 to	 the	
inside	with	no	hint	to	a	size	restriction	attributed	to	either	of	the	molecules.	
Nonetheless,	static	binding	studies	yielded	reductions	of	pDNA	binding	capacities	>50%	for	
plasma	treated	Fractogel	media.	These	reductions	can	be	explained	by	a	reduced	number	of	
ligands	on	the	surface	of	the	supports	in	conjuncture	to	shorter	incubation	times,	not	allowing	
the	pDNA	to	diffuse	and	bind	throughout	the	core.	However,	lacking	ligands	on	the	surface	of	
the	supports	does	not	significantly	alter	the	equilibrium	binding	capacity.	
Figure	3-31	CLSM	analysis	of	EMD	Fractogel	(M)	DEAE;	
left:	overlay	of	Cy5	(red)	and	Syto9	(green)	fluorescence	channels	with	ROI;		
right:	intensity	profiles	of	Cy5	and	Syto	9	along	ROI	
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The	idea	to	create	multifunctional	supports	by	etching	away	the	ligands	off	the	surface	of	AEC	
media	 is	 relying	on	the	stationary	phase	blocking	access	of	 large	molecules	 to	 the	 internal	
porous	structure	of	the	beads.	Both	media	based	on	Sepharose	6	FF	show	these	properties,	
while	the	Fractogel	does	not.		
Due	to	the	ability	of	pDNA	to	diffuse	and	bind	throughout	the	entire	internal	volume	of	the	
supports,	given	enough	time	to	do	so,	the	Fractogel	base	matrix	is	unsuitable	to	be	used	for	
plasma	etching	techniques	to	create	a	bilayered	support	media	for	pDNA	purification.		
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3.3.2.14.	ESEM	analysis	of	cold	atmospheric	pressure	plasma	treated	chromatography	
supports	
Following	 up	 on	 the	 light	micrographs	 of	 plasma	 treated	 chromatography	 supports	 taken	
alongside	 CLSM	 images,	 to	 evaluate	 the	 impact	 the	 plasma	 treatment	 has	 on	 the	 visual	
appearance	of	the	structural	 integrity	of	Q	Sepharose	FF	adsorbent	material,	ESEM	images	
were	taken	as	described	in	2.3.11.	
As	mentioned	previously,	 some	Q	 Sepharose	 FF	beads	 show	 ‘imperfections’	 both	on	 their	
surface	as	well	as	inside	the	internal	core	structure	of	the	beads	(Figure	3-32).	Imperfections	
in	this	 regard	were	defined	as	particles	without	a	smooth	surface	and/	or	spherical	shape.	
These	 imperfections	 range	 from	minor	dents	and	cracks	on	 the	surface	 (Figure	3-32,	B)	 to	
major	disfigurations;	‘beads	inside	bead’,	split	open	(outer)	shell	of	particles	(Figure	3-32,	C),	
punctured	surfaces	granting	non-diffusive	access	to	buffer	solutions	to	the	core	of	the	media	
(Figure	3-32,	D).	
When	comparing	the	 images	of	Q	Sepharose	FF	to	the	 images	of	beads	following	different	
plasma	 treatments	 (Figure	 3-33),	 the	 same	 patterns	 of	 imperfections	 occur.	 Both	 He-O2	
Figure	3-32	ESEM	images	of	Q	Sepharose	FF	at	different	magnifications	
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(99.5%-	0.5%)	plasma	treated	samples	(3.6	W;	7	W,	both	5	min)	show	macro	pores	granting	
open	 access	 to	 the	 core	 structure	 of	 the	 support,	 as	well	 as	 ‘bead-inside-bead’	 structures	
similar	to	those	observed	in	untreated	Q	Sepharose	FF.	
The	 observation	 that	 He-O2	 (99.5%-	 0.5%)	 plasma	 has	 no	 visual	 impact	 on	 the	 structural	
integrity	of	agarose	based	chromatographic	media	is	in	accordance	with	previously	published	
work	(Olszewski	et	al.,	2013),	which	concluded	that	cold	atmospheric	pressure	helium/	oxygen	
plasma	treatment	was	gentle	enough	(cold	enough)	to	not	cause	any	damage	to	the	supports.	
However,	 comparing	 the	 images	 of	 Q	 Sepharose	 FF	 control	 and	 oxygen	 plasma	 treated	
supports	depicted	in	Figure	3-33	(C	&	D)	indicate	that	damage	that	was	previously	associated	
with	thermal	alteration	as	a	result	of	contacting	intensely	hot	plasma	filaments	was	in	fact	not	
caused	by	the	plasma	treatment	itself,	but	is	an	inherent	flaw	of	the	media	as	a	result	of	its	
manufacturing	process.	
The	similarity	of	images	does	not	lend	itself	to	the	interpretation	that	the	plasma	treatment	
in	the	FBR	set-up	(both	pure	oxygen	plasma	and	helium/	oxygen	admixed	plasma)	has	inflicted	
any	alteration	in	the	visual	appearance	of	the	chromatography	resins.	All	imperfections	also	
qualitatively	appear	in	particles	‘straight	from	the	manufacturer’.	
Agarose	based	chromatography	media	have	been	studied	extensively	over	recent	decades,	
however,	 to	 the	 authors	 knowledge,	 little	 work	 on	 visual	 depiction	 of	 chromatography	
particles	 has	 been	 published	 in	 the	 literature	with	 regards	 to	 ‘naturally’	 occurring	 surface	
imperfections	(Caramelo-Nunes	et	al.,	2013;	Santos	et	al.,	2017).		
Although	supports	such	as	the	ones	observed	in	this	study	do	appear	in	other	publications,	
none	of	them	mention	their	presence	nor	are	concerned	about	an	impact,	misshaped	supports	
may	have	on	the	purification	performance	of	respective	media	(Figure	3-34).		
The	 problem	 of	 structural	 imperfections	 in	 agarose	 based	 media	 is	 known	 amongst	
manufacturers	of	chromatography	adsorbents.	The	complexity	of	controlling	the	associated	
parameters	during	the	manufacturing	process	is	tricky	and	generally	not	paid	much	attention.	
However,	media	with	better	surface	integrity	could	be	custom	made	to	order	(Gilbert,	2018).	
	 -	119	-	
	
SEC	is	based	(with	regards	to	nanoplexes)	on	the	principle	that	large	molecules	cannot	access	
the	pores	of	the	media	but	only	travel	through	the	column	in	the	inter-particle	volume.	Due	
to	 this	 reduced	 access	 of	 column	 space,	 larger	 molecules	 will	 elute	 earlier	 than	 smaller	
molecules,	which	are	kept	longer	in	the	column	due	to	their	longer	diffusive	pathways	through	
the	porous	stationary	phase. 
Figure	3-33	ESEM	images	of	Q	Sepharose	FF	at	different	magnifications	after	treatment	with	cold	atmospheric	
pressure	plasmas		
A,	B:	He-O2	(99.5%-	0.5%)	plasma;	3.6	W;	5	min	
C,	D:	He-O2	(99.5%-	0.5%)	plasma;	7	W;	5	min		
E,	F:	Oxygen	plasma;	10	W;	5	min	
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Even	in	such	a	classic	chromatography	environment	the	presence	of	these	imperfections	may	
impact	the	purification	performance	of	the	media.		
		
Especially	when	SEC	columns	are	used	to	approximate	the	molecular	weight	of	a	compound,	
well	defined	structural	properties	of	the	chromatography	supports	are	of	key	importance.	If	a	
compound	has	access	to	complex	structures	(such	as	the	observed	‘bead-inside-bead’)	and	is	
not	limited	to	the	columns	void	volume,	the	overall	retention	time	of	the	compound	changes,	
ultimately	 resulting	 in	 peak	broadening/	 tailing	 (Rouessac	 et	 al.,	 2000;	Ninfa	 et	 al.,	 2010).	
Another	problem	in	flow	through	chromatography	operations	is	column	fouling.	The	use	of	
non-spherical	 chromatography	 supports	 with	 holes	 and	 imperfections	 enhances	 these	
problems	as	compounds	get	more	easily	‘trapped’	in	the	crevices	created	by	imperfections.	
The	need	to	clean/	strip	the	column	becomes	more	frequent	and	CIP	protocols	need	to	be	
adjusted	in	order	to	deal	with	larger	concentrations	of	compounds	expected	from	spherical	
particles	with	smooth	surfaces.		
The	high	reactivity	of	plasma	species	makes	it	less	likely	that	the	species	will	get	close	enough	
to	the	‘beads-inside-a-bead’	and	other	hidden	ligands	to	etch	away	the	functional	groups	in	
these	 imperfections.	 The	 radicals	 only	 diffuse	 very	 short	 distances	 out	 of	 the	 gas	 plasma	
Figure	3-34	SEM	image	of	Sepharose	beads	at	150x	magnification,	red	arrows	highlighting	‘disfigured’	
beads,	with	access	to	the	core	of	the	beads,	rendering	them	problematic	to	use	in	a	SEC	column	operation	
(image	taken	from:	(Caramelo-Nunes	et	al.,	2013))	
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bubbles	and	will	react	with	the	first	surface	they	encounter,	leading	to	overtreatment	of	the	
more	easily	 accessible	 surfaces,	 leaving	 functional	 groups	 in	hard	 to	 access	 regions	of	 the	
particles	untouched.	
However,	 in	 frontal	 loading	 chromatography	 applications,	 pDNA	 will	 diffuse	 into	 these	
crevices	and	imperfections	and	bind	to	the	ligands	that	have	not	been	etched	away	by	plasma	
radicals.	These	remaining	binding	sites	will	get	supersaturated	with	pDNA	due	to	their	strong	
negative	 charges,	 distributed	 evenly	 all	 over	 the	molecule.	When	 granted	 enough	 time	 to	
equilibrate,	 the	 more	 desirable	 sc	 conformation	 of	 pDNA	 is	 likely	 to	 change	 its	 spatial	
orientation	in	order	to	fit	in	more	molecules	on	these	remaining	binding	sites.	
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3.3.2.15.	Quantification	of	the	‘natural’	occurrence	of	imperfections	in	different	
chromatography	media	
SEM	 image	 analysis	 qualitatively	 showed	 the	 presence	 of	 imperfect	 beads	 and	 raised	 the	
question	to	what	quantitative	scope	they	are	part	of	support	populations.	To	get	an	overview	
of	the	magnitude	of	imperfections	in	large	populations	of	different	chromatography	media,	
light	micrographs	were	 recorded	 and	 analysed	 by	 visual	 inspection.	 Each	 support	 entirely	
within	an	image	was	graded	and	associated	to	one	of	the	following	three	categories	(Figure	3-
35):	
Green-	spherical	particles	with	a	smooth	surface		
Yellow-	minor	indentations	and	cracks	on	the	surface	
Red-	majorly	disrupted	surfaces	granting	access	to	the	core	of	the	support;	complex	structures	
without	easily	accessible	functional	groups	exposed	to	the	surface	
	
Figure	3-35	Light	microscopic	image	analysis	of	Sepharose	FF	supports	(10x	magnification)	to	quantify	the	
number	of	imperfect	beads	(in	%	of	total	population);	arrows	showcase	examples	of	visual	grading;	green:	
spherical	particles	with	a	smooth	surface;	yellow:	minor	imperfections	(indentations,	cracks);	red:	heavily	
misshaped	particles,	‘bead	inside	bead’	structures	
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The	extend	of	imperfections	was	quantified	for	the	following	chromatography	media:	
- Q	Sepharose	FF	
- Oxygen	plasma	treated	Q	Sepharose	FF	supports	(15	V;	150	s;	18.5%	SBV	in	a	total	of	
8	mL	MQW)		
- He-O2	admixed	(99.5%-	0.5%)	plasma	treated	Q	Sepharose	FF	supports	(10	V;	150	s;	
25%	SBV	in	a	total	of	8	mL	MQW)		
- DEAE	Sepharose	FF	
- Capto	Core	700	
- Q	Hyper	Z	
- EMD	Fractogel	
Due	to	the	opacity	of	Q	Hyper	Z,	a	quantitative	analysis	of	
the	 visual	 integrity	 of	 the	 beads	 was	 not	 possible		
(Figure	3-36).	
	
Table	3-4	Quantification	of	visual	integrity	of	different	chromatography	media,	analysed	by	light	microscopic	
imaging	
	Media	 	particles	analysed	
‘green’	graded	
particles	[#/	%]	
‘yellow	graded	
particles	[#/	%]	
‘red’	graded	
particles	[#/	%]	 Conf.	interval	
Q	Sepharose	FF	 664	 109 16.4%	
419 
63.1%	
136 
20.5%	 3.8	
He-	O2	plasma	
treated	(15	V;	
150	s;	18.5%	
SBV)	
770	 171 22.2%	
438 
56.9%	
161 
20.9%	 3.53	
He-	O2	plasma	
treated	 
(10	V;	150	s;	
25%	SBV)	
786	 202 25.7%	
445 
56.60%	
139 
17.70%	 3.49	
EMD	Fractogel	
(M)	DEAE	 664	
444 
66.9%	
172 
25.9%	
48 
7.2%	 3.8	
Capto	Core	700	 726	 509 70.1%	
198 
27.3%	
19 
2.6%	 3.63	
DEAE	
Sepharose	FF	 917	
205 
22.4%	
556 
60.6%	
156 
17.0%	 3.24	
	
For	all	other	media,	population	sizes	were	selected	to	grant	a	minimum	confidence	level	of	
95%	with	confidence	intervals	of	max	4%	(Table	3-4).	However,	light	microscopic	imaging	only	
analyses	half	of	each	particle;	the	‘actual’	percentage	of	especially	yellow	classed	particles	is	
likely	to	be	slightly	higher	when	analysed	with	optical	sorting	instruments.	
Figure	3-36	Light	microscopic	image	
of	Q	Hyper	Z	supports	
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Unsurprisingly,	both	chromatography	resins	based	on	Sepharose	FF	base	matrix	(functional	
groups	DEAE	and	Q)	show	similar	distributions	of	imperfections,	both	for	major	impairments	
as	well	as	minor	flaws.	The	ligand	on	the	surface	has	no	impact	on	the	visual	appearance	of	
the	particles,	leading	to	the	assumption	that	imperfections	occur	during	the	manufacturing	
process	of	the	base	matrix.	Overall,	the	majority	of	supports	are	spherical	and	without	(major)	
imperfections	(79.5%	Q	Sepharose	FF;	83%	DEAE	Sepharose	FF);	however,	the	distribution	of	
imperfections	does	not	match	the	size	distribution	of	the	particles	as	the	occurrence	of	major	
imperfections	is	almost	exclusively	limited	to	larger	particles.	
For	plasma	treated	support	samples,	two	samples	were	selected	and	analysed:		
(i) The	 helium/	 oxygen	 plasma	 treated	 sample	 with	 highest	 loss	 of	 surface	 binding	
capacity	in	static	binding	studies	(around	70%).	
(ii) The	oxygen	plasma	treated	sample	that	showed	highest	loss	of	core	binding	capacity	
in	static	binding	studies	(around	30%).	
	
	 	
Figure	3-37	Quantitative	distribution	of	visual	imperfections	in	different	chromatography	media:	Q	Sepharose	
FF,	oxygen	plasma	treated	(15	V;	150	s;	18.5%	SBV	in	8	mL	MQW)	Q	Sepharose	FF,	He-O2	plasma	treated	(10	V;	
150	s;	25%	SBV	in	8	mL	MQW)	Q	Sepharose	FF,	EMD	Fractogel	(M)	DEAE,	Capto	Core	700,	DEAE	Sepharose	FF	
Red:	heavily	disfigured;	yellow:	minor	imperfections;	green	spherical	particles	with	a	smooth	surface	
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Comparing	 the	 visual	 integrity	 of	 plasma	 treated	 supports	 to	 untreated	 control	 beads,	 no	
difference	can	be	observed	with	confidence	intervals	of	the	distributions	overlapping.		
Previously	 it	 was	 suggested	 that	 the	 high	 loss	 of	 core	 binding	 capacity	 in	 oxygen	 plasma	
treated	 support	 samples	 could	be	due	 to	plasma	puncturing	holes	 into	 the	 surface	of	 the	
beads,	reducing	the	overall	core	binding	volume	(Olszewski	et	al.,	2013).	It	must	be	concluded,	
that	 previously	 recorded	 SEM	 images	 were	 not	 representative	 of	 the	 phenomena	 but	
singularities	that	occur	in	all	Sepharose	FF	based	media.	
Capto	 Core	 700	 stands	 out	 from	 other	 Sepharose	 based	 media	 with	 only	 2.6%	 of	 beads	
showing	major	imperfections.	Being	a	highly	specialised	media	(and	at	a	retail	price	of	more	
than	 three	 times	 as	 much	 as	 Q	 Sepharose	 FF	 (GE	 Healthcare,	 2018d;	 GE	 Healthcare	 Bio-
Science,	2018))	it	is	likely	that	the	media	is	either	produced	differently	or	that	it	went	through	
a	more	vigorous	sieving	protocol	in	the	production	process.	
Similar	to	Capto	media,	EMD	Fractogel	(M)	DEAE	media	has	an	even	size	distribution	and	a	
low	amount	of	‘red	classed’	particles,	making	it	similarly	suitable	for	plasma	etching	based	on	
the	visual	appearance	of	 the	particles	 (however,	 the	media	 is	still	unsuitable	based	on	the	
presence	of	diffusive	pores,	granting	pDNA	binding	throughout	the	media.	
3.3.2.16.	CLSM	analysis	of	‘imperfect’	supports	
SEM	 images	as	well	 as	quantitative	 light	microscopic	analysis	of	different	 chromatography	
support	media	have	shown	that	large	portions	of	the	populations	have	visual	imperfections	
on	their	surfaces.	These	imperfections	range	from	minor	visual	impairments	(dents,	cracks	on	
the	 surface)	 to	 major	 ‘disfigurements’.	 Comparing	 images	 of	 plasma	 treated	 supports	 to	
respective	images	of	untreated	control	samples	yielded	that	these	imperfections	are	not,	as	
previously	 assumed	 a	 result	 of	 the	 plasma	 treatment	 process	 but	 find	 their	 origin	 in	 the	
manufacturing	process	of	the	media.	
The	 static	 binding	 capacities	 of	 the	media	was	 assessed,	 but	 static	 binding	 capacities	 of	 a	
media	as	a	whole	does	not	explain	whether	the	presence	of	imperfections	has	an	impact	on	
the	chromatographic	performance/	binding	capacity	of	the	media	on	a	single	bead	level.	
Although	 plasma	 treatment	 clearly	 reduces	 surface	 binding	 of	 chromatography	 supports,	
none	of	the	samples	showed	a	total	elimination	of	surface	charge	in	static	binding	studies.	
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As	seen	in	the	light	microscopic	analyses	of	chromatography	media,	up	to	8%	of	beads	show	
(at	 least	minor)	 imperfections.	 If	 the	 residual	 binding	 capacity	 is	mainly	 accounted	 for	 by	
imperfections,	the	overall	outcome	of	the	plasma	treatment	of	chromatography	media	could	
be	significantly	enhanced	by	using	‘more	perfect’	media.		
To	assess	how	and	to	what	extend	the	presence	of	imperfections	affects	the	performance	of	
the	media	as	a	whole	and	to	visualise	the	distribution	of	(pDNA)	binding	sites	in	plasma	treated	
media,	 CLSM	 stack	 images	 of	 said	 imperfect	 beads	 were	 recorded	 as	 described	 in	 2.3.12	
focussing	on	imperfect	single	beads.	
Static	 binding	 studies	 as	 well	 as	 CLSM	 analysis	 of	 chromatography	 supports	 treated	 with	
He-	O2	gas	plasma	(99.5%-	0.5%)	showed	a	significant	reduction	of	pDNA	binding	capacity	on	
the	surface	of	the	supports	for	both	DEAE	Sepharose	FF	as	well	as	Q	Sepharose	FF.		
CLSM	analysis	of	imperfect	DEAE	Sepharose	FF	beads	for	two	sets	of	plasma	parameters	are	
depicted	in	Figure	3-38	and	Figure	3-39	respectively.		
		
Figure	3-38	CLSM	analysis	of	a	helium-oxygen	plasma	treated	DEAE	Sepharose	FF	chromatography	support	
(10	V;	150	s)		
Left:	Overlay	of	fluorescence	channels	(Cy5	tagged	BSA,	ex/em:	635	nm/654-	715	nm;	Syto	9	tagged	pDNA,	
ex/em:	488	nm/492-533	nm),	ROI	for	intensity	distribution	analysis	(150	µm	x	5	µm)	
Middle:	Light	microscopic	image	of	the	scanned	bead	
Right:	Fluorescence	intensity	profile	after	image	analysis:	x-axis	shows	distance	along	meridian	of	the	particle,	
y-axis	average	fluorescence	intensity	over	5	µm	above	the	x-coordinate	(in	arbitrary	units)	
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The	respective	 intensity	profiles	show	that	significantly	more	pDNA	 is	adsorbed	within	 the	
imperfections	than	on	the	smooth	(outer)	surface	of	the	media.		
The	 plasma	 treatment	 of	 chromatography	 supports	 is	 an	 efficient	 way	 to	 modify	 the	
functionality	 of	 the	beads	 on	 the	 surface	of	 the	media,	 however	 the	modification	 can,	 by	
design	 of	 the	 reactor,	 only	 take	 place	when	ROS	 get	 into	 contact	with	 the	 ligands	 on	 the	
surface.		
The	very	short	lifespan	of	the	species,	especially	when	diffused	out	of	the	plasma	gas	bubble	
makes	it	crucial	for	the	targeted	surface	to	be	in	close	proximity	to	the	host	gas	bubble	of	the	
radicals.	Making	the	surfaces	less	accessible	to	the	reactive	plasma	species	hinders	them	in	
reacting	with	the	ligands,	reducing	the	treatment	efficiency	of	lesser	accessible	areas	of	the	
beads.		
Imperfections	 in	 chromatography	 adsorbents	 have	 different	 impacts	 on	 their	 binding	
capacities	depending	on	the	location	they	occur.	
	 	
Figure	3-39	CSLM	analysis	of	a	helium-oxygen	plasma	treated	DEAE	Sepharose	FF	chromatography	support	
(20	V;	150	s)	
Left:	Overlay	of	fluorescence	channels	(Cy5	tagged	BSA,	ex/em:	635	nm/654-	715	nm;	Syto	9	tagged	pDNA,	
ex/em:	488	nm/492-533	nm),	ROI	for	intensity	distribution	analysis	(150	µm	x	5	µm)	
Middle:	Light	microscopic	image	of	the	scanned	bead	
Right:	Fluorescence	intensity	profile	after	image	analysis:	x-axis	shows	distance	along	meridian	of	the	particle,	
y-axis	average	fluorescence	intensity	over	5	µm	above	the	x-coordinate	(in	arbitrary	units)	
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Holes	or	‘beads-inside-beads’	structures	found	inside	a	bead	(no	connection	of	the	hole	to	the	
surface	of	the	particle;	Figure	3-40,	A)	will	affect	only	the	core	binding	capacity	by	decreasing	
the	overall	binding	volume	(and	subsequently	capacity)	of	the	particle	due	to	a	lack	of	binding	
ligands	in	the	area:	 𝑉 = 43𝜋	(𝑟Y − 𝑟JY)	
Where;	 Vb		 is	core	binding	volume	of	the	bead		
	 	 rb	 is	the	radius	of	the	bead	
	 	 ri	 is	the	radius	of	a	(spherical)	imperfection	
Although	a	reduction	of	overall	core	binding	capacity	 is	not	desirable	 in	a	chromatography	
operation,	using	bilayered	chromatographic	media	intended	for	pDNA	purification	in	negative	
mode	chromatography,	the	core	binding	capacity	is	less	important	than	other	defining	factors	
of	the	media,	all	related	to	the	shape	and	functionality	of	the	media’s	surface.	
	
	 	
Figure	3-40	Impact	of	imperfections	of	chromatography	media	on	(A)	the	volumetric	binding	capacity	of	a	
chromatography	adsorbent	due	to	reduction	of	the	overall	available	backbone	structure	of	the	support	(holes	
not	connected	to	the	surface	of	the	media)	and	(B)	the	shell	binding	capacity	due	to	the	increase	of	surface	
binding	area	with	imperfections	connected	to	the	surface	of	the	particle	
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Unlike	imperfections	occurring	within	the	beads,	a	connection	of	holes	to	the	surface	of	the	
media,	 will	 not	 only	 reduce	 the	 core	 binding	 capacity,	 the	 shell	 binding	 is	 also	 altered	 in	
comparison	to	a	spherical	particle	(Figure	3-40;	B):	𝐴 = 4𝜋	𝑟 − 2𝜋	𝑟ℎ + 2𝜋	𝑟J𝑥		
With:	 	 Ab		 is	the	binding	surface	of	the	bead	
	 	 rb	 is	the	radius	of	the	bead	
	 	 ri	 is	the	radius	of	a	(spherical)	imperfection	
	 	 h		 height	of	the	missing	cap	of	the	bead	
	 	 x	 height	of	the	imperfection		
This	increase	of	overall	accessible	surface	area	is	directly	linked	to	the	surface	binding	capacity	
of	the	media	in	comparison	to	spherical	particles	with	smooth	surfaces,	making	a	spherical	
bead	preferable	due	to	the	its	surface	to	volume	ratio.	
CLSM	 images	 of	 imperfect	 cold	 atmospheric	 pressure	 helium-oxygen	 gas	 plasma	 treated	
chromatography	 supports	 (Figure	 3-38	 to	 Figure	 3-42)	 show	 that	 the	 plasma	 is	 unable	 to	
significantly	 modify	 the	 surfaces	 occurring	 within	 the	 imperfections	 (both	 Q	 and	 DEAE	
Sepharose	 FF).	 The	 reactive	 plasma	 species	 cannot	 access	 the	 crevices	 created	 by	
imperfections,	 nor	 are	 they	 able	 to	 diffuse	 far	 enough	 from	 the	 gas	 bubbles	 to	 reach	 the	
concave	interiors	of	the	‘beads-inside-a-bead’	to	etch	away	the	binding	ligands.		
The	intensities	of	pDNA	adsorbed	onto	the	smaller	particles	inside	the	(main)	chromatography	
bead	(imperfections)	are	around	three	to	four	times	higher	than	the	intensity	values	observed	
on	the	outside	shell	of	the	(main)	bead	of	plasma	treated	DEAE	Sepharose	FF	(Figure	3-38).	
Following	the	intensities	across	the	bead,	a	slight	increase	can	be	observed	on	the	shell	of	the	
bead,	similar	to	the	binding	intensities	observed	in	the	respective	spherical	beads	of	the	same	
sample	(Figure	3-30).		
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The	 BSA	 intensities	 remain	 similar	 throughout	 the	 bead	 with	 the	 exception	 that	 in	 close	
proximity	to	the	imperfection,	BSA	fluorescence	is	higher	than	in	the	centre	of	the	bead.		
As	 stated	previously,	 the	 fluorescence	 intensity	 on	 the	 surface	of	 a	 sample	will	 always	be	
(slightly)	higher	 than	on	 the	bottom	or	 the	bulk	of	 a	 sample	as	 the	photons	need	 to	pass	
through	media	of	different	refractive	indices.	
However,	 the	 BSA	 intensity	 underneath	 the	 surface	 of	 the	main	 bead	 is	 still	 lower	 when	
compared	to	the	intensity	observed	in	close	proximity	to	the	imperfect	cut-out,	suggesting	
that	the	ligand	density	is	higher	around	the	imperfections	than	the	normal	bead.		
The	agarose	concentration	(and	consequently	the	Sepharose	backbone	structure)	around	the	
imperfections	seems	to	be	slightly	higher	than	the	6%	(GE	Healthcare	Bio-Science,	2014)	found	
in	the	bulk	of	the	media.	As	a	result,	one	would	expect	a	change	of	refractive	index	in	these	
areas,	which	can	be	observed	in	the	light	microscopic	images	taken	of	the	particles	(Figure	3-
38	&	Figure	3-39).	
Figure	3-41	CSLM	analysis	of	a	helium-oxygen	plasma	treated	Q	Sepharose	FF	chromatography	support	(20	V;	
150	s)	
Left:	Overlay	of	fluorescence	channels	(Cy5	tagged	BSA,	ex/em:	635	nm/654-	715	nm;	Syto	9	tagged	pDNA,	
ex/em:	488	nm/492-533	nm),	ROI	for	intensity	distribution	analysis	(150	µm	x	5	µm)	
Middle:	Light	microscopic	image	of	the	scanned	bead	
Right:	Fluorescence	intensity	profile	after	image	analysis:	x-axis	shows	distance	along	meridian	of	the	particle,	
y-axis	average	fluorescence	intensity	over	5	µm	above	the	x-coordinate	(in	arbitrary	units)	
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During	 the	 manufacturing	 process	 of	 Sepharose	 based	 chromatography	 media,	 molten	
agarose	droplets	are	being	cooled	down	to	induce	agarose	gelling.	During	this	process,	the	
surface	tension	of	the	droplets	influences	the	agarose	content,	leading	to	a	slightly	different	
agarose	 content	 of	 the	 smaller	 ‘beads-inside-a-bead’	 imperfections	 in	 comparison	 to	 the	
larger	 (main)	 particle.	 The	parameters	 controlling	 the	 cooling	of	 the	media	 are	difficult	 to	
control	and	so	it	is	likely	that	batch	to	batch	variations	of	a	final	product	can	lead	to	different	
agarose	contents	within	the	same	bead.		
In	 addition	 to	 the	 inability	 to	 etch	 binding	 ligands	 off	 the	 surfaces	 of	 the	 beads,	 a	 higher	
amount	 of	 pDNA	 binds	 within	 the	 grooves	 of	 the	 surfaces	 due	 to	 supersaturation	 of	 the	
remaining	 accessible	 binding	 sites	 as	 well	 as	 trapping	molecules	 inside	 eddies	 of	 caverns	
(molecules	 get	 transported	 to	 the	 openings	 of	 the	 grooves	 via	 convection,	 diffuse	 into	
macropores	but	cannot	leave	again	due	to	weak	interactions	and	missing	convective	flows).		
Comparing	the	fluorescence	intensities	observed	in	the	imperfections	to	the	intensities	on	the	
surface	of	untreated	Sepharose	FF	media,	a	2	to	2.5-fold	increase	for	both	DEAE	Sepharose	FF	
and	Q	Sepharose	FF	was	observed.	This	is	either	due	to	the	outlined	supersaturation	of	the	
remaining	 accessible	 binding	 sites	 or	 due	 to	 higher	 pDNA	adsorption	 as	 a	 result	 of	 locally	
increased	ligand	density.	
Overall,	the	presence	of	 imperfections	 in	chromatography	media	hinder	the	efficacy	of	the	
plasma	treatment	by	creating	surface	area	available	for	plasmid	binding	that	is	inaccessible	
Figure	3-42	CSLM	analysis	of	a	He-O2	plasma	treated	Q	Sepharose	FF	chromatography	support	(10	V;	300	s)	
Left:	Overlay	of	fluorescence	channels	(Cy5	tagged	BSA,	ex/em:	635	nm/654-	715	nm;	Syto	9	tagged	pDNA,	
ex/em:	488	nm/492-533	nm),	ROI	for	intensity	distribution	analysis	(150	µm	x	5	µm)	
Middle:	Light	microscopic	image	of	the	scanned	bead	
Right:	Fluorescence	intensity	profile	after	image	analysis:	x-axis	shows	distance	along	meridian	of	the	particle,	
y-axis	average	fluorescence	intensity	over	5	µm	above	the	x-coordinate	(in	arbitrary	units)	
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for	ROS	eliminating	ligands	on	the	surface.	They	are	one	of	the	main	contributors	for	residual	
binding	of	pDNA	in	plasma	treated	media.	The	imperfections,	leading	to	several	complications,	
make	it	imperative	that	for	further	research	being	conducted,	the	media	to	be	treated	is	of	a	
(more)	homogenous	distribution.		
Little	compromise	can	be	made	to	the	sphericity	of	the	particles,	leading	to	several	options	to	
ensure	spherical	particles	as	starting	media.		
Sieving	 of	 existent	 base	media	 is	 not	 only	 hard	 to	 implement	 but	 also	 lacks	 the	 scope	 of	
scalability.	 Swapping	 Sepharose	 FF	 media	 for	 a	 starting	 media	 providing	 better	 optical	
properties	 could	 lead	 to	 great	 improvements	 of	 media	 performance.	 Capto	 media,	 for	
example,	has	shown	to	be	superior	over	Sepharose	FF	in	terms	of	level	of	imperfect	supports.	
Conversations	 with	 media	 manufacturers	 concerning	 sphericity	 and	 surface	 integrity	 of	
chromatography	supports	suggest	that	‘more	perfect’	media	could	be	made	to	order	(Gilbert,	
2018).	For	future	work	being	conducted	in	this	area,	collaborations	with	media	manufacturers	
are	hence	strongly	encouraged.	
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3.3.2.17.	Chemical	characterisation	of	plasma	etched	chromatography	supports	by	Time-of-
Flight	Secondary	Ion	Mass	Spectrometry	(ToF-SIMS)	
In	chromatographic	applications	tailored	for	pDNA	purification,	binding	interactions	between	
the	nanoplex	molecules	and	chromatography	ligands	take	place	in	the	outer	few	micrometres	
of	the	beads	surfaces	(Ljunglof	et	al.,	1999).	It	is	therefore	of	great	interest	to	investigate	the	
chemical	 structure	 of	 the	 outside	 of	 chromatography	 supports	 targeted	 for	 nanoplex	
purification.		
ToF-SIMS	 has	 proven	 to	 be	 useful	 as	 a	 surface	 analysis	 technique	 for	 the	 chemical	
characterization	of	polymer	surfaces	(Vickerman	et	al.,	2001).	In	order	to	assess	modifications	
to	the	surface,	happening	during	plasma	etching	of	chromatography	supports,	the	technique	
was	 used	 for	 the	 qualitative	 and	 semi-quantitative	 analysis	 of	 surface	 compositions	 of	
Q	Sepharose	FF	media	prior	and	post	cold	atmospheric	pressure	plasma	treatment	(both	pure	
oxygen	as	well	as	helium-oxygen	admixed	(99.5%-	0.5%)	gas	plasma	samples).		
The	 resulting	 mass	 spectra	 contain	 a	 large	 number	 of	 peaks	 corresponding	 to	 various	
compounds,	 which	 by	 evaluating	 the	 masses	 associated	 to	 the	 signals,	 can	 lead	 to	 their	
identification	from	the	molecular	ion	of	the	sample	or	its	fragments	(Belu	et	al.,	2003).	
Chromatography	 support	 samples	 were	 dried	 as	 described	 in	 2.3.10.	 All	 samples	 were	
mounted	on	carbon	tape	before	using	a	ToF-SIMS	5	(IonToF	Münster	Germany)	equipped	with	
a	Bi(3+)	source	for	the	sample	analysis.	
For	 each	 sample,	 duplicate	 spectra,	 both	 negative	 and	
positive	 (area	 of	 analysis	 20x20	 µm	 (Figure	 3-43)	 were	
recorded.	 Due	 to	 the	 volume	 of	 data	 recorded	 for	 each	
sample,	Matlab	 (R2017A)	was	used	 for	data	processing	as	
well	as	graphical	depiction	of	results.	
All	 analysed	media	 are	based	on	 Sepharose	6	 FF	with	 the	
functional	 Q	 ligands	 covalently	 attached	 to	 the	 agarose	
backbone	of	the	supports	with	no	spacers	used	(Pezzini	et	
al.,	2009).	It	was	furthermore	previously	reported	that	the	
molecular	surface	structure	of	Sepharose	6	FF	resembles	that	of	agarose	(Johansson	et	al.,	
2004).	
Figure	3-43	ToF-SIMS	area	of	analysis	
(20	x	20	µm)	
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After	eliminating	machine	artefacts,	intensity	values	recorded	by	ToF-SIMS	were	normalised	
to	respective	maximum	peak	values	of	each	sample.	All	recorded	spectra	were	compared	to	
the	spectrum	of	the	reference	carbon	tape	(without	any	sample	media)	to	avoid	false	peak	
associations.	No	overlaps	between	carbon	tape	peaks	and	sample	peaks	were	detected	(see	
Appendix	A-4	for	the	positive	ToF-SIMS	spectrum	of	the	background	carbon	tape).		
	
The	positive	ToF-SIMS	spectrum	of	Sepharose	6	FF	contains	a	large	number	of	peaks	that		
have	been	 identified	as	CxHyOz	and	CxHy	molecules	 (Figure	3-45	 ;	Table	3-5).	 It	was	 shown	
previously	that	anion	exchange	ligands	coupled	on	to	the	surface	of	Sepharose	6	FF	strongly	
influence	the	positive	ToF-SIMS	spectra	of	the	media	(Johansson	et	al.,	2004).	
	 	
Figure	3-44	Left:	Chemical	structure	of	agarose	(Sepharose),	the	polymer	of	the	repeating	unit	of	the	
disaccharide	D-galactose	and	3,6-anhydro-L-galactopyranose	(PubChem-Substance-Database,	2016)	
right:	Tentative	chemical	structure	of	the	strong	anion	exchange	ligand	Q	Sepharose	FF	(GE	Healthcare	Bio-
Science,	2016)	
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Table	3-5	Major	positive	ions	found	in	Sepharose	6	FF	and	Q	Sepharose	FF	in	their	respective	TOF-SIMS	spectra	
Prominent	
positive	ion	
peaks	(m/z)	
Structural	
assignment	
Mainly	base	matrix/	
Q	ligand	associated	
Prominent	
positive	
ion	peaks	
(m/z)	
Structural	
assignment	
Mainly	base	matrix/	
Q	ligand	associated	
15.02	 CH3	 Sepharose	 60.09	 C3H10N	 Ligand	
27.02	 C2H3	 Sepharose	 69.03	 C4H5O	 Sepharose	
29	 CHO	 Sepharose	 71.01	 C3H3O2	 Sepharose	
29.04	 C2H5	 Sepharose	 73.03	 C3H5O2	 Sepharose	
31.02	 CH3O	 Sepharose	 81.04	 C5H5O	 Sepharose	
39.02	 C3H3	 Sepharose	 85.03	 C4H5O2	 Sepharose	
41.04	 C3H5	 Sepharose	 97.03	 C5H5O2	 Sepharose	
42.03	 C2H4N	 Ligand	 100.12	 C6H14N	 Ligand	
43.02	 C2H3O	 Sepharose	 102.09	 C5H12NO	 Ligand	
43.06	 C3H7	 Sepharose	 116.11	 C6H14NO	 Ligand	
45.03	 C2H5O	 Sepharose	 132.1	 C6H14NO2	 Ligand	
53.04	 C4H5	 Sepharose	 174.15	 C9H20NO2	 Ligand	
55.02	 C3H3O	 Sepharose	 176.13	 C8H18NO3	 Ligand	
55.06	 C4H7	 Sepharose	 190.15	 C9H20NO3	 Ligand	
57.04	 C3H5O	 Sepharose	 206.14	 C9H20NO4	 Ligand	
58.07	 C3H8N	 Ligand	 234.17	 C11H24NO4	 Ligand	
59.07	 C3H9N	 Ligand	 	 	 	
	
The	fingerprint	pattern	of	the	positive	ion	spectrum	of	Q	Sepharose	FF	is	hence	expected	to	
be	 similar	 to	 its	 backbone	matrix	 structure	 Sepharose	 6	 FF,	with	 additional	 ligand	 specific	
peaks	 characterizing	 the	 spectrum.	 Most	 of	 the	 peaks	 associated	 with	 the	 Q	 ligand	
(CH2N(CH3)2)	occur	due	 to	 their	 size	at	higher	m/z	values	 (Table	3-5).	All	 ligand	associated	
peaks	bear	nitrogen	atoms,	although	it	 is	evident	that	CH2	and	CH3	fragments	of	the	ligand	
also	contribute	to	the	spectra,	which	are	unfortunately	overlapping	with	peaks	recorded	for	
the	Sepharose	backbone.	
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The	ToF-SIMS	spectrum	of	Q	Sepharose	FF	is	dominated	by	peaks	associated	to	the	Q	ligand,	
although	 the	 ligand	 density	 is	 reported	 to	 only	 be	 around	 0.21	 mmol/mL	 medium	 ((GE	
Healthcare	Bio-Science,	2014);	Figure	3-45	).	Two	different	explanations	could	be	responsible	
for	this	effect-	the	ligand	density	is	higher	on	the	surface	than	on	the	inside	of	the	bulk	media,	
the	other	is	that	ligand	specific	groups	break	more	easily	under	the	influence	of	the	ion	beam	
than	the	cross-linked	Sepharose	backbone.		
Confocal	microscopic	 images	recorded	of	Q	Sepharose	FF	(Figure	3-36),	as	well	as	previous	
studies	 however	 confirm	 that	 the	 ligand	 is	 homogenously	 distributed	 across	 the	 beads	
(Johansson	et	al.,	2004).	
The	highest	peak	of	the	spectrum	is	the	first	ligand	associated	fragment	at	58.07	m/z	(C3H8N).	
It	dominates	 the	spectrum	with	 the	 following	second	peak	being	40%	of	 the	height	of	 the	
ligand	molecule.	This	being	the	quaternary	amine	fragment	suggests	that	the	C-C	bonds	are	
harder	to	break	than	the	C-N	bonds	by	the	beam,	which	is	expected	given	the	stability	of	the	
resulting	fragments.	
Figure	3-45	Positive	ion	spectra	of	Sepharose	6	FF	(top)	and	Q	Sepharose	FF	(bottom)	
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Both	 Sepharose	 6	 FF	 and	Q	 Sepharose	 FF	 have	 very	 characteristic	 ‘fingerprint	 spectra’	 of	
respective	ToF-SIMS	peaks	 (Figure	3-45	 )	with	 the	 Sepharose	6	 FF	 ‘fingerprint’	 depicting	 a	
surface	of	 a	media	exclusively	made	of	 agarose,	while	
the	Q	Sepharose	FF	‘fingerprint’	illustrates	the	impact	of	
the	 presence	 of	 Q	 ligands	 has	 on	 the	 spectrum.	 To	
evaluate	the	effect	of	cold	atmospheric	pressure	plasma	
treatments	 on	 the	 external	 (chemical)	 surface	
composition	 of	 Q	 Sepharose	 FF	 chromatography	
supports,	 their	 recorded	 positive	 ToF-SIMS	 spectra	
(Figure	 3-37)	were	 compared	 to	 fingerprint	 spectra	 of	
untreated	control	media	(Figure	3-38).		
To	 assess	 the	 impact,	 plasma	 treatments	 have	 on	 the	
ToF-SIMS	 spectra	 of	 Q	 Sepharose	 FF	 supports,	 two	 different	 conditions-	 He-	 O2	 admixed	
(99.5%-	0.5%)	gas	plasma	(20	V;	150	s;	12.5%	SBV)	and	pure	oxygen	gas	plasma	treated	(15	V;	
150	s;	18.75%	SBV)	samples	were	analysed.		
Both	 samples	 showed	 reductions	of	 surface	 (66.3%	and	44.2%	 reduction	of	 pDNA	binding	
capacity,	 respectively)	 as	 well	 as	 core	 binding	 capacity	 (0%	 and	 24%	 loss	 of	 BSA	 binding	
capacity,	respectively)	in	static	binding	studies	(Olszewski	et	al.,	2013).	
Comparing	the	first	recorded	spectrum	of	helium	plasma	treated	supports	to	the	fingerprint	
spectrum	of	the	untreated	Q	Sepharose	FF,	it	is	apparent	that	different	peaks	dominate	the	
spectrum.		
Figure	3-36	CLSM	image	of	Q	
Sepharose	FF	with	Cy5	tagged	BSA	
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The	main	 ligand	associated	peak	at	58.07	 (C3H8N+)	 is	 still	 visible	 in	 the	spectrum,	but	a	 lot	
smaller	in	comparison	to	the	untreated	equivalent.	Although	ToF-SIMS	intensity	counts	are	
not	directly	transferable	across	samples,	comparing	the	absolute	intensity	counts	reveals	that	
the	peak	height	has	been	reduced	by	95%	(from	500k	counts	to	only	25k	counts).		
All	Q	ligand	associated	peaks	have	been	significantly	reduced	and	none	of	them	exceed	10%	
of	the	maximum	peak	intensity	of	the	spectrum.	
Figure	3-37	Positive	ion	spectrum	of	Q	Sepharose	FF	supports	treated	with	helium-oxygen	gas	(99.5-	0.5%)	
plasma	(20	V;	150	s;	12.5%	SBV;	top	and	centre)	and	pure	oxygen	gas	plasma	(15	V;	150	s;	18.75%	SBV;	
bottom)	
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In	contrast	to	the	reduction	of	Q	ligands	on	the	surface,	the	peaks	have	shifted	to	Sepharose	
backbone	associated	peaks	now	dominating	the	spectrum.	Post	helium	plasma	treatment,	the	
ToF-SIMS	spectrum	is	very	similar	to	Sepharose	6	FF	with	only	a	residual	presence	of	Q	ligands	
(Figure	3-38).		
The	helium-oxygen	plasma	treatment	of	the	supports	has	not	only	etched	away	a	significant	
portion	of	the	surface	of	the	chromatography	matrix	but	it	has	done	so	in	a	selective	way;	ToF-
SIMS	as	a	method	of	analysis	cannot	predict	whether	the	agarose	backbone	structure	of	the	
media	has	been	interacted	with	by	the	plasma,	but	it	is	evident	that	the	reaction	is	heavily	
selective,	etching	away	the	Q	ligands	off	the	surface	over	the	backbone	agarose	structure.	
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Figure	3-38	Top:	Q-ligand	associated	positive	ToF-SIMS	peaks	for	different	analysed	media	normalised	to	their	
respective	maximum	peak		
Bottom:	Sepharose	backbone	associated	positive	ToF-SIMS	peaks	for	different	analysed	media	normalised	to	
their	respective	maximum	peak	
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The	duplicate	of	the	helium	plasma	treated	sample	spectrum	shows	a	reduction	of	the	main	
ligand	 peak	 of	 52%	 (from	 500k	 counts	 to	 240k	 counts),	 however,	 without	 adopting	 the	
fingerprint	pattern	of	Sepharose	6	FF,	suggesting	that	although	the	majority	of	Q	ligands	have	
been	etched	away	during	the	plasma	treatment,	the	residual	few	still	have	an	impact	on	the	
ToF-SIMS	spectrum	(ligand	concentration	0.21	mmol/mL).		
It	is	evident	that	some	areas	have	been	almost	entirely	cleared	of	ligands,	with	others,	despite	
the	overall	effectiveness	of	the	plasma	in	eliminating	surface	charges,	some	‘binding	islands’	
remain.	These	islands	(although	minor)	may	have	an	impact	on	the	ToF-SIMS	analysis	due	to	
the	small	area	of	analysis	(lateral	resolution/	probe	size	~0.2	µm;	20x20	µm	analysis	area)-	if	
the	 window	 of	 analysis	 hits	 one	 of	 these	 islands,	 lesser	 etched	 areas	 will	 bear	 a	 strong	
resemblance	to	the	Q	Sepharose	FF	spectra,	rather	than	Sepharose	6	FF.	
	
Spectrum	 of	 oxygen	 gas	 plasma	 treated	 sample	 resembles	 the	 ‘fingerprint’	 pattern	 of	 Q	
Sepharose	FF.	Similarly,	to	the	second	helium	gas	plasma	spectrum,	all	ligand	associated	peaks	
have	 been	 reduced	 in	 comparison	 to	 the	 untreated	 control	 sample,	 while	maintaining	 its	
characteristic	peaks.	As	static	binding	studies	suggest,	the	core	damage	inflicted	by	oxygen	
gas	plasma	is	more	severe	than	observed	in	the	helium	gas	plasma	samples	(illustrated	by	the	
BSA	binding	capacity	reduction).	As	etching	takes	place	in	the	subsurface	region	(damage	to	
the	core)	it	is	not	surprising	that	the	ToF-SIMS	spectrum	is	less	affected	by	the	treatment	than	
its	helium	gas	plasma	equivalent,	given	the	small	penetration	depth	of	the	technique.		
To	avoid	false	positives,	derived	from	a	single	spectrum,	the	helium	plasma	treated	sample	
was	reanalysed	focussing	on	different	particles	of	the	same	batch.	Due	to	the	occurrence	of	
Bromine	peaks	
Figure	3-39	Negative	ion	spectrum	of	Q	Sepharose	FF,	normalised	to	its	maximum	peak	
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small	‘undertreated’	regions	observed	at	20x20	µm,	the	spectra	were	recorded	focussing	on	
larger	analysis	areas	(50	x	50	µm	and	100	x	100	µm	respectively).	
Positive	ToF-SIMS	spectra	can	be	found	in	Appendix	A-4;	with	summaries	of	agarose	and	Q	
ligand	associated	peaks	depicted	in	Figure	3-50	and	Figure	3-51		respectively.	
As	observed	previously	 in	 the	20	 x	20	µm	analysis	 area,	 the	base	matrix	 associated	peaks	
dominate	the	spectra	of	both	plasma	treated	samples	with	the	ligand	associated	peaks	still	
being	present	but	having	been	diminished	significantly	in	comparison	to	the	untreated	control	
sample.	
	
	 	
	
	
Figure	3-50	Agarose	associated	positive	ToF-SIMS	peaks	of	helium	plasma	treated	Q	Sepharose	FF	
chromatography	supports	with	analysis	areas	of	50	x	50	µm	and	100	x	100	µm,	as	well	as	Sepharose	6	FF	and	
(untreated)	Q	Sepharose	FF	all	normalised	to	their	respective	maximum	peak	
	
	
Figure	3-51	Q	ligand	associated	positive	ToF-SIMS	peaks	of	helium	plasma	treated	Q	Sepharose	FF	
chromatography	supports	with	analysis	areas	of	50	x	50	µm	and	100	x	100	µm,	as	well	as	Sepharose	6	FF	and	
(untreated)	Q	Sepharose	FF	all	normalised	to	their	respective	maximum	peak	
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The	negative	ion	spectra	for	all	analysed	media	contain	far	fewer	characteristic	peaks	due	to	
the	AEC	nature	of	the	Q	ligand.	One	decisive	difference	in	the	analysed	spectra	of	Q	Sepharose	
FF	(as	well	as	its	plasma	treated	samples)	in	comparison	to	the	underivatised	Sepharose	6	FF	
was	 the	 presence	 of	 two	 bromine	 associated	 peaks	 79Br-	 and	 81Br-	 around	 80	 m/z.	 The	
remaining	presence	of	Bromine	atoms	on	the	surface	of	the	supports	are	thought	to	be	‘left-
overs’	from	the	coupling	process	with	which	the	ligands	are	coupled	onto	the	agarose	matrix	
via	bromination	of	allyl	groups.	
In	 general,	 the	 negative	 ion	 spectra	 are	 expected	 to	 provide	more	 information	 for	 cation	
exchange	supports	and	have	hence	not	been	investigated	further	in	this	study.	The	respective	
spectra	of	the	plasma	treated	samples,	Sepharose	6	FF	as	well	as	the	carbon	tape	can	be	found	
in	Appendix	A-4.	
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3.4.	Conclusions	and	suggested	future	work	
The	work	presented	in	this	study	has	shown	that	cold	atmospheric	pressure	plasma	can	be	
employed	 to	 selectively	 modify	 the	 exteriors	 of	 chromatography	 supports,	 generating	
bilayered	 SEC-IEC	 materials	 with	 reduced	 surface	 pDNA	 binding.	 Although	 plasma	
technologies	are	normally	known	to	act	at	the	nanoscale,	the	presented	results	suggest	that	
the	 effective	 penetration	 depth	 can	 run	 to	 several	 microns	 when	 applied	 to	 porous	
chromatography	materials.	
Cold	atmospheric	pressure	plasma	treatment	under	helium	gas	in	a	DBD	configuration	yielded	
selectivity	indices	of	up	to	3.0,	corresponding	to	75%	loss	of	pDNA	binding	capacity	with	just	
25%	 loss	 of	 BSA	 binding.	 Selectivity	 indices	 (up	 to	 2.5)	 seen	 for	 Q	 Hyper	 Z	 in	 the	 DBD	
configuration	compare	favourably	to	results	seen	in	previous	studies	with	low	temperature	
low	pressure	plasma	 treatments	 (Arpanaei	 et	 al.,	 2010)	 (selectivity	 indices	up	 to	2.0).	 The	
formation	of	plasma	streamers,	observed	during	DBD	operation,	could	 lead	 to	 issues	 from	
inconsistent	 treatment	 and	 localised	 support	 damage	 when	 operating	 at	 larger	 scale,	 a	
problem	 that	 can	 be	 avoided	 by	 the	 use	 of	 fluidised	 bed	 plasma	 treatment	 using	 He-O2	
bubbles.		
Fluidised	bed	plasma	treatment	was	shown	to	be	suitable	for	treating	soft	hydrogel	materials	
such	 as	 Q	 Sepharose	 FF	 and	 DEAE	 Sepharose	 FF	 to	 produce	 SEC-IEC	 supports	 with	 high	
selectivity	indices	(up	to	3.0,	corresponding	to	66%	loss	of	pDNA	binding	in	exchange	for	0%	
loss	of	BSA	binding).	These	results	compare	well	with	methods	used	for	‘bottom-up’	synthesis	
of	 SEC-IEC	 materials	 based	 on	 Sepharose	 CL-6B	 seen	 in	 the	 literature	 (Bergstrom,	 1997;	
Gustavsson	et	al.,	2004).	‘Bottom-up’	methods	have	been	shown	to	produce	slightly	superior	
selectivity	indices	(up	to	3.5)	(Karnchanasri,	2012).	The	used	technique	does,	however,	require	
a	 far	more	costly	multi-step	synthesis	contrasting	with	the	simplicity	and	efficiency	of	cold	
atmospheric	pressure	plasma	treatments	used	in	this	work.	
ESEM	images	of	plasma	treated	supports	yielded	that,	unlike	previously	reported	(Olszewski	
et	al.,	2013),	cold	atmospheric	plasma	treatment	is	a	gentle	method,	that	does	not	alter	the	
visual	appearance	of	chromatographic	supports	during	treatment.	
A	CLSM	method	has	been	developed	to	simultaneously	visualise	the	binding	topography	of	
chromatography	media	in	regard	to	pDNA	and	protein	binding.	Application	of	the	method	to	
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plasma	etched	supports	revealed	imperfect	chromatography	beads	within	the	total	sample	
population	 in	 agarose	 based	media.	 The	 unsmooth	 fissures/	 crevices	 on	 particle	 surfaces	
hinder	the	elimination	of	ligands	within	said	imperfections,	due	to	the	short-lived	nature	of	
ROS.	 Quantitative	 light	 microscopic	 analysis	 of	 various	 batches	 of	 agarose	 based	
chromatography	media	suggest	that	imperfect	supports	account	for	the	majority	of	residual	
binding.	
ToF-SIMS	analysis	of	plasma	treated	Q	Sepharose	FF	media	confirmed	that	the	presence	of	
residual	 pDNA	 binding	 is	 limited	 to	 binding	 islands	 with	 residual	 Q	 ligands.	 The	 chemical	
composition	 on	 the	 smooth	 surface	 of	 supports	 resembles	 the	 one	 of	 pure	 agarose,	
confirming	 that	 the	 plasma	 reaction	 selectively	 etches	 the	 ligands	 over	 the	 stationary	
backbone	structure.	
Underwater	 plasma	 treatment	 offers	 real	 promise	 for	 converting	 mono-functional	
chromatography	 supports	 into	 multifunctional	 varieties,	 such	 as	 the	 bilayered	 SEC-IEC	
materials	described	in	this	chapter.	The	recorded	selectivity	indices	of	3.0	are:	(i)	higher	than	
those	delivered	previously	by	low	temperature	low	pressure	plasma	modification	and	RDB.	
Additional	advantages	of	creating	bilayers	by	cold	plasma	modification,	rather	than	by	RDB	or	
lamination	(Jahanshahi	et	al.,	2008)	approaches,	 include	its	comparative	simplicity,	meagre	
energy	requirements	and	potential	use	as	a	generic	‘add	on’	treatment.	The	supplementation	
of	 established	manufacturing	 processes	 for	 beaded	 chromatography	materials	with	 a	 cold	
atmospheric	pressure	plasma	modification	stage,	could	allow	these	materials	to	be	converted	
into	layered	varieties	through	addition	of	a	single	cost-effective	step.	
The	 success	 of	 cold	 atmospheric	 plasma	 treatment	 for	 creating	 SEC-IEC	 chromatography	
supports	 indicates	a	need	for	 further	research	 in	 this	area.	 It	 is	also	 likely	 that	 larger-scale	
plasma	treatment	using	an	adapted	fluidised	bed	set-up	would	allow	estimates	of	costs	of	
fluidised	 bed	 plasma	 operation	 at	 an	 industrial	 scale.	 Finally,	 in	 order	 to	 establish	 the	
competitiveness	of	these	cold	atmospheric	plasma	treatments,	the	performance	of	the	media	
in	static	and	dynamic	binding	studies	needs	to	be	compared	to	those	of	commercially	available	
materials	to	identify	the	relative	strengths	and	weaknesses	of	plasma	treatment.	
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Chapter	4 SEC-AEC	bilayered	chromatography	media	manufactured	via	
Viscosity	Enhanced	Reaction	Diffusion	Balancing-	analysis	and	limitations	
	
Abstract	
Bilayered	 chromatography	 supports	were	manufactured	 in	 a	bottom-up	approach	 via	AGE	
activation-partial	 bromination	 of	 Sepharose	 CL-6B.	 Viscosity	 enhanced,	 reaction	 diffusion	
balancing	through	sucrose	addition	to	control	viscosity	was	applied	to	control	thickness	and	
homogeneity	of	the	ligand	free	size-exclusion	layer.		
A	CLSM	method	was	developed	to	screen	the	binding	topography	of	prepared	supports	by	
investigating	simultaneous	binding	of	fluorescently	tagged	pDNA	and	BSA.	
CLSM	and	light	microscopy	was	applied	to	confirm	the	integrity	of	the	manufactured	media,	
while	 addressing	 the	 limitations	 of	 the	 technique	with	 regards	 to	 the	 reduction	 of	 pDNA	
binding	capacity	in	comparison	to	unmodified	control	media.	It	was	found	that	the	quality	of	
the	 final	 product	 is	 strongly	 dependent	 on	 the	 starting	 SEC	 chromatography	media,	 with	
flawed	support	beads	binding	pDNA	after	modification.	These	imperfections	at	the	surface	of	
the	 supports	 act	 as	 diffusion	 barriers	 during	 the	 partial	 bromination	 step,	 preventing	 the	
formation	of	a	ligand-free	zone	within	crevices/	grooves	and	account	for	the	majority	of	pDNA	
binding	to	the	supports	after	bilayer	creation.	
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4.1.	Introduction	
Interest	 in	DNA	vaccines	has	 led	to	an	explosive	 increase	of	related	patents	from	less	than	
20	p.a.	in	1996	to	close	to	100	in	the	2010s	(Ghanem	et	al.,	2013).	DNA	vaccination	uses	DNA	
molecules	of	pathogens	to	induce	immunity	against	specific	diseases	by	providing	genes	that	
encode	for	target	proteins	and	invoke	both	a	cellular	immune	as	well	as	a	humoral	(antibody	
mediated	 immunity)	 response	 (Wolff	 et	 al.,	 1990).	 Plasmid	DNA	vaccine	production	offers	
quick	development	and	manufacturing,	 as	 the	production	process	does	not	 rely	on	 time-/	
labour	consuming	means	such	as	chicken	eggs	or	cell	cultures,	but	can	easily	be	fermented	in	
bacteria	(Ghanem	et	al.,	2013).	Furthermore,	the	stability	of	pDNA	vaccine	formulations	eases	
transport	and	storage	restrictions,	encountered	in	traditional	vaccines	(Manoj	et	al.,	2004).	
Gene	 therapy	 uses	 genes	 as	 treatment	 for	 genetic	 defects	 and	 acquired	 diseases	 such	 as	
cancer	and	viral	diseases	(Abdulrahman	et	al.,	2018).	
Many	 clinical	 trials	 involving	 gene	 therapy	 and	 DNA	 vaccination	 are	 showing	 promising	
efficacies,	however	safety	concerns	mainly	regarding	their	delivery	systems	have	hampered	
approval	of	therapeutic	products	for	human	applications	(Sousa	et	al.,	2010b).	
These	safety	concerns	led	to	the	rediscovery	and	focus	of	research	on	non-viral	vector	designs	
such	 as	 naked	 pDNA.	 Other	 means	 of	 application	 such	 as	 viral	 vectors	 exist	 and	 are	 still	
commonly	 used	 in	 clinical	 trials	 but	 pDNA	 is	 considered	 safer	 and	 expected	 to	 be	 easier	
produced	on	a	large	scale	at	reasonable	cost	(Ginn	et	al.,	2013).	However,	low	transfection	
efficiencies	 of	 plasmid-based	 vectors	 do	 make	 large	 dosages	 mandatory	 (Ferreira	 et	 al.,	
2000b),	 raising	 the	 need	 for	 large	 quantities	 of	 highly	 pure	 pDNA	 formulations	 and	
subsequently	 production	 facilities	 to	 meet	 the	 demand	 for	 cost-effective	 production	 and	
purification.	
Among	the	different	forms	of	pDNA,	the	sc	isoform	is	the	most	desirable	for	pharmaceutical	
applications	due	to	its	antigenicity	and	stability	(Sousa	et	al.,	2012).	
Of	the	several	available	downstream	processing	techniques,	beaded	liquid	chromatography	is	
still	 the	go-to	method	 for	nanoplex	purification	 (Xenopoulos	 et	al.,	2014).	On	a	 laboratory	
scale,	purification	of	pDNA	is	generally	viewed	as	a	simple	procedure,	especially	considering	
that	 such	 production	 strategies	 aim	 for	 small	 quantities	 of	 pDNA	 at	 high	 quality.	 Typical	
upstream	processes	of	pDNA	production	under	such	non-optimised	conditions	yield	very	low	
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volumetric	titres	of	5-40	mg/L	(Prather	et	al.,	2003).	However,	these	purification	methods	do	
not	aim	for	economic	viability	and	scaling	them	to	industrial	production	levels	leads	to	very	
poor	yield.	
An	 industrial	 process,	 designed	 for	 large	 scale	 production	 of	 pharmaceutical	 grade	 pDNA	
formulations,	typically	includes	several	consecutive	steps	(Figure	4-1).	
	
	
	
Many	burdens	are	being	put	on	purification	steps	of	pDNA	after	cell	lysis	due	to	similarities	of	
physicochemical	properties	of	the	target	product	and	many	of	its	main	contaminants	such	as	
molecular	weight,	charge	and	hydrophobicity	(Stadler	et	al.,	2004).	
Among	the	plethora	of	DSP	purification	techniques,	SEC	and	IEC	are	widely	applied	methods	
used	for	pDNA	purification	(Gustavsson	et	al.,	2004;	Xenopoulos	et	al.,	2014).		
AEC	utilises	positively	charged	ligands	mounted	onto	a	stationary	phase,	taking	advantage	of	
negatively	charged	phosphate	backbone	groups	of	DNA.	While	contaminants	may	be	similar	
in	overall	net-charge	and	molecular	weight,	 the	pDNA	isoform	influences	the	density	of	 its	
charge	 distribution	 on	 the	 surface	 (Ghanem	 et	 al.,	 2013).	 These	 negative	 charges	 interact	
locally	 with	 ligands	 on	 stationary	 phases	 and	 are	 consecutively	 eluted	 by	 applying	 a	 salt	
gradient.	The	charge	density	is	closely	related	to	chain	length	due	to	the	amount	of	phosphate	
groups	 in	 the	molecule	and	consequently	 the	 sc	 isoform	 interacts	more	 strongly	with	AEC	
ligands	than	the	oc	isoform,	eluting	at	lower	salt	molarity	(Quaak	et	al.,	2009).	
Commercial	 IE	 chromatographic	 separation	 media	 have	 been	 optimised	 for	 protein	
purification,	rather	than	for	pDNA	applications	(Prather	et	al.,	2003).	With	common	pore	sizes	
of	beaded	supports	being	smaller	than	twice	the	radius	of	gyration	of	common	sized	pDNA	
molecules	(Ellegren	et	al.,	1989),	pDNA	binding	is	restricted	to	the	outer	surface	of	support	
	
Figure	4-1	Flow	chart	of	an	industrial	pDNA	production	process	(Prazeres,	2011)	
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particles	due	to	steric	hindrance	(Ljunglof	et	al.,	1999).	This	 inability	of	pDNA	molecules	to	
diffuse	into	the	porous	core,	and	consequent	inability	to	interact	with	ligands	lining	the	pore	
walls,	leads	to	low	binding	capacities.	While	commercial	AEC	media	bind	proteins	in	the	range	
from	10	to	100	g/Lmedium	and	in	some	cases	up	to	200	mg/mLmedium	(Shamlou,	2003),	the	same	
columns	achieve	pDNA	binding	capacities	of	merely	0.2	to	2	g/Lresin	(Prather	et	al.,	2003).	
Several	 research	 attempts	 have	 been	 undertaken	 to	 circumvent	 these	 drawbacks	 by	
enhancing	the	low	binding.	Reducing	the	radius	of	gyration	of	pDNA	molecules	via	addition	of	
compaction	 agents	 shrinks	 pDNA	 molecules	 and	 allows	 for	 deeper	 pore	 penetration,	
enhancing	pDNA	binding	capacity	by	up	to	40%	(Murphy,	2003).	
The	use	of	 perfusive	media	 allows	pDNA	molecules	 to	 enter	 supports	 via	 larger	 perfusion	
pores,	 binding	 to	 ligands	 lining	 the	 pore	 walls.	 Superporous	 beads	 increase	 the	 available	
binding	area	of	conventional	AEC	media	by	crafting	supports	containing	flow	through	pores	
(2-30	µm	diameter).	These	pores	allow	pDNA	to	enter	 the	beads	via	convective	 flow,	with	
additional	binding	sites	being	provided	on	the	pore	walls,	while	at	the	same	time	allowing	for	
increased	flow	velocities	due	to	reduced	back	pressure	(Deshmukh	et	al.,	2005;	Tiainen	et	al.,	
2007c).	Monoliths	use	a	rigid	porous	stationary	phase	with	convective	flow	pores	lined	with	
adsorptive	ligands	(Zöchling	et	al.,	2004;	Urthaler	et	al.,	2005c;	Sousa	et	al.,	2011).		
Extension	of	the	externally	available	surface	area	was	achieved	by	crafting	polymers	on	the	
surfaces	of	adsorbents.	 In	conjuncture	with	 reduction	of	particle	 size	 for	EBA	applications,	
these	supports	were	found	to	enhance	pDNA	binding	capacity	25	to	70	fold.	(Theodossiou	et	
al.,	2001).	
Enhanced	 binding	 capacity	 via	 size	 reduction	 of	 supports	 yields	 to	 the	 low	 capacities	 of	
classical	supports,	accepting	the	restriction	of	pDNA	binding	to	the	supports	surfaces	alone.	
These	 small	 beads	 have	 however,	 a	 larger	 overall	 surface	 area.	 Issues	 associated	 with	
increased	back	pressure	are	partially	circumvented	by	choosing	a	non-porous	stationary	phase	
(Tiainen	 et	 al.,	 2007d).	 However,	 enhanced	 flow	 velocities	 cause	 concern	 for	 pDNA	
degradation	as	a	result	of	higher	shear	stresses	(Carlson	et	al.,	1995;	Levy	et	al.,	1999).	
Purity	demands	of	pDNA	 formulations	 to	be	used	 in	pharmaceutical	 applications	 raise	 the	
need	for	other	purification	techniques	to	be	applied	such	as	SEC	(Bellot	et	al.,	1993;	Ferreira	
et	al.,	1999).		
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SEC	aims	to	separate	moieties	in	solution	via	size	difference	(molecular	weight)	between	the	
target	molecule	and	its	contaminants.	Due	to	the	nature	of	the	technique,	higher	column	loads	
lead	to	reduced	resolution	as	well	as	a	diluted	sample.	This	could	be	circumvented	by	larger	
column	diameters,	however	packing	of	such	columns	is	challenging	and	generally	avoided.	
Each	 applied	 unit	 operation	 in	 the	 purification	 process	 does	 have	 its	 own	 yield	 and	
consequently	a	margin	of	product	 loss.	With	pDNA	single	 step	 recovery	 rates	beyond	85%	
being	considered	economically	viable	 (Abdulrahman	et	al.,	2018),	 the	appeal	of	combining	
two	 unit	 operations	 in	 a	 single	 column	 is	 a	 very	 interesting	 consideration.	 Operating	 the	
column	in	negative	mode	chromatography	allows	for	the	product	not	to	bind	to	the	column	
and	elute	in	the	flow	through.	A	technique	that	allows	pDNA	to	not	interact	with	the	stationary	
phase	furthermore	reduces	product	losses	caused	by	irreversible	binding	and	conformational	
changes	due	to	binding/	elution	cycles.	
An	alternative	to	classical	IEC	media,	is	a	multifunctional	support	type	with	a	non-interactive	
surface,	with	the	easiest	architecture	imaginable	being	a	SEC-AEC	bilayered	support,	retaining	
positive	 charge	 properties	 on	 the	 inside	 of	 the	 support,	 while	 an	 inert	 exterior	 prevents	
binding	of	pDNA	to	the	surface	of	the	beads.	
The	 principle	 of	 bilayered	 separation	 media	 with	 a	 core-shell	 design	 conveys	 numerous	
advantages	in	HPLC	applications,	like	processing	speed	and	resolution	(de	Faria	et	al.,	2017).	
With	 commercial	 media	 of	 this	 type	 becoming	 more	 readily	 available	 for	 large	 scale	
purification	of	VLPs,	this	design	also	offers	attractive	possibilities	for	challenging	separations	
of	 emerging	 bionanoparticulate	 products	 (plasmids,	 IgMs,	 etc.).	 However,	 fabrication	
methods	employed	for	core-shell	HPLC	packings	do	not	readily	lend	themselves	to	soft	gels,	
such	as	agarose,	required	for	separation	of	large	biological	entities.		
Gustavsson	et	al.	(2004)	created	bilayered	core-shell	adsorbents	using	the	well-known,	fast	
reaction	 of	 limited	 amounts	 of	 bromine	 (reactant)	 with	 double	 bonds,	 homogeneously	
distributed	 throughout	 the	 support	 (Bergstrom,	 1997;	 Berg,	 2003;	 Larsson	 et	 al.,	 2003;	
Gustavsson	et	al.,	2004).	This	new	‘lid	bead’	technology	has	been	used	in	an	integrated	process	
for	pDNA	purification	from	crude	cell	lysates	as	a	final	polishing	step	(Kepka	et	al.,	2004).	A	
single	process	step	plasmid	yield	of	88%	suggests	however,	 that	not	all	of	 the	surface	was	
cleared	of	ligands,	especially	as	remaining	pDNA	was	eluted	via	salt	gradient.	The	success	of	
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the	approach	requires	balancing	of	the	reaction	rate	(bromine	with	AGE)	against	depth	and	
speed	of	diffusion	into	the	pores	of	the	supports.	Reaction-diffusion	balancing	is	affected	by	
three	obvious	parameters;	temperature,	reactant	size	and	viscosity	of	the	bulk	phase.	
Challenges	for	the	manufacturing	of	bilayered	chromatography	media	for	pDNA	purification	
via	the	AGE-activation	partial	bromination	route	reside	in	controlling	the	layer	thickness	of	
the	 applied	method	 in	 order	 to	 accommodate	 both	 the	 elimination	 of	 all	 surface	 ligands,	
whilst	also	keeping	the	shell	as	thin	as	possible	to	compromise	as	little	as	possible	on	overall	
binding	 capacity	 (30%	 loss	 of	 core	 binding	 capacity	 cf.	 fully	 Q	 functionalized	 supports	 in	
Gustavsson’s	initial	study).	Controlling	the	partial	bromination	step	is	hence	key	to	achieve	a	
homogenous,	thin	shell.		
During	 partial	 bromination	 the	 high	 reactivity	 of	 bromine	 is	 of	 particular	 importance;	 low	
viscosity	 in	 the	 surrounding	 buffer	 leads	 to	 a	 ‘directional’,	 inhomogeneous	 bilayer	
development,	as	bromine	is	not	given	the	chance	to	fully	engulf	the	support	(diffusion	rate	
into	core	>	mass	transfer	‘around’	the	bead).	
However,	if	the	transport	of	reactant	to	the	surface	is	delayed	too	much,	bromine	is	lost	prior	
to	reaction	with	AGE	groups	due	to	hydrolysis	in	water.	Bromine	reacting	with	sucrose	may	
play	a	minor	part,	but	overall	the	reaction	rate	with	sucrose	is	slower	cf.	hydrolysis	of	bromine.	
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This	chapter	aims	to	study	AEC-SEC	bilayered	chromatography	supports,	manufactured	via	the	
outlined	AGE	activation-partial	bromination	VE-RDB	approach.	In	this	‘bottom-up‘	technique,	
commercially	 available	 Sepharose	CL-6B	 SEC	media	was	utilised	 as	 a	 starting	material	 and	
chemical	functionality	was	built	up	in	the	supports	via	an	adapted	5-step	protocol	(Gustavsson	
et	 al.,	 2004).	 The	 impact	 of	 different	 parameters	 such	 as	 viscosity	 of	 surrounding	 buffer	
solution	during	partial	bromination,	degree	of	bromination	and	repetitive	bromination	cycles	
on	the	performance	of	the	media	in	static	binding	studies	with	pDNA	(surface	binding)	as	well	
as	BSA	(core	binding)	was	assessed.	
CLSM	is	a	very	powerful	visualisation/	quantification	tool	and	finds	widespread	application	in	
chromatographic	research	(Hubbuch	et	al.,	2008).	A	CLSM	method	was	developed	to	screen	
the	binding	topography	of	bilayered	supports,	allowing	simultaneous	visualisation	of	pDNA	as	
well	as	protein	binding	to	the	supports.	Applying	CLSM	yielded	insights	into	the	location	of	
residual	pDNA	binding	sites	on	the	beads’	surfaces	and	helped	in	understanding	the	limitations	
of	 the	 technique	 due	 to	 single	 irregular	 shaped	 supports,	 preventing	 the	 formation	 of	 a	
distinct	demarcation	zone.	
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4.2.	Materials	and	Methods	
Due	to	similar	methodologies	throughout	different	chapters	of	this	work,	several	methods	are	
presented	in	a	separate	section	of	this	thesis	(Chapter	2).	
Some	 of	 the	 conducted	 experiments	 do	 however	 require	 more	 explanation	 in	 regard	 to	
specific	 parameters,	 as	 Chapter	 2	 only	 describes	 their	 implementation.	 When	 further	
information	 is	 essential,	 it	 is	 given	 in	 the	 respective	 sections	 to	 aid	 readability	 and	
understanding	of	their	processes.	
Methods	describing	experiments	that	are	exclusive	to	this	chapter	are	listed	below.	
To	 avoid	 repetition,	 a	 comprehensive	 list	 covering	 all	 materials	 and	 equipment	 used	 to	
perform	 experiments	 during	 the	 practical	 implementation	 of	 the	 project	 is	 described	 in	
Chapter	2.	
4.2.1.	Preparation	of	SEC-AEC	supports	via	AGE-activation-	partial	bromination,	VE-
RDB	
AEC-SEC	 media	 used	 in	 this	 chapter	 were	 manufactured	 and	 kindly	 provided	 for	 further	
analysis	by	Dr	Karnchanasri	following	an	adapted	protocol	by	(Gustavsson	et	al.,	2004).	 
The	five-step	process	is	depicted	in	Figure	4-2	followed	by	a	more	detailed	description	below.	
4.2.1.1.	AGE	activation	
60	mL	of	Sepharose	CL-6B	media	were	washed	in	MQW,	suction	dried	on	a	vacuum	filter	frit	
and	incubated	with	24	mL	of	50%	(wt/v)	NaOH	containing	0.25	g	sodium	borohydride	and	6.7	g	
sodium	sulphate	at	50°C	for	1	h	(gently	stirred).	The	supports	were	suction	dried	to	remove	
excess	NaOH	from	solution	and	incubated	overnight	(16	h)	with	41	mL	AGE	in	a	stirred	water	
bath	(40°C;	170	RPM).	
To	remove	chemical	 residues,	supports	were	washed	with	MQW,	70%	ethanol	 (ETOH)	and	
MQW	prior	to	storage	in	20%	ETOH	(4°C).	
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4.2.1.2.	Partial	bromination/	viscosity	measurement	of	sucrose	solutions	
Several	 different	 concentrations	 of	 sucrose	 in	MQW	were	 used	 as	 viscosity	 enhancement	
reagent	(wt/v).	After	equilibrating	15	mL	of	supports	three	times	in	the	respective	solution,	
the	media	was	suction	dried	and	suspended	in	12	mL	of	the	respective	sucrose	solution.	
An	amount	of	1%	(v/v)	bromine	solution	in	MQW	was	added	based	on	the	aim	of	targeted	
AGE	elimination	 levels	 (10%;	20%;	10%+	10%	of	total	allyl	content).	The	reaction	tube	was	
shaken	 until	 the	 reaction	 had	 finished	 (discoloration	 of	 solution)	 and	 supports	 repeatedly	
washed	in	MQW.	
Prior	 to	 suspending	 support	 beads	 in	 sucrose	 solutions,	 the	 rheological	 behaviour	 of	 the	
solutions	 was	 assessed.	 An	 Advanced	 Rheometer	 AR1000	 (TA	 Instruments;	 New	 Castle;	
Delaware;	USA)	equipped	with	a	2°	angle,	40	mm	stainless	steel	cone	shaped	geometry	was	
used	 for	 viscosity	measurements.	 Temperature	 dependencies	 of	 viscosity	 were	measured	
while	applying	a	temperature	ramp	of	4°	K/min	from	2°C	to	90°C	(shear	rate	10	s-1).	
	
Figure	4-2	Flow	chart	of	the	manufacturing	process	for	bilayered	AEC-SEC	supports	applying	VE-RDB/	partial	
bromination	prior	to	ligand	coupling;	as	the	reaction	of	allyl	groups	with	bromine	is	carried	out	in	aqueous	
solution	the	brominated	reaction	product	is	likely	a	mixture	of	bromoalcohol	(bromohydrin)	and	di-bromo	
adducts,	the	precise	balance	of	these	is	dependent	both	on	the	rate	of	addition	and	the	additives	present	
(Zabicky	et	al.,	1986)	
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4.2.1.3.	Hydrolysis		
1.12	mL	of	50%	(wt/v)	NaOH	and	0.04	g	NaBH4	were	added	to	a	tube	containing	10	mL	(SBV;	
suction	 dried)	 partially	 brominated	 supports	 in	 10	 mL	 MQW	 and	 incubated	 at	 room	
temperature	overnight	on	an	orbital	shaker	incubator.	
The	supports	were	subsequently	suction	dried	and	repeatedly	washed	 in	MQW	to	remove	
chemical	residues.	
4.2.1.4.	Full	bromination	and	ligand	coupling		
8	mL	 (SBV)	of	 supports	were	 rehydrated	 in	3.48	mL	MQW	and	0.39	g	sodium	acetate	was	
dissolved	 in	 the	 slurry.	 Bromine	 solution	 (1%	 v/v)	 was	 added	 to	 the	 suspension	 until	 a	
permanent	yellow/orange	colour	was	obtained.	The	supports	were	drained	and	repeatedly	
washed	with	MQW	before	resuspending	them	 in	3.48	mL	of	MQW.	2.61	mL	of	50%	NaOH	
(wt/v)	followed	by	35	mg	NaBH4	were	added	and	mixed	before	adding	5.07	mL	of	65%	(wt/v)	
trimethylamine	chloride	(Q-ligand).	The	sample	was	mixed	overnight	on	a	blood	tube	rotator	
(21°C).	The	bilayered	AEC-SEC	supports	were	washed	with	MQW,	1	M	NaCl	and	MQW	prior	to	
storage	at	4°C	in	20%	ETOH.	
Fully	Q-coupled	 control	media	was	manufactured	 by	 skipping	 the	 partial	 bromination	 and	
hydrolysis	steps,	fully	brominating	the	supports	immediately	after	AGE	activation.	
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4.2.2.	Light	microscopic	analysis	of	AEC-SEC	supports	dyed	with	Congo	red	to	
highlight	the	SE	layer	
For	visualisation	of	the	SE	layer	of	AEC-SEC	supports,	1	mL	of	supports	(SBV)	was	washed	three	
times	 in	MQW	and	 incubated	 for	 1	 h	with	 a	 saturated	 aqueous	 CR	 solution.	 Due	 to	 their	
negative	charge,	CR	dye	molecules	bind	to	AEC	 ligands	while	not	 interacting	with	the	base	
matrix	of	the	supports	(Figure	4-3).	
	
	
The	supports	were	centrifuged	to	assist	sedimentation	(2,000	g;	10	s),	supernatant	pipetted	
out	and	beads	washed	three	times	in	MQW	to	remove	unbound	CR.	
80	µL	 of	 chromatography	 supports	 slurry	 in	MQW	were	pipetted	onto	 a	microscope	 slide	
(VWR	VistaVision	Microscope	Slides,	VWR	 International,	UK)	and	covered	with	a	cover	slip	
(VWR	Micro	 Cover	Glasses),	 carefully	 avoiding	 the	 formation	 of	 air	 bubble	 inclusions.	 The	
sample	was	 then	analysed	 in	an	Olympus	BX50	Light	microscope	using	4x,	10x,	20x	or	40x	
magnification	 respectively.	 For	 images	 taken	 with	 a	 100x	 magnification,	 a	 droplet	 of	
immersion	oil	(Sigma	Aldrich)	was	used	to	bridge	the	gap	between	lens	and	cover	slide.	
Images	were	 taken	with	 a	Moticam	800x600	PIX,	 controlled	by	Motic	 Images	 plus	 2.0	ML	
software.	
	 	
	
Figure	4-3	Chemical	structure	of	the	azo	dye	CR	(skeletal	formula)	
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4.2.3.	Light	microscopic	analysis	and	visual	grading	of	chromatography	media	
Light	microscopic	analysis	of	supports	was	conducted	as	described	in	4.2.2.	but	without	the	
aforementioned	addition	of	CR	(thus	the	bilayered	structures	were	not	highlighted).	
Further	image	analysis	was	conducted	with	(Fiji	is	just)	ImageJ	(Version	1.0	for	Mac).	
To	grade	the	visual	integrity	of	chromatography	beads,	light	microscopic	images	at	10x	and	
20x	magnification	were	analysed,	respectively.	With	a	confidence	level	of	95%,	a	confidence	
interval	of	5	and	assuming	an	infinitely	large	population,	a	minimum	of	384	single	beads	need	
to	be	graded	for	statistical	analysis	(Amemiya,	1994):	
	 𝑠𝑠 = 𝑍 ∗ 0.25𝑐 	
	 With:	
	 ss	=	sample	size	
	 Z	=	Z-value	(1.96	for	a	confidence	interval	of	95%)	
	 c	=	confidence	interval	in	[%]		
	For	each	sample,	several	images	were	taken	to	acquire	a	total	particle	count	of	at	least	400	
supports.		
Only	whole	particles	were	graded	(no	supports	on	the	edge	of	images)	and	three	categories	
of	beads	were	distinguished:	
Particles	with	no	visual	imperfections	were	rated	green.	Beads	with	small	 imperfections	on	
the	surfaces	(dents,	crevices,	etc.	of	approximate	depth	up	to	5	µm),	that	are	shallow	enough	
to	be	fully	integrated	into	the	SE	layer	after	the	partial	bromination	step	were	rated	yellow.	
Particles	with	major	imperfections	that	grant	core	access	to	larger	nanoplexes	after	creation	
of	the	SE	layer	were	rated	red.	
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4.3.	Results	and	Discussion	
4.3.1.	Static	binding	reductions	of	VE-RDB	media	
Crafting	 bilayered	 SEC-AEC	 supports	 following	 the	 bottom	 up	 approach	 described	 by	
Gustavsson	involves	a	total	of	five	working	steps	(Gustavsson	et	al.,	2004);	(i)	introduction	of	
allyl	 groups	 throughout	 the	 stationary	 phase	 of	 Sepharose	 CL-6B	 by	 reacting	 AGE	 with	
hydroxyl	groups	on	the	backbone	of	the	agarose	based	media;	 (ii)	partial	bromination	of	a	
targeted	 amount	 of	 allyl	 groups	 at	 the	 support	 surface;	 (iii)	 hydrolysis	 of	 the	 brominated	
surface	groups	to	generate	an	inert	outer	layer;	(iv)	excess	bromination	of	residual	allyl	groups	
throughout	the	support	(v)	coupling	trimethylamine	(Q)	to	the	core	of	the	media	(Figure	4-2).	
While	steps	(i)	and	(iii)-(v)	are	reactions	with	surplus	reactants	aiming	for	reaction	equilibrium,	
partial	 bromination	 involves	 several	 non-equilibrium	 transport	 phenomena,	 which	 have	
crucial	impact	on	the	shape	and	size	of	the	inert	shell.		
Dispersion	of	 bromine	 into	 the	 reaction	 vessel,	 aiming	 for	 immediate	mixing;	 transport	 of	
bromine	from	slurry	to	bead	surface,	aiming	for	swift	engulfing	to	avoid	directionality	of	layer	
creation	prior	to;	diffusion	of	bromine	into	the	bead	from	the	surface;	reaction	of	bromine	
with	allyl	groups	(almost	instantaneous).	
Meanwhile,	further	reactions	occur	simultaneously;	hydrolysis	of	bromine	in	aqueous	solution	
(Liebhafsky,	1939)	and	loss	of	bromine	to	oxidation	of	sucrose	(Andersson	et	al.,	1980).	
Addition	 of	 viscosity	 enhancing	 reagents	 (such	 as	 sucrose)	 offers	 control	 over	 the	 partial	
bromination	by	balancing	reaction	and	diffusion	rates.		
Among	 other	 parameters	 influencing	 the	 partial	 bromination	 step	 (reaction	 temperature,	
addition	of	adjuvants,	etc.),	 this	 study	 focusses	on	 the	degree	of	partial	bromination	all	at	
different	viscosities	adjusted	via	sucrose	addition	(0-	80%).	
Three	sets	of	bilayered	support	samples	were	manufactured,	featuring	single	10%	and	20%	of	
the	 total	 allyl	 content,	 as	 well	 as	 double	 10%	 partial	 bromination.	 Double	 10%	 partial	
bromination	was	achieved	by	following	an	initial	10%	partial	bromination	with	a	washing	step	
prior	to	applying	another	10%	partial	bromination	followed	by	hydrolysis.		
Crafted	media	were	analysed	for	static	pDNA	and	BSA	binding	capacities,	degree	of	allylation	
and	 ionic	 capacity.	 SI	 values	 were	 calculated	 for	 all	 three	 ‘core	 parameters’	 against	 fully	
derivatised	AEC	control	media;	results	are	depicted	in	Figure	4-4.	
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Both	single	brominations	without	sucrose	addition,	targeting	10	and	20%	of	allyl	groups	lead	
to	reductions	of	all	‘core	parameters’	(ionic	capacity,	protein	adsorption,	allyl	content)	of	~10	
and	20%	respectively.	
While	selectivity	is	very	poor	at	low	viscosities	(<1.5),	with	pDNA	binding	reductions	of	~20	and	
45%	respectively,	addition	of	50	and	64%	sucrose	led	to	targeted	reduction	of	surface	binding	
up	 to	 80%. Sucrose	 contents	 exceeding	 64%	 however,	 led	 to	 a	 decline	 in	 pDNA	 binding	
reduction	in	both	single	10	and	20%	partial	bromination.		
The	results	suggest	that	the	viscosity	is	too	high,	preventing	effective	transport	of	bromine	to	
the	 surface	 of	 the	 beads.	 Respectively	 low	 reductions	 of	 core	 parameters	with	 increasing	
sucrose	contents,	furthermore	suggest	that,	the	longer	bromine	molecules	take	to	get	to	allyl	
groups,	the	longer	it	is	exposed	to	loss	prior	to	reaction	due	to	bromine	hydrolysis/	oxidation	
of	sucrose	(Trombotto	et	al.,	2004).	
While	 it	 is	beneficial	to	allow	bromine	solution	to	engulf	supports	before	diffusing	into	the	
shell/	 reacting	with	 allyl	 groups	 to	 avoid	 directionality	 of	 layer	 creation,	 enhancing	 buffer	
viscosity	too	much	reduces	the	amount	of	bromine	available	for	reaction	(Figure	4-5).	
	
Without	addition	of	sucrose	to	the	supports	slurry,	reduction	of	 ‘core	parameters’	 indicate	
that	 double	 partial	 bromination	 of	 10%	 led	 to	 reductions	 of	 ~30%	 of	 allyl	 groups.	 Higher	
reduction	 levels	 than	 the	 targeted	10+10%	were	associated	 to	difficulties	 in	pipetting	very	
small	 sample	 volumes	 and	 immediate	 mixing	 of	 bromine.	 The	 resulting	 preparation	 can	
however	be	taken	as	a	30%	partial	bromination	via	repetitive	incremental	reaction.	
Consistently	 high	 pDNA	 binding	 reductions	 >70%	 were	 found	 for	 all	 VE-RDB	 double	 10%	
bromination	 samples,	 with	 a	 decline	 in	 reduction	 of	 core	 binding	 capacity	 at	 increasing	
viscosities,	similar	to	the	trends	observed	in	single	bromination	samples.		
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Figure	4-4	Characteristics	of	SEC/	IEC	supports	produced	via;	A)	single	10%,	B)	single	20%	and	C)	double	
10+10%	partial	bromination/	hydrolysis	cycle	at	room	temperature	(21°C)	without	further	additives;	
reductions	of	static	pDNA-	(purple)/	protein	binding	capacity	(blue),	allyl	content	(green)	and	ionic	capacity	
(yellow)	to	fully	derivatised	AEC	control	media	
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The	highest	SI	values	(>4)	were	recorded	for	double	10%	bromination	with	sucrose	contents	
of	64%	and	above.	However,	these	are	subject	to	bromine	loss	 in	solution	as	no	additional	
pDNA	binding	reduction	occurs	while	reduced	core	reduction	levels	elevate	the	SI.	
Irrespective	of	the	sucrose	content	or	degree	of	partial	bromination,	no	preparation	was	able	
to	eliminate	pDNA	binding	entirely.	It	appears	that	a	base	level	of	residual	pDNA	binding	of	
around	 20%,	 unaffected	 by	 the	 bilayer	 creation	 at	 the	 surface	 cannot	 be	 overcome	 by	
additional	bromination	and	is	independent	of	viscosity	enhancing	reagents.	This	effect	cannot	
be	explained	by	means	of	static	binding	capacity	reductions	alone.	
To	 evaluate	 the	 effect	 of	 residual	 pDNA	 binding	 (on	 the	 surface?),	 the	 supports	 were	
investigated	further	using	visualization	techniques	(light	microscopy	and	CLSM	respectively).		
Avoiding	 samples	with	 enhanced	bromine	 loss	 due	 to	hydrolysis/	 sucrose	oxidation,	while	
providing	significant	selectivity,	the	three	configurations	featuring	64%	sucrose	addition	were	
selected	for	investigation.	
 
	
	
	 	
	
Figure	4-5	Bromine	stability	in	aqueous	solutions	at	room	temperature;	in	water	(x);	80%	sucrose	(w/v; )  
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4.3.2.	Light	microscopic	visualisation	of	restricted	access	media’s	architecture	
manufactured	via	VE-RDB	during	partial	bromination	
Restricted	access	media	as	manufactured	and	previously	described	by	(Karnchanasri,	2012)	
call	for	validation	through	visualisation	of	the	supports’	architecture.	Figure	4-6		(top)	shows	
a	micrograph	of	Sepharose	CL-6B	supports	provided	with	a	SE	 layer	manufactured	via	10%	
bromination	 (64%	 (wt/v)	 sucrose;	 0.032	 Pa·s).	 The	 supports’	 positively	 charged	 core	 was	
stained	with	negatively	charged	dye,	CR,	and	imaged	as	described	in	4.2.2.	.		
While	the	dye	bound	to	the	core	of	the	supports,	staining	it	in	a	strong	orange/	red	colour,	the	
non-charged	outer	layer	of	the	supports	appears	entirely	uncoloured.	This	demarcation	zone	
between	the	outer	layer	and	the	core	of	the	supports	is	very	distinct	with	a	sharp	interface.	
Fully	 Q-coupled	 Sepharose	 CL-6B	 (Figure	 4-6	 ,	 bottom)	 did,	 as	 expected,	 not	 show	 a	
demarcation	zone,	with	the	dye’s	orange	colour	being	homogenously	spread	across	the	entire	
bead.	This	leads	to	the	conclusion	that	ligands	are	evenly	distributed	across	the	base	matrix.	
	
Although	visually	compelling,	light	microscopic	imaging	does	not	possess	the	resolution	to	pick	
up	on	minor	traces	of	‘left	over’	ligands	that	may	have	withstood	the	partial	bromination	step.	
Furthermore,	due	to	the	nature	of	this	technique,	light	micrographs	are	unable	to	provide	3D	
insights	of	structures	and	are	limited	to	a	projective	examination.	
	
Figure	4-6	Light	micrographs	of	Sepharose	CL-6B	based	restricted	access	media	(dyed	with	CR),	with	a	distinct	
demarcation	zone	(top)	and	homogenous	supports	(bottom)	both	at	40x	(left)	and	100x	magnification	(right)	
respectively;	difference	in	(background)	colouring	due	to	diffraction	effect	
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CLSM	has	proven	to	be	a	suitable	tool	addressing	both	of	these	limitations,	providing	3D	stack	
analyses	as	well	as	picking	up	charge	traces	in	chromatography	media	(Hubbuch	et	al.,	2002).	
It	was	however	reported	that	small	remnants	of	ligand	in	the	shell	would	not	lead	to	significant	
pDNA	adsorption	(Gustavsson	et	al.,	2004).		
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4.3.3.	CLSM	analysis	of	VE-RDB	manufactured	AEC-SEC	supports	
Light	micrographs	of	AEC-SEC	supports	showed	a	non-adsorptive	layer	surrounding	a	charged	
core	after	incubating	supports	with	CR.	
CLSM	has	been	employed	as	a	tool	for	visualisation,	to	get	a	more	refined	insight	in	the	charge	
distribution	within	bilayered	supports.	To	assess	the	location	of	residual	pDNA	binding	sites,	
support	samples	were	incubated	with	fluorescently	tagged	pDNA	solution.	To	simultaneously	
also	get	access	to	core	binding	data,	the	supports	were	subsequently	incubated	with	tagged	
BSA	solution	(binding	throughout	all	binding	sites	of	the	bead)	before	analysing	the	samples	
as	described	in	2.3.12.	
As	control	without	a	non-adsorptive	exterior,	Sepharose	CL-6B	SEC	media	was	conjugated	with	
the	 strong	 anion-exchange	 ligand	 Q	 via	 AGE-activation,	 directly	 followed	 by	 excess	
bromination	and	ligand	coupling.		
CLSM	 images	 of	 control	 supports	 show	 a	 bright	 green	 halo	 (SYTO-9	 fluorescently	 tagged	
pDNA)	 surrounding	 a	 red	 core	 (Cy5	 labelled	 BSA).	 The	 pDNA	 is	 too	 large	 (26.88	 kbp)	 to	
penetrate	 through	 the	 outer	 micrometres	 of	 the	 porous	 bead	 and	 bind	 to	 ligands,	 lining	
internal	pores	of	the	supports.	Binding	is	hence	limited	to	the	surface	of	the	supports.	BSA	is	
small	 enough	 (66.5	 kDa)	 to	 diffuse	 into	 the	 interior	 and	 bind	 throughout	 the	 particle		
(Figure	4-7).	
		
	 	
	
Figure	4-7	Left:	Overlay	of	CLSM	channels	(red-	fluorescently	tagged	BSA;	green-	pDNA)	analysing	IEC	
support	manufactured	via	AGE	activation,	full	bromination/	trimethylamine	chloride	(Q)	coupling	(control	
sample	without	SE	layer)	
Right:	Respective	light	microscopic	image		
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In	order	to	compromise	the	least	on	overall	binding	capacity,	the	ligand	free	layer	of	AEC-SEC	
media	would	ideally	be	as	thin	as	possible,	while	still	preventing	binding	to	the	surface	of	the	
supports.	 CLSM	 coupled	 with	 light	 microscopic	 imaging	 was	 employed	 to	 investigate	 the	
architecture	of	bilayered	supports	manufactured	via	10%	partial	bromination.	After	incubating	
support	samples	with	both	fluorescently	labelled	BSA	(exemplifying	core	binding;	depicted	in	
red)	and	SYTO-9	tagged	pDNA	solutions	(binding	to	residual	ligands	on	the	supports	surfaces;	
green),	the	sample	was	analysed	focussing	on	meridians	of	single	support	particles.		
	
	
Figure	4-8	Left:	Overlay	of	CLSM	channels	(red-	fluorescently	tagged	BSA;	green-	pDNA)	analysing	SEC/	IEC	
supports	manufactured	via	single	10%	partial	bromination/	hydrolysis	cycle	at	room	temperature	(21°C);	
sucrose	content	of	64%	w/v	(0.032	Pa·s)	
Right:	respective	light	microscopic	images	with	shell	thicknesses	of	SE	layer	in	µm	
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Figure	4-8	confirms	a	very	thin	ligand-free	layer	of	around	2.5-3	µm	(15.4%	predicted	loss	of	
binding	 capacity-	 based	 on	 volume	 weighted	 mean	 D[4.3]=	 110.81	 µm	 (Figure	 4-9)).	 The	
demarcation	zone	surrounding	the	core	is	of	homogenous	thickness.		
Sucrose	slows	down	the	diffusion	of	bromine	into	the	core	and	hence	condenses	the	charge	
elimination	 to	 a	 small	 area.	 This	 leads	 to	 a	 sharp	 cut-off	 between	 the	 non-interactive	
stationary	phase	cleared	of	ligands	and	the	charged	core.		
While	providing	a	desirable	distinct	shell,	sucrose	also	slows	down	the	overall	mass	transport	
of	bromine	to	the	reaction	sites	at	the	supports.	Delaying	the	reaction	of	bromine	with	AGE	
groups	of	the	supports	allows	more	time	for	bromine	hydrolysis	 in	the	surrounding	buffer.	
Whilst	 addition	 of	 sucrose	 reduces	 the	 rate	 of	 bromine	 hydrolysis	 in	 aqueous	 solutions	
(Joseph,	2018-	 in	preparation),	 the	effect	 is	outweighed	by	a	slower	 rate	of	bromine	mass	
transfer	from	the	bulk	solution	to	the	supports.	This	reduces	the	overall	amount	of	bromine	
being	accessible	 for	 reaction,	explaining	why	 less	allyl	 groups	are	 removed	 than	expected.	
Assessing	 the	amount	of	allylation	after	a	 targeted	10%	bromination	yielded	reductions	of	
only	8%	of	the	allyl	groups	(Figure	4-4).	
While	support	B	is	totally	inert	to	pDNA	binding	on	its	surface,	the	10%	partial	bromination	
was	 insufficient	 to	 clear	 all	 ligands	 on	 the	 surface	 of	 supports	 A	 and	 C.	 The	 cleared	 zone	
surrounding	the	core	of	bead	C	appears	too	thin,	allowing	pDNA	binding	to	occur,	raising	the	
demand	for	an	overall	thicker	SE	layer	to	avoid	under	treatment	of	single	supports.	
	
	
Figure	4-9	Particle	size	distributions	of	Sepharose	CL-6B	based	AEC-SEC	supports	modified	by	10%	partial	
bromination	at	room	temperature	in	64%	(w/v)	sucrose	(0.032	Pa·s	viscosity);	solid	line-	volumetric;	dash-
dotted	line-	surface	weighted;	dotted	line-	number	weighted	distribution 
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Increasing	the	level	of	partial	bromination	to	20%	should	thwart	the	occurrence	of	residual	
binding	isles.		
As	 expected,	 the	 increase	 in	 the	 amount	 of	 bromine	 led	 to	 a	 formation	 of	 a	 thicker	 non-
adsorptive	layer.	Figure	4-10	illustrates,	that	with	increased	layer	thickness,	the	likelihood	of	
residual	surface	charge	is	indeed	diminished.	Only	the	third	support	(C)	shows	a	small	island	
of	residual	pDNA	binding,	whereas	the	others	are	entirely	devoid	of	surface	binding.	
The	layer	preventing	pDNA	adsorption	is	however,	not	as	homogenous	as	observed	in	the	10%	
single	bromination	media.	The	direction	of	the	flux-	pathway	of	bromination	is	clearly	visible.		
	
	
Figure	4-10	Left:	Overlay	of	CLSM	channels	(red-	fluorescently	tagged	BSA;	green-	pDNA)	analysing	SEC/	IEC	
supports	manufactured	via	single	20%	partial	bromination/	hydrolysis	cycle	at	room	temperature	(21°C);	
with	a	sucrose	content	of	64%	w/v	(0.032	Pa·s)	
Right:	Respective	light	microscopic	image	with	shell	thickness	of	SE	layer	in	µm	
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While	the	SE	 layer	on	one	side	of	the	supports	being	slightly	thicker	than	on	its	flanks,	the	
demarcation	zone	on	the	opposing	side	is	very	thin.	
The	shape	of	the	SE	layer	depends	on	mass	transfer	of	bromine	to	the	brink	of	the	bead,	the	
diffusion	rate	through	the	stationary	phase	into	the	core	of	the	particle	as	well	as	the	reaction	
rate	with	AGE,	all	while	bromine	gets	slowly	hydrolysed.	The	shape	of	the	supports	hints	that	
a	 single	 20%	 partial	 bromination	 step	 results	 in	 fast	mass	 transfer	 into	 the	 bead	without	
granting	the	bromine	enough	time	to	first	enshroud	the	support	as	a	whole	even	at	higher	
sucrose	concentrations.	Such	an	inconsistent	thickness	of	the	SE	layer	(6.5-	17	µm),	sacrifices	
(too)	much	core	binding	capacity	as	only	the	shortest	distance	is	of	importance	to	the	overall	
media	performance	when	aiming	to	fully	eliminate	surface	binding	(characteristic	length).	
In	an	attempt	to	avoid	directional	layering,	as	observed	in	20%	partially	brominated	supports,	
while	providing	a	slightly	thicker	overall	layer	than	10%	partially	brominated	beads,	supports	
were	treated	repeatedly.	Two	thin	layers	statistically	avoid	both	thin	spots	in	the	SE	layer	as	
well	as	under-/	overtreatment	due	to	diffusion	barriers.	
10%	partially	brominated	supports	were	exposed	to	a	second	10%	partial	bromination	step	
following	the	same	protocol,	prior	to	hydrolysis	(10%+	10%).	
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Light	micrographs	of	prepared	supports	show,	as	expected	a	homogeneous	layer	devoid	of	
pDNA	binding	with	no	connection	of	the	core	to	the	surface	(Figure	4-11).		
The	thickness	of	the	surrounding	 layer	was,	as	expected,	thicker	than	observed	in	the	10%	
partial	 bromination	 supports,	 with	 the	 additional	 bromination	 eliminating	 the	 spots	 of	
residual	binding	caused	by	the	directionality	of	applying	bromine	in	a	single	step	as	seen	in	
the	20%	partial	bromination	supports.		
However,	these	minor	flaws	in	shape	and	thickness	of	the	SE	layer	of	manufactured	AEC-SEC	
bilayered	media,	cannot	account	for	retentions	of	22.5,	24.1	and	32.5%	static	pDNA	binding	
capacity	in	comparison	to	AEC	control	supports	(10%;	20%	and	10%+10%	partially	brominated	
respectively).		
It	is	apparent	that	a	different	effect	has	to	be	responsible	for	residual	pDNA	binding	to	media	
en	gros.	
	
Figure	4-11	Left:	Overlay	of	CLSM	channels	(red-	fluorescently	tagged	BSA;	green-	pDNA)	analysing	SEC/	IEC	
supports	manufactured	via	double	10+10%	partial	bromination/	hydrolysis	cycle	at	room	temperature	
(21°C);	with	a	sucrose	content	of	64%	w/v	(0.032	Pa·s)	
Right:	Respective	light	microscopic	image	with	shell	thickness	of	SE	layer	in	µm	
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4.3.4.	Imperfect	beads	with	flawed	surfaces	
Upon	analysing	AEC-SEC	media	(CLSM,	light	microscopy),	a	number	of	non-spherical,	damaged	
and/	or	misshaped	chromatography	particles	stood	out	from	the	bulk	of	the	population.		
Several	different	patterns	of	imperfections	were	observed,	affecting	the	crafting	of	bilayered	
support	structures	in	their	own	ways.		
Hollow	spots	within	the	internal	structure	of	particles	were	observed	(Figure	4-12,	A).	These	
hollow	spots	are	not	beneficial	from	an	overall	(core)	binding	capacity	point	of	view,	as	they	
create	 additional	 internal	 void	 volume	 in	 a	 column.	 However,	 they	 do	 not	 influence	 the	
crafting	of	a	SE	layer	onto	AEC	supports	via	the	AGE	activation-	partial	bromination	route	as	
long	as	they	are	fully	inside	the	support	without	connection	to	the	surface.		
	
Small	crevices/	dents	on	the	surface	of	supports	are	‘swallowed’	by	the	SE	layer	(Figure	4-12,	
B).	As	a	result,	the	layer	thickness	is	locally	slightly	thinner	in	these	creviced	surface	regions.	
However,	 the	 crafted	 layer	 does	 still	 prevent	 pDNA	 adsorption	 and	 the	 impact	 of	 small	
impairments	on	the	surface	can	be	discarded	for	the	manufacturing	process,	as	long	as	their	
depth	is	less	than	the	thickness	of	the	surrounding	shell.	
	
Figure	4-12	AEC-SEC	support	containing	internal	hollow	areas	(A),	small	impairments	that	can	be	ignored	
due	to	the	layer	thickness	(B);	dents	causing	pDNA	binding	(C);	bead	crafted	via	20%	single	step	
bromination,	50%	sucrose	addition	
Left:	Overlay	of	CLSM	channels	(red-	fluorescently	tagged	BSA;	green-	pDNA)		
Right:	Respective	light	microscopic	image	
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Only	when	dents	on	the	surface	are	too	deep	or	too	inaccessible,	pDNA	can	be	found	to	bind	
to	the	support	(Figure	4-12,	C).	
However,	among	such	minor	imperfections,	more	severe	impactions	to	the	particles’	shapes	
arose	concern	as	to	whether	the	applied	bromine	would	reach	within	these	 imperfections.	
Unless	the	bromine	diffuses	into	the	crevices	lining	the	surfaces	of	these	craters,	it	cannot	cut	
the	double	bond	of	AGE	molecules	and	as	a	result,	Q	 ligands	will	subsequently	be	coupled	
onto	the	pores	exposed	to	hidden	away	surfaces.	Not	eliminating	AGE	double	bonds	will	hence	
ultimately	lead	to	pDNA	adsorption	to	the	support	media.		
Light	micrographs	revealed	‘bead-inside-a-bead’	structures,	where	small	particles	are	partially	
submerged	into	the	surface	of	larger	particles.	CLSM	analysis	of	such	a	support	clearly	shows	
how	imperfect	areas	on	the	surface	of	the	beads	bind	pDNA	to	the	support.	
	
	 	
	
Figure	4-13	Z-stack	projection	of	overlaid	CLSM	fluorescent	intensities	(averaged)	orthogonal	to	the	visual	
plane	(51	stacks;	1.5	µm	slice	thickness;	left);	respective	top	view	light	micrograph	of	10%	partially	
brominated	support	(right)	
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Figure	4-13	(left)	shows	a	3D	z-stack	projection,	of	51	cross-sectional	stacks	being	compiled	
into	one	image,	with	the	respective	light	micrograph	given	on	the	right.	The	smooth	surface	
of	the	support	shows	no	pDNA	binding,	as	the	ligand	free	layer	prevents	adsorption.	However,	
pDNA	was	found	to	bind	to	the	surface	of	the	‘bead-inside-a-bead’	structure.	The	bromine	
was	evidently	unable	to	react	with	AGE	groups	tucked	away	from	the	easily	accessible	surface,	
allowing	ligand	coupling	at	the	creviced	surface	of	imperfections.	Plasmid	DNA	in	static	binding	
experiments	 (CLSM)	was	subsequently	able	to	diffuse	 in	between	the	surfaces	and	bind	to	
exposed	 ligands	deep	within	the	grooves,	yielding	retentions	of	at	 least	22.5%	static	pDNA	
binding	capacity	in	comparison	to	fully	Q-coupled	control	media.	
Similar	 effects	 were	 observed	 in	 other	 supports	 with	 smaller	 ‘beads-inside-the-bead’	
imperfections	(Figure	4-14).	
	
Furthermore,	it	appears	that	some	hollow	areas	described	earlier	do	indeed	have	channels	to	
the	surface	of	the	beads.	These	channels	connect	the	surrounding	buffer	with	the	ligands	of	
the	 core	and	allow	pDNA	 to	diffuse	 from	 the	buffer	 solution	 through	 these	 ‘entrances’	 to	
ligands	situated	in	the	core	of	the	particle	(Figure	4-15).	The	3D	projection	of	such	a	support	
confirms	that,	while	the	SE	layer	prevents	pDNA	adsorption	to	the	surface	of	the	bead,	a	small	
opening	on	the	left	side	has	granted	access	to	pDNA	to	bind	to	the	ligands	lining	the	hollow	
areas	inside.	
	
Figure	4-14	Rotated	view	of	3D	projection	of	z-stack	CLSM	images	(36	stacks;	1.5	µm	slice	thickness;	left);	
respective	top	view	light	micrograph	of	10%	partially	brominated	support	(right)	
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Overlaying	CLSM	channels	with	their	respective	light	micrographs	confirms	that	bromination	
eliminates	all	surface	charges	that	are	easily	accessible	to	the	bromine,	while	pDNA	binding	is	
limited	to	the	inside	of	surface	imperfections	(Figure	4-16	).	
	
	
	
	
	
Figure	4-15	Top	view	of	3D	projection	of	z-stack	CLSM	images	(36	stacks;	1.5	µm	slice	thickness;	left);	
respective	top	view	light	micrograph	of	10%	partially	brominated	support	(right)	
	
	
Figure	4-16	Overlay	of	centre	stack	meridian	CLSM	fluorescence	channels	with	light	micrograph	of	bilayered	
chromatography	support	after	double	10+10%	partial	bromination	
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4.3.5.	Quantification	of	misshaped	bead	population	
CLSM	investigation	of	 imperfect	supports	within	the	bulk	of	chromatographic	media	shows	
that	 some	 of	 the	 retention	 of	 pDNA	 binding	 capacity,	 after	 the	 application	 of	 partial	
bromination-	AGE	activation-	ligand	coupling	steps	can	be	attributed	to	imperfect	supports	in	
the	SEC	base	matrix.	
This	raises	concern	about	the	quantitative	extent	of	which	these	imperfect	beads	are	part	of	
the	 overall	 population	 and	 subsequently	 are	 responsible	 for	 residual	 pDNA	 binding	 post	
treatment.	To	assess	the	degree	to	which	the	presence	of	misshaped	supports	within	a	sample	
population	 contribute	 to	 remaining	 pDNA	 binding	 of	 restricted	 access	 media,	 light	
micrographs	of	a	large	population	of	supports	have	been	collected	and	evaluated.	For	each	
analysed	SEC	media	(fully	derivatised	media	based	on	Sepharose	CL-6B	used	as	control	media	
for	 static	 binding	 studies	 and	 CLSM;	 a	 different	 batch	 of	 the	 same	 media;	 10%	 partially	
brominated	supports	(64%	sucrose	addition);	Superose	6;	Superose	12	and	Sepharose	6	FF)	a	
statistically	relevant	sample	size	of	particles	was	imaged	and	grading	of	visual	integrity	of	each	
bead	 was	 performed	 as	 described	 in	 4.2.3.	 Flawless	 supports	 were	 rated	 green,	 minor	
imperfections	(dents/	crevices	on	the	surface)	were	rated	yellow,	while	supports	assumed	to	
grant	pDNA	binding	post	SE	layer	application	were	rated	red	(Figure	4-17	features	example	
supports	of	all	three	categories).	
	
	
Figure	4-17	Grading	categories	of	chromatography	supports	for	their	use	in	VE-RDB	experiments	
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Figure	 4-18	 summarises	 the	 quantitative	 analysis	 of	 light	 microscopic	 images	 taken	 from	
random	sample	populations	of	various	chromatography	media.		
The	shell	thickness	of	successful	VE-RDB	media	are	in	a	range	from	2.5-10	µm	as	confirmed	by	
CLSM	studies.	The	yellow	graded	beads	show	small	imperfections	on	their	surfaces,	that	are	
expected	 to	 be	 fully	 integrated	 into	 the	 SE	 layer	 when	 exposed	 to	 partial	 bromination,	
controlled	by	VE-RDB.	To	determine	whether	a	SEC	media	is	suitable	for	VE-RDB	treatment,	
the	yellow	and	green	populations	can	hence	be	combined	into	one	category	with	regards	to	
expected	pDNA	binding	post	bilayered	chromatography	media	creation.		
The	red	graded	population	is	considered	to	be	responsible	for	residual	pDNA	binding	and	the	
limiting	factor	of	a	base	matrix.		
The	control	group	of	fully	functionalised	supports	and	the	partial	bromination	VE-RDB	sample	
(10%	bromination;	64%	sucrose	addition)	showed	25	and	23%	of	their	respective	populations	
to	have	major	surface	imperfections.	These	imperfect	beads	would	bind	pDNA,	if	used	in	a	
chromatographic	 operation.	 Given	 that	 both	 media	 are	 based	 on	 the	 same	 batch	 of	
	
Figure	4-18	Grading	of	visual	integrity	of	different	chromatography	media	as	part	of	the	bulk	population;	
red:	supports	with	major	surface	imperfections	granting	pDNA	binding	post	SE	layer	application;	yellow:	
minor	impairments	on	the	surface	that	can	be	covered	up	via	the	SE	layer	creation;	green:	spherical	
supports	without	any	flaws	on	the	surface		
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Sepharose	CL-6B,	it	is	not	surprising	that	the	ratings	of	the	visual	integrity	of	both	media	are	
very	similar.		
The	amount	of	red	graded	particles	used	for	VE-RDB	controlled	partial	bromination	studies	is	
however	high	in	comparison	to	other	commercial	SEC	media	such	as	Sepharose	6	FF,	Superose	
6	and	Superose	12	with	9%,	6%	and	2%,	respectively.	Purely	based	on	the	visual	appearance	
of	 the	 supports,	 all	 three	 media	 are	 expected	 to	 yield	 better	 SI	 when	 crafted	 into	 RAM	
following	a	similar	protocol.		
The	population	of	 ‘red’	 supports	 in	 the	second	Sepharose	CL-6B	batch,	was	with	3%,	a	 lot	
smaller	than	the	batch	used	for	crafting	bilayered	media.	This	highlights	the	importance	of	
batch-to-batch	 variations.	 The	main	 function	 of	 the	media	 is	 targeted	 for	 gel	 filtration	 of	
proteins,	peptides,	polynucleotides	and	other	biomolecules	on	a	micro-preparative	scale	(GE	
Healthcare,	2013).	Within	their	field	of	application,	the	media	may	be	performing	according	
to	expectations	and	the	presence	of	imperfect	supports,	as	well	as	the	outlined	batch-to-batch	
variance,	does	not	change	their	chromatographic	performance.		
It	is	therefore	imperative	to	assess	the	quality	of	each	batch	prior	to	its	use	as	base	matrix	in	
a	bottom	up	manufacturing	technique	for	the	creation	of	restricted	access	AEC-SEC	support	
media.	
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4.4.	Conclusion/	suggested	future	work	
Bilayered	AEC-SEC	supports	manufactured	via	partial	bromination	VE-RDB	pathway	comprise	
of	a	thin,	inert	homogeneous	SE	layer,	surrounding	a	positively	charged	core.		
A	novel	CLSM	method	was	developed,	allowing	for	direct	and	simultaneous	visualisation	of	
the	binding	topography	of	both	protein	and	pDNA	binding	to	chromatography	matrices.	
Applying	the	method	to	investigate	bilayered	media,	manufactured	via	AGE	activation-	partial	
bromination	pathway	yielded	that	spherical	RAM	supports	with	smooth	surfaces	are	totally	
inert	to	pDNA	binding	due	to	steric	limitations	(core),	as	well	as	a	lack	of	available	binding	sites	
on	the	surface	due	to	the	inert	shell	surrounding	the	inner	charged	core.		
Respective	 micrographs	 of	 RAM	 media	 revealed	 that	 structurally	 imperfect	 beads	 with	
irregular	surface	properties	occur	within	total	support	populations.	Minor	structural	flaws	on	
the	surface	of	starting	media	do	not	contribute	to	the	residual	pDNA	binding	of	the	media	as	
they	are	overcome	by	the	creation	of	the	ligand-free	zone.	
However,	 large	 surface	 imperfections	 including	macropores,	 deep	 fissures,	 ‘bead-inside-a-
bead’	 structures	 as	well	 as	 deep	 craters,	 create	 areas	 on	 support	 surfaces	 that	 cannot	 be	
accessed	by	bromine	during	the	partial	bromination	step	of	manufacturing.		
This	leads	to	the	creation	of	ligands	on	the	surface	being	exposed	to	the	surrounding	feed.	
Plasmid	DNA	is	unable	to	bind	to	ligands	inside	the	core,	however	it	still	adsorbs	to	surface	
exposed	ligands.	This	effect	overall	accounts	for	residual	surface	binding	capacities	of	at	least	
22.5%	in	comparison	to	a	fully	derivatised	media.	
Quantifying	the	populations	of	these	flawed	beads	in	several	different	chromatography	media	
revealed	that	the	majority	of	residual	static	pDNA	binding	capacity	can	be	attributed	to	the	
presence	 of	 such	 imperfect	 chromatography	 supports.	 The	 amount	 of	 flawed	 supports	 is	
hereby	strongly	dependant	on	the	respective	batch	and	type	of	SEC	starting	media	used.		
While	 on	 a	 laboratory	 scale,	 a	 visual	 inspection/	 sieving	 of	 imperfect	 beads	 would	 be	
conceivable,	it	is	not	a	serious	consideration	for	industrial	production	scale.	This	emphasises	
the	 importance	 of	 starting	media	 selection,	 as	 well	 as	 a	 visual	 batch-to-batch	 analysis	 of	
support	surface	integrity.	
Quantitative	 analysis	 of	 CLSM	 fluorescence	 intensity	 traces	 indicate	 that	 pDNA	 binding	 to	
remaining	 binding	 sites	within	 the	 groves	 of	 imperfections	 are	 elevated	 in	 comparison	 to	
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smooth	 surfaces	 of	 control	media.	 In	 static	 binding	 studies,	 the	 10%	 partially	 brominated	
media	 (64%	 sucrose	 addition)	 showed	 a	 reduction	 of	 77.5%	 pDNA	 binding	 capacity	 in	
comparison	to	the	fully	derivatised	control	sample,	with	23%	of	the	supports	binding	pDNA	
due	to	major	surface	imperfections.		
Matching	of	numbers	may	be	coincidental,	but	given	the	strong	pDNA	fluorescence	within	the	
imperfections	 and	 that	 no	 binding	 was	 observed	 in	 CLSM	 images	 of	 ‘perfect’,	 spherical	
supports,	the	data	suggests	that	the	main	residual	pDNA	binding	can	be	attributed	to	hidden	
areas	on	the	surface	or	within	the	internal	structure	of	supports,	both	caused	by	the	presence	
of	surface	imperfections	in	the	starting	media.	
	
Having	yielded	a	better	understanding	of	the	limitations,	underlying	the	processes	involved	in	
the	manufacturing	 of	 RAM	 via	 the	 AGE-activation,	 partial	 bromination	 route,	 a	 couple	 of	
improvements	are	to	be	considered	when	applying	the	technique	for	future	work.	
To	 avoid	mismatching	 values	 between	 targeted	 bromination	 and	 actual	 reduction	 of	 allyl	
contents,	it	is	suggested	to	base	calculations	for	bromine	addition	on	the	amount	consumed	
within	the	support	sample	(accounting	for	bromine	loss	due	to	hydralisation),	rather	than	on	
the	total	amount	of	AGE	groups	in	the	starting	sample.	
While	single	10%	bromination	left	some	particles	undertreated,	increasing	the	concentration	
to	20%	in	a	single	bromination	step	led	to	directionality	of	layer	expression.	Repeated	10%	
partial	bromination	helped	reduce	directionality	of	layer	expression	on	the	expense	of	core	
binding	capacity,	so	it	stands	to	expect	that	a	repeated	5%	plus	5%	bromination	would	yield	
better	results,	avoiding	the	creation	of	residual	binding	sites	on	support	surfaces	while	at	the	
same	time	compromising	very	little	on	overall	(core)	binding	capacity	and	homogeneity	of	the	
non-adsorptive	layer.	
The	dependence	of	 the	 final	product	on	 the	visual	 integrity	of	 the	 starting	media	 calls	 for	
application	 of	 the	 technique	 to	 use	 ‘better’	 SEC	 resins.	 These	 could	 either	 be	 crafted	 to	
purpose	by	changing	the	existing	production	protocols	in	a	collaboration	with	a	manufacturer	
for	 chromatography	 resins,	 or,	 as	 a	 starting	 point,	 use	 commercial	 resins	 such	 as	
Superose	6/	12,	that	have	fewer	beads	inducing	pDNA	binding	post	treatment	due	to	flawed	
or	imperfect	supports.	
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Some	of	the	outlined	suggestions	have	already	been	incorporated	to	create	AEC-SEC	bilayered	
media,	however	these	further	experiments	exceed	the	scope	of	this	project.		
By	 using	 the	 ‘better’	 base	matrix	 Superose	 6	 over	 the	 ‘more	 flawed’	 Sepharose	 CL-6B,	 SI	
indices	of	up	to	370	could	be	achieved,	confirming	the	conclusions	presented	in	this	study,	
that	 sphericity	 and	 lack	 of	 imperfections	 on	 the	 surface	 of	 agarose	 media	 are	 crucial	
parameters	for	the	production	of	bilayered	SEC-AEC	media	via	the	VE-RDB	approach	(Joseph,	
2018-	in	preparation).	
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Chapter	5 Characterization	of	the	commercial	bilayered	chromatography	
resin	Capto	Core	700	
Abstract	
Since	its	introduction	to	the	commercial	market	in	2012,	Capto	Core	700	has	been	used	for	
the	 intermediate	 purification	 of	 large	 nanoplex	 biomolecules,	 such	 as	 VLPs.	 Although	 the	
manufacturer	suggests	reducing	nucleic	acid	concentrations	in	the	feed	prior	to	loading	it	onto	
a	 column,	 its	 SEC-MMC	bilayered	 architecture	 suggests	 that	 it	 could	 be	 ideal	 for	 negative	
adsorptive	chromatographic	purification	of	pDNA	from	crude	E.	coli	lysates.	
Several	characterization	tools	have	been	applied	to	investigate	pDNA	purification	properties	
of	the	media	from	crude	lysates,	yielding	encouraging	results	for	the	medias	performance	in	
dynamic	chromatography	studies,	where	RNA	and	HCP	were	retained	 in	the	core,	allowing	
larger	(26.88	kbp)	pDNA	molecules	to	flow	through	the	column	unretained.	
However,	in	static	binding	studies,	pDNA	was	found	to	bind	to	remaining	octylamine	ligands	
on	the	‘inert’	surface	of	adsorbents,	especially	after	longer	(>2	h)	incubation	times.	
These	 observations	were	 confirmed	 by	 CLSM	 analysis	 of	 the	 binding	 topography	 of	 single	
supports,	using	Syto	9	and	Cy5	as	fluorescent	markers	for	pDNA	and	BSA,	respectively.	
Applying	a	gentle	cold	atmospheric	pressure,	helium	plasma	etching	treatment	(9	W;	14.5	kHz;	
10	min	treatment	time)	in	a	FBR	set-up	to	Capto	Core	700	was	able	to	reduce	the	pDNA	binding	
capacity	 of	 the	media	 by	 up	 to	 7.7%	 in	 static	 binding	 studies,	 providing	 a	 simple	 add-on	
treatment	to	(further)	reduce	residual	surface	binding	ligands	of	the	media.	
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5.1.	Introduction	
Capto	 Core	 700	 (CC700)	 was	 the	 first	 multifunctional	 chromatography	 resin	 for	 the	
intermediate	purification	and	polishing	of	viruses,	and	other	larger	biomolecules,	for	process	
scale	chromatography,	to	be	introduced	to	the	commercial	market	in	2012	(GE	Healthcare,	
2012).	
The	media	 is	based	on	a	highly	cross-linked	spherical	agarose	stationary	phase	(d~	85	µm)	
functionalised	by	the	‘core	bead	technology’.	The	core	of	the	particles	is	activated	with	the	
MMC	 ligand	 octylamine,	 surrounded	 by	 a	 5	 µm	 layer	 devoid	 of	 ligands.	 The	 outer	 layer	
prevents	large	target	molecules	from	binding	to	ligands,	while	smaller	contaminants	can	enter	
freely	into	the	beads,	where	they	are	being	retained	via	strong	multimodal	interaction	with	
the	stationary	phase.	The	size	cut	off	of	the	agarose	shell	is	700	kDa,	any	molecule	larger	than	
that	will	pass	through	the	column	in	flow	through	mode	(Figure	5-1).	
	
The	media	 is	 available	 in	 different	 packing	 formats	 (GE	 Healthcare,	 2018b):	 prepacked	 as	
HiScreen	 columns	 optimised	 for	 method	 and	 process	 development,	 HiTrap	 columns	 for	
manual	 or	 automated	 purification	 at	 the	 laboratory	 scale	 and	 ReadyToProcess	 as	 beaded	
media	in	various	packaging	sizes.	
	
Figure	5-1	Schematic	representation	of	the	principle	for	CC700.	Large	targets	are	excluded	from	the	beads,	
whereas	smaller	impurities	can	enter	into	the	core	where	they	are	being	captured	by	MMC	ligands	(GE	
Healthcare	Bio-Science,	2012;	Ge	Healthcare,	2018a)	 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Table	5-1	Product	specifications	of	Capto	Core	700	and	Capto	Core	400	as	published	by	the	manufacturer	(Ge	
Healthcare,	2018a,	GE	Healthcare,	2018b)	
Parameter	 Capto	Core	700	 Capto	Core	400	
Ligand	 Octylamine	 Octylamine	
Particle	size,	d50v	 ~90	µm	 90	µm	
Matrix	 Highly	cross-linked	agarose	 Highly	cross-linked	agarose	
Binding	capacity/mL	
chromatography	medium	
~13	mg	ovalbumin	 22	mg	ovalbumin	
pH	stability	(operational)	 3-13	 3-13	
pH	stability	(CIP)	 2-14	 3-14	
Flow	velocity	 <500	cm/h	 700	cm/h	
Molecular	weight	cut-off	 ~700	kDa	 400	kDa	
	
In	2018,	Capto	Core	400	was	introduced	to	the	market.	The	media	has	a	smaller	size	cut-off	of	
400	kDa	and	resembles	CC700	in	most	other	specifications	(Table	5-1). 
Mixed	mode	chromatography	is	based	on	a	stationary	phase	that	interacts	with	solutes	via	
more	 than	 one	 mode	 of	 interaction	 (Yang	 et	 al.,	 2011).	 Octylamine	 interacts	 with	 small	
contaminants	(HCP,	Endotoxins,	etc.)	based	on	two	methods;	positive	groups	in	conjuncture	
with	a	hydrophobic	nature	(Cunha	et	al.,	2016).	The	recommended	application	of	CC700	as	a	
negative	chromatography	resin	to	capture	only	impurities,	renders	the	structural	integrity	of	
contaminants	 unimportant.	 This	 is	 crucial	 given	 the	 vigorous	 elution	 conditions	 that	 are	
necessary	to	reverse	the	ligands	strong	interactions	post	loading.	
Since	 its	release,	CC700	media	has	been	successfully	used	 in	various	DSP	strategies	for	the	
production	 of	 VLPs	 (Nestola	 et	 al.,	 2015;	 Zhao	 et	 al.,	 2015;	 Lagoutte	 et	 al.,	 2016;	
Somasundaram	et	al.,	2016),	nanoparticles	(He	et	al.,	2016),	virus	purification	(Weigel	et	al.,	
2014;	James	et	al.,	2016;	Lee	et	al.,	2016;	Mundle	et	al.,	2016;	Shen	et	al.,	2016;	Tseng	et	al.,	
2018),	capsular	polysaccharides	(Ji	et	al.,	2014),	extracellular	vesicles	(Corso	et	al.,	2017)	and	
secretory	immunoglobulins	(Matlschweiger	et	al.,	2017). Furthermore,	it	is	part	of	patented	
endotoxin	removal	strategies	(Adielsson	et	al.,	2018)	and	von-Willebrand-Factor	purification	
(Schroeder,	2016). 
The	 route	 of	 manufacturing	 of	 CC700	 is	 proprietary,	 however	 several	 patents	 suggest	 a	
manufacturing	 process	 based	 on	 chemical	 build-up	 of	 functionality	 within	 porous	 soft	
hydrogel	beads	(‘bottom-up’	approach)	involving	AGE-activation	partial	bromination,	similar		
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to	the	process	described	in	Chapter	4	(Bergstrom,	1997;	Berg,	2003;	Gustavsson	et	al.,	2004;	
Maloisel	et	al.,	2016;	Hall	et	al.,	2018).	Although	the	manufacturer	advertises	further	bilayered	
chromatography	media	with	different	pore	sizes/	particle	size	distribution	(PSD),	as	well	as	
tailoring	ligands	to	specific	binding	properties	to	satisfy	operational	demands	can	be	achieved	
(Figure	5-2),	only	the	two	aforementioned	multifunctional	bilayered	chromatography	resins	
have	been	released	to	date	(Glaser,	2013;	Maloisel	et	al.,	2016;	GE	Healthcare,	2018c).	
In	 this	 chapter,	options	 for	 the	purification	of	pDNA	 from	crude	E.	 coli	 feedstocks	utilizing	
CC700	have	been	explored.	Several	visualisation	techniques	have	been	employed	to	analyse	
the	bilayered	media	and	its	limitations	for	pDNA	applications.		
Figure	5-2	Different	designs	of	bilayered	chromatography	resins,	featuring	different	size	cut-offs	as	well	as	
ligands	tailored	for	specific	modes	of	interaction	(image	source:	(GE	Healthcare	Life	Sciences,	2012))	
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Cold	atmospheric	pressure	plasma	 treatment	 in	a	FBR,	 for	 the	 functionalisation	of	beaded	
hydrogel	 chromatography	 media	 has	 been	 explored	 to	 provide	 an	 add-on	 treatment,	
attempting	to	enhance	plasmid	yield.	
5.2.	Materials	and	Methods	
Several	experimental	methods	applied	in	this	chapter	have	been	utilised	in	different	sections	
of	this	work.	To	avoid	describing	methods	that	found	application	in	more	than	one	chapter	of	
this	thesis,	a	collection	of	‘general’	M&M	as	well	as	a	conclusive	list	of	materials	used	for	their	
implementation	can	be	found	in	the	respective	sections	of	this	thesis	(Chapter	2).	
Methods	 related	 to	 experiments	 that	 are	 exclusive	 to	 this	 chapter	 are	 presented	 below.	
Experiments	that	deviate	from	the	outlined	methods	are	provided	in	the	respective	sections	
or	where	additional	information	is	required	for	better	understanding.	
5.2.1.	Column	packing	and	frontal	loading	column	chromatography	for	purification	of	
pDNA	from	crude	E.	coli	lysates	
All	 column	chromatography	was	performed	at	 room	temperature	on	an	Äkta	Explorer	100	
system	controlled	by	UNICORN	Software	(version	4.11;	GE	Healthcare,	Uppsala,	Sweden).		
Capto	Core	700	was	packed	into	a	Tricorn	5/50	column	to	a	final	bed	height	of	5	cm	(1	mL	SBV	
total;	settling	beads	at	0.1	mL/min	for	60	min;	column	compacted	at	1	mL/min	for	10	min	
using	MQW).	
The	column	was	then	washed	and	equilibrated	(0.1	mL/min)	with	5	CV	of	Buffer	A.	Buffer	A	
was	prepared	as	follows;	36	mL	of	10	mM	Tris-HCl;	pH	8	containing	61	mM	glucose	and	50	mM	
EDTA	were	mixed	with	78	mL	of	0.2	M	NaOH	containing	1%	SDS;	the	solution	was	mixed	with	
59	mL	of	3	M	potassium	acetate	(4°C);	pH	5.5	and	the	final	solution	was	sterile	filtered	with	a	
Millex	 syringe	 filter	 unit	 (Millipore,	 Sigma)	 and	 adjusted	 to	 a	 conductivity	 of	 33	 mS/cm,	
mimicking	the	composition	of	clarified,	neutralized	alkaline	E.	coli	lysate.		
The	lysate	obtained	in	2.3.3	was	diluted	with	MQW	to	a	conductivity	of	33	mS/cm	before	it	
was	loaded	onto	the	column	using	a	P-960	sample	pump	(flow	rate	0.1	mL/min;	80	mL	total	
loading	volume).	After	the	loading	of	the	column,	it	was	washed	with	4	CV	Buffer	A	before	
elution	of	bound	species	using	a	gradient	salt	elution	of	20	CV	(2	M	NaCl;	1	mM	EDTA;	25	mM	
Tris–HCl;	pH	8).	The	system	was	stripped	with	25	CV	of	stripping	buffer	(0.2	M	NaOH;	2	M	NaCl	
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solution).	 Throughout	 chromatography	 runs,	 UV260,	 UV280	 absorbance	 as	 well	 as	 pH	 and	
conductivity	 were	 monitored,	 and	 5	 mL	 fractions	 were	 collected	 for	 subsequent	 NA	
quantification	via	DPA	and	Orcinol	assay	as	well	as	gel	electrophoresis.	
5.2.2.	Static	RNA	binding	studies	for	optimisation	of	elution	conditions		
CC700	media	was	washed	twice	in	MQW	and	equilibrated	in	a	buffer	resembling	the	loading	
buffer	 of	 frontal	 chromatographic	 experiments.	 The	 beaded	 supports	 (75	 µl	 SBV)	 were	
incubated	with	1.5	mL	of	0.5	mg/mL	baker’s	yeast	RNA	(S.	cerevisiae)	for	30	min	on	a	blood	
tube	 rotator.	 The	 suspension	 was	 subsequently	 centrifuged	 (2,000	 g;	 10	 s)	 and	 the	
supernatant	carefully	pipetted	out.	The	samples	were	then	incubated	with	1.5	mL	of	various	
elution	buffers	for	30	min,	centrifuged	and	the	supernatant	and	the	supports	were	analysed	
separately	for	their	RNA	contents	via	Orcinol	assay.		
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5.3.	Results	and	Discussion	
5.3.1.	Frontal	loading	chromatography	for	purification	of	a	26.88	kbp	plasmid	from	
cleared	E.	coli	feedstock	
CC700	 aims	 at	 the	 intermediate	 purification	 of	 viruses	 and	 other	 large	 biomolecules.	 The	
manufacturer	suggests	to	reduce	the	amount	of	NA	in	the	feedstock	as	“high	levels	of	DNA	
and	RNA	can,	in	some	cases	impair	the	performance	of	CC700”	(GE	Healthcare,	2012).	
The	shell	of	 the	beaded	media	 is,	according	to	the	manufacturer,	devoid	of	 ligands	on	the	
outside	of	the	particles	and	is	permeable	only	by	moieties	<700	kDa,	such	as	RNA	or	HCP	(GE	
Healthcare,	2018b).	These	properties	should	make	the	media	ideal	for	capturing	pDNA	from	
crude	E.	 coli	 feedstocks,	 if	 the	 plasmid	 is	 large	 enough	 to	 not	 enter	 and	 bind	 to	 the	 core	
alongside	contaminants	in	the	lysate,	such	as	RNA	and	HCP.	
The	 size	 of	 plasmid	 IT14:	 pPR322-p170	 is	 26.88	 kbp	 (16.49	MDa	 (GSL	 Biotech	 LLC,	 2004;	
Bioinformatics,	2017)).	NA	and	protein	weights	are	not	directly	comparable	and	hydrodynamic	
radii	of	pDNA	molecules	and	proteins	of	equal	MW	will	be	slightly	different	due	to	differences	
in	density	and	conformation. 
However,	the	plasmid	is	more	than	20	times	larger	than	the	size	cut-off	of	the	media	and	the	
inert	SEC	shell	should	prevent	pDNA	molecules	from	penetrating	through	the	shell	and	elute	
in	the	flow	through	fraction	of	a	chromatographic	operation.	With	a	size	cut-off	of	700	kDa,	it	
is	unclear	what	the	manufacturers	concerns	about	high	NA	concentrations	in	feedstocks	may	
be. 
The	 high	 copy	 number	 plasmid	 IT14	 was	 introduced	 into	 potent	 E.	 coli	 DH5α	 cells	 and	
fermented	as	described	in	2.3.1	and	2.3.2.	Cells	were	subsequently	disrupted	via	alkaline	cell	
lysis	and	genomic	DNA	and	cell	debris	were	removed	by	centrifugation	(2.3.3).	The	resulting	
cell	lysate	was	adjusted	to	33	mS/cm	and	loaded	onto	a	1	mL	SBV	CC700	column	(5.2.1).	After	
loading	80	mL	of	lysate	onto	the	column,	a	salt	gradient	was	used	to	elute	bound	moieties	
from	the	core	of	the	supports	(1	M	NaCl;	25	mM	Tris-HCl;	1	mM	EDTA).	
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Looking	 at	 the	 gel	 electrophoresis	 image	 of	 the	 chromatographic	 fractions,	 several	 points	
stand	 out;	 the	 absence	 of	 RNA	molecules	 in	 loading	 fractions	 indicate	 that	 breakthrough	
capacity	of	the	core	 is	not	reached	after	 loading	80	mL	of	cleared	 lysate	on	to	the	column	
(Figure	5-3,	top).	Furthermore,	pDNA	did	elute	in	the	flow	through	during	the	loading	phase	
without	interacting	with	the	media,	with	fractions	L2-L16	resembling	the	pDNA	contents	of	
the	cleared	lysate	(CL).	However,	small	amounts	of	pDNA	show	up	in	the	elution/	stripping	
fractions.	These	small	amounts	of	pDNA	correlate	with	the	first	loading	fraction	(L1),	showing	
a	reduced	amount	of	pDNA,	suggesting	that	small	amounts	of	pDNA	can	in	fact	interact	with	
	
	
Figure	5-3	Top:	Agarose	gel	electrophoresis	of	obtained	chromatographic	fractions;	M:	Lambda-	HinDIII	
marker;	CL:	cleared	lysate	(control);	L1-L16:	cleared	lysate	led	through	the	column;	W:	wash;	E1-E8:	elution	
fractions;	S:	strip;	Fraction	size	5	CV;	conductivity	33	mS/cm;	linear	flow	rate	6	mL/h	
Bottom:	Chromatograms	of	loading	cleared	E.	Coli	lysate	onto	1	mL	SBV	CC700,	dashed	line:	A280,	solid	line:	
A260	(left);	respective	chemical	quantification	of	NA	contents	in	the	elution	fractions	(right)	
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the	media	during	initial	stages,	until	binding	areas	have	been	quenched	and	subsequent	pDNA	
flows	through	the	column	without	interacting	with	the	media.	
Residual	 binding	 of	NA	 to	 the	media	 after	 elution	 suggests	 that	NA,	 bound	 to	 octylamine	
ligands,	 cannot	 be	 eluted	 by	 enhancing	 the	 ionic	 strength	 alone,	 as	 is	 customary	 for	 AEC	
operations	 (Prazeres	 et	 al.,	 1998;	 Ferreira	 et	 al.,	 2000a;	 Pitarresi	 et	 al.,	 2004).	 The	 mass	
balance	for	pDNA	and	RNA	furthermore	suggests	that	even	after	stripping	the	column	with	
2	M	NaCl	and	0.5	M	NaOH,	some	NA	moieties	are	still	tightly	bound	to	the	core	of	the	media.	
Overall,	 CC700	 is	 suitable	 as	 an	 initial	 purification	 step	 for	 capturing	 pDNA	 in	 negative	
chromatography	mode	from	typical	contaminants.	A	small	compromise	of	yield	was	observed	
as	a	result	of	initial	interactions	of	small	amounts	of	pDNA	with	the	media.	However,	elution	
conditions	as	well	as	applied	CIP	regimes	are	in	need	of	optimisation	to	regenerate	the	column	
for	a	sustainable	process.	
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5.3.1.1.	Optimisation	of	elution	conditions	for	clearing	bound	nucleic	acids	from	Capto	Core	
700	
Elution	of	bound	NA	post	stripping	of	a	1	mL	SBV	column	of	CC700	after	loading	cleared	E.	coli	
lysate	 containing	 a	 26.88	 kbp	plasmid,	 via	 an	 applied	 salt	 gradient	 leaves	 residual	NA	 still	
bound	to	the	media.	Enhancing	the	salt	concentration	from	1	M	to	2	M	was	insufficient	to	
clear	out	 and	 sanitise	 the	media	 for	 future	applications,	 although	 small	 amounts	of	pDNA	
could	be	eluted	using	2	M	NaCl	(Figure	5-4).	
	
Isopropanol	 has	 been	 described	 as	 a	 suitable	 eluent	 in	 HIC	 by	 weakening	 hydrophobic	
interactions	 (Tseng	et	al.,	2005;	Shukla	et	al.,	2007).	However,	applying	a	10%	 isopropanol	
gradient	elution	did	not	weaken	the	binding	interactions	of	RNA	to	CC700	enough	to	clear	the	
core	of	the	beads	(Figure	5-5	,	A).	The	multimodal	octylamine	ligand	combines	properties	of	
both	traditional	AEC	and	HIC.	Preparation	of	an	elution	buffer	combining	both	 isopropanol	
and	salt	was	shown	to	be	effective	in	stripping	bound	molecules	from	Quiagen	AEC	columns	
and	showed	promising	results	for	application	with	CC700,	by	eluting	a	large	peak	of	RNA	from	
	
Figure	5-4	Chromatograms	of	loading	cleared	E.	Coli	lysate	onto	1	mL	SBV	CC700,	dashed	line:	A280,	solid	
line:	A260	(left);	respective	chemical	quantification	of	NA	contents	in	the	elution	fractions	(right)	
A:	1	m	NaCl	elution	buffer	
B:	2	M	NaCl	elution	buffer	
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the	 column	 (Figure	 5-5	 ,	 B;	 (Budelier	 et	 al.,	 1998)).	 The	 chaotropic	 agent	 guanidine	
hydrochloride	is	routinely	used	as	an	additive	to	elution	buffer	preparations	for	the	removal	
of	lipids	and	proteins	from	chromatography	resins.	The	moieties	disrupt	the	hydrogen	bonds,	
responsible	 for	 stabilising	bound	molecules	by	weakening	 the	hydrophobic	effect	and	as	a	
consequence	 enhance	 solubility	 of	 hydrophobic	 molecules.	 At	 higher	 concentrations	
however,	protein	structures	are	fully	denatured	and	consequently	reduce	the	dynamic	binding	
capacity	of	AEC	columns	 (Ng	et	al.,	2007;	Ge	Healthcare	Bio-Science,	2013).	Application	of	
1	M	guanidine	hydrochloride	(GuHCl)	in	conjuncture	with	1	M	NaCl	for	removal	of	bound	NA	
to	CC700	however,	did	not	yield	any	RNA	elution	from	the	column	(Figure	5-5	,	C).	
	
	
Figure	5-5	Chromatograms	of	loading	cleared	E.	Coli	lysate	onto	1	mL	SBV	CC700,	dashed	line:	A280,	solid	
line:	A260	(left);	respective	chemical	quantification	of	NA	contents	in	the	elution	fractions	(right);	A:	10%	
Isopropanol	as	elution	buffer;	B	15%	Isopropanol	with	1.25	M	NaCl	elution	buffer	C:	1	M	Guanidine	HCl	with	
1	M	NaCl	elution	buffer	
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Further	elution	buffer	conditions	were	investigated	by	loading	CC700	media	with	baker’s	yeast	
RNA	in	static	binding	studies	as	described	in	5.2.2.	
Three	 different	 groups	 of	 elution	 buffers	 were	 analysed,	 (i)	 focussing	 on	 different	
concentrations	 of	 NaOH	 and	 isopropanol	 (Biosciences,	 2001;	 Blom	 et	 al.,	 2014),		
(ii)	combinations	of	NaCl	and	Isopropanol,	and	(iii)	stripping	buffer	(2	M	NaCl;	0.5	M	NaOH).	
All	buffer	preparations	from	the	first	group	performed	very	similarly,	eluting	around	80%	of	
bound	 RNA	 (incubation	 time	 30	 min).	 Formulations	 containing	 high	 concentrations	 of	
isopropanol	(30%)	in	conjuncture	with	1.25	M	NaCl	as	well	as	the	high	salt	(2	M)	buffer	with	
15%	isopropanol	proved	the	most	suitable,	eluting	all	RNA	from	the	core.	
Given	the	high	elution	values	for	all	buffer	preparations	in	comparison	to	the	frontal	loading	
experiments,	this	suggests	that	incubation	time	of	the	media	with	elution	buffer	plays	a	pivotal	
role	when	attempting	to	clear	out	bound	moieties	adsorbed	to	CC700,	which	is	in	accordance	
with	the	manufacturers	suggestions	(GE	Healthcare	Bio-Science,	2012).		
	
Difficulties	to	clean	the	media	after	chromatographic	operations	could	be	the	reason	why	a	
reduction	 of	 NA	 concentrations	 prior	 to	 the	 application	 of	 cleared	 lysate	 to	 CC700	 was	
recommended.	
	
Figure	5-6	Elution	of	baker’s	yeast	RNA	from	CC700	obtained	from	supernatants	in	static	binding	studies	
with	different	elution	buffers;	%Eluted	RNA	based	on	loading	RNA	
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Attempts	 to	 determine	 the	 residual	 RNA	 contents	 still	 bound	 to	 CC700	 after	 elution,	 via	
Orcinol	assay	proved	unsuitable,	as	chemical	reactions	with	the	base	matrix	during	sample	
incubation	 caused	 sample	 discoloration,	 preventing	 spectrophotometric	 analysis	 of	 the	
supernatants	(Figure	5-7).	
	
5.3.2.	Visualization	and	characterization	of	bilayered	architecture		
5.3.2.1.	Environmental	Scanning	Electron	Microscopic	analysis	and	particle	size	distribution	
of	Capto	Core	700	
To	 analyse	 the	 visual	 integrity	 of	 CC700,	 ESEM	 images	 of	 the	 media	 were	 recorded	 as	
described	in	2.3.11.1.	As	sample	preparation	for	ESEM	via	freeze	drying	was	reported	to	cause	
bead	disruption	to	the	visual	integrity	of	chromatography	resins,	the	sample	supports	were	
dehydrated	in	ethanol	followed	by	critical	point	drying	(Nweke	et	al.,	2016).	
Particle	size	distribution	data	was	recorded	on	a	Mastersizer	2000	as	described	in	2.3.13.	The	
refractive	 index	of	 the	media	was	estimated	at	1.43	 resembling	 the	value	of	pure	agarose	
(following	manufacturers	suggestions).	
	
Figure	5-7	Discoloration	of	Orcinol	sample	after	resuspension	of	20	µL	SBV	CC700	in	200	µL	of	MQW,	
followed	by	incubation	with	working	reagent	at	95°C	for	20	min	and	centrifuged	at	14,000	rpm;	elution	
buffer:	1.25	M	NaCl,	30%	isopropanol	(left)	and	MQW	(right)	
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Unlike	 other	 beaded	 chromatography	 media	 (see	 Chapter	 3	 for	 ESEM	 illustrations	 of	 Q	
Sepharose	FF),	the	surfaces	of	the	supports	are	very	smooth	without	macropores	leading	into	
the	internal	structure	of	the	beads	(Figure	5-8).	Furthermore,	the	vast	majority	of	beads	are	
spherical	with	very	few	‘misshaped’	beads	in	the	population	suggesting	that	a	lot	of	care	was	
taken	during	the	manufacturing	process	of	the	Capto	base	matrix.	The	split	shell,	that	can	be	
observed	in	some	particles	(Figure	5-8,	bottom	left	&	right),	reveal	the	core	structure	of	the	
media.	 The	 patterns	 give	 the	 impression	 to	 be	 due	 to	 mechanical	 disruption	 of	 support	
surfaces	rather	than	originating	from	the	production	process	of	the	agarose	base	matrix.	
Overview	images	(Figure	5-8,	top	left/	middle)	show	that	support	particles	are	of	very	similar	
size,	which	was	confirmed	by	PSD	analysis	(Figure	5-9).	The	population	has	a	volumetric	span	
of	0.792,	corresponding	to	a	very	narrow	and	homogenous	PSD	(compared	to	other	beaded	
chromatographic	 media:	 spanQ	 Sepharose	 FF=	 0.995;	 spanSepharose	 6	 FF=	 1.032;	
spanSepharose	CL	6B=	1.054).		
	
	 	 	 	 	 𝑠𝑝𝑎𝑛 =  ,N. ^(,N.)(,N.T) 	 	 	 	 	
	
With	a	volume	weighted	mean	of	D[4,3]	=	86.95	µm,	the	results	confirm	the	manufacturers	
specification	 of	 the	media	 (cumulative	 volumetric	mean	 d[50V]	 =	 83.3	µm	vs	 ‘~90	µm’	 (GE	
Healthcare,	2012)	or	‘~85	µm’	(GE	Healthcare,	2018c)).		
	
Figure	5-8	Scanning	electron	micrographs	of	Capto	Core	700	media	at	different	magnifications	
	 -	193	-	
	
	 	
	
Figure	5-9	Particle	size	distribution	functions	of	Capto	Core	700;	left:	integral	step	distribution;	right:	size	
distribution;	solid	line-	volumetric;	dash-dotted	line-	surface	weighted;	dotted	line-	number	weighted	
distribution	
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5.3.2.2.	Light	microscopic	analysis	
Illustrations	 of	 the	 working	 principle	 of	 the	 ‘core	 bead	 technology’	 depict	 the	 shell	 of	 a	
different	 composition	 than	 the	 core.	 However,	 light	 microscopic	 images	 (Figure	 5-10,	 A)	
suggest	that	the	supports	are	of	homogenous	composition	as	no	change	in	refractive	index	at	
the	interface	between	core	and	shell	can	be	observed.	However,	the	applied	optical	tools	may	
not	 be	 able	 to	 showcase	 a	 solid-solid	 interface	 with	 refractive	 indices	 being	 very	 similar	
(typical	agarose	concentrations	of	agarose	supports	range	from	4-6%,	with	refractive	indices	
of	1.3325	and	1.42	for	water	and	agarose	respectively	(Hale	et	al.,	1973;	Deane,	2013)).	
Due	to	the	multimodal	nature	of	the	octylamine	ligand,	dye	molecules	willingly	bind	to	the	
core	of	CC700,	highlighting	the	demarked	zone	devoid	of	ligands	in	the	shell	(Figure	5-10,	B	&	
C).	The	shell	thickness	of	supports	is	between	5-10	µm.	A	thin	shell	is	preferable	for	bilayered	
chromatography	media	 to	 compromise	 as	 little	 as	 possible	 on	 core	 binding	 capacity.	 The	
manufacturer	states	static	protein	(ovalbumin)	binding	capacities	of	around	20	mg/mL	SBV	
(GE	Healthcare,	2012),	which	is	low	compared	to	AEC	media	with	binding	capacities	more	than	
two-three	times	higher	(static	BSA	binding	capacity	was	slightly	higher	with	around	30	mg/mL;	
see	Appendix	A-6	for	BSA	binding	isotherm	of	CC700).	
As	already	observed	in	the	ESEM	images,	a	small	fraction	of	the	support	population	present	
deviations	in	their	visual	appearance,	compared	to	the	bulk	of	the	media.	
	
Visual	grading	of	CC700	media	and	quantification	of	disfigured	supports	as	part	of	a	 larger	
population	 was	 conducted	 as	 described	 in	 4.2.3.	 Figure	 5-11	 depicts	 the	 prevalence	 of	
misshaped	supports	in	CC700.	Overall	the	media	has	outstanding	sphericity	with	only	2.6%	of	
the	supports	showing	major	imperfections	on	their	surfaces	and	very	little	binding	of	pDNA	to	
surface	exposed	ligands	is	to	be	expected,	which	is	in	accordance	with	the	chromatographic	
data	(5.3.1.	).		
	
Figure	5-10	Light	micrograph	of	single	CC700	supports;	A:	in	MQW;	B&C:	core	stained	with	CR	
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5.3.2.3.	CSLM	analysis	of	CC700	beads		
BSA	is,	at	66.5	kDa	small	enough	to	pass	through	the	pores	in	the	shell	of	CC700.	To	visualise	
the	 binding	 behaviour	 and	 spatial	 distribution	 of	 protein	 binding	 in	 CC700,	 BSA	 was	
fluorescently	 tagged	with	CY-5	as	described	 in	2.3.12,	and	 loaded	onto	CC700	 followed	by	
CLSM	analysis.	
The	fluorescence	signals	in	Figure	5-12	confirm	that	BSA	binding	is	limited	to	the	core,	while	
the	 ligand-free	 shell	 surrounding	 the	 charged	 core	 being	 visible	 in	 the	 respective	 light	
micrographs.	
The	thickness	of	the	shell	structure	varies	slightly	across	supports	ranging	from	around	5	µm	
up	to	15	µm.	The	ligands	are	evenly	distributed	inside	the	support,	forming	structures,	with	
slightly	different	degrees	of	sphericity	inside	the	supports.		
ESEM	analysis	of	CC700	media	suggested,	that	misshaped	beads	may	be	able	to	bind	pDNA	by	
circumventing	the	size	cut-off	of	the	shell	via	direct	exposure	of	ligands	within	the	core	to	the	
surrounding	buffer.	
	
	
Figure	5-11	Visual	grading	and	quantification	of	CC700	media	as	part	of	total	population;	red:	supports	with	
major	surface	imperfections	(presumably)	granting	pDNA	binding;	yellow:	minor	surface	impairments;	
green:	spherical	supports	without	any	flaws	on	the	surface;	total	number	of	beads	analysed:	729	
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Analysing	whether	 pDNA	 could	 potentially	 bind	 to	 irregularly	 shaped	 supports,	 CLSM	was	
employed	 to	 trace	 both	 tagged	 BSA	 and	 pDNA	 in	 a	 single	
support	(Figure	5-14).	Against	expectations,	the	entire	support	
was	 surrounded	 by	 a	 thin	 green	 halo	 correlating	 to	 the	
fluorescence	signal	of	tagged	pDNA	molecules.	Although	the	
size	 cut-off	 has	 prevented	 pDNA	 to	 penetrate	 through	 the	
pores	on	the	surface,	pDNA	evidently	was	able	to	bind	to	the	
surface	of	the	media.	
Lowering	 the	 fluorescence	 threshold/	 adjusting	 the	 look	 up	
table	(LUT)	of	images	from	Figure	5-12	does	suggest	miniscule	
binding	 of	 tagged	 BSA	 within	 the	 ‘ligand-free’	 zone	
surrounding	 the	 core	 (Figure	 5-13).	 This	 faint	 glow	may	 result	 from	 unspecific	 binding	 or	
indicate	the	presence	of	very	low	amounts	of	ligands	in	the	shell.	The	strong	negative	charge	
of	 the	 sugar	 phosphate	 backbone	 of	 NA	 could,	 in	 conjuncture	 with	 minor	 amounts	 of	
octylamine	ligand	on	bead	surfaces,	explain	the	presence	of	pDNA	on	the	surface	of	CC700	
supports	(no	penetration	of	pDNA	into	the	shell	due	to	pore	size	restrictions).	
	
Figure	5-12	CLSM	analysis	of	CC700	media	incubated	with	CY-5	tagged	BSA	(top);	respective	light	
micrographs	of	single	supports	(bottom)	
	
	
Figure	5-13	LUT/	threshold	
adjusted	CLSM	image	of	CC700,	
suggesting	ligand	presence	in	
the	demarked	shell	zone	
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The	3D	projection	in	Figure	5-14,	E	showcases	the	structure	of	CC700,	the	pDNA	highlights	the	
brim	of	the	support,	while	(separated	by	the	shell)	the	BSA	reveals	the	underlying	stationary	
matrix	lined	with	ligands.	
To	 investigate	 the	 ‘binding’	 of	 pDNA	 to	 the	 surface	 of	 CC700	 supports,	 the	 media	 was	
incubated	with	Syto9	tagged	pDNA	solution	for	various	lengths	of	time.	
5.3.3.	CLSM	analysis	of	pDNA	creeping	into	the	shell	of	Capto	Core	700	over	time	
Feeding	 cleared	 E.	 coli	 lysate	 onto	 a	 CC700	 column	 in	 frontal	 loading	 chromatography	
experiments	have	suggested	that	the	architecture	of	CC700	is	not	truly	inert	to	pDNA	binding.	
Furthermore,	 CLSM	 images	 of	 CC700	 supports	 incubated	 with	 fluorescently	 tagged	 pDNA	
revealed	that	pDNA	was	able	to	bind	to	the	surface	of	the	supports	when	given	enough	contact	
time.	
	
Figure	5-14	CLSM	analysis	of	CC700	media	post	incubation	with	tagged	CY-5	tagged	BSA	and	Syto9	tagged	
pDNA;	BSA	fluorescence	channel	(A);	pDNA	Fluorescence	channel	(B);	overlay	of	both	channels	(C);	
respective	light	micrograph	(D);	3D	stack	projection	of	fluorescence	signals	(E)	
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To	investigate	this	‘creeping’	over	time,	CC700	media	was	incubated	with	Syto	9	tagged	pDNA	
solution,	 followed	by	 incubation	with	 CY	 5	 tagged	BSA	 to	 visualise	 the	 shell	 region	 of	 the	
supports.	
With	a	size	cut-off	of	700	kDa,	IT14:	pPR322-p170	(26.88	kbp)	should	not	be	able	to	diffuse	
through	the	inactive	shell	of	CC700	due	to	size	limitations	(Ljunglof	et	al.,	1999;	Gustavsson	et	
al.,	2004;	GE	Healthcare	Bio-Science,	2012).		
The	green	pDNA	‘binding	halo’,	surrounding	the	supports	in	Figure	5-15	does	however	confirm	
that	despite	their	large	size,	pDNA	molecules	do	bind	at	surface	of	the	supports.	This	suggests	
either	(i)	the	presence	of	a	small	amount	of	octylamine	ligands	within	the	inactive	shell	of	the	
media,	or	(ii)	the	presence	of	macropores	with	sizes	>700	Da.	
The	molecular	weight	of	proteins	is	dependent	on	their	amino	acid	composition,	as	well	as	
other	factors.	The	size	cut	off	of	700	kDa	for	the	outer	shell	of	CC700	correlates	to	proteins	of	
around	5850	amino	acid	residues	(120	g/mol)	and	a	hydrodynamic	radius	of	around	8-12	nm	
(Tyn	et	al.,	1990;	CalcTool,	2008).		
Several	 attempts	 have	 been	 made	 to	 explain	 pDNA	 permeation	 through	 nanopores	 in	
membranes	 via	 expanded	 plasmid	 elasticity	 (Ager	 et	 al.,	 2009;	 Latulippe	 et	 al.,	 2009;	
Arkhangelsky	et	al.,	2011).	Although	the	reasons	for	transport	are	still	not	entirely	explained,	
it	was	 found	that	plasmids	of	380	nm	diameter	can	penetrate	through	pores	as	narrow	as	
10	nm	under	hydrodynamic	pressure	(Arkhangelsky	et	al.,	2008).		
To	 confirm	 that	 the	observed	effect	 is	 due	 to	pDNA	binding	 and	not	 a	 result	 of	 artefacts,	
caused	 by	 Syto-9,	 bound	 to	 pDNA	molecules;	 CC700	media	was	 incubated	 overnight	with	
pDNA	solution	(50	µL	SBV	with	1	mL	of	15	µg/mL	pDNA	solution).	After	washing	the	supports	
three	times	in	MQW	and	buffering	in	TE	buffer,	the	suspension	was	mixed	with	5	µL	of	5	µM	
Syto-9	solution	(serially	diluted	from	DMSO	stock	in	MQW;	same	dye/bp	ratio	as	CLSM)	and	
CLSM	images	were	taken	as	described	in	2.3.12.	
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Figure	5-15	pDNA	diffusion	into	the	shell	of	CC	700	over	time;	left:	overlay	of	CLSM	channels	for	tagged	BSA	
(red)	and	pDNA	binding	(green);	middle:	respective	light	micrograph	of	the	support;	right:	plotted	intensity	
traces	along	an	125x	1	µm	ROI	(dotted	line)	and	125x	5	µm	ROI	(solid	line);	After	10	min	(A),	30	min	(B),	
60	min	(C),	120	min	(D)	and	overnight	incubation	(E)	
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The	green	halo	surrounding	the	support	in	Figure	5-16	confirms	that	pDNA	binding	to	the	shell	
of	CC700	is	independent	of	fluorophores	tagged	onto	pDNA	prior	to	static	binding	studies.	
Incubating	the	SEC	media	Sepharose	6	FF	with	pDNA	solution	in	the	same	way	revealed	that	
the	concentration	of	pDNA	in	the	supernatant	did	not	diminish	over	time	(Figure	5-17,	left).	
Unlike	the	penetration	of	pDNA	into	the	shell	of	CC700,	CLSM	confirms	that	no	pDNA	diffuses	
into	the	outer	regions	of	Sepharose	6	FF	supports	(Figure	5-17,	middle/	right).	
After	 incubating	CC700	supports	with	BSA	prior	to	pDNA,	 in	order	to	allow	smaller	protein	
molecules	to	quench	residual	octylamine	ligands	within	the	shell	of	the	supports,	the	pDNA	
binding	halo	 can	 still	 be	observed,	 suggesting	 that	 stronger	 interactions	of	pDNA	with	 the	
ligands	compete	with	and	supplant	the	BSA	molecules.	
	
	
	
Figure	5-16	Penetration	of	pDNA	into	the	shell	of	CC700	in	the	absence	of	fluorophore	during	incubation	
(addition	of	Syto-9	post	incubation	of	supports	with	pDNA).	
Left:	CLSM	emission	image	of	the	meridian	stack	of	a	CC700	support	excited	at	488	nm	(Syto	9	tagged	
pDNA)	
Right:	respective	light	micrograph	of	the	support	
	
	
Figure	5-17	Plasmid	concentration	in	supernatant	of	Sepharose	6	FF/	pDNA	suspension	over	time;	50	µL	of	
supports	incubated	with	1mL	of	pDNA	solution	(15	µg/mL),	OD260	measured	over	time	(left)	
Middle:	CLSM	image	of	Sepharose	6	FF	after	overnight	incubation	with	tagged	pDNA	(no	pDNA	binding	
detected)	
Right:	Respective	light	micrograph	of	support	
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5.3.4.	Cold	atmospheric	pressure	plasma	treatment	of	Capto	Core	700	to	eliminate	
remaining	surface	binding	sites		
The	SEC-AEC/	HIC	architecture	of	Capto	Core	700	has	proven	to	be	‘almost	perfect’,	i.e.	the	
outer	layer	of	the	supports	is	inert,	surrounding	an	AIC/	HIC	core.	
However,	when	 incubated	with	pDNA	 (especially	 for	 longer	 incubation	periods)	 the	media	
does	bind	low	amounts	of	pDNA	(Figure	5-14).	
Light	microscopy	 image	analysis	 of	 chromatography	media	 indicated	 that	 chromatography	
supports	based	on	Capto	base	matrix	were	in	terms	of	sphericity,	lacking	in	imperfections	and	
monodispersity	 the	 best	 base	 matrix	 for	 cold	 atmospheric	 pressure	 plasma	 treatment	 to	
eliminate	surface	binding	of	AEC	media.	
To	 investigate	 whether	 the	 remaining	 pDNA	 binding	 sites	 of	 CC	 700	 can	 be	 eliminated/	
reduced,	 CC700	 support	 samples	were	 treated	 in	 the	 FBR	 as	 described	 in	 2.3.5	 using	 the	
parameters	listed	in	Table	5-2.	
Table	5-2	Plasma	parameters	for	Capto	Core	700	plasma	treatment	
Power	input	
[W]	
SBV	of	supports	
[mL]	
Treatment	
time	[min]	
Frequency	
[kHz]	
Gas	
composition		
Gas	flow	Rate	
[L/min]	
7	 0.5	 10	 12.5	 helium	CP	
grade	
0.75	
9	 0.5	 10	 12.5	 helium	CP	
grade	
0.75	
	
In	previous	experiments,	it	was	observed	that	the	incubation	time	of	CC700	for	static	binding	
studies	had	an	impact	on	the	amount	of	pDNA	bound	to	supports;	static	binding	studies	post	
plasma	 treatment	 were	 conducted	 for	 30	 min	 and	 120	 min	 incubation	 time	 with	 pDNA	
solution	(1	mL;	15	µg/mL).	
Incubation	 of	 CC700	 with	 pDNA	 solutions	 in	 static	 binding	 studies	 for	 30	 min	 (binding	
4.15	 µgpDNA/mLSBV)	 yielded	 a	 binding	 capacity	 of	 around	 half	 cf.	 incubation	 for	 120	 min	
(8.4	µgpDNA/mLSBV),	confirming	the	role	of	incubation	time.	
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Cold	atmospheric	pressure	plasma	treatment	of	CC700	supports	was	able	 to	 reduce	pDNA	
binding	capacities	of	supports	in	static	binding	studies	(Figure	5-18).	For	the	samples	treated	
at	7	W,	binding	was	reduced	by	4%	and	6.5%	for	30	min	and	120	min	incubation,	respectively.	
For	higher	power	treatment	(9	W)	a	similar	reduction	was	observed	with	4%	reduction	for	
30	min	incubation	and	7.7%	reduction	for	120	min.	
Although	plasma	etching	and	oxidation	reduced	the	binding	capacity	of	CC700	in	all	samples,	
the	overall	reductions	are	lower	than	seen	previously	with	other	base	matrices/ligands.	The	
reason	for	these	low	reduction	levels	may	be	that	the	high	reactivity	of	ROS	limits	their	efficacy	
when	treating	supports	with	very	few	(remaining)	binding	sites	on	the	surface	of	the	beads	
(maximum	binding	capacity	of	untreated	control	CC700	was	8.4	µgpDNA/mLSBV	in	comparison	
to	Q	Seph	FF	with	~300	µgpDNA/mLSBV).	Treatment	of	support	samples	with	high	ligand	density	
on	the	surface	requires	plasma	species	to	get	to	the	proximity	of	a	bead	in	order	to	find	a	
reaction	partner,	while	treating	support	particles	with	few	remaining	scattered	ligands	on	the	
surface	 are	 statistically	 less	 likely	 to	 be	 ‘found’	 by	 the	 plasma	 radicals	 within	 their	 short	
lifetime.	So,	although	specific,	the	reaction	is	sterically	hindered	by	the	availability	of	suitable	
reaction	partners.		
Figure	5-18	Reduction	of	static	pDNA	binding	capacity	of	Capto	Core	700	plasma	treated	chromatography	
supports	(0.5	mL	SBV;	10	min;	750	mL/min	helium	CP	grade;	12.5	kHz)	
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For	both	power	levels,	samples	incubated	for	120	min	show	higher	losses	of	pDNA	binding	
than	 the	 30	min	 samples.	 Longer	 incubation	 times	 lead	 to	 reorientation	 of	 pDNA	 on	 the	
surface	(Diogo	et	al.,	2005),	accommodating	further	molecules	to	adsorb	to	a	binding	region	
on	the	surface	of	a	support.	This	effect	was	reduced	by	plasma	etching	suggesting	that	the	
limited	binding	sites	have	been	etched,	so	longer	incubation	times	do	not	lend	themselves	to	
higher	pDNA	binding	(anymore).	
CC700	has	shown	to	have	very	few	binding	sites	for	pDNA	to	adsorb	on	its	surface.	However,	
the	few	remaining	ligands	lead	to	losses	when	using	the	media	for	pDNA	purification.	
Cold	atmospheric	pressure	plasma	etching	and	oxidation	treatment	of	CC700	supports	has	
been	demonstrated	to	reduce	the	(limited)	pDNA	binding	further	by	up	to	7.7%.	Depending	
upon	 the	scale	of	operation,	a	plasma	treatment	of	 the	media	prior	 to	 its	use	 in	DSP	may	
reduce	the	overall	costs	associated	to	the	unit	operation,	where	loosing	less	product	due	to	
undesired	 binding	 to	 the	 supports	 is	 only	 one	 of	 the	 advantages;	 CIP	 regimes	 need	 to	 be	
applied	 less	 often	 as	 column	 fouling	 becomes	 less	 of	 an	 issue,	 reducing	 ‘dead	 time’	 in	
purification	facilities	during	cleaning	procedures.	
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5.4.	Conclusion	and	suggested	future	work		
The	structure	and	working	method	of	CC700	make	the	media	ideal	for	purification	of	 large	
pDNA	molecules	directly	from	crude	cell	lysates	via	negative	adsorption	chromatography.	
Loading	80	mL	of	cleared	lysate,	containing	the	26.88	kbp	plasmid	IT14:	pPR322-p170	onto	a	
1	mL	 chromatography	 column	packed	with	 the	 SEC-MMC	bilayered	 chromatography	 resin	
yielded	no	breakthrough	of	RNA/	HCP	in	the	flow	through	fractions,	despite	the	overall	low	
binding	 capacity	of	 the	media	 (around	30	mgBSA/mLSBV).	With	minor	amounts	of	pDNA	co-
eluted/	stripped	from	the	column	alongside	captured	impurities,	the	media	performed	well	as	
a	first	capture	step	for	pDNA	from	crude	E.	coli	feedstocks	in	frontal	loading	chromatographic	
operations.	
Light	micrographs	of	beaded	supports	stained	with	negatively	charged	dye	CR	illustrate	the	
bilayered	topology	of	CC700,	where	the	stained	core	is	surrounded	by	a	clearly	defined	shell	
of	5-15	µm	and	its	narrow	PSD	suggests	a	careful	crafting	of	the	agarose	beads,	followed	by	
several	sieving	regimes.		
Plasmid	DNA	was	found	to	bind	to	the	‘inert’	surface	in	static	binding	studies,	especially	after	
long	contact	times	with	the	resin	(>2	h).	CLSM	analysis	of	the	binding	topography	of	single	
supports,	using	labelled	pDNA	and	BSA	confirmed	the	presence	of	pDNA	on	the	surface	of	the	
media.	 Monitoring	 pDNA	 accumulation	 over	 time	 yielded	 significant	 adsorption,	 with	
160	µgpDNA/mLSBV	after	overnight	incubation	of	CC700	with	a	load	of	300	µgpDNA/mLSBV	in	static	
binding	studies.	
Applying	a	gentle	cold	atmospheric	pressure	helium	plasma	treatment	(9	W;	14.5	kHz;	10	min	
treatment	time)	 in	a	FBR	was	able	to	reduce	the	pDNA	binding	capacity	of	CC700	by	up	to	
7.7%	in	static	binding	studies.	The	use	of	plasma	etching	and	oxidation	technology	for	altering	
the	surface	properties	of	chromatography	resins,	could	provide	a	simple	add-on	treatment	to	
reduce	(remaining)	surface	binding	ligands.	
Overall,	 pDNA	 binding	 is	 very	 minimal	 for	 short	 contact	 times	 in	 frontal	 loading	
chromatography,	making	the	use	of	CC700	a	considerable	option	for	capturing	pDNA	products	
directly	from	crude	cell	lysates,	when	operating	at	higher	flow	rates.	
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Chapter	6 Concluding	remarks	and	future	work	
Attempts	to	improve	and	control	human	life	have	fascinated	medical	scientists	through	the	
ages.	To	date,	only	a	limited	number	of	gene	therapies	have	been	approved	by	authorities	for	
the	treatment	of	human	diseases.	
Recent	 advances	 in	 gene	 therapy,	 however,	 have	 opened	 a	 door	 that	 could	 not	 only	
permanently	influence	the	way	we	think,	but	ultimately	who	we	as	humans	are.	We	may	have	
already	entered	the	age	where	human	genetic	augmentation	is	reality	and	even	if	it	still	may	
be	a	young	 field	of	 scientific	 interest,	 the	opportunities	as	well	 as	potential	 consequences	
develop	at	a	very	quick	pace.	
Facing	ethical	questions	associated	 to	gene	 therapy,	especially	 in	non-somatic	 cells,	which	
would	allow	genetic	alterations	to	be	passed	on	to	future	generations	will	become	crucially	
important.	Scientific	interest	deserves	moral	guidance	provided	by	authorities	and	should	not	
be	left	to	companies	or	individuals	to	drive	the	speed	of	innovation.	
Technical	questions	associated	to	the	production	of	pDNA	products	to	satisfy	future	market	
needs	requiring	large	scale	production	facilities	can,	however,	already	be	addressed	today.		
While	new	purification	strategies	are	being	developed,	the	use	of	packed	bed	chromatography	
is	still	the	method	of	choice	to	face	separation	challenges.	
Most	chromatographic	media	for	the	purification	of	biotherapuetic	products	have,	however,	
been	 designed	 for	 protein	 based	 products.	 Due	 to	 the	 porous	 structure	 of	 classical	 AEC	
adsorbents,	 pDNA	 binding	 is	 restricted	 to	 the	 supports’	 surface,	 resulting	 in	 poor	 column	
binding	capacities.	
Combining	two	DSP	unit	operations	in	size	exclusion	and	anion	exchange	chromatography	in	
a	 single	 chromatographic	 operation,	 using	 bilayered	 supports	 with	 a	 non-adsorptive,	 size	
selective	shell,	surrounding	a	charged	core,	has	been	shown	to	provide	significant	advantages	
for	chromatographic	separation	of	pDNA	from	chemically	similar,	but	smaller	contaminants	
from	crude	lysates.		
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The	 feasibility	 to	 prepare	 multifunctional	 bilayered	 SEC-AEC	 materials	 from	 commercially	
available	 AEC	 media	 in	 a	 ‘top-down’	 approach	 by	 applying	 plasma	 etching	 and	 oxidation	
treatments	to	soft	hydrogel	support	surfaces	was	investigated.	
The	oxidative	potential	of	 cold	atmospheric	pressure	plasmas	was	used	 to	 selectively	etch	
away	binding	ligands	off	the	surface	of	commercial	AEC	adsorbents.	Plasma	treatments	in	a	
parallel	plate	DBD	set-up	with	helium	as	carrier	gas,	have	led	to	reductions	of	up	to	85%	pDNA	
binding	capacity	with	SI	values	of	up	to	5.		
Cold	atmospheric	pressure	plasma	treatment	of	AEC	supports	in	a	FBR	set-up	have	shown	to	
reduce	surface	over	core	binding	capacity,	with	SI	values	up	to	3.	
ESEM	 images	 of	 plasma	 treated	 supports	 yielded	 that,	 unlike	 previously	 reported,	 cold	
atmospheric	pressure	plasma	 treatment	 is	 a	gentle	method,	 that	does	not	alter	 the	visual	
appearance	of	chromatographic	supports	during	treatment.	
	Although	 plasma	 technologies	 are	 known	 to	 act	 at	 the	 nanoscale,	 the	 presented	 results	
suggest	that	effective	penetration	depths	can	run	to	several	microns	when	applied	to	porous	
chromatography	materials.	
Applying	CLSM	analysis	to	simultaneously	visualise	the	binding	topography	of	BSA	and	pDNA,	
adsorbed	 to	 chromatography	 adsorbents,	 revealed	 limitations	 of	 the	 plasma	 etching	 and	
oxidation	technique	due	to	the	presence	of	irregularities	on	the	surface	of	single	adsorbents.	
	
Preparations	 of	 bilayered	 supports	 produced	 via	 ‘bottom-up’	 approach	 of	 AGE	 activation-	
partial	bromination,	controlled	by	viscosity	enhanced	reaction-diffusion	balancing,	led	to	the	
creation	of	‘nice’	supports	in	previous	studies.		
However,	 independent	 of	 associated	 parameters,	 all	 support	 preparations	 resulted	 in	
supports	with	a	minimum	20%	residual	pDNA	binding	capacity,	which	could	not	be	explained.	
Investigation	 of	 the	 binding	 topography	 of	 pDNA	 and	 BSA	 to	 bilayered	 supports	 in	 CLSM,	
revealed	that	 imperfections,	as	part	of	the	overall	sample	population	offer	binding	sites	at	
particles’	surfaces.	
Quantification	of	the	phenomena	via	analysis	of	light	micrographs,	revealed	a	heavy	reliance	
on	structural	integrity	of	the	starting	media.	Minor	structural	surface	flaws	were	found	to	not	
contribute	to	residual	pDNA	binding	of	the	media	as	they	can	be	overcome	by	the	creation	of	
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the	ligand-free	zone,	deep	fissures	and	other	disfigurations	resulting	from	the	manufacturing	
process	account	for	residual	pDNA	binding.	
Implementing	the	findings	by	selecting	a	more	suitable	base	matrix	consequently	yielded	SI	
values	>300,	corresponding	to	a	99%	clearance	of	pDNA	binding	at	the	expense	of	only	4.3%	
loss	of	BSA	binding	capacity.	
	
The	 commercial	 bilayered	media	 Capto	 Core	 700	was	 successfully	 implemented	 as	 a	 first	
capture	step	for	purifying	a	26.88	kbp	plasmid	from	cleared	E.	coli	lysate,	with	column	binding	
capacity	>80	mL/mLSBV	before	breakthrough.		
Although	 the	 media	 performed	 well	 in	 frontal	 loading	 chromatography	 operations,	 static	
binding	 studies	 revealed	 that	pDNA	 to	bind	 to	 remaining	octylamine	 ligands	on	 the	 ‘inert’	
surface	of	adsorbents,	especially	after	longer	incubation	times.	
These	 observations	were	 confirmed	 by	 CLSM	 analysis	 of	 the	 binding	 topography	 of	 single	
supports,	using	Syto	9	and	Cy5	as	fluorescent	markers	for	pDNA	and	BSA,	respectively.	
By	applying	a	gentle	cold	atmospheric	pressure	plasma	treatment	using	He-O2	as	a	carrier	gas	
in	 a	 FBR	 set-up,	 the	 pDNA	 binding	 to	 Capto	 Core	 700	 was	 reduced	 further	 by	 up	 7.7%,	
providing	 a	 simple	 and	 inexpensive	 add-on	 treatment	 to	 reduce	 residual	 surface	 binding	
ligands	of	the	media.	
	
	 	
	 -	208	-	
For	future	continuation	of	work	 in	the	field	outlined	in	this	thesis,	the	following	points	are	
suggested	for	consideration:	
	
While	 exploring	 the	main	 parameters,	 associated	 with	 cold	 atmospheric	 pressure	 plasma	
treatments	 for	 the	 selective	 alteration	 of	 surface	 properties	 of	 beaded	 chromatography	
support	samples	yielded	valuable	insights	as	to	how	the	ROS	interact	with	ligand	structures	
on	the	surfaces	of	soft	hydrogel	chromatography	supports,	 further	parameters	need	to	be	
investigated.	 By	 further	 optimising	 the	 parameters	 of	 cold	 atmospheric	 pressure	 plasma	
treatments	to	selectively	reduce	surface	over	core	binding	capacity,	a	boost	in	efficacy	of	the	
treatments	is	to	be	expected.		
In	the	dye	decolourization	studies,	the	use	of	pure	(cp	grade)	helium	as	a	carrier	gas	has	shown	
even	 more	 promising	 reduction	 levels	 than	 the	 recommended	 admixture	 found	 in	 the	
literature.	
With	surface	 imperfections	creating	difficult	 to	reach	areas	for	ROS	hampering	the	etching	
and	oxidation	of	surface	ligands,	more	care	should	be	taken	when	choosing	the	AEC	starting	
media.	Light	microscopic	image	analysis	has	proven	to	be	a	suitable	tool	for	evaluating	batches	
prior	to	cold	atmospheric	pressure	plasma	treatment.	
As	nanoplex	of	choice	throughout	this	study,	pDNA	was	used.	Due	to	its	structural	properties,	
having	a	high	charge	density,	small	residual	‘binding-islands’	are	enough	to	retain	the	large	
molecules,	especially	when	granting	enough	time	for	reorientation	(like	i.e.	in	static	binding	
studies).	 By	 investigating	 further	 nanoplexes	with	 lower	 charge	 densities,	 bilayered	media	
produced	following	the	outlined	process,	may	be	more	suited	cf.	its	pDNA	counterpart.	
With	new	bilayered	media	entering	the	commercial	market,	potential	residual	pDNA	binding	
needs	to	be	investigated	prior	to	application	of	the	media	for	pDNA	purification.	The	use	of	
Capto	Core	700	as	an	initial	capture	step	for	purification	of	pDNA	indicated	pDNA	binding	to	
the	 commercial	 SEC-AEC	 supports.	 Although	 at	 this	 stage	 it	 seems	 unlikely	 that	 a	 full	
elimination	of	 surface	binding	 can	be	achieved	by	means	of	plasma	etching	and	oxidation	
alone,	the	technique	holds	great	promise	as	an	add-on	treatment	targeting	residual	surface	
ligands	on	bilayered	beads	manufactured	via	different	approaches.		
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The	use	of	more	suitable	starting	media	for	the	manufacturing	of	bilayered	supports	following	
the	 VE-RDB	 approach	 has	 shown	 to	 provide	 significant	 selectivities	 of	 surface	 over	 core	
binding	reduction.	Without	the	necessity	to	‘cover	up’	imperfections	on	supports	surfaces,	the	
thickness	of	the	cleared	layer	should	be	considered.	An	estimated	layer	thickness	of	5	µm	is	
expected	to	compromise	very	little	on	core	binding	capacity,	while	the	non-adsorptive	layer	is	
thick	enough	to	prevent	binding	of	large	nanoplex	products.	
In	order	 to	 reduce	 the	 loss	of	 core	binding	capacity	even	 further,	 the	use	of	big	bead	SEC	
starting	media,	 available	 from	various	 suppliers	 should	be	 considered,	 as	 layers	of	 several	
micrometres	devoid	of	ligands	have	less	of	an	impact	on	core	binding	due	to	the	beneficial	
surface	to	volume	ratio	in	spheres	with	larger	diameters.		
In	addition	to	the	points	outlined	above,	a	piece	of	advice	related	to	handling	small	quantities	
of	 beaded	 chromatography	 media	 (i.e.	 for	 static	 binding	 studies);	 when	 pipetting	 small	
volumes	of	SBV	supports	it	is	highly	advised	to	prepare	10x	suspensions	using	large	pipettes.	
Around	the	nozzle	of	the	pipette,	liquid	drag	on	the	particles	can	lead	to	over-/under	pipetting,	
so	in	order	to	grant	equal	sample	sizes,	slow	liquid	ejection	is	crucial	while	preventing	bead	
settling	within	the	pipette	tip.	
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Appendix	
A	1.	Bacterial	growth	curve	of	E.	coli	(DH5a)	containing	plasmid	IT14:	pPR322-p170	
The	 production	 of	 plasmid	 containing	 cells	 was	 conducted	 as	 described	 in	 2.3.2.	 The	
fermentation	was	 terminated	 after	 the	 cells	 had	 reached	 the	 late	 exponential	 stage	 (final	
OD600	8.55).	
The	overall	yield	was	65	g	wet	cell	paste	or	16.25	g/Lmedium.	
	
A	2.	Calibration	standard	curve	for	fluorometric	pDNA	quantification		
	
	 	
	
Figure	A-1	Growth	curve	of	DH5a	E.	coli	containing	plasmid	IT14:	pPR322-p170	batch	fermentation	for	the	
production	of	pDNA	solution	for	binding	studies	as	well	as	frontal	loading	chromatography	experiments	
	
	
Figure	A-2	Standard	curve	of	ct	DNA	tagged	with	Hoechst	dye	33258	and	analysed	as	described	in	2.3.8.2	
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A	3.	Plasmid	map	of	pBR322-P170	
	
	
Figure	A-3:	Plasmid	Map	of	pBR322-P170	containing	a	hok/sok	sequence	(579bp),	a	tetracycline	efflux	protein	
conferring	Tetracycline	resistance	(900	bp),	a	rop	sequence	encoding	for	the	rop	protein,	which	maintains	the	
plasmid	at	low	copy	numbers	(192	bp),	a	pBR322	basis	of	mobility	region	(bom,	141	bp),	a	high-copy-number	
ColE1/	pMB1/	pBR322/	pUC	origin	of	replication	(ori,	589	bp),	and	an	Ampicillin	resistance	cassette	consisting	
of	the	β-Lactamase	gene	(AmpR,	861	bp)	under	control	of	the	AmpR-promoter	(105	bp).	The	C1G-insert	
comprises	a	BamH1	inserted	22118	bp	stretch	from	the	Saccharomyces	Cerevisiae	chromosome	III	
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A	4.	Supplementary	data	of	TOF-SIMS	experiments	
Figures	 A-4	 to	 A-6	 comprise	 of	 supplementary	 data	 collected	 during	 TOF-SIMS	 analysis	 of	
plasma	 treated	 Q	 Sepharose	 FF.	 All	 figures	 are	 referenced	 in	 their	 respective	 sections	 in	
3.3.2.17.		
	
	
Figure	A-4:	Positive	(top)	and	negative	(bottom)	TOF-SIMS	spectra	of	carbontape	background	
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Figure	A-5:	Negative	TOF-SIMS	spectra	of	Sepharose	6	FF	(top),	Q	Sepharose	FF	plasma	etched	with	He-O2	
(99.5-0.5%	v/v)	(middle)	and	pure	Oxygen	(bottom)	plasma	(see	3.3.2.17.	for	details)		
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Figure	A-6:	Positive	TOF-SIMS	spectra	of	Q	Sepharose	FF	treated	with	He-	O2	gas	(99.5%-	0.5%)	plasma	
(20	V;	150	s;	12.5%	SBV);	analysis	area	of	50	x	50	µm	(top)	and	100	x	100	µm	(bottom)	
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A	5.	Decomposition	of	azo	dye	solutions	in	FBR	
Initial	 scouting	experiments	 for	parameters	of	 the	FBR	were	conducted	by	plasma	treating	
aqueous	azo-dye	solutions	(MO	and	CR).	Although	not	directly	transferable	to	the	etching	and	
oxidation	of	soft	gel	chromatography	supports,	it	yielded	valuable	insights	into	the	efficacy	of	
the	generated	ROS.	
Figure	A-7	depicts	the	native	spectra	of	CR	and	MO	in	aqueous	solution.	The	spectra	are	stable	
over	time,	with	no	alteration	detectable	after	10	days.	
Plasma	treating	MQW	(followed	by	immediate	mixing	of	the	‘ROS	solution’	with	MO	solution)	
was	not	able	to	generate	a	‘ROS	solution’	able	to	alter	the	absorbance	spectrum	of	MO	(Figure	
A-8).		
Applying	cold	atmospheric	pressure	plasma	generated	from	pure	helium	gas	to	MO	solutions	
(20	 µg/mL)	 revealed	 that	 longer	 treatment	 times	 lead	 ultimately	 to	 the	 largest	 peak	
reductions	over	time	(Figure	A-9).	A	treatment	time	of	10	min	let	to	full	decolourisation	of	the	
solution	after	5	days.		
Applying	He-O2	admixed	gas	plasmas	(99.5%-0.5%)	led	to	similar	trends	with	overall	slightly	
reduced	decolourisation	efficacies	 in	comparison	to	the	samples	treated	with	plasma	using	
pure	helium	as	a	carrier	gas	(Figure	A-10).	
Even	after	5	days	incubation	post	plasma	treatment	using	pure	oxygen	gas	plasmas,	none	of	
the	MO	absorbance	spectra	showed	any	effect,	concluding	that	plasmas	generated	from	pure	
oxygen	gas	are	unable	to	provide	ROS	necessary	for	decolouring	MO	(Figure	A-11).	
Figures	 A-12	 to	 A-14	 depict	 the	 changes	 cold	 atmospheric	 pressure	 plasmas	 have	 on	 CR	
solutions	using	the	same	parameters	and	experimental	set-up	as	for	MO	solutions.	All	trends	
observed	with	the	MO	spectra	repeat	itself	in	the	CR	solutions.	
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Figure	A-7:	Absorbance	spectra	of	azo	dye	solutions	of	CR	(top)	and	MO	(bottom),	initial	(blue	line)	and	
after	10	days	(black	line);	absorbance	corrected	by	background	spectra	of	MQW	in	quartz	cuvette	(red	line)	
	
Figure	A-8:	Peak	absorbance	of	MO	solution	after	contact	with	pure	gas	plasma	treated	MQW	(5	min	
treatment	time);	oxygen	7	W	(solid	line),	10	W	(dashed	line);	7	W	Helium	(dotted	line)	
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Figure	A-9:	Time	resolved	effects	of	cold	atmospheric	pressure	helium	plasma	treatment	of	MO	solution	
(20	µg/mL)	for	different	plasma	treatment	times	(top:	1	min;	middle:	5	min;	bottom:	10	min)	
Spectrum	of	MO	(UV-visible),	pre-plasma	treatment	(blue	line);	immediately	after	the	plasma	treatment	
(solid	line);	after	1	h	(dashed	line);	after	24	h	(dash-dotted	line);	after	5	days	(dotted	line)	
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Figure	A-10:	Time	resolved	effects	of	cold	atmospheric	pressure	He-O2	(99.5%-0.5%	v/v)	plasma	treatment	
of	MO	solution	(20	µg/	mL)	for	different	plasma	treatment	times	(top:	1	min;	middle:	5	min;	bottom:	
10	min)	
Spectrum	of	MO	(UV-visible),	pre-plasma	treatment	(blue	line);	immediately	after	the	plasma	treatment	
(solid	line);	after	1	h	(dashed	line);	after	24	h	(dash-dotted	line);	after	5	days	(dotted	line)	
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Figure	A-11:	Time	resolved	effects	of	cold	atmospheric	pressure	oxygen	plasma	treatment	of	MO	solution	
(20	µg/mL)	for	different	plasma	treatment	times	(top:	1	min;	middle:	5	min;	bottom:	10	min)	
Spectrum	of	MO	(UV-visible),	pre-plasma	treatment	(blue	line);	immediately	after	the	plasma	treatment	
(solid	line);	after	1	h	(dashed	line);	after	24	h	(dash-dotted	line);	after	5	days	(dotted	line)	
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Figure	A-12:	Time	resolved	effects	of	cold	atmospheric	pressure	helium	plasma	treatment	of	CR	solution	
(1.073e-5	mol/L)	for	different	plasma	treatment	times	(top:	1	min;	middle:	5	min;	bottom:	10	min)	
Spectrum	of	CR	(UV-visible),	pre-plasma	treatment	(blue	line);	immediately	after	the	plasma	treatment	
(solid	line);	after	1	h	(dashed	line);	after	24	h	(dash-dotted	line);	after	5	days	(dotted	line)	
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Figure	A-13:	Time	resolved	effects	of	cold	atmospheric	pressure	He-O2	(99.5%-0.5%	v/v)	plasma	treatment	
of	CR	solution	(1.073e-5	mol/L)	for	different	plasma	treatment	times	(top:	1	min;	middle:	5	min;	bottom:	
10	min)	
Spectrum	of	CR	(UV-visible),	pre-plasma	treatment	(blue	line);	immediately	after	the	plasma	treatment	
(solid	line);	after	1	h	(dashed	line);	after	24	h	(dash-dotted	line);	after	5	days	(dotted	line)	
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Figure	A-14:	Time	resolved	effects	of	cold	atmospheric	pressure	oxygen	plasma	treatment	of	CR	solution	
(1.073e-5	mol/L)	for	different	plasma	treatment	times	(top:	1	min;	middle:	5	min;	bottom:	10	min)	
Spectrum	of	CR	(UV-visible),	pre-plasma	treatment	(blue	line);	immediately	after	the	plasma	treatment	
(solid	line);	after	1	h	(dashed	line);	after	24	h	(dash-dotted	line);	after	5	days	(dotted	line)	
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A	6.	Protein	binding	isotherm	of	CC700	
	
	
	
Figure	A-15:	BSA	binding	isotherm	of	CC700	
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